Tun yaushe ne ka fuskanci irin wannan bayyanar?
kuma kullum dole ne a bi da ciwon kirji ta wannan hanyar, musamman a shekarunta
kuma zazzabi
kuma dole ne a lura da yawan cholesterol da kuma karfin jini
kuma yana da zazzabi yanzu?
kuma kuna jin wannan ciwon kirji yanzu?
kuma yana da wahalar numfashi
kuma za ka iya gaya mini wasu alamun da kake da shi banda wannan?
da kuma yawan zafin jiki da ta samu
kuma ina da tari
kuma ina da wani sanyi da kuma tari
kuma a yau ina da ciwon kirji mai tsanani
Kuma wannan lokaci ne da ya dace da rashin lafiyarku ga man fetur
Kuma akwai ciwon kirji
kuma ina ganin ina da zazzabi kadan
kuma ina so ka bayyana inda kake jin ciwon kirji
kuma suna da zazzabi kuma
da kuma tarihin ciwon sukari
kuma ka sani, ina jin kamar kirjina na na karye
kuma ka sani, mutane suna tari a kaina a duk lokacin
kuma yana jin zafi a kirji
kuma ya ce yana da matsa lamba a kirji
wani a cikin iyalin yana da matsalar zuciya, cututtukan zuciya, bugun zuciya, yawan cholesterol, hauhawar jini
wani alama ko matsala da ka lura da ita banda ciwon tsoka?
Shin akwai wasu marasa lafiya kamar ku da ke da irin wannan alamun a gidanku?
Shin akwai wasu alamun cutar?
Shin akwai wani rashin numfashi?
Har yanzu yana jin zafi a kirji
Domin wannan lokacin na mura ne
Amma kuma, bai kamata su yi watsi da mu ba saboda ciwon kirji na zuciya.
Amma yanzu wani abu mafi muhimmanci shi ne ciwon kirji
amma ina da wahalar numfashi
amma na san mutane da yawa suna tari a kaina
Amma dole ne mu bi da ciwon kirji da tsanani
amma yanzu kana numfashi sosai, ko ba haka ba?
Na manta da shi gaba daya saboda wannan ciwon kirji
Yana jin kamar wani ya fasa kirjinka
Har yanzu yana jin kamar rashin iska
Shin suna gunaguni cewa suna da irin wannan rashin lafiya?
shin kana da wata cuta mai tsanani, kamar hauhawar jini ko wani abu makamancin haka?
kuna da wata cuta, wata cuta ta kullum, kamar ciwon sukari?
Shin kuna da rashin numfashi a cikin ƙirjinku?
Shin tana da karfin jini?
Shin kana da wasu lokuta na rashin numfashi tare da wannan?
Ka san alamun da ke damunsa?
Ka ga hoton?
sha ruwa mai yawa a yau
Duk da haka, ina yin gwajin ciwon sukari.
Duk da haka, yana da alamun da suka yi kama da na kaina.
Yaya yawan zafin jikinsa yake?
Yaya karfin jini yake?
idan kuna da zazzabi mai zafi
idan kuna da zazzabi na digiri ɗari biyu ko fiye
idan kuna ganin alamunku ko matsalolinku sun sa a yi muku bincike mafi kyau
Na ji zazzabi a jiya
Na kuma yi zazzabi kadan
Na yi zazzabi jiya
Ina da ciwo mai tsanani a nan, a cikin kirji
Ina da wahalar numfashi kuma
Zan aiko maka da hoto
yau ina da ciwon kirji kadan
yau kawai ina da ɗan ciwon kai da kuma zazzabi
A ganina, wannan shi ne mura.
A ganina, yana da ɗan mura.
kamar wani mai nauyi ne sosai yana zaune a kirjinsa?
Ya fara ne da ciwon kai da zazzabi a lokaci guda
ciwon tsakiyar kirji na ciwo
Wannan matsin lamba ne kamar ciwon kirji
Yana cikin kirji na
Yana tsakiyar ƙirjina
Yana tsakiyar kirji
Ina jin zafi a kirji
Ina matukar damuwa da wannan ciwon kirji
Ina so ka gaya mini yadda za ka kwatanta wannan ciwon kirji
kamar hawan jini ko ciwon sukari
kamar a tsakiyar kirji
Yanzu zaka iya shan takardar Tachipirin don zazzabi
Yanzu, Mary, kwana nawa ne ka samu alamun
Yanzu ya ce yana da ciwon kirji
Wani lokaci ina jin zafi a kirji.
To, akwai wata alama a gare ta ban da wannan, ba kawai ciwo ba.
Ko kuma wani da yake zaune a kirjinsa?
daidai, tare da zazzabi da tari, ciwon kai da ciwon tsoka
A tsakiyar kirji
Ka nuna min a wannan hoton inda kake jin zafi
tun lokacin da yake da zazzabi
To, kuna ganin wasu daga cikin wadannan cututtukan na iya danganta da ciki?
Shin yaranku suna da irin wadannan cututtukan?
Ka gaya mani game da ciwon kirjinka
zafin jiki ya fi girma da dare
zazzabin da na sha a cikin kwanaki biyu da suka gabata
zazzabin ya fara daukaka a daren jiya
Wannan shi ne Dr. Porter a cibiyar bincike ta gaggawa.
To, za ka iya gaya mini game da ciwon kirjinka?
Na ji zafi a gaba na jiki, a nan a kirji.
Na ji zafi sosai a kirji.
To, a lokacin da nake da wannan ciwon kirji
wane irin ciwo kake da shi a kirji?
A yaushe ne wannan ciwon kirji ya fara?
inda kake jin zafi a kirji?
{NS}
Yana jin kamar zalunci a kirji
ka san ina da ciwon sukari da sauransu
ya ce yana jin wannan ciwon kirji
Yawan kamuwa da cutar coronavirus (COVID-19) a cikin Tarayyar Turai ko Yankin Tattalin Arzikin Turai da Burtaniya, daga 1 ga Janairu zuwa 15 ga Maris, 2020
Yawan kamuwa da cutar coronavirus (COVID-19) ya nuna irin wannan yanayin a kasashen Tarayyar Turai ko Yankin Tattalin Arzikin Turai da Burtaniya, wanda ya tabbatar da cewa, ko da yake a matakai daban-daban dangane da ƙasar, cutar COVID-19 tana ci gaba da sauri a duk ƙasashe.
Bisa ga kwarewar Italiya, ƙasashe, asibitoci da wuraren kulawa mai tsanani suna buƙatar haɓaka shirye-shiryen su don raƙuman marasa lafiya na COVID-19 waɗanda zasu buƙaci kulawar likita, musamman kulawar gaggawa.
A ranar 31 ga Disamba, 2019, an samu rahoton wasu cututtukan cutar huhu da ba a san su ba a Wuhan, lardin Hubei, China.
A ranar 9 ga watan Janairun 2020, Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta kasar Sin ta ruwaito cewa mai haddasa cutar coronavirus ne wanda yanzu ake kira coronavirus 2 na cutar ta numfashi mai tsanani (SARS-CoV-2).
Tun daga wannan lokacin, cutar da kamuwa da cutar SARS-CoV-2 ta haifar an kira ta cutar coronavirus (COVID-19).
Bayanai sun nuna cewa kashi 80 cikin dari na mutanen da ke fama da cutar COVID-19 suna da wata cuta mai sauƙi, wato kamuwa da cutar numfashi tare da ko ba tare da cutar huhu ba, kuma yawancin suna warkewa.
A cikin kashi 14 cikin dari na shari'o'in, COVID-19 ya ci gaba zuwa wani mummunan cuta wanda ke buƙatar asibiti, yayin da sauran kashi 6 cikin dari na shari'o'in ke haɓaka mummunan cuta wanda ke buƙatar kulawa mai tsanani.
Mutuwar marasa lafiya da ke asibiti saboda COVID-19 ya kai kashi 4 cikin 100.
A cikin wannan binciken, mun bincika yanayin da ake samu na COVID-19 a kowace ƙasa ta Tarayyar Turai ko Ƙasar Tattalin Arzikin Turai (EU/EEA) da Burtaniya (UK) kuma mun kwatanta su da na lardin Hubei, China.
Mun kuma kwatanta adadin shari'o'in COVID-19 na yanzu a cikin ƙasashen EU/EEA da Burtaniya da na Italiya daga Janairu 31 zuwa Maris 15, 2020.
Kasashen EU/EEA da Birtaniya sun kamu da cutar COVID-19
Bayan China, COVID-19 ya ci gaba da yaduwa a fannin duniya kuma motsin cutar COVID-19 a sauran duniya a halin yanzu yana ci gaba da wannan ƙasar.
A ranar 11 ga Maris, 2020, babban darektan Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar 5 ga Maris na Eurosurveillance 2020, Spiteri et al. sun ba da rahoton farkon tabbatar da shari'o'in COVID-19 a Turai bisa ga ma'anar shari'ar WHO.
A cikin EU/EEA, an fara samun mutane uku da aka tabbatar da cutar a Faransa a ranar 24 ga Janairu, 2020, a cikin mutanen da suka dawo daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, an gano shari'o'in COVID-19 a cikin ƙasashen 30 na EU / EEA da Burtaniya (RU), bisa ga abin da tsakanin 31 ga Disamba na 2019 zuwa wannan ranar har ma, an yi rikodin shari'o'i 39 768 da mutuwar 1727, daga cikinsu 17 750 da mutuwar 1441 sun faru a Italiya kawai.
Samun adadin da aka samu da kuma yawan kamuwa da cutar COVID-19
A Cibiyar Kula da Cututtuka ta Turai (ECDC), ana sabunta ƙididdigar shari'o'in COVID-19 da aka ruwaito a kowace ƙasa a duniya, wanda aka samo daga tushen hukuma kawai, kamar Ma'aikatar Lafiya ta ƙasashe, hukumomin kiwon lafiya na ƙasa da na yanki da WHO, kowace rana a karfe 8:00 na safe.
An yi amfani da wannan bayanan ne don bincika yanayin COVID-19 a cikin EU/EEA da Burtaniya da kuma kwatanta su da na Italiya.
A matsayin mai nuna alamun yawan mutanen da ke kamuwa da cutar COVID-19, mun ƙididdige yawan adadin COVID-19 da aka yanke zuwa kwanaki 14; ta wannan hanyar, mun yi la'akari da yanayin COVID-19, a kowace ƙasa ta EU / EEA da Burtaniya, a lokacin Janairu 1 zuwa Maris 15, 2020.
Mun kuma gabatar da adadin adadin shari'o'in da aka ruwaito a kowace ƙasa zuwa 15 ga Maris, 2020, da karfe 8:00 na safe, idan aka kwatanta da na Italiya don lokacin 31 ga Janairu zuwa 15 ga Maris, 2020.
Yanayin COVID-19 a ƙasashen EU/EEA da Burtaniya
Yanayin da aka samu na kamuwa da cutar COVID-19 a cikin kwanaki 14 a cikin ƙasashen EU/EEA da Birtaniya gaba ɗaya, ya biyo bayan na lardin Hubei (China) (hoto na 1).
A cikin EU/EEA da UK gabaɗaya, cutar COVID-19 ta fara ƙaruwa a kusa da 21 ga Fabrairu sannan ta ƙaru sosai a kusa da 28 ga Fabrairu 2020 (ƙarin bayani).
Wannan ya kasance ne saboda saurin karuwar adadin shari'o'in da aka ruwaito daga Italiya, amma duk sauran ƙasashen EU/EEA da Burtaniya sun nuna abubuwan da suka faru na COVID-19 da suka faru (abubuwan da suka dace).
Hoton 2 ya nuna adadin adadin COVID-19 a cikin ƙasashen EU/EEA da Burtaniya, idan aka kwatanta da na Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Ya ce, a ranar 15 ga Maris da karfe 8:00 na safe, wasu ƙasashen EU/EEA da Birtaniya sun riga sun yi rikodin adadin adadin da ya yi daidai da na Italiya makonni 3 ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin shari'o'in COVID-19 da aka ruwaito suna ƙaruwa cikin sauri a cikin EU/EEA da Burtaniya.
Hanyoyin da aka lura a cikin yawan cutar COVID-19 sun nuna cewa annobar tana ci gaba da irin wannan saurin a duk ƙasashe.
Wannan haka yake duk da matakai daban-daban da kasashe ke ciki, bambance-bambance a cikin amsoshin lafiyar jama'a na ƙasa da, mai yiwuwa, ma'anar shari'a daban-daban a cikin ƙasashe da ladabi daban-daban don zaɓar marasa lafiya waɗanda dole ne su shiga gwajin don tabbatar da COVID-19, gami da jinkirin gwaji.
A farkon watan Maris na shekarar 2020, likitoci a yankunan da cutar ta shafa a Italiya sun bayyana halin da ake ciki inda kashi 10 cikin dari na marasa lafiya da ke fama da COVID-19 ke bukatar kulawa mai tsanani, kuma kafofin watsa labarai sun ruwaito cewa asibitoci da wuraren kula da gaggawa a waɗannan yankuna sun riga sun kai iyakar ƙarfin su.
Bayanai game da shigar da COVID-19 a asibiti ko cibiyar kulawa mai tsanani a halin yanzu suna samuwa a EU/EEA don kashi 6 cikin 100 da 1 cikin 100 na shari'o'in, bi da bi (ba a nuna bayanan ba).
Duk da haka, ya kamata a tattara su a cikin tsari don ƙarin bayanan kulawa na yanzu wanda ke mai da hankali kan yawan shari'o'in da aka bayar da rahoto da yawan mutuwar.
Wani bincike da aka yi a shekara ta 201011 ya nuna cewa akwai babban canji a yawan gado na kulawa mai tsanani da kuma na matsakaici a Turai, daga 29.2 a Jamus zuwa 4.2 a cikin mazauna 100 000 a Portugal.
Wannan yana nufin cewa ƙasashe za su iya samun albarkatu fiye da Italiya (wurin yin barci na gaggawa da kuma na matsakaici a kowace mutane 100,000 a 201011).
An ba da misali na yanayin cikawar iyawar kula da lafiya, tare da ƙididdiga ga kowace ƙasa ta EU/EEA da Burtaniya na yawan cututtukan asibiti na COVID-19 da ke da alaƙa da haɗarin >90% na ƙaruwa a cikin ƙarfin gado na kulawa mai tsanani, a cikin sabuntawa ta shida na ECDC na COVID-19 saurin kimantawa.
Tun da yake har yanzu an sami tarin shari'o'i a wasu yankuna na EU/EEA da na UK, kuma asibitoci da wuraren kulawa da gaggawa suna kula da yawan mutanen da aka tsara a yankin, ya kamata a samar da bayanai game da shari'o'i da wuraren kula da gaggawa a matakin Nomenclature na Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigar Ƙididdigarƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙ
Kwarewar Italiya da abubuwan da ke faruwa a yanzu a wasu ƙasashe sun nuna cewa annobar COVID-19 tana ci gaba da sauri a cikin EU / EEA da Burtaniya.
Saboda haka, dole ne kasashe, asibitoci da wuraren kula da gaggawa su shirya don yanayin watsawar SARS-CoV-2 na al'umma da kuma karuwar yawan marasa lafiya da ke fama da COVID-19 da ke buƙatar kulawar likita, musamman, kulawar gaggawa, kamar yadda ke faruwa a yankunan da aka shafa a Italiya.
Kamar yadda aka nuna a cikin saurin kimanta haɗarin ECDC, yana da mahimmanci a ɗauki hanzari, mai aiki, da kuma cikakkiyar hanyar da za a jinkirta yaduwar SARS-CoV-2, tare da sauyawa daga hanyar dakile zuwa hanyar ragewa, saboda ƙimar da aka yi hasashen yawan lokuta na iya ba da isasshen lokaci ga masu yanke shawara da asibitoci don fahimta, yarda da daidaita amsar su yadda ya kamata idan ba a aiwatar da su ba da wuri.
Har ila yau, saurin tantance haɗari ya lissafa matakan kiwon lafiyar jama'a da ake buƙata don rage tasirin cutar.
Akwai ɗan gajeren lokaci na dama a lokacin da ƙasashe ke da damar zurfafa ƙoƙarin sarrafa su don hana yaduwar SARS-CoV-2 da rage matsin lamba akan tsarin kiwon lafiya.
Idan ba a yi haka ba, tsarin kiwon lafiya na sauran ƙasashen EU/EEA na iya fuskantar raƙuman marasa lafiya da ke bukatar kulawa mai tsanani a cikin kwanaki da makonni masu zuwa.
Cutar cutar coronavirus 2019 (COVID-19), wadda ta haifar da cutar coronavirus 2 ta rikicin numfashi mai tsanani (SARS) (SARS-CoV-2), har zuwa yanzu ta kashe mutane 3000 kuma ta kamu da fiye da mutane 80,000 a China da sauran wurare a duniya, wanda ya haifar da bala'i ga mutane.
Kamar yadda yake da cutar SARS-CoV, wadda ta haifar da SARS a dubban mutane a 2003, SARS-CoV-2 ma zai iya kamuwa daga bats kuma ya haifar da irin wannan bayyanar ta hanyar irin wannan tsari.
Koyaya, COVID-19 yana da ƙarancin tsanani da mutuwa fiye da SARS, amma yana da yawa fiye da watsawa kuma yana shafar tsofaffi fiye da matasa kuma yana shafar maza fiye da mata.
A sakamakon yawan wallafe-wallafen da ake yi game da cutar da ke tasowa, manufar wannan labarin ita ce samar da cikakken bincike na bincike a kan batun, wanda ke faruwa da sauri.
Za mu tattauna muhimman fannoni na cututtuka, etiology, virology, ganewar asali, magani, tsinkaya da rigakafin cutar.
Ko da yake ba a amsa tambayoyi da yawa ba, muna fata wannan bincike zai taimaka mana mu fahimci wannan cuta mai tsanani kuma mu kawar da ita.
Bikin bazara na 25 ga Janairu na 2020 ya zama abin tunawa da ba a taɓa ji ba ga duk Sinawa, waɗanda aka ƙarfafa su su zauna a gida a duk lokacin bikin kuma har tsawon makonni da yawa saboda barkewar sabuwar cuta ta kwayar cuta.
Wannan kwayar cutar tana da kusan iri ɗaya da cutar coronavirus (CoV) wanda ya haifar da barkewar cutar ta cutar ta numfashi mai tsanani (SARS) a shekara ta 2003; saboda haka, a ranar 11 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya (WHO) ta kira ta SARS-CoV-2, kuma cutar da ke tattare da ita ta kira cutar coronavirus 2019 (COVID-19).
Cutar ta fara ne a birnin Wuhan na kasar Sin kuma ta bazu cikin sauri a fadin kasar da kuma kusan kasashe 50 a duniya.
A ranar 2 ga Maris, 2020, cutar ta haifar da fiye da 80 000 da aka tabbatar da COVID-19, tare da fiye da 40 000 marasa lafiya da aka sake su kuma fiye da 3000 marasa lafiya sun mutu.
Hukumar ta WHO ta yi gargadin cewa COVID-19 ita ce babbar magabcin jama'a kuma tana da iko fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin kasa da watanni biyu, an wallafa labarai na kimiyya sama da 200 game da COVID-19, gami da virology, epidemiology, etiology, diagnosis da magani, tun daga rahoton farko na Janairu 7, 2020, wanda ya ƙayyade jerin cututtukan da aka keɓe daga marasa lafiya da yawa.
Manufar wannan bincike ita ce taƙaita ci gaban bincike a kan wannan sabon batun da ke ci gaba da sauri.
A duk lokacin da zai yiwu, za mu gwada COVID-19 da SARS da kuma wani cuta da COVID ke haifarwa, ciwon numfashi na Gabas ta Tsakiya (MERS, barkewar cutar a shekarar 2012).
Za mu kuma bincika abin da aka sani game da rigakafi da kuma tsinkayar cutar, da kuma wasu tambayoyi masu muhimmanci da ba a amsa su ba tukuna.
Ana ganin cewa cutar coronavirus ba ta mutuwa ba ce ga mutane, kuma a yawancin lokuta tana haifar da kusan kashi 15 cikin 100 na mura 4.
Duk da haka, a wannan karni, mun sami cututtukan coronavirus sau biyu masu cutarwa a cikin mutane, wato SARS-CoV da MERS-CoV, wanda suka haifar da barkewar cutar a China, a 2003, da Saudi Arabia, a 2012, bi da bi, kuma nan da nan suka bazu zuwa wasu ƙasashe da yawa tare da mummunan kamuwa da cutar da mutuwar.
Saboda haka, barkewar cutar COVID-19 ta yanzu ita ce ta uku ta coronavirus da aka yi rikodin a tarihin bil'adama.
Kamar yadda aka nuna a Fig. 1,1, an fara bayar da rahoton tarin cututtukan huhu na asali da ba a sani ba a ranar 31 ga Disamba, 2019 daga Wuhan zuwa Hukumar Lafiya ta kasar Sin.
Bayan kwana bakwai, an sanar da jerin sunayen cutar coronavirus.
A ranar 15 ga Janairu, 2020, an yi rikodin mutuwar farko a Wuhan.
A halin yanzu, annobar ta bazu cikin sauri zuwa birane, larduna da ƙasashe makwabta.
A ranar 20 ga watan Janairu, an samu rahoton kamuwa da cutar daga masu ba da kulawar lafiya, wanda ya nuna cewa ana iya watsa ta tsakanin mutane.
A ranar 23 ga watan Janairu, an sanya birnin Wuhan a cikin killace kuma an dakatar da duk jigilar jama'a.
A ranar 24 ga watan Janairu, binciken farko na asibiti kan cutar ya ba da rahoton cewa, daga cikin marasa lafiya 41 da aka tabbatar da cutar, 21 ne kawai suka yi hulɗa kai tsaye da kasuwar kifin teku ta Wuhan wanda aka ɗauka wuri ne na asalin kamuwa da cutar daga asalin dabba da ba a sani ba.
A ranar 30 ga Janairu, WHO ta ayyana barkewar cutar a matsayin gaggawa na kiwon lafiya a duniya.
A lokacin da aka ba da rahoton, cutar ta riga ta bazu ko'ina cikin Sin da kuma kusan ƙasashe 50 a duniya (Fig. 2).
Tun da yanayin ya ci gaba da sauri, ba a iya ƙayyade girman da kuma tsanani na ƙarshe na barkewar cutar ba tukuna.
A ranar 11 ga Fabrairu, 2020, wani bincike mai yawa na marasa lafiya 8866, ciki har da marasa lafiya 4021 da aka tabbatar da COVID-19, ya gabatar da ƙarin bayani na cutar da aka bayyana a ƙasa (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane na kowane zamani, amma galibi mutane daga shekaru 30 zuwa 65.
Kusan rabin (47.7%) na waɗanda suka kamu da cutar sun fi shekaru 50, kaɗan ne kawai suka kai shekaru 20, kuma mutane 14 ne kawai suka kamu da cutar suka kai shekaru 10.
SARS-CoV-2 ya fi kamuwa da maza (0.31/100 000) fiye da mata (0.27/100 000).
COVID-19 ya bazu cikin manyan taro galibi a Hubei da kewaye da shi.
A matsakaita, kwanaki 5 (2 zuwa 9) sun wuce tsakanin bayyanar COVID-19 da ganewar asali.
Matsakaicin lokacin yin amfani da ita ya kai kwanaki 4.8 (daga 3.0 zuwa 7.2).
Matsakaicin lokacin daga bayyanar zuwa mutuwa ya kasance kwanaki 9.5 (daga 4.8 zuwa 13).
Ƙididdigar haihuwa ta asali (R0) ita ce 3,77 (CI na 95%: 3,51-4,05) da kuma daidaitaccen R0 ita ce 2,23-4,82.
Yawan mutanen da suka kamu da cutar ya karu sosai kafin 23 ga Janairu, 2020, wanda ya dace da lokacin gagarumin tattara mutane kafin bikin bazara a China.
Mutuwar marasa lafiya da aka tabbatar da cutar ta kasance 1.44% (CI na 95%: 1.10-1.86%) da kuma daidaitaccen mutuwar dukan marasa lafiya ya kasance 3.06% (CI na 95%: 2.02-4.59%).
Babban abubuwan haɗari guda uku na COVID-19 sune jinsi (maza), shekaru (≥60) da cutar huhu mai tsanani.
Kwayoyin cutar coronavirus wani nau'i ne na manyan ƙwayoyin cuta masu haɗuwa waɗanda ke ƙunshe da RNA mai ƙunshe da ke da ma'ana ɗaya.
Ana iya raba su zuwa nau'i hudu, wato alpha, beta, gama da delta, daga cikinsu alphacoronavirus da deltacoronavirus sune ke kamuwa da mutane.
Glycoprotein spike (S) na kunshin yana haɗuwa da masu karɓar kwayoyinsa, angiotensin 2 (ACE2) mai canza enzyme da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV, bi da bi, sannan haɗuwa da membranes yana faruwa.
An saki kwayoyin RNA na kwayar cuta zuwa cikin cytoplasm; bayan an sake kwayar kwayoyin cuta, RNA na kwayar cuta, tare da glycoproteins na ɓoye da furotin nucleocapside, suna haifar da ƙwayoyin cuta waɗanda ke dauke da virions, waɗanda daga baya suka haɗu da membrane na plasma don sakin kwayar cuta.
An sanar da jerin kwayoyin halitta na farko na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano cewa SARS-CoV-2 sabon nau'in betacoronavirus ne wanda ke da asalin kwayoyin halitta sama da kashi 99.98 cikin ɗari a cikin samfurori 10 da aka ɗauka daga asalin wurin barkewar cutar: kasuwar kifin teku Huanan na Wuhan.
SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV.
A cikin microscope na lantarki na watsawa, an gano ƙwayoyin SARS-CoV-2 a cikin ƙananan sassan ƙwayar numfashi na mutum.
An gano cewa ACE2 na mutum mai karɓar SARS-CoV-2 ne, da kuma SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana haɗuwa da ACE2 na ɗan adam fiye da na SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da kamuwa da cutar da ba ta da tsanani a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 na iya kuma samar da sabon gajeren furotin da aka yi wa lambar ta orf3b da kuma furotin da aka yi wa lambar ta orf8.
SARS-CoV-2 orf3b na iya taka rawa wajen cutar ta kwayar cuta da hana bayyana IFNβ; duk da haka, orf8 ba ya dauke da wani sanannen yanki ko dalili na aiki.
A ranar 18 ga Fabrairu, 2020, Zhou, et al., sun bayyana tsarin lantarki na ECA2 na tsawon mutum a ƙuduri 2.9 Å, a cikin hadadden tare da amino acid mai jigilar B0AT1.
Sun gano cewa wannan tsari, wanda yake da tsari na bude da rufe, yana haɗuwa kamar dimer, kuma ACE2-B0AT1 zai iya haɗa sunadarai S biyu, wanda ke ba da hujjoji don ganewa da kamuwa da cutar coronavirus.
B0AT1 na iya zama wata hanyar magance cutar don nazarin magunguna don kawar da kamuwa da cutar SARS-CoV-2.
Asalin da kuma baƙo na tsakiya
An san cewa SARS-CoV da MERS-CoV sun fito ne daga bats kuma an watsa su ga mutane ta hanyar civets da raƙuma, bi da bi.
A cikin kwatancen ilimin halittu na SARS-CoV-2 da sauran coronavirus, an yi la'akari da cewa bats shine mai masaukin SARS-CoV-2, saboda sabon kwayar cutar ta kasance daidai da kashi 96% ga coronavirus biyu masu kama da SARS na bats da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Amma har yanzu ba a san wane baƙo na tsakiya ya taimaka wa kwayar cutar ta ƙetare shinge na jinsuna don kamuwa da mutane ba, kuma har yanzu ba a bayyana hanyar watsawa ba.
Ji, da sauransu sun gabatar da macizai a matsayin masu dauke da kwayar cutar daga bats zuwa mutane, wanda ya ƙunshi sake haɗuwa da juna a cikin furotin S.
A cewar wani bincike, masu bincike daga Guangzhou, China, sun nuna cewa pangolins (masu mamaye masu dogon hanci waɗanda ke cin abinci daga tsutsa kuma galibi ana amfani da su a cikin maganin gargajiya na kasar Sin) suna iya zama baƙo na SARS-CoV-2 bisa ga homology na 99% na kwayoyin halitta a cikin coronavirus da aka gano a pangolins da SARS-CoV-2.
Duk da haka, bambanci na 1% da aka yada ta hanyar dukkanin genomes biyu ya kasance babban bambanci; saboda haka, ana sa ran samun sakamako mai kyau wanda zai ba da tabbaci mai kyau (Fig.
Har yanzu ba a san halaye na jiki da sinadarai na SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya rayuwa a cikin in vitro na tsawon sa'o'i 48 a cikin yanayi mai bushe har zuwa kwanaki 5 a ƙasa da 20 °C tare da zafi na 40-50%.
SARS-CoV-2 na iya samun irin wannan kaddarorin.
An ruwaito cewa SARS-CoV-2 yana da saurin hasken ultraviolet da zafi a 56 °C na tsawon minti 30; ether, ethanol zuwa kashi 75%, mai tsabtace jiki tare da chlorine, percloric acid, chloroform da sauran masu narkewa masu ƙonawa, amma ba chlorhexidin ba, suna da tasiri wajen kashe cutar.
Dukan mutanen duniya ba su da kariya ga SARS-CoV-2 kuma saboda haka suna iya kamuwa da sabon coronavirus.
Har zuwa yanzu, ba a sanar da wani cikakken bincike kan maganin rigakafi ga SARS-CoV-2 ba.
Saboda haka, za mu iya komawa ga binciken da aka yi a baya kawai tare da sauran coronavirus, musamman SARS-CoV da MERS-CoV (Fig. (Fig. 4).4).
A yawancin lokaci, bayan cutar ta mamaye baƙon, an fara gane shi ta hanyar tsarin rigakafin baƙon ta hanyar masu karɓar ganewar asali (PRR), gami da masu karɓar lectin irin C, masu karɓar nau'in Toll (TLR), masu karɓar nau'in NOD (NLR), da masu karɓar nau'in RIG-I (RLR).
Ta hanyoyi daban-daban, ƙwayar cuta tana haifar da bayyanar cututtuka na kumburi, ƙwayoyin dendritic da kuma haɗuwa da interferons na nau'in I (IFN) waɗanda ke iyakance yaduwar ƙwayar cuta da hanzarta phagocythosis na magungunan ƙwayar cuta.
Duk da haka, furotin N na SARS-CoV na iya taimaka wa kwayar cutar ta tsere daga amsawar rigakafi.
Nan da nan, maganin rigakafi na daidaitawa ya shiga cikin yaki da cutar.
T lymphocytes, ciki har da CD4+ da CD8+ T cells, suna da muhimmiyar rawa wajen kāre kansu.
Kwayoyin T na CD4+ suna motsa ƙwayoyin B su samar da rigakafin da suka dace da kwayar cutar, kuma ƙwayoyin T na CD8+ suna kashe ƙwayoyin da suka kamu da kwayar cutar kai tsaye.
Kwayoyin T masu haɗin kai suna samar da cytokines masu ƙonewa don taimakawa ƙwayoyin masu karewa.
Koyaya, coronavirus na iya hana ayyukan T-cell ta hanyar haifar da apoptosis na T-cell.
Ƙarfin jiki na jiki, wanda ya haɗa da kari kamar C3a da C5a da rigakafi, yana da muhimmanci wajen yaki da kamuwa da cutar.
Alal misali, rigakafin da aka yi wa wani mai haƙuri da ya dawo ya hana cutar ta MERS-CoV.
A wani ɓangare kuma, tsarin rigakafi mai tsanani yana haifar da ƙwayoyin cuta masu yawa a gida, wanda zai iya haifar da mummunan lahani ga huhu da sauran gabobin jiki, kuma a mafi munin yanayin, rashin ƙarfi da mutuwa.
Cutar SARS-CoV-2, wadda ta bayyana a cikin tarin mutane, tana iya shafar tsofaffi masu fama da cutar da kuma mata masu juna biyu.
Mutane da yawa da suka kamu da ƙwayoyin cuta ko kuma waɗanda tsarin rigakafi na jiki ya raunana suna da wataƙila za su kamu da cutar fiye da wasu.
Matsakaicin matsakaicin lokacin tsinkaye na SARS-CoV-2 ya kai kwanaki 1 zuwa 14, mafi yawa tsakanin kwanaki 3 zuwa 7, a cewar wani binciken da aka yi na farkon shari'o'in 425 a Wuhan.
Amma, wani bincike na shari'o'i 1099 ya nuna cewa lokacin yin ciki yana da kwanaki 3 a matsakaita kuma yana daga kwana 0 zuwa 24.
Wani bincike na kwanan nan, kamar yadda aka bayyana a baya, ya nuna cewa lokacin yin amfani da shi ya kasance kwanaki 4.8 (daga 3.0 zuwa 7.2) bisa alƙaluma na shari'o'i 8866.
Yana da muhimmanci sosai cewa hukumomin kiwon lafiya su daidaita lokacin killacewa mai inganci bisa ga ainihin lokacin yin amfani da shi don hana mutane da suka kamu da cutar ba tare da wata alama ba su watsa cutar ga wasu.
A matsayinka na al'ada, mutanen da suka kamu da cutar ko kuma suka kamu da cutar za su kasance a cikin killace na kwanaki 14.
Shin, an tsawaita dokar hana fita zuwa kwanaki 24?
Zazzabi shine babban bayyanar cututtukan COVID-19, wanda zai iya kasancewa tare da wasu alamun bayyanar cututtukan kamar tari, rashin jin daɗi, ciwon tsoka, ƙyama, ciwon kai, ciwon wuya, rhinorrea, ciwon kirji, diarrhea, ƙwayoyin cuta da amai.
Wasu marasa lafiya sun sha wahala daga rashin jin daɗi ko hypoxemia mako guda bayan bayyanar cutar.
A cikin matsanancin yanayi, marasa lafiya suna ci gaba da sauri har zuwa ciwon cutar numfashi mai tsanani, tsokoki na septic, ƙwayar cuta mai yawa, da kuma ciwon jini.
Maza da zazzabi ko alamun numfashi da zazzabi mai tsanani, har ma da marasa ƙarancin huhu a cikin nazarin hoto, ya kamata a gwada su da cutar don ganewar asali na farko.
Wani bincike na yawan jama'a a karshen watan Disamba na 2019 ya nuna cewa kashi 98 cikin dari na alamun sun kasance na zazzabi, kashi 76 cikin dari na tari, kashi 55 cikin dari na zubar da jini, da kuma kashi 3 cikin dari na fitsari; kashi 8 cikin dari na marasa lafiya suna bukatar taimakon numfashi.
An samu irin wannan binciken a cikin bincike guda biyu na baya-bayan nan na wani iyali da kuma wani da ya faru da mutum marar alamar cutar.
Hakazalika, wani bincike na 2012 ya nuna cewa marasa lafiya da ke da cutar MERS-CoV suna da zazzabi (98%) da tari mai bushe (47%) da kuma rashin jin daɗi (55%) a matsayin manyan alamun.
Amma kashi 80 cikin dari na su na bukatar taimakon numfashi, fiye da marasa lafiya da ke fama da COVID-19 kuma daidai da yadda cutar ta MERS ta fi muni a kan COVID-19.
Ana kuma lura da ciwon ciki (26%) da kuma ciwon wuya (21%) a cikin marasa lafiya da ke fama da cutar MERS.
A cikin marasa lafiya da ke fama da SARS, an nuna cewa zazzabi (99%-100%), tari mai bushe (29%-75%), rashin numfashi (40%-42%), diarrhea (20%-25%) da kuma ciwon wuya (13%-25%) sune manyan alamun bayyanar cututtuka kuma ana buƙatar taimakon numfashi a cikin kimanin kashi 14 zuwa 20% na marasa lafiya.
A ranar 14 ga Fabrairu, mutuwar COVID-19 ta kasance kashi 2 cikin dari lokacin da aka tabbatar da shari'o'in sun kai 66 576 a duk duniya.
Hakazalika, mutuwar SARS a watan Nuwamba na 2002 ta kai kashi 10 cikin 100 a cikin mutane 8,096.
A cikin wani bincike na alƙaluma na watan Yuni na 2012, mutuwar MERS ta kai kashi 37 cikin dari a cikin 2494 da aka tabbatar.
A wani binciken da aka yi a baya, an ruwaito cewa R0 na SARS-CoV-2 yana da girma kuma ya kai 6,47 tare da matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin
Ana kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da bayyanar cututtuka, mutuwa, da R0 a cikin teburin tebur 1.1.
Lambobin da suka gabata sun nuna cewa SARS-CoV-2 na da damar yadawa fiye da MERS-CoV da SARS-CoV, amma rashin mutuwarsa ya fi na biyun nan.
Saboda haka, yana da wuyar sarrafa cutar SARS-CoV-2 fiye da cutar MERS-CoV da SARS-CoV.
Sau da yawa, ana yin taro a cikin iyali ɗaya ko kuma a cikin taro ko mota ɗaya, kamar jirgin ruwa.
Yawancin lokaci marasa lafiya suna da tarihin tafiya ko zama a Wuhan da sauran yankunan da ke fama da cutar ko tuntuɓar mutane masu kamuwa da cutar ko marasa lafiya a cikin makonni biyu kafin bayyanar.
Duk da haka, an bayar da rahoton cewa mutane na iya ɗaukar cutar ba tare da bayyanar cututtuka ba har tsawon makonni biyu kuma marasa lafiya da aka sake fitar da su daga asibiti na iya sake kamuwa da cutar, alamar faɗakarwa cewa dole ne a ƙara lokacin killacewa.
Marasa lafiya suna da ƙananan ƙananan ƙananan ƙananan ƙwayoyin jini (musamman lymphocytes) a farkon lokaci.
Alal misali, an lura da cutar lymphopenia tare da ƙididdigar ƙwayoyin fari na <4×109/l, ciki har da ƙididdigar ƙwayoyin lymphocytes na <1×109/l, da kuma matakan aspartate aminotransferase a cikin marasa lafiya 1099 da ke fama da COVID-19.
Ƙarfin hanta da na tsoka da na myoglobin sun yi yawa a cikin jinin wasu marasa lafiya, kuma sun fi yawan sunadarai masu aiki da sinadarin C da kuma ƙwayar ƙwayar ƙwayar cuta a cikin jinin yawancin marasa lafiya.
A cikin marasa lafiya masu tsanani, matakin dimer-D, wanda ya samo asali ne daga rage fibrin a cikin jini, ya yi yawa, kuma yawan ƙwayoyin lymphocytes ya ragu a hankali.
Ana gano rashin daidaito a cikin hotunan X-ray na ƙirjin yawancin marasa lafiya da COVID-19, wanda ke nuna inuwa ko opacities a cikin gilashin mirgine na biyu a cikin huhu.
A yawancin lokuta, marasa lafiya suna fama da cutar huhu, da kuma cutar huhu mai tsanani da kuma ciwon hanzari na numfashi (SDRA).
Lokacin da SDRA ya faru, rashin kulawa da kumburi, tarin ruwa da ci gaba da fibrosis suna shafar musayar iskar gas sosai.
Rashin aiki na huhu na Type I da Type II yana rage matakin surfactant kuma yana ƙara ƙarfin jiki, yana rage ƙarfin huhu don faɗaɗa kuma yana ƙara haɗarin fashewar huhu.
Saboda haka, sakamakon da ya fi muni a cikin hotunan kirji na kirji yana daidai da yanayin da ya fi tsanani.
A ranar 18 ga watan Fabrairun 2020, bincike na farko na cutar ta COVID-19 ya nuna cewa an cire huhu daga huhu, an kafa membrane hyaline kuma an shigar da lymphocytes a cikin interstitium, da kuma ƙwayoyin sinci na nucleated a cikin huhu na mai haƙuri wanda ya mutu saboda cutar, wanda ya dace da cututtukan kamuwa da cuta ta kwayar cuta da SDRA, kuma yayi kama da waɗanda ke fama da SARS da MERS.
An yi amfani da gano RNA na SARS-CoV-2 ta hanyar yin layin polymerase tare da juyawa transcriptase (RT-PCR) a matsayin babban ma'auni don gano COVID-19.
Duk da haka, saboda yawan ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigardigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙ a cikin ƙididdigar ƙididdigar ƙididdigardigar ƙididdigar ƙididdigar ƙ a cikin ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙ a cikin ƙididdigar ƙididdigardigar ƙididdigardigar ƙ a cikin ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙ a cikin ƙididdigar ƙ
Wani irin yanayi ya faru da cutar SARS.
Saboda haka, haɗuwa da tarihin rashin lafiya, bayyanar cututtuka, gwaje-gwaje na dakin gwaje-gwaje da kuma binciken radiology yana da muhimmanci kuma yana da muhimmanci don ganewar asali mai kyau.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana yarjejeniyar amfani da fasaha ta SHERLOCK da ke tushen CRISPR don gano SARS-CoV-2, wanda ke gano ɓangarorin RNA na SARS-CoV-2 a tsakanin 20 × 10-18 mol/l da 200 × 10-18 mol/l (10-100 kwafi a kowace microlitre samfurin) ta amfani da sandar digiri a ƙasa da awa ɗaya wanda baya buƙatar kayan aiki masu rikitarwa.
Da fatan, sabon fasaha zai iya ƙara ƙwarewa da dacewa idan aka gwada shi a cikin gwajin asibiti.
Saboda rashin gogewa game da sabon coronavirus, likitoci galibi suna iya ba da kulawa mai goyan baya ga marasa lafiya da COVID-19, yayin da suke gwadawa tare da magunguna daban-daban waɗanda aka yi amfani da su ko kuma aka gabatar a baya don magance sauran coronavirus, kamar SARS-CoV da MERS-CoV, da sauran cututtukan kwayar cuta (tebur (tebur 2).2).
Wadannan magunguna sun hada da magani da ake amfani da shi a yanzu ko kuma a yi amfani da shi a nan gaba tare da magungunan rigakafi, masu hana rigakafi, steroids, plasma na marasa lafiya da suka dawo, maganin kasar Sin da kuma goyon bayan tunani.
An kuma yi amfani da plasma na marasa lafiya da suka warke don magani.
Kamfanonin magunguna suna fafatawa domin ganin wanda ya fara samar da rigakafi da alluran rigakafin cutar.
SARS-CoV-2 ya fara kai hari ga huhu a farkon kuma, mai yiwuwa, zai kai hari, a ƙananan digiri, ga sauran gabobin da ke nuna ACE2, kamar na narkewa da koda.
Amma, rashin aiki da kuma rashin numfashi sune mafi girma a cikin haɗari ga marasa lafiya da kuma babban dalilin mutuwa.
Saboda haka, taimakon numfashi yana da mahimmanci don sauƙaƙe bayyanar cututtuka da ceton rayuka, kuma ya haɗa da maganin oxygen gaba ɗaya, oxygen mai gudana, iska mai ba da izini da iska mai ba da izini bisa ga yanayin rashin lafiya.
Marasa lafiya da ke fama da cututtukan numfashi masu tsanani suna bukatar taimakon oxygenation by extracorporeal membrane (OMEC), wata fasaha ce ta karkata da huhu da aka yi amfani da ita wajen magance cututtukan zuciya ko kuma rashin numfashi da ke da haɗari.
Bugu da ƙari, kula da daidaiton electrolyte, hanawa da kuma magance cututtukan cututtuka na biyu da kuma bugun jini, da kuma kare ayyukan gabobin rayuwa suna da mahimmanci ga marasa lafiya da SARS-CoV-2.
An san cewa hadari na cytokines sakamakon wani mummunan aiki na tsarin rigakafi a cikin marasa lafiya da SARS da MERS.
Cytokine guguwa wani nau'i ne na tsarin kumburi wanda aka nuna ta hanyar sakin jerin cytokines, wanda ya haɗa da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ da MCP-1.
Waɗannan ƙwayoyin sun sa ƙwayoyin rigakafi su saki ƙwayoyin free radicals da yawa waɗanda suke da alhakin SDRA da kuma rashin aikin kwayoyin halitta.
Maganin rigakafi yana da muhimmanci wajen magance hadari na cytokine, musamman a cikin marasa lafiya masu tsanani.
An yi amfani da corticosteroids da kuma tocilizumab, wanda shi ne anti-IL6 anti-receptor monoclonal antibody, don magance hadari na cytokines.
Sauran hanyoyin da za a iya magance matsalar rigakafin jiki don guguwar cytokines su ne daidaitawar tsarin rigakafin jiki na T-cell; toshe IFN-γ, IL-1 da TNF; hana JAK; blinatumomab; mai hana siginar cytokine na hanyar 4, da kuma masu hana HDAC.
Ana amfani da steroids, kamar su immunosuppressants, a yawancin lokaci wajen magance SARS don rage yawan cutar ta kumburi.
Duk da haka, steroids a manyan allurai ba su da amfani ga mummunan rauni a huhu a cikin marasa lafiya da SARS da COVID-19.
Amma, suna iya haifar da mummunan sakamako masu illa, musamman osteonecrosis, wanda ke shafar hangen nesa sosai.
Duk da haka, an ba da shawarar yin amfani da corticosteroids a hankali a cikin ƙananan zuwa matsakaici a cikin ɗan gajeren lokaci ga marasa lafiya da ke da COVID-19 a cikin mawuyacin hali.
A lokacin da aka yi wannan bincike, ba a tabbatar da ingancin maganin rigakafi ba.
Duk da haka, an tabbatar da ingancin remdesivir, wani nau'in nucleotide, wanda aka ba da shi ta hanyar intravenous a cikin wani mai haƙuri na Amurka da COVID-19.
Remdesivir sabon magani ne na rigakafin cutar da Gilead ta fara samarwa don magance cututtukan da ƙwayoyin cutar Ebola da Marburg suka jawo.
Daga baya, remdesivir ya kuma nuna yiwuwar hana wasu ƙwayoyin cuta da ke da RNA guda, kamar su MERS da SARS.
A bisa wadannan, Gilead ta ba kasar Sin sinadarin don gudanar da wasu gwaje-gwaje a kan mutanen da ke dauke da cutar SARS-CoV-2, kuma ana sa ran sakamakon zai zo.
Bugu da ƙari, an ba da shawarar baricitinib, interferon alfa, lopinavir/ ritonavir, da ribavirin a matsayin yiwuwar magani ga marasa lafiya da ke fama da cututtukan numfashi.
Ana iya samun ciwon hanta, jin haushi, zubar da ciki, cutar hanta da sauran cututtukan da ba su dace ba bayan an yi maganin tare da lopinavir/ ritonavir.
Dole ne a lura da yadda waɗannan magunguna suke hulɗa da wasu magunguna da ake amfani da su a cikin marasa lafiya.
Plasma na marasa lafiya da aka dawo da su da kuma samar da rigakafi
Ba sabon abu ba ne a cire jini daga marasa lafiya da suka warke daga wata cuta mai kamuwa da ita don a yi wa wasu marasa lafiya da suka kamu da wannan cuta magani ko kuma don a kāre mutane da suka warke daga kamuwa da cutar.
A gaskiya ma, marasa lafiya da suka warke suna da ƙwayoyin rigakafi masu yawa a cikin jini.
Kwayoyin rigakafi sune immunoglobulin (Ig) da kwayoyin cutar B ke samarwa don yaƙi da cututtuka da wasu abubuwa na waje, kuma suna gane wasu kwayoyin a cikin cututtuka kuma suna hana su kai tsaye.
A kan wannan, an cire plasma daga jinin wasu marasa lafiya da suka warke daga COVID-19 kuma an yi wa marasa lafiya 10 da ke fama da rashin lafiya.
A cikin sa'o'i 24, bayyanar cututtukan sun inganta, kuma sun rage ciwon kumburi da kuma ƙwayar cuta da kuma samun iskar oxygen a cikin jini.
Duk da haka, yana da muhimmanci a tabbatar da wannan kuma a bayyana shi don samar da hanyar don amfani da shi a kan babban sikelin har sai an samar da takamaiman magunguna.
Bugu da ƙari, saboda maganin da ake yi, ya kamata a yi la'akari da wasu rashin amfani da jini.
Alal misali, rigakafi na iya sa jikin mutum ya yi fama da rashin lafiyan mutum kuma ya haifar da cututtukan cytokine da ke sa mutum ya yi rashin lafiya.
Yawan rigakafin jini a jini yana da ƙasa, kuma ana bukatar jini sosai don kula da marasa lafiya da ke cikin mawuyacin hali.
Yana da wuya a ci gaba da samar da takamaiman rigakafi da sauri don yaƙar cutar ta duniya.
Saboda haka, yana da muhimmanci kuma ya fi dacewa a ware ƙwayoyin B daga marasa lafiya da aka dawo da su kuma a gano lambobin kwayoyin da ke ba da lambar rigakafin da ke da tasiri ko kuma a nemi rigakafin da ke da tasiri a kan ƙwayoyin ƙwayoyin cuta na cutar.
Ta haka ne za mu iya ƙara yawan kwayoyin rigakafi.
An yi amfani da MCT na shekaru dubbai don magance cututtuka a kasar Sin.
Duk da haka, tasirinsa ya dogara ne sosai da haɗuwa da abubuwa da yawa a cikin tsari wanda ya bambanta dangane da ganewar asali na cutar bisa ga ka'idodin MCT.
Yawancin abubuwan da ke da tasiri har yanzu ba a sani ba ko kuma ba su da tabbas, saboda yana da wuya a cire da kuma tabbatar da waɗannan abubuwan ko kuma haɗuwa da su.
A halin yanzu, saboda rashin ingantacciyar magani na musamman don COVID-19, MCT ya zama ɗayan manyan hanyoyin magance magunguna ga marasa lafiya masu sauƙi zuwa matsakaici ko waɗanda suka dawo daga matakai masu tsanani.
Alal misali, an tabbatar da cewa Shu Feng Jie Du capsules da Lian Hua Qing Wen capsules suna da tasiri wajen magance COVID-19.
An lura da manyan matakan dawo da marasa lafiya na COVID-19 a larduna da dama na kasar Sin da suka yi amfani da MCT a cikin kashi 87 cikin dari na marasa lafiyarsu, ciki har da Gansu (63.7 cikin dari), Ningxia (50 cikin dari) da Hunan (50 cikin dari), yayin da lardin Hubei, wanda ya yi amfani da MCT a cikin kusan kashi 30 cikin dari na marasa lafiyar COVID-19, ya sami mafi ƙarancin matakin dawo da su (13 cikin dari).
Amma wannan kwatanci ne mai kyau, domin wasu dalilai masu tasiri kamar yawan marasa lafiya da kuma tsanani ya kamata a haɗa su cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun buga wani binciken da ya kwatanta maganin likitancin yamma (MO) da maganin MO da MCT kawai.
Sun gano cewa lokutan da ake bukata don dawo da zafin jiki, bayyanar cututtuka, da kuma asibiti sun fi ƙanƙanta a cikin ƙungiyar MO+MCT fiye da a cikin ƙungiyar MO kadai.
Abin mamaki, yawan rashin lafiyar (na ɗan sauƙi zuwa na tsanani) ya kasance ƙasa da na MO+MCT kawai (kashi 7.4 bisa dari 46,2 bisa dari) kuma mutuwar ta kasance ƙasa da na MO+MCT kawai (kashi 8.8 bisa dari 39 bisa dari).
Duk da haka, ana jiran ƙarin gwaje-gwaje masu kyau da aka yi a kan manyan sikelin da kuma cibiyoyi don tabbatar da inganci da amincin MCT.
Zai kuma zama da ban sha'awa a kwatanta tsarin ayyuka da kuma sanin abubuwan da ke cikin MCT magani ko kuma haɗuwa da su idan zai yiwu.
Marasa lafiya da ake zargin ko kuma tabbatar da COVID-19 yawanci suna tsoron cutar mai yaduwa da mutuwa, kuma mutanen da ke cikin killacewa suna fuskantar gajiya, kadaici da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar zazzabi, rashin ƙarfi da tari, da kuma sakamako masu illa na magani, kamar rashin barci da ake samu daga shan maganin corticosteroid, suna iya jawo ƙarin damuwa da kuma damuwa ta hankali.
A farkon fasalin barkewar cutar SARS, an samu wasu cututtukan psychiatric, ciki har da ciwon ciki, damuwa, tashin hankali, tashin hankali, alamun psychotic, haushi har ma da son kashe kansa.
Binciken tuntuɓar da kuma tilasta yin rigakafi, a matsayin ɓangare na amsoshin kiwon lafiyar jama'a ga barkewar COVID-19, na iya sa mutane su ji tsoro da laifi game da tasirin kamuwa da cuta, tilasta yin rigakafi da kuma lalata danginsu da abokansu.
Saboda haka, ya kamata a kula da lafiyar hankali ga marasa lafiya da ke fama da COVID-19, da mutanen da ake zargi da kuma mutanen da ke hulɗa da su, da kuma jama'a da ke bukatar hakan.
Taimakon na tunani ya kamata ya hada da horar da kungiyoyin kiwon lafiya na hankali, sadarwa mai kyau tare da sabuntawa na yau da kullun da kuma daidai game da barkewar SARS-CoV-2 da tsare-tsaren magani da amfani da na'urorin lantarki da aikace-aikacen sana'a don hana kusanci tsakanin mutane.
Suna da muhimmanci a yi amfani da su wajen hana watsawar dabbobi da kuma mutane da ke da cutar zuwa ga masu shan magani, kuma suna taimakawa wajen magance cutar a wajen magance annobar da ke tasowa.
An yi ƙoƙari don samar da alluran rigakafi na gina jiki na S don samar da ƙwayoyin rigakafi masu ƙarfi da na dogon lokaci ko rigakafin rigakafi don karewa daga SARS-CoV.
An gwada alluran rigakafi da ke dauke da kwayar cutar mai rai a cikin samfurin dabba don SARS.
Duk da haka, ingancin in vivo na waɗannan yiwuwar alluran rigakafi a cikin tsofaffi da kuma samfurin motsa jiki na mutuwa da kariya daga kamuwa da cutar cutar zoonotic har yanzu dole ne a tabbatar kafin a fara nazarin asibiti.
Wannan na iya faruwa ne domin SARS ta mutu shekaru 17 da suka gabata kuma ba a samu wani sabon kamuwa da cutar ba tun daga lokacin.
Amma, a Gabas ta Tsakiya, har yanzu akwai wasu lokuta da kuma tarin MERS da ke yaduwa zuwa wasu yankuna saboda ci gaba da samun magungunan da ke cikin yankunan da ke da iyaka.
An kirkiro dabarun rigakafin cutar ta MERS ta amfani da ƙwayoyin cuta da ba a kashe su ba, plasmids na DNA, masu ɗaukar hoto na kwayar cuta, nanoparticles, ƙwayoyin cuta masu kama da kwayar cuta da kuma subunits na furotin da ke sake haɗuwa, kuma an gwada wasu a cikin samfurin dabba.
Ci gaban allurar rigakafi mai lafiya da inganci akan SARS-CoV-2 ga mutanen da ba su da kariya ga cutar gaggawa ne kuma aiki ne mai gaggawa don sarrafa cutar ta yanzu.
Duk da haka, yana da wuya a shawo kan matsalolin saboda tsawon lokaci (watau watanni 18) da ake buƙata don haɓaka allurar rigakafi da kuma canje-canje masu ƙarfi na coronavirus.
A matsayin sabon cuta, COVID-19 ya fara bayyana cikakken yanayin asibitin a dubban marasa lafiya.
A yawancin lokuta, marasa lafiya suna iya warkewa a hankali ba tare da wani sakamako ba.
Duk da haka, kamar yadda yake tare da SARS da MERS, COVID-19 kuma yana da alaƙa da babban kamuwa da cuta da mutuwa a cikin marasa lafiya masu tsanani.
Saboda haka, samar da tsarin tsinkaya na cutar yana da muhimmanci don hukumomin kiwon lafiya su iya ba da fifiko ga ayyukan su, musamman a yankunan da ke da iyakantaccen albarkatu.
Bisa ga binciken asibiti da aka samu zuwa yanzu, waɗannan dalilai na iya shafar ko kuma suna da alaƙa da hangen nesa na marasa lafiya da ke fama da COVID-19 (tebur (tebur 33):
Shekara: Shekara ita ce mafi muhimmanci wajen tsara cutar SARS, kuma hakan ya dace da COVID-19.
COVID-19 ya fi faruwa ne a cikin mutane masu shekaru 30 zuwa 65 kuma kashi 47,7 cikin dari na waɗanda suka kamu da cutar sun fi shekaru 50 a cikin binciken da aka yi na mutane 8866, kamar yadda aka bayyana a baya.
Marasa lafiya da ke bukatar kulawa mai tsanani sun fi samun ciwo da rikitarwa da kuma tsananin rikitarwa fiye da waɗanda ba su da (ƙananan shekaru 66 da 51), wanda ya nuna cewa shekaru suna da tasiri a kan ci gaban marasa lafiya da COVID-19.
Jima'i: SARS-CoV-2 ya kamu da maza fiye da mata (0.31/100 000 da 0.27/100 000), kamar yadda aka bayyana a baya.
Haɗuwa da rikitarwa: marasa lafiya da ke fama da cutar COVID-19 da ke bukatar kulawa mai tsanani suna da mafi yawan haɗarin ciwon zuciya da kuma rashin ƙarfi.
Har ila yau, cututtukan zuciya ne ke haifar da mutuwar marasa lafiya da ke fama da cutar SARS.
An ruwaito cewa SARS-CoV-2 na iya haɗuwa da ACE2 mai kyau colangiocytes, wanda zai iya haifar da rashin aikin hanta a cikin marasa lafiya da COVID-19.
Ya kamata a lura cewa shekaru da cututtuka suna da alaƙa sosai kuma suna iya tsoma baki.
Sakamakon gwaji na yau da kullum: matakin furotin C mai aiki (PCR) a cikin jini yana nuna yadda ƙwayar ta samu ciwo ko kuma lalacewar ƙwayar ta samu tsanani kuma an ba da shawarar cewa yana iya zama sanadin rashin lafiya, amsa ga magani, da kuma farfadowa.
An kuma gabatar da batun daidaitawa tsakanin matakin PCR da tsanani da kuma hasashen COVID-19.
Bugu da ƙari, yawan lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT) da creatine kinase (CK) na iya taimakawa wajen hango ko hasashen ci gaban mai haƙuri.
Waɗannan enzymes suna bayyana sosai a gabobin jiki da yawa, musamman a zuciya da hanta, kuma suna fitowa idan aka lalata nama.
Saboda haka, suna nuna alamun cututtukan zuciya ko hanta.
Babban alamun asibiti: za a yi nazarin radiography na kirji da kuma ci gaban alamun asibiti na ɗan lokaci tare da sauran alamun don hango sakamakon asibiti da rikitarwa na COVID-19.
Amfani da Steroids: Kamar yadda aka bayyana a baya, steroids suna da rigakafi wanda aka fi amfani da su a matsayin magani mai taimako don cututtukan cututtuka don rage yawan lalacewar kumburi.
Tun da yawan amfani da kwayoyin corticosteroid a cikin marasa lafiya masu fama da SARS, mutane da yawa da suka tsira sun kamu da osteonecrosis na avascular tare da rashin iya aiki na dindindin da rashin ingancin rayuwa.
Saboda haka, idan ya cancanta, ya kamata a yi amfani da steroids a ƙananan allurai kuma a ɗan gajeren lokaci a cikin marasa lafiya da COVID-19.
Matsalar hankali: kamar yadda aka bayyana a baya, a lokacin barkewar COVID-19, marasa lafiya da yawa sun sha wahala daga damuwa mai ban mamaki, saboda gabaɗaya, sun jimre da tsawan lokaci a cikin killacewa da rashin tabbas mai tsanani, kuma sun halarci mutuwar dangi na kusa da sauran marasa lafiya.
Yana da muhimmanci a yi wa marasa lafiya na nan gaba magani da kuma tallafa musu don su warke daga damuwa kuma su koma rayuwarsu ta yau da kullum.
Bisa ga binciken alƙaluma da aka gudanar har zuwa yanzu, COVID-19 ya bayyana yana da halaye na cutar daban-daban daga SARS.
Baya ga yin kwayar cutar a cikin hanyoyin numfashi na ƙasa, SARS-CoV-2 na iya yin kwayar cutar yadda ya kamata a cikin hanyoyin numfashi na sama kuma yana haifar da bayyanar cututtuka masu sauƙi ko kuma ba ya haifar da bayyanar cututtuka a farkon lokacin kamuwa da cuta, kamar yadda yake faruwa da sauran coronavirus waɗanda ke haifar da sanyi na yau da kullun.
Saboda haka, marasa lafiya da suka kamu da cutar a farkon lokaci ko lokacin da suke yin kamuwa da cutar za su iya samar da ƙwayoyin cuta da yawa a yayin ayyukan su na yau da kullum, wanda ke sa ya zama da wuya a sarrafa cutar.
Duk da haka, an yi la'akari da cewa watsa SARS-CoV ya faru ne lokacin da marasa lafiya ke da mummunan rashin lafiya, yayin da watsawa galibi ba ya faruwa a farkon lokaci.
Saboda haka, barkewar cutar COVID-19 ta yanzu ta fi tsanani da kuma wahalar sarrafawa fiye da barkewar cutar SARS.
Ana yin manyan ƙoƙari a halin yanzu a China, ciki har da rufe Wuhan da garuruwan da ke kewaye da shi da kuma ci gaba da killace kusan dukkanin jama'a da fatan dakatar da watsa SARS-CoV-2.
Ko da yake wadannan matakan suna haifar da mummunan lalacewa ga tattalin arziki da sauran bangarorin kasar, adadin sabbin marasa lafiya yana raguwa, wanda ke nuna jinkirin annobar.
A cewar kyakkyawan hangen nesa, cutar za ta ƙare a watan Maris kuma za a yi watanni 3 ko 4.
Amma wasu masana ba su da irin wannan begen.
Paul Hunter, et al., ya kiyasta cewa COVID-19, wanda ya zama mafi kamuwa da cutar fiye da SARS, ba zai ƙare ba a shekarar 2020.
Ira Longini, et al., ya kirkiro wani tsari don hango ko wane irin annobar za ta faru kuma ya nuna cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan duniya.
Wata kungiya ta Kanada ta ruwaito an gano SARS-CoV-2 a cikin nasal da pharynx exudate a cikin marasa lafiya waɗanda suka warke kuma suka bar asibiti makonni 2 da suka gabata, wanda ke nuna cewa cutar da aka gano kwanan nan na iya zama wani yanayi na tsakiya kamar mura.
Duk da haka, an ga alamun da za su nuna cewa akwai alkawura a kasar Sin da ke nuna cewa akwai raguwar yawan sababbin cututtuka, wanda ke nuna cewa dabarun da ake amfani da su a yanzu suna iya aiki.
An yi hasashen cewa cutar Ebola za ta haddasa mutum miliyan ɗaya da kuma mutuwar mutane miliyan rabin.
Amma, ta hanyar yin rigakafi da kuma warewa, an iya sarrafa cutar.
Kamar SARS-CoV, SARS-CoV-2 na iya raunanawa dangane da kamuwa da cutar kuma a ƙarshe ya ɓace ko ya zama ƙarancin cutar da ke rayuwa tare da mutane.
Ana kwatanta annobar COVID-19 da ta SARS da MERS a ƙasa (Fig. (fig. 55).
SARS-CoV-2 yana da matukar yaduwa ta hanyar tari ko ta hanyar taɓo, kuma mai yiwuwa ta hanyar kai tsaye da kayan da suka kamu da cutar.
An kuma gano cutar a cikin fitsari, wanda ya nuna yiwuwar watsawa ta hanyar magungunan.
Wani bincike na kwanan nan na shari'o'i 138 ya nuna cewa kashi 41 cikin 100 na shari'o'in da ake yi a nan gaba sun kasance sakamakon kamuwa da cuta a asibitocin da ke kula da marasa lafiya, ciki har da marasa lafiya 17 da suka kamu da wasu cututtuka da kuma masu kula da lafiya 40.
Saboda haka, dole ne a yi tsaro don kare mutane, musamman ma masu ba da kulawa ta kiwon lafiya, ma'aikatan jin kai, danginsu, abokan aiki, har ma da masu wucewa da ke hulɗa da marasa lafiya ko masu kamuwa da cutar.
Hanyar farko da za a iya karewa don rage haɗarin kamuwa da cuta ita ce yin amfani da masks; yin amfani da masks na tiyata da masks tare da numfashi N95 (serial number 1860) yana taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Masks na tiyata suna hana jinin mutum mai cutar da za a iya watsawa ta iska ko kuma su manne wa farfajiya, daga inda za su iya kaiwa wasu mutane.
Duk da haka, N95 masks (serial number 1860) ne kawai ke iya karewa daga shan inhalation na virions kamar 10 zuwa 80 nm, kuma kashi 5 cikin 100 na virions ne kawai ke iya shiga su gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV a girma kuma duka suna auna kusan 85 nm.
Tun da ƙwayoyin za su iya shiga cikin masks na tiyata guda biyar da aka tara, masu ba da kulawa na likita da ke hulɗa da marasa lafiya dole ne su yi amfani da masks na N95 (serial number 1860) kuma ba masks na tiyata ba.
Baya ga abin rufe fuska, dole ne masu ba da sabis na kiwon lafiya su yi amfani da rigunan keɓewa na musamman don rage haɗuwa da ƙwayoyin cuta.
Hakanan ƙwayoyin cuta na iya kamuwa da mutum ta idanunsa.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da SARS-CoV-2 duk da cewa ya yi amfani da abin rufe fuska na N95; yana yiwuwa cutar ta shiga jikinsa ta hanyar idanunsa masu kumburi.
Saboda haka, masu ba da kulawar lafiya suna bukatar su saka kayan kariya ko tabarau masu haske yayin da suke aiki da marasa lafiya.
Ga jama'a a yankunan da ke fama da cutar ko kuma waɗanda za a iya cutar da su, an ba da shawarar sosai cewa jama'a su wanke hannayensu da sabulu mai tsabta fiye da yadda suka saba, su yi ƙoƙarin zama a gida a cikin killace na son rai kuma su iyakance hulɗa da mutanen da za su iya kamuwa da cutar.
An ce ƙafa uku ne ya dace da mutane su nisanta kansu daga mai haƙuri.
Waɗannan matakan suna da tasiri wajen rage haɗarin kamuwa da cuta da kuma hana yaduwar cutar.
Ko da yake SARS-CoV-2 ya bayyana a matsayin sabon kwayar cutar ga duniyar ɗan adam, babban kamanceceniya da SARS-CoV, kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020, ya kamata ya haifar da babban faɗakarwa a China saboda kwarewar da ta samu daga barkewar SARS a 2003.
Sai dai a ranar 19 ga watan Janairun 2020 ne shugaban Cibiyar Kula da Cututtuka ta Wuhan ya kwantar da hankalin 'yan kasar inda ya ce sabon kwayar cutar tana da karancin kamuwa da cutar da kuma iyakance karfin haihuwa tsakanin mutane, kuma babu wata matsala wajen hana da kuma dakile cutar.
Wannan sakon ya rage tsananin fargaba a cikin jama'a, musamman a lokacin da duk kasar ke shirin bikin bazara, kuma an yi amfani da wannan lokacin don rage cutar a ƙarancin sikelin a Wuhan.
Hukumar kula da cututtuka ta kasar Sin ta kamata ta koyi darasi daga wannan mummunan abu kuma ta yi gagarumin gyara a nan gaba.
Alal misali, waɗannan hukumomi ya kamata su kasance (1) masu hankali wajen yin sanarwa ga jama'a, tun da kowane kalma tana da mahimmanci ga 'yan ƙasa kuma tana iya sa su canza hali ko yanke shawara; (2) masu saurin fahimta da kuma amsawa ga bayanan da ba a saba gani ba daga asibitoci, maimakon jiran rahotanni na yau da kullun daga likitoci ko jami'ai; (3) masu ƙuntatawa don hana yiwuwar annobar a farkon matakin, maimakon ƙoƙarin tabbatar da jama'a; da (4) masu daidaitawa a cikin aiwatar da daidaitaccen da ingantattun horo don haɓaka wayar da kan jama'a game da cututtukan annobar da kuma gwadawa da inganta tsarin amsawar jama'a a kai a kai.
Cutar COVID-19 da sabon kwayar cutar SARS-CoV-2 ta haifar ta fara ne a ƙarshen Disamba na 2019.
A cikin kasa da watanni biyu, ya bazu ko'ina cikin kasar Sin da kuma wasu kasashe 50 a duniya a lokacin da aka yi wannan bincike.
Tun da cutar ta yi kama da SARS-CoV kuma akwai kamanceceniya tsakanin alamun COVID-19 da SARS, barkewar COVID-19 ta haifar da jin kamar SARS ta sake bayyana.
Duk da haka, akwai wasu bambance-bambance masu ban mamaki tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci don dakile cutar da kuma kula da marasa lafiya.
COVID-19 ya fi rinjayar tsofaffi fiye da matasa da maza fiye da mata, kuma tsanani da mutuwa sun fi girma a cikin tsofaffi fiye da matasa.
SARS na da yawan mutuwa fiye da COVID-19 (10,91%) idan aka kwatanta da 1.44%.
Marasa lafiya da COVID-19 suna watsa kwayar cutar ko da ba su da wata alama, yayin da marasa lafiya da SARS yawanci suna yin hakan lokacin da suke da mummunan rashin lafiya, wanda ke haifar da matsala mafi girma wajen dakile yaduwar COVID-19 idan aka kwatanta da SARS.
Wannan ya bayyana, a wani ɓangare, dalilin da ya sa SARS-CoV-2 ya bazu cikin sauri da kuma yaduwa fiye da SARS-CoV.
Gwajin RNA na yau da kullun don SARS-CoV-2 na iya zama mara kyau ga wasu marasa lafiya da COVID-19.
A wani bangare kuma, marasa lafiya da suka warke za su iya sake samun cutar.
Waɗannan sakamakon sun ƙara haɗarin yaduwar cutar sosai.
Ganin ci gaban da ake samu cikin bincike kan COVID-19, akwai wasu muhimman batutuwa da ba a warware ba, kamar su:
Daga ina SARS-CoV-2 ya fito?
Ko da yake an gano kashi 96 cikin dari na homology tsakanin SARS-CoV-2 da kuma coronavirus guda biyu na bats masu kama da SARS, har yanzu ba a iya kammala cewa SARS-CoV-2 ya fito ne daga bats.
Wane dabba ne ya ba da cutar daga mahaifar farko, wato, ƙuƙwalwa, zuwa ga mutane?
Idan ba a san amsoshin da aka ba da a lambobin 1 da 2, ba za a iya hana watsawar ba yadda ya kamata, kuma cutar za ta iya sake barkewa a kowane lokaci.
Ko da yake samfurin kwayoyin halitta da gwaje-gwajen sinadarai sun nuna cewa SARS-CoV-2 yana haɗuwa da ACE2, ta yaya ainihin cutar ta shiga cikin ƙwayoyin numfashi kuma ta haifar da canje-canje na cutar?
Shin kwayar cutar tana haɗuwa da ƙwayoyin da ke bayyana ACE2 a wasu gabobin jiki?
Idan babu amsoshi masu kyau ga waɗannan tambayoyin, ba za a iya yin bincike da sauri da kuma magani mai kyau ba.
Har yaushe cutar za ta ci gaba?
Ta yaya kwayar cutar ta samo asali yayin da take watsawa tsakanin mutane?
Shin zai zama annoba ta duniya, zai mutu kamar SARS ko kuma zai sake tashi a kai a kai kamar mura?
Ko da yake zai ɗauki lokaci, yana da muhimmanci mu nemi amsoshin waɗannan tambayoyin da kuma wasu da yawa.
Duk da haka, ko yaya, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu koma rayuwarmu ta yau da kullun.
Asalin cutar coronavirus a cikin mutane
Cutar da kuma daidaitawa sun sa kwayar cutar ta coronavirus da kuma wadanda suka kai ta, ciki har da mutane, su ci gaba da juyin halitta na tsawon shekaru.
Har zuwa 2003, an san cewa mutum biyu masu cutar coronavirus suna haifar da ƙananan cututtuka, kamar sanyi.
Cutar cutar ta hanyar numfashi mai tsanani (SARS) da kuma cutar numfashi ta Gabas ta Tsakiya (MERS) sun juya kudin ta hanyar bayyana yadda cutar coronavirus na iya zama mummunar cuta ga mutane.
Fitowar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake sanya coronavirus a cikin hankali kuma ya ba mu mamaki tare da babban watsawa da rage ƙwayoyin cuta idan aka kwatanta da ɗan'uwansa, SARS-CoV.
Cutar kwayar cutar coronavirus a cikin mutane zoonosis ce kuma zai taimaka mana mu san asalin cutar coronavirus a cikin mutane.
Yawancin cututtukan coronavirus na mutane sun samo asali ne daga bats, wanda ba su da cutar.
An kuma san baƙi na matsakaiciyar ajiya na wasu coronavirus na mutane.
Gano dabbobi masu baƙi yana da tasiri kai tsaye a rigakafin cututtuka a cikin mutane.
Binciken hulda tsakanin coronavirus da baƙi a cikin dabbobi na iya, ƙari, fitar da mahimman bayanai game da cutar coronavirus a cikin mutane.
A cikin wannan bincike, mun gabatar da cikakken bayanin ilimin da ke akwai game da cututtukan coronavirus bakwai na mutane, tare da jaddada tarihin gano su, da kuma asalin su na zoonotoci da kuma watsa tsakanin jinsuna.
Abin lura, mun kwatanta da kuma kwatanta coronavirus daban-daban na mutane daga hangen nesa na juyin halitta na kwayar cutar da kuma sake haɗuwa da kwayoyin halitta.
Ana nazarin annobar cutar coronavirus 2019 (COVID-19) a wannan mahallin.
Bugu da ƙari, an kuma nuna bukatun don canje-canjen baƙi masu nasara da kuma tasirin ci gaban kwayar cutar a cikin tsanani na cutar.
Kwayoyin cutar korona suna cikin dangin Coronaviridae, wanda ya ƙunshi rukuni na kwayoyin RNA mai kyau tare da murfin.
Wadannan kwayoyin, wadanda suke da babban kwayoyin halitta, daga kilobase 26 zuwa 32, a cikin kwayoyin RNA, an kira su coronavirus saboda yanayin su, saboda siffar kambi da suke da shi a karkashin microscope na lantarki.
A bangaren tsarinsa, cutar coronavirus tana da kwayoyin halitta da ba a rarraba su ba, wadanda suke da irin wannan tsari.
Kimanin kashi biyu bisa uku na genom din suna dauke da manyan manyan tsarin karatu guda biyu (ORF1a da ORF1b), wanda ke fassara zuwa polyprotein replicase pp1a da pp1ab.
Ana kuma sarrafa polyproteins har zuwa samar da sunadarai 16 da ba na tsarin ba, da ake kira nsp1~16.
Ragowar ƙwayar halitta tana ɗauke da ORF don furotin na tsarin, ciki har da furotin (S), furotin (E), membrane (M) da nucleoprotein (N).
Hakanan ana sanya wasu nau'ikan sunadarai na musamman na kowane zuriya ta hanyar zuriyar coronavirus daban-daban.
Dangane da bambancin a cikin jerin sunadarai, ana rarraba coronavirus zuwa nau'i hudu (alfacoronavirus, betacoronavirus, gammacoronavirus da deltacoronavirus), daga cikinsu nau'in betacoronavirus ya ƙunshi yawancin kwayar cutar ta ɗan adam kuma an raba shi zuwa layin (A, B, C da D).
Shaidar ilimin halittu ta nuna cewa bats da rodents sune tushen kwayoyin halitta na yawancin alphacoronavirus da betacoronavirus, yayin da tsuntsaye sune babban tanadi na gammacoronavirus da deltacoronavirus.
A cikin dubban shekaru, coronavirus sun ci gaba da ƙetare shingen jinsuna kuma wasu sun fito ne a matsayin manyan cututtukan mutum.
A halin yanzu, an san mutane bakwai da suka kamu da cutar coronavirus.
Daga cikin su, HCoV-229E da HCoV-NL63 alphacoronavirus ne.
Sauran betacoronavirus guda biyar sune HCoV-OC43, HCoV-HKU1, coronavirus na rikitarwa mai tsanani na numfashi (SARS-CoV), coronavirus na rikitarwa na numfashi na Gabas ta Tsakiya (MERS-CoV), da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da bayyanar cututtuka masu sauƙi, kamar sanyi na yau da kullun ko diarrhea.
A gefe guda, SARS-CoV, MERS-CoV da kuma sabon gano SARS-CoV-2 suna da cututtuka masu cutarwa kuma suna haifar da kamuwa da cututtukan iska na ƙasa a cikin yawan marasa lafiya, tare da yiwuwar haɓaka cutar ta hankula ta hankula (SDRA) da bayyanar cututtukan huhu.
HCoV-229E na farko, B814, ya ware daga ɓoyewar hanci na marasa lafiya masu sanyi a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin ilimi ta hanyar cikakken bincike game da HCoV-229E da HCoV-OC43, waɗanda ke haifar da alamun da ba su da iyaka.
A gaskiya ma, har zuwa barkewar cutar SARS, an yarda da shi sosai cewa kamuwa da cutar coronavirus a cikin mutane ba ta da lahani.
Cutar SARS da ta barke a shekara ta 2003 ita ce mafi munin a tarihin zamani kuma ta yi wa mutane sama da 8000 kamuwa da cutar, tare da yawan mutuwar kusan kashi 10.
Shekaru goma bayan haka, cutar ta MERS ta kai ga barkewar cutar a yankin Larabawa da ta bazu zuwa sauran duniya.
Sabon cutar coronavirus ta 2019 (2019-nCoV), wanda daga baya aka kira SARS-CoV-2, shine mai haifar da cutar ta cutar coronavirus 2019 (COVID-19), wanda ya kashe fiye da rayuka 3120 kuma ya kamu da mutane sama da 91,000 a ranar 3 ga Maris, 2020.
An yi ta yin gargadi kuma dole ne duniya ta shirya don annobar SARS-CoV-2 da ke gabatowa.
Kwayar cutar coronavirus guda bakwai na mutum tana da asalin zoonotic a cikin bats, beraye ko dabbobi na gida.
Akwai shaidu da yawa da suka nuna cewa an samo dukkanin cututtukan coronavirus daga mutane a cikin bats, inda ƙwayoyin cuta suka dace sosai kuma ba su da cutar, amma suna da bambancin kwayoyin halitta.
Cutar COVID-19 ta kawo manyan kalubalen kiwon lafiya, kimiyya, zamantakewa da kuma halin kirki a kasar Sin da sauran duniya.
Bin diddigin asalin cutar coronavirus a cikin mutane yana ba da tsarin fahimtar tarihin halitta, ƙarfin motsawa da abubuwan hana tsalle tsakanin jinsuna.
Wannan kuma na iya jagorantar ko sauƙaƙe gano tanadi da baƙi na dabbobi masu matsakaici da masu haɓaka SARS-CoV-2, wanda zai sami mahimman abubuwan da za su shafi hana yaduwar nan gaba.
A cikin wannan bincike, mun gabatar da cikakken bayanin asalin zoonotic, watsa tsakanin jinsuna da cutar coronavirus ta mutum.
Musamman, mun nuna kuma mun bincika batun gama gari cewa ƙwayoyin cuta na coronavirus na ɗan adam ba su da ƙwayoyin cuta a cikin baƙi na ajiyarsu na halitta, amma sun zama ƙwayoyin cuta bayan watsawa tsakanin nau'ikan zuwa sabon baƙo.
Mun kuma bincika yanayin juyin halitta na kwayar cutar coronavirus a cikin mutane, inda ƙaruwar watsawa yawanci ke haifar da raguwar kamuwa da cuta.
Ana kuma nazarin ci gaban barkewar cutar SARS-CoV-2 a wannan mahallin.
An san game da cutar coronavirus daga dabbobi tun daga ƙarshen shekarun 1930.
Kafin a fara ware nau'in B814 na HCoV-229E daga nasal secretion marasa lafiya da suka kamu da sanyi na yau da kullun, an ware coronavirus daban-daban a cikin dabbobi daban-daban da suka kamu, kamar kaza, linzamin kwamfuta, saniya, alade, cat da kare.
A cikin shekaru da dama da suka gabata, an gano mutum bakwai da ke dauke da cutar coronavirus.
A takaice taƙaitaccen tarihin binciken kwayar cutar ta mutum a cikin tsari na lokaci (tebur na 1) zai zama mai ba da bayani da kuma bayani.
HCoV-229E na farko ya ware daga hanyoyin numfashi na marasa lafiya da ke da kamuwa da cutar ta hanyar numfashi a shekara ta 1966 kuma daga baya, an daidaita shi don girma a cikin layin WI-38 na huhu.
Marasa lafiya da ke dauke da cutar HCoV-229E sun nuna alamun sanyi na kowa, kamar ciwon kai, taurin kai, rashin jin daɗi da kuma ciwon wuya, tare da zazzabi da tari a cikin kashi 10 zuwa 20 cikin dari na lokuta.
Daga baya, a shekara ta 1967, HCoV-OC43 ya ware daga girma na kwayoyin halitta kuma ya wuce a hankali a kwakwalwar berayen da ke shan nono.
Halin cututtukan cututtukan HCoV-OC43 ya yi kama da na HCoV-229E, wanda alamun su na kama da na sauran cututtukan numfashi, kamar cutar mura A da rinoviruses.
HCoV-229E da HCoV-OC43 suna rarraba a duniya kuma suna yaduwa a lokacin hunturu, a cikin yanayi mai laushi.
A gaba ɗaya, lokacin yin amfani da waɗannan ƙwayoyin cuta biyu bai kai mako ɗaya ba, sannan kuma lokacin rashin lafiya na kusan makonni biyu.
A cewar wani bincike da aka yi da masu aikin sa kai na mutum, mutanen da ke da lafiya da suka kamu da cutar HCoV-229E sun kamu da sanyi mai tsanani.
Wasu marasa lafiya da ke fama da cutar sun sami kamuwa da cutar ta kasa.
SARS, wanda aka fi sani da atypical pneumonia, ya haifar da annobar farko da cutar coronavirus ta mutum ta haifar a tarihin ɗan adam, kuma wakili na etiological shine SARS-CoV, coronavirus na uku na mutum da aka gano.
An fara samun cutar SARS a ƙarshen shekara ta 2002 a lardin Guangdong, China.
Cutar SARS ta haifar da shari'o'i 8096 da aka ruwaito tare da mutuwar 774 kuma ta bazu a ƙasashe da nahiyoyi da yawa.
Baya ga masu yadawa, an kiyasta cewa kowane hali zai iya haifar da wasu lokuta biyu na biyu, tare da lokacin yin amfani da kwanaki 4 zuwa 7 da kuma farawar mafi girman nauyin kwayar cutar a rana ta goma ta rashin lafiya.
Marasa lafiya da ke dauke da cutar SARS-CoV suna fara da ciwon hanci, ciwon kai, zazzabi, rashin jin daɗi da sanyi, sannan suna da rashin jin daɗi, tari da kuma wahalar numfashi a matsayin alamun rashin lafiya.
Lymphopenia, rashin aikin hanta, da kuma yawan creatine kinase sun zama sanannun sakamako a gwajin SARS.
Ana ganin cutar alveolar da ta bazu, ƙwayoyin epithelial da kuma karuwar macrophages a cikin marasa lafiya da ke fama da SARS.
Kimanin kashi 20 zuwa 30 cikin 100 na marasa lafiya suna bukatar kulawa mai tsanani da kuma taimakon numfashi.
Baya ga ƙananan hanyoyin numfashi, gabobin jiki da dama, ciki har da gastrointestinal tube, hanta da koda, na iya kamuwa da cutar a cikin waɗannan mawuyacin hali, yawanci tare da hadari na cytokines, wanda zai iya zama mai kisa, musamman a cikin marasa lafiya masu rashin ƙarfi.
An fara gano cutar ne daga binciken da aka yi a cikin huhu na wani dangin wanda ya fara tafiya daga Guangzhou zuwa Hong Kong.
Tun daga wannan lokacin, an yi ƙoƙari sosai wajen bincike kan cutar coronavirus a cikin mutane.
HCoV-NL63 ya rabu da wani yaro mai wata bakwai daga Netherlands a ƙarshen 2004.
Da farko an gano cewa yana da yawa a cikin yara ƙanana, tsofaffi da marasa lafiya masu rashin lafiya da cututtukan numfashi.
Coriza, conjunctivitis, zazzabi da bronchiolitis sun zama ruwan dare a cikin cutar da HCoV-NL63 ta haifar.
Wani bincike na daban ya bayyana cewa an ware wannan kwayar daga samfurin hanci na wani yaro mai wata takwas da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi a Netherlands, a gaskiya an rarraba shi a duniya.
An kiyasta cewa HCoV-NL63 yana haifar da kusan kashi 4.7 cikin dari na cututtukan numfashi na yau da kullun, kuma mafi yawan cututtukan su suna faruwa a farkon bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da cutar laryngitis ta obstructive, wanda aka fi sani da crup.
A shekarar nan, HCoV-HKU1 ya ware daga wani mutum mai shekaru 71 da aka kwantar da shi asibiti da ciwon huhu da bronchiolitis a Hong Kong.
Baya ga cutar huhu da kuma cutar sankarar hanta da aka samu a cikin al'umma, an bayar da rahoton cewa HCoV-HKU1 yana da alaƙa da matsanancin cutar asma.
Kamar HCoV-NL63, HCoV-229E, da HCoV-OC43, HCoV-HKU1 yana ko'ina cikin duniya kuma yana haifar da ƙananan cututtukan numfashi.
Wadannan mutane hudu da aka samu a cikin al'umma sun dace da mutane sosai kuma, gabaɗaya, ba su da wataƙila su canza don haifar da cututtukan cututtuka masu cutarwa, kodayake akwai haɗari daga dalilai da ba a sani ba, kamar a cikin wani abu da ba a saba gani ba na wani nau'in cutar HCoV-NL63, wanda kwanan nan aka ruwaito ya haifar da kamuwa da cutar ta hanyar numfashi a China.
Gabaɗaya, lokacin da waɗannan cututtukan coronavirus na ɗan adam suka sami ikon watsawa yadda ya kamata kuma su ci gaba da kasancewa a cikin ɗan adam, suma sun zama marasa ƙarfi ko masu cutarwa.
An fara ware cutar MERS-CoV a shekarar 2012 daga huhu na wani mutum mai shekaru 60 da haihuwa wanda ya kamu da cutar huhu mai tsanani da kuma rashin karfin koda a Saudiyya.
Ko da yake yawancin cututtuka da aka tabbatar a cikin dakin gwaje-gwaje sun fito ne daga Gabas ta Tsakiya, an yi rahoton wasu cututtuka da aka shigo da su tare da kamuwa da cutar ta yau da kullum zuwa ga mutane da yawa a ƙasashen Turai da Tunisiya.
Wani yaduwar cutar ta biyu ta faru a Koriya ta Kudu a shekarar 2015 inda aka tabbatar da mutum 186.
Halin da ake nunawa a asibiti na MERS ya yi kama da na SARS, wanda ke nuna ci gaba da cutar huhu mai tsanani.
Ba kamar SARS ba, marasa lafiya da yawa da ke fama da cutar MERS sun kuma sami rashin lafiyar koda mai tsanani, wanda har zuwa yanzu MERS ne kawai ke faruwa a cikin cututtukan da cutar ta haifar da mutane.
Fiye da kashi 30 cikin dari na marasa lafiya suna da alamun gastrointestinal, kamar su diarrhea da kuma amai.
A ranar 14 ga Fabrairu, 2020, an tabbatar da fiye da 2500 a cikin dakin gwaje-gwaje, tare da babban kisa na 34,4%, wanda ya sa MERS-CoV ya zama ɗayan ƙwayoyin cuta mafi lalacewa ga mutane da aka sani.
Daga tsakiyar zuwa ƙarshen Disamba na 2019, an gano tarin marasa lafiya da cutar huhu a Wuhan, lardin Hubei, China, waɗanda a baya suka danganta da SARS-CoV-2.
Hukumar Lafiya ta Duniya ta bayyana barkewar kamuwa da cutar ta hanyar numfashi ta kasa da ta haifar da SARS-CoV-2 a matsayin gaggawa na lafiyar jama'a na duniya kuma, a baya, ta kira cutar COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da shari'o'i 90 053 a duk duniya, tare da mutuwar 3,4%.
Abin lura, a birnin Hubei na kasar Sin, yawan mutuwa ya kai kashi 4.2 cikin dari, yayin da a wajen kasar, kashi 1.2 cikin dari.
SARS-CoV-2 yana haifar da kamuwa da cutar numfashi mai tsanani, kamar SARS-CoV da MERS-CoV, wanda ke nunawa kamar zazzabi, tari da rashin numfashi.
An kuma lura da ciwon ciki a wasu marasa lafiya.
Ciwon huhu yana cikin alamun da suka fi tsanani kuma yana iya saurin zama ciwon numfashi mai tsanani.
Ko da yake SARS-CoV da SARS-CoV-2 sun yi kama da juna saboda babban homology na nucleotide na 82%, an rarraba su zuwa rassan daban-daban na itacen phylogenetic.
SARS-CoV-2 a bayyane yake ba shi da cutar, amma ya fi watsawa idan aka kwatanta da SARS-CoV da MERS-CoV.
An samu rahoton mutane marasa alamar cutar SARS-CoV-2, wanda zai iya taimakawa wajen yaduwar ta cikin sauri a duniya.
Idan aka kwatanta SARS-CoV-2 da sauran cututtukan coronavirus shida na mutum, ana gano kamanceceniya da bambance-bambance masu ban sha'awa.
Na farko, lokacin da ake yin kwayar cutar da tsawon lokacin da cutar ta coronavirus ke faruwa a cikin mutane suna kama da juna.
A wannan bangaren, SARS-CoV-2 ya bi al'amuran sauran cututtukan coronavirus shida na mutum.
Na biyu, tsanani na bayyanar cututtukan COVID-19 ya kasance tsakanin SARS-CoV da kuma kwayar cutar coronavirus guda hudu na mutane da aka samu a cikin al'umma (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da cutar SARS-CoV-2 tana da halaye da aka fi gani a kamuwa da cutar coronavirus ta mutane da aka samu a cikin al'umma, wanda ya haɗa da gabatar da alamun bayyanar cututtuka marasa mahimmanci ko kuma marasa ƙarfi ko ma rashin bayyanar cututtuka.
A gefe guda kuma, an lura da ƙaramin ƙaramin ƙaramin ƙaramin COVID-19 kamar yadda yake faruwa da kamuwa da cutar SARS-CoV, kodayake alaƙar ta ɗan ragu.
Na uku, watsa SARS-CoV-2 kuma yana nuna wasu halaye masu ban sha'awa na coronavirus na mutane da aka samo a cikin al'umma da SARS-CoV.
A gefe guda, watsawar SARS-CoV-2 tana da sama da na kwayar cutar coronavirus da aka samu a cikin al'umma.
A gefe guda kuma, ya rage a duba ko watsawar SARS-CoV-2 ta ragu bayan wucewa tsakanin mutane, kamar yadda yake faruwa da SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran cututtukan coronavirus na mutum, ana iya gano SARS-CoV-2 a cikin samfurori na ƙura.
Ko watsawar SARS-CoV-2 ta hanyar magungunan magunguna tana da muhimmiyar rawa, kamar yadda yake a SARS-CoV, aƙalla a wasu yanayi, har yanzu yana buƙatar bayyanawa a cikin nazarin gaba.
Har ila yau, yana da matukar sha'awa a gano ko SARS-CoV-2 na iya nuna yanayi, kamar yadda yake a cikin yanayin coronavirus na mutane da aka samo a cikin al'umma.
Duk da haka, siffofin SARS-CoV-2, gami da watsawa, kamuwa da cuta da kuma ci gaba da yaduwa bayan wucewa tsakanin mutane, za su yi tasiri a ƙarshen barkewar cutar COVID-19.
An samu cututtukan cutar coronavirus guda hudu daga mutane da suka kamu da su a cikin al'umma da ke haifar da bayyanar cututtuka masu sauƙi sun dace da mutane sosai.
Daga wani ra'ayi, zai iya zama gaskiya cewa mutane sun daidaita da kyau ga wadannan cututtukan coronavirus guda hudu na mutane.
A wasu kalmomin, su biyun na iya tsira daga annobar cutar coronavirus ta mutane.
An kawar da kwayar cutar coronavirus daga mutane da ke haifar da cututtuka masu tsanani a cikin mutane da kuma mutane da suka sami cututtuka masu tsanani ta hanyar coronavirus daga mutane.
Don haka, dole ne a yi kwayar cutar coronavirus a cikin mutane a isa ya ba da damar tarin canje-canje masu dacewa waɗanda ke magance abubuwan hana baƙo.
A wannan ma'anar, idan cutar SARS-CoV-2 ta ci gaba da yaduwa kuma mutane da yawa sun kamu da cutar, hakan zai sa ta zama mai yiwuwa ta dace da mutane gaba ɗaya.
Idan ya dace da shi, zai yi wuya a hana shi watsawa ga mutane ta hanyar killacewa ko kuma wasu matakan sarrafa kamuwa da cuta.
Shekaru da dama, cututtukan coronavirus guda hudu da aka samu a cikin al'umma sun yi yawo a cikin al'ummomin mutane kuma sun haifar da sanyi na yau da kullun a cikin mutanen da ke da rigakafi.
Waɗannan ƙwayoyin ba sa bukatar wani tankin dabba.
A akasin haka, SARS-CoV da MERS-CoV masu cutar da ke da cutar ba su dace da mutane ba kuma watsa su tsakanin mutane ba shi da inganci.
Suna bukatar su ci gaba da yadawa a wuraren da suke ajiye su na dabbobi kuma suna neman damar da za su iya yadawa ga mutane masu iya kamuwa da cutar, wataƙila ta hanyar baƙo na tsakiya ɗaya ko fiye da masu faɗaɗa.
SARS-CoV-2 yana da halaye iri ɗaya da SARS-CoV da MERS-CoV da kuma kwayar cutar coronavirus huɗu na ɗan adam da aka samo daga al'umma.
Yana da matukar yaduwa kamar yadda cutar coronavirus ta mutum ta samu a cikin al'umma, aƙalla a yanzu.
Duk da haka, ya fi cutarwa fiye da kwayar cutar ta 'yan adam da aka samu a cikin al'umma kuma ya fi cutarwa fiye da SARS-CoV ko MERS-CoV.
Za a ga ko zai dace da mutane sosai kuma zai yi tafiya tsakanin mutane ba tare da wani mai ba da sabis na dabba ko kuma mai ba da sabis ba.
Kafin mu bincika asalin dabbobi na coronavirus na mutane, zai taimaka mana mu bincika ma'anoni da halaye na masu baƙon juyin halitta, na halitta, na tanadi, matsakaici da masu haɓaka coronavirus na mutane.
Dabba tana aiki a matsayin mai baƙon juyin halitta na coronavirus na mutane idan tana da kakan da ke da alaƙa da juna wanda ke da babban homology a matakin jerin nucleotides.
Kwayar cutar ta asali tana da kyau kuma ba ta da cutar a cikin wannan baƙon.
Hakazalika, wani baƙo a cikin tanki yana ɗaukar wani kwayar cutar coronavirus ta mutum a cikin dogon lokaci.
A lokuta biyu, baƙi suna kamuwa da cutar ta halitta kuma baƙi ne na al'ada na coronavirus na mutane ko kuma ƙwayar cutar.
Amma idan an shigar da cutar coronavirus a cikin baƙon matsakaici kafin ko kusan lokaci guda da aka gabatar da ita a cikin mutane, ba ta dace da sabon baƙon ba kuma yawanci tana da cutar.
Mai watsa shiri na tsakiya na iya zama tushen zoonotic na kamuwa da cuta a cikin mutane kuma ya cika aikin mai karfafawa ta hanyar ba da damar cutar ta sake karuwa ta ɗan lokaci sannan kuma ta watsawa ga mutane don ƙara girman kamuwa da cuta a cikin mutane.
Wani mutum mai dauke da cutar coronavirus zai iya haifar da kamuwa da cutar a cikin baƙon da ya mutu idan ba zai iya ɗaukar watsawar ba a cikin baƙon da ya shiga tsakani.
A akasin haka, kwayar cutar coronavirus na mutum na iya daidaitawa ga baƙon matsakaici kuma, har ma, haifar da cutar ta dogon lokaci.
A wannan yanayin, baƙon matsakaici ya zama baƙon ajiyar halitta.
Bayanai na cututtuka sun nuna a baya cewa farkon SARS ya yi hulɗa da dabbobi masu farauta.
Binciken da aka yi a baya game da cutar ta HIV ya nuna cewa masu sayar da dabbobi suna da yawan IgG na cutar SARS-CoV fiye da yawan jama'a.
Cifeta daga masked dabbobi (Paguma larvata) da kuma kare raccoon a cikin kasuwannin dabbobi masu rai sune farkon masu ɗaukar ƙwayoyin cuta masu kama da SARS-CoV waɗanda kusan daidai suke da SARS-CoV.
Wannan ya goyi bayan rashin daidaito ta hanyar rashin samun karin cututtukan SARS bayan an kashe dukkan 'yan kasuwa a kasuwannin.
Duk da haka, an ruwaito cewa civets daga daji masked dabbobi ko gonaki ba tare da fallasa zuwa kasuwannin dabbobin rai ba sun fi yawa ba da cutar SARS-CoV, wanda ke ba da shawarar cewa civets daga masked dabbobi kawai zasu yi aiki a matsayin matsakaiciyar baƙo mai haɓaka, amma ba a matsayin tanadi na halitta na SARS-CoV ba.
Abin lura, tun da kashi 80 cikin 100 na dabbobi daban-daban a kasuwannin Guangzhou suna da rigakafin anti-SARS-CoV, ba za a iya ƙyale yiwuwar cewa wasu ƙananan dabbobi masu shayarwa ma suna aiki a matsayin baƙi masu haɓaka SARS-CoV ba.
Dukkansu sun bayyana a matsayin baƙi na ƙarshe na SARS-CoV.
Bincike na baya na baƙon dabba na SARS-CoV ya nuna wani nau'in cutar kwayar cutar kwayar cutar da ke da alaƙa da juna, wanda ake kira CoV HKU3 na kwayar cutar Rhinolophus da ke da alaƙa da SARS (SARSr-Rh-BatCoV HKU3), wanda ke wanzu a cikin kwayar cutar ta kasar Sin.
Wadannan bats suna da kyau a cikin anti-SARS-CoV antibodies da kuma SARSr-Rh-BatCoV HKU3 genomic tsari.
Wannan da sauran cututtukan kwayar cutar bats suna da daidaituwa na kashi 88-92 cikin dari na tsarin nucleotide tare da SARS-CoV.
Waɗannan binciken sun kafa tushen sabon ra'ayin cewa bats suna da ƙwayoyin cuta a cikin mutane.
An gano wasu cututtukan coronavirus masu kama da SARS (SL-CoV) a cikin bats, amma babu wani daga cikinsu, sai dai wanda ake kira WIV1, wanda zai iya ware kansa a matsayin kwayar cutar mai rai.
An san cewa enzyme mai canza angiotensin 2 (ACE2) na mutum shine mai karɓar SARS-CoV.
An nuna cewa WIV1 da aka samu daga samfurin ƙwayoyin ƙwayoyin cuta na ƙwayoyin cuta yana amfani da ACE2 na ƙwayoyin cuta, civets da mutane a matsayin mai karɓa don shiga cikin kwayoyin.
Abin mamaki, magungunan marasa lafiya da ke da cutar SARS sun iya hana cutar ta WIV1.
Har zuwa yanzu, WIV1 yana wakiltar asalin SARS-CoV mafi alaƙa da juna a cikin bats, wanda ke da daidaituwa na 95% na nucleotide.
Duk da yawan homology tsakanin wadannan kwayoyin cutar biyu, a gaba ɗaya an yi imanin cewa WIV1 ba shine cutar iyaye ta SARS-CoV ba kuma cewa bats ba su da baƙon ajiyar SARS-CoV.
A cewar nazarin ilimin halittu, MERS-CoV an rarraba shi cikin rukuni ɗaya da CoV-HKU4 na bat da CoV-HKU5 na bat.
CoV-HKU4 na bats da MERS-CoV suna amfani da mai karɓar mai karɓar guda ɗaya, dipeptidyl peptidase 4 (DPP4), don shigar da kwayar.
Tsarin RNA na RNA na MERS-CoV na RNA na RNA suna kusanci da kwatancen betacoronavirus na bat wanda aka gano a Turai da Afirka.
Har yanzu ba a iya samun wani MERS-CoV mai rai a cikin bats na daji ba.
MERS-CoV da kuma danginsa mafi kusa, CoV-HKU25 na bats, suna da homology na nucleotide na kashi 87 cikin ɗari.
Saboda haka, ƙanƙara ba zai iya zama baƙon ajiyar MERS-CoV ba.
A gefe guda kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa dromedaries suna da cutar HIV a cikin ƙwayoyin rigakafin MERS-CoV musamman, kamar yadda raƙuma da suka fito daga Gabas ta Tsakiya a wasu ƙasashen Afirka.
Wani MERS-CoV mai rai wanda yayi kama da cutar da aka samu a cikin mutane ya ware daga nasal exudate na dromedaries, wanda ya ƙara tallafawa raƙuma suna aiki a matsayin baƙi na tabbataccen tanadi na MERS-CoV.
Haka kuma, ya kamata a lura cewa, a gaba ɗaya, an lura da bayyanar cututtuka masu sauƙi, amma yaduwar cutar a cikin raƙuma da aka kamu da su don bincike tare da MERS-CoV.
Ana lura cewa raƙuman da suka kamu da cutar suna yada kwayar cutar ba ta hanyar numfashi kawai ba, har ma ta hanyar ƙwayoyin cuta na bakin ciki, wanda kuma shine babbar hanyar yada kwayar cutar daga bats.
Duk da haka, har yanzu akwai tambayoyi, saboda yawancin shari'o'in MERS da aka tabbatar ba su da tarihin hulɗa da raƙuma kafin bayyanar cututtuka, wanda ana iya danganta shi da watsa tsakanin mutane ko kuma ta hanyar watsawa da ba a sani ba wanda ya shafi jinsunan dabbobi da ba a san su ba da ke dauke da MERS-CoV.
SARS-CoV-2 yana da kashi 96,2% na nucleotide homology tare da kwayar cutar kwayar cutar, RaTG13, ta ware daga kwayar cutar Rhinolophus affinis.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin tsari tsakanin SARS-CoV-2 da RaTG13 ya yi yawa don sanya dangantaka ta iyaye.
Wannan yana nufin cewa bats bazai iya zama baƙi na SARS-CoV-2 ba sai dai idan sun kasance a cikin coronavirus na gaba na bat kusan iri ɗaya.
Ana zaton cewa, baƙi na dabbobi na SARS-CoV-2 ya kamata su kasance cikin jinsunan daji da ake siyarwa da kashewa a kasuwar sayar da kifin teku ta Huanan, wanda yawancin farkon shari'o'in COVID-19 suka haɗu da shi, wanda ke nuna yiwuwar watsawar dabba zuwa mutum.
Wasu binciken da aka yi kwanan nan dangane da tsarin tsara halittu sun nuna cewa wasu ƙananan dabbobi masu haɗari, da aka sani da pangolines (Manis javanica), na iya zama gida ga betacoronavirus na asali da suka shafi SARS-CoV-2.
Jini na sabon cutar sankolin nan ta bangolin nan tana da daidaituwa tsakanin kwayoyin halitta 85-92% da SARS-CoV-2.
Duk da haka, suna da alaƙa da RaTG13 kuma suna da kusan kashi 90 cikin ɗari na ainihin nucleotide.
Ana tattara su zuwa ƙananan kwayoyin cutar biyu masu kama da SARS-CoV-2 a cikin itacen halitta, ɗayan yana da yankin haɗin mai karɓa (RBD) wanda ya fi kama da SARS-CoV-2, tare da asalin amino acid na 97,4%.
A bambanci mai ban mamaki, RBD na SARS-CoV-2 da RaTG13 sun fi bambanta, duk da yawan homologin tsari a cikin dukkanin kwayoyin halitta.
Wani binciken da aka yi a baya a kan 'yan kungiya masu rashin lafiya ya kuma ba da rahoton gano cututtukan kwayar cutar a cikin samfurori na huhu, wanda ya bayyana cewa suna da alaƙa da SARS-CoV-2.
Wannan binciken ya yi amfani da hanyoyin da za a yi amfani da su wajen yin gyare-gyare da kuma gyara su da hannu don samar da jerin kwayoyin halitta na ɓangare wanda ya ƙunshi kusan kashi 86.3 cikin 100 na kwayoyin halitta na cikakken tsawon.
Ba za mu iya ƙin yiwuwar cewa pangolin yana ɗaya daga cikin dabbobi masu tsakiya na SARS-CoV-2.
Duk da haka, a halin yanzu babu wata hujja da ke tallafawa asalin kai tsaye a cikin SARS-CoV-2 pangolin saboda bambancin tsari tsakanin SARS-CoV-2 da betacoronavirus na pangolin da suka shafi SARS-CoV-2.
Bugu da ƙari, nisan da ke tsakanin SARS-CoV-2 da RaTG13 ya fi na SARS-CoV-2 da kuma betacoronavirus na pangolin da ke da alaƙa da SARS-CoV-2 karami.
Har yanzu ba a gano hanyar juyin halitta na SARS-CoV-2 a cikin bats, pangolins da sauran dabbobi masu shayarwa ba.
Ko da yake an sami mafi girman homologue a cikin RBDs tsakanin SARS-CoV-2 da pangolin, betacoronavirus da suka shafi SARS-CoV-2, SARS-CoV-2 da RaTG13 suna da mafi girman cikakken homologue na genome.
Yana da matukar zato cewa babban kamance tsakanin RBDs na betacoronavirus na pangolin da suka shafi SARS-CoV-2 da SARS-CoV-2 ya danganta da juyin halitta mai juyawa ta hanyar zaɓaɓɓu.
Wani takaddama na kare sake haɗuwa tsakanin betacoronavirus na pangolin da ke da alaƙa da SARS-CoV-2 da RaTG13 a cikin nau'in dabba na uku.
A matsayin mai motsawa a juyin halitta, sake haɗuwa yana yaduwa tsakanin betacoronavirus.
Har yanzu ba a cimma wata hujja ba game da asalin zoonotic na SARS-CoV-2.
Baya ga cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Shaidar ilimin halittu ta nuna cewa HCoV-NL63 da HCoV-229E na iya fitowa daga kwayar cutar bats, yayin da aka gano kwayoyin cutar HCoV-OC43 da HCoV-HKU1 a cikin rodents.
An bayar da rahoton cewa wani kwayar cutar kwayar cutar da ake kira ARCoV.2 (coronavirus na tsaunukan Appalaches) da aka gano a cikin kwayar cutar tricolor a Arewacin Amurka tana da alaƙa da HCoV-NL63.
A gefe guda kuma, HCoV-229E yana da alaƙa ta hanyar kwayoyin halitta da wani coronavirus na bats, mai suna Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, kodayake an yi zargin cewa chamelets ne baƙi na tsakiya.
Don ƙarin bayani, an taƙaita ilimin da aka samu game da asalin dabbobi na cutar coronavirus daga mutane da aka sani a hoto na 1 da tebur na 2.
Binciken ilimin halittu ya ba da hujjoji game da abubuwan da suka faru na watsa coronavirus daga mutane zuwa jinsuna a tarihi.
Lokacin da HCoV-OC43 ya ratsa tsakanin jinsuna har ya kamu da mutane daga dabbobi a cikin 1890, an yi rikodin annobar kamuwa da cutar numfashi.
Ba a san tarihin watsa HCoV-229E tsakanin jinsuna ba daidai.
An gano alphacoronavirus na bats da ke da alaƙa da HCoV-229E.
Daga cikin su akwai alpaca alphacoronavirus.
Akwai shaidu da yawa da suka nuna cewa cutar ta tashi daga bats zuwa mutane kai tsaye.
Na farko, ba kamar alpacas ba, mutane za su iya yin hulɗa da bats a cikin wani yanki na muhalli.
Amma, mutane suna da dangantaka mai kyau da alpacas.
Na biyu, alphacoronavirus na bats da ke da alaƙa da HCoV-229E sun bambanta kuma ba su da cutar a cikin bats, yayin da alphacoronavirus na alpacas ya haifar da barkewar cutar numfashi a cikin dabbobi masu kamuwa da cutar.
A ƙarshe, ba a gano cutar alphacoronavirus ta alpacas a cikin dabbobin daji ba.
Saboda haka, ba za a iya ƙin yiwuwar alpacas su sami alphacoronavirus da ke da alaƙa da HCoV-229E daga mutane ba.
A gaskiya, bats ne tushen kai tsaye na ƙwayoyin cuta masu cutar a cikin mutane, kamar su ƙwayar zazzabi, ƙwayar cutar Ebola, ƙwayar Nipah, da kuma ƙwayar Hendra.
Saboda haka, ba abin mamaki ba ne cewa bats suna watsa HCoV-229E kai tsaye zuwa ga mutane.
A madadin haka, yayin da alphacoronavirus na bats ke aiki a matsayin tarin kwayoyin HCoV-229E, alpacas da dromedaries na iya aiki a matsayin baƙi na tsakiya waɗanda ke watsa ƙwayoyin cutar ga mutane, musamman a cikin yanayin MERS-CoV.
MERS-CoV misali ne mai kyau na watsawa tsakanin jinsuna, daga bats zuwa dromedaries, da kuma dromedaries zuwa mutane.
An gano asalin juyin halitta na MERS-CoV a cikin bats, tare da gano shi na farko, kuma an kuma goyi bayan binciken da ya gabata.
A bayyane yake cewa ƙwayoyin cuta suna taimakawa wajen musayar kwayoyin halitta tsakanin jinsuna da kuma watsa su tsakanin jinsuna.
Rayuwa mai tsawo, yawan mazaunan da ke cikin gida, da kuma kusantar da mutane da kuma iyawar tashi, duk suna da kyau sosai kuma suna sa ƙwari su zama "mai yada kwayar cutar".
A gefe guda kuma, cutar ta MERS-CoV ta shiga cikin dromedaries na shekaru da yawa.
Ya dace da waɗannan raƙuman, waɗanda suka zama baƙo na matsakaici, zuwa baƙo na ajiyar ruwa mai ɗorewa.
MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana riƙe da ƙananan canjin canji a cikin waɗannan dabbobi.
Yadawar sa zuwa ga mutane ba zato ba tsammani ne kuma mutane har yanzu baƙi ne na ƙarshe na MERS-CoV, saboda watsawar ba ta da ɗorewa.
Idan aka kwatanta da rawar da raƙuma ke takawa wajen watsa MERS-CoV, rawar da pangolin ke takawa, idan akwai, wajen watsa SARS-CoV-2 ta bambanta.
A cikin al'ada, betacoronavirus na pangolin suna da matukar cutarwa a pangolin.
Suna iya zama baƙo na betacoronavirus da ke da alaƙa da SARS-CoV-2, kamar yadda civets ke da alaƙa da SARS-CoV.
Akwai yiwuwar watsa SARS-CoV-2 tsakanin jinsuna daga dabba zuwa mutum, dole ne a tabbatar ko a watsar da su a cikin nazarin gaba.
Da farko dai, bats na iya zama mai masaukin ajiya na wani kwayar cutar da ta shafi SARS-CoV-2, kusan iri ɗaya da SARS-CoV-2.
Mutane za su iya raba yankin da suke da kyau da kuma bats ta hanyar kashewa ko kuma hakar danyen kwal.
Na biyu, pangolin na iya kasancewa ɗaya daga cikin baƙi masu haɓaka na tsakiya wanda cutar da ke da alaƙa da SARS-CoV-2 ta shigo kwanan nan.
Mutane suna kamuwa da cutar ta hanyar kashe da cin naman farauta.
Da yawa daga cikin dabbobi masu shayarwa, ciki har da dabbobi na gida, suna iya kamuwa da SARS-CoV-2.
Ana bukatar nazarin rigakafin a cikin dabbobi da kuma daji.
Na uku, kamar yadda aka ambata a baya, sake haɗuwa da daidaita SARS-CoV-2 na iya faruwa a cikin nau'i na uku wanda ke da lamba da bats da pangolins.
Ana ci gaba da binciken asalin dabbobi na SARS-CoV-2.
Baya ga nau'ikan dabbobi masu baƙo, manyan abubuwa uku a cikin yanayin ƙwayoyin cuta suna da muhimmiyar rawa wajen sauƙaƙa coronavirus don ƙetare shingen nau'in.
Na farko, yawan mutations da suke yi a RNA replication.
Idan aka kwatanta da sauran kwayoyin RNA guda ɗaya, ana iya ɗaukar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigarƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙƙ.
Kwayoyin cutar coronavirus suna da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Abin sha'awa, an san cewa analog na remdesivir na nukiliyotid yana kawar da kwayar cutar coronavirus ta hanyar hana wannan exorribonuclease da RNA mai dogaro da RNA polymerase.
Remdesivir yana daya daga cikin masu bada shawara mafi yawa na anti-SARS-CoV-2 da aka gwada a cikin gwaji na asibiti.
Duk da haka, yawan mutations na coronavirus kusan sau miliyan ne fiye da na baƙi.
Bugu da ƙari, yawanci yawan canjin yana da yawa idan ƙwayoyin cuta na coronavirus ba su dace da baƙo ba.
Idan aka kwatanta da SARS-CoV, wanda ke da yawan canjin canji, yawan canjin SARS-CoV-2 a bayyane yake ƙasa, yana ba da shawarar matakin daidaitawa mafi girma ga mutane.
Da fatan ya riga ya daidaita da wani baƙo kusa da mutane.
Baya ga SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya dace da dromedaries.
A ka'idar, ba zai yiwu ba cewa juyin halitta ya sa alluran rigakafi da maganin rigakafin SARS-CoV-2 su rasa ingancin su da sauri.
Na biyu, RNA mai tsawo na coronavirus yana ba da ƙarin filastik a cikin gyaran genom don maye gurbin da sake haɗuwa kuma, ta wannan hanyar, yana ƙara yiwuwar haɓaka tsakanin jinsuna, wanda ke ba da damar bayyanar sabbin coronavirus lokacin da aka ba da yanayin da ya dace.
Wannan yana da nasaba da tsarin karantawa na musamman da ke buɗewa da kuma ayyukan furotin da aka yi wa lakabi zuwa ga tsarin 3' na genom.
Na uku, kwayar cutar coronavirus tana sauya samfuran ta hanyar bazuwar da kuma sau da yawa yayin kwafin RNA ta hanyar tsarin copy-choice na musamman.
A cikin baƙo da ke aiki a matsayin abin haɗi, sauya sarkar yana faruwa sau da yawa yayin fassarar RNA na coronavirus.
Ana iya haɗa RNA mai tsawon lokaci da kuma ƙananan kwayoyin halitta don samar da sabon coronavirus.
An sami hujjojin filogenetic na sake haɗuwa ta halitta a cikin HCoV-HKU1 da HCoV-OC43, da kuma a cikin coronavirus na dabbobi, kamar SL-CoV na bat da CoV-HKU9 na bat.
Hadin gwiwar ƙwayar cuta da mai watsawa dangane da watsawa
Baya ga abubuwan da aka ambata a baya, haɗuwa da ƙwayar cuta tare da mai karɓar mai karɓar wani muhimmin factor ne wanda ke shafar watsa tsakanin jinsuna.
A halin yanzu, ana ɗaukar sake haɗuwa da SARS-CoV a matsayin misali na yau da kullun, wanda kuma ya nuna hujja na zaɓi mai kyau a cikin abubuwan watsa tsakanin jinsuna.
Bisa ga bincike na kwatancen tsakanin SARS-CoV na mutum da na civet, ana ganin SARS-CoV yana fuskantar saurin daidaitawa a cikin baƙi daban-daban, musamman tare da mutations a cikin RBD na furotin S.
Gabaɗaya, RBD na furotin S na coronavirus yana hulɗa da mai karɓar sel kuma ana zaɓar shi sosai ta hanyar amsawar rigakafin baƙo.
A cikin SARS-CoV, RBD yana cikin amino acid 318 zuwa 510 a cikin sashin S1, wanda ke haɗe da ACE2 na mutum da masu daidaitawa don shigarwar kwayar cutar.
RBD na SARS-CoV na iya gane masu karɓar ACE2 na dabbobi da yawa, gami da bats, civet, mouse, da kuma kare raccoon, yana ba da damar watsa cutar tsakanin jinsuna.
A gaskiya ma, an lura cewa amino acid 6 ne kawai suka bambanta da nau'ikan kwayar cutar mutum da civet a cikin RBD kuma 4 daga cikinsu suna cikin hanyar ɗaurewa ga mai karɓa don hulɗa da mai karɓar ACE2.
SARS-CoV na civet yana da K479N da S487T masu canji a cikin RBD, wanda zai iya ƙara haɗuwa da hulɗar furotin na spike tare da mai karɓar ACE2.
A wasu kalmomi, maye gurbin amino acid guda biyu na iya zama muhimmiyar mahimmanci don daidaitawar kwayar zuwa mutane.
Ya kamata a lura cewa SARS-CoV-2 yana da ƙwayar cuta iri ɗaya da SARS-CoV.
Bambanci na kashi 30 cikin dari tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na furotin S yana nufin cewa haɗakar S na furotin tare da ACE2 na mutum na iya canzawa.
A gaskiya ma, binciken e-cryomicroscopy ya nuna cewa wannan haɗin yana da dangantaka sau 10 zuwa 20 fiye da na ACE2 na mutum da furotin S na SARS-CoV.
Zai kuma kasance da sha'awa a tantance ko wani correceptor zai iya zama dole don watsa SARS-CoV-2.
Abin mamaki, HCoV-NL63 ma yana da alaƙa da ACE2, amma tare da wani ɓangare na S.
Akwai sauran masu karɓar kwayar cutar coronavirus a cikin mutane, kamar aminopeptidase N a cikin HCoV-229E da siallic acid 9-O-acetyl a cikin HCoV-OC43.
Suna iya zama masu alhakin nasarar daidaita wadannan cututtukan coronavirus a cikin mutane, bayan watsa su tsakanin jinsuna daga baƙi na dabbobi.
Baya ga masu karɓar wayar hannu, sakamakon watsa tsakanin jinsunan kwayar cutar ta mutum kuma an ƙaddara shi ne ta wasu abubuwan dogaro da ƙuntatawa na baƙo.
Rashin daidaituwa tsakanin waɗannan furotin masu baƙo tsakanin mutane da baƙi na ajiyar halitta na coronavirus na mutane, kamar kwari, dromedaries da rodents, na iya zama cikas ga watsa tsakanin jinsuna.
Ana buƙatar kwayar cutar ta mutum ta yi amfani da abubuwan dogaro da baƙo da kuma rushe abubuwan da ke hana baƙo don watsa tsakanin jinsuna ya yi nasara.
A wannan batun, ƙididdigar kwayoyin halitta a wannan muhimmin yanki na hulɗar ƙwayar cuta-mai masaukin baki har yanzu dole ne a gano su kuma a ƙayyade su.
Ana iya samun amfani da bincike na gaba ɗaya na tushen kwayoyin halitta na tushen tushen da ƙuntatawa ga SARS-CoV-2 ta amfani da fasahar CRISPR mai ci gaba.
Fitowar sabbin cututtukan coronavirus daga mutane: mun fara daga sifili
Bambancin cututtukan coronavirus na bats yana ba da dama ga bayyanar sabbin cututtukan coronavirus na mutane.
A wannan yanayin, kwayar cutar kwayar cutar ta bats tana aiki ne a matsayin kayan adana kwayoyin cutar coronavirus na mutane.
Bugu da kari, saurin maye gurbin kwayoyin halitta da kuma sake hada kwayoyin halitta, suna kuma inganta juyin halittar kwayar cutar coronavirus a cikin mutane kuma suna da muhimman matakai biyu na wannan tsari.
Alal misali, samun ko rasa sababbin kwayoyin halitta masu ƙunsar furotin na da ikon canja yanayin ƙwayar cuta sosai.
Daga cikin furotin na SARS-CoV, an yi la'akari da cewa ORF8 yana da mahimmanci wajen daidaitawa ga mutane, saboda an ware ƙwayoyin cuta na ƙwayoyin cuta da suka shafi SARS-CoV, amma an gano cewa suna ba da furotin ORF8 daban-daban.
An gano kawar da nucleotides 29 na SARS-CoV a cikin nau'ikan da aka keɓe a farkon annobar a cikin mutane.
Wannan kawar da ORF8 ya raba ORF8a da ORF8b, kuma an yi imanin cewa shi ne maye gurbin da ke inganta canjin baƙo.
Bugu da ƙari, SARS-CoV yana da yiwuwar rikodin rikodin tare da zuriyar alpha da gammacoronavirus, wanda aka gano ƙananan ƙananan yankuna masu rikodin a cikin RNA polymerase mai dogaro da RNA.
An kuma gano wuraren sake haɗuwa a nsp9, mafi yawan nsp10 da kuma sassan nsp14.
Hakazalika, an tabbatar da cewa cutar ta MERS-CoV ta sha wahala daga abubuwan da suka faru na sake haɗuwa tsakanin zuriya daban-daban, wanda ya faru a dromedaries a Saudi Arabia.
Baya ga SARS-CoV da MERS-CoV, an kuma lura da abubuwan da suka faru na sake haɗuwa a cikin sauran coronavirus na mutum, inda coronavirus na mutum ke sake haɗuwa da sauran coronavirus na dabbobi a cikin kwayoyin halitta na su.
Ya kamata kuma a lura cewa zabin mutum na iya taimakawa wajen canzawa ba a so a cikin kwayoyin cuta, wanda zai iya haifar da sakin ƙwayoyin cuta daga matsin lamba na zabin da aka yi, alal misali, ta tsarin rigakafin mai masaukin baki.
Misali na irin wannan tasirin shine asarar cikakken tsawon ORF4 a cikin samfurin HCoV-229E, saboda kawar da nucleotides biyu.
Ko da yake an lura da ORF4 ba tare da lalacewa ba a cikin ƙwayoyin cuta na bats da raƙuma da ke da alaƙa da HCoV-229E, alphacoronavirus na alpacas yana nuna shigar nucleotide guda ɗaya, wanda ke haifar da canjin tsarin.
A ƙarshe, ko da yake ba kasa da muhimmanci ba, ci gaban sabon coronavirus na mutane kuma yana motsawa ne ta hanyar matsin lamba a cikin baƙi na tanadi.
Babu alamun bayyanar cututtuka ko kuma kawai an gano alamun bayyanar cututtuka lokacin da aka kamu da kwari tare da coronavirus, wanda ke nuna daidaitawar juna tsakanin coronavirus da kwari.
A bayyane yake, bats sun dace da coronavirus a fannin jiki da na jiki.
Alal misali, rashin inganci a cikin kunna amsawar kumburi a cikin bats yana rage cututtukan da coronavirus ke haifarwa.
Bugu da ƙari, an kawar da ayyukan kwayoyin halitta masu kisa a cikin bats saboda kyakkyawan tsarin kwayar cutar NKG2/CD94 mai hana kwayoyin halitta masu kisa da kuma ƙananan matakan magana na kwayoyin aji na I na babban tsarin haɗin haɗin gwiwar.
Bugu da ƙari, babban matakin nau'ikan oxygen masu aiki (ROS) da aka samar daga haɓakar ƙwayar cuta na bats zai iya kawar da kwayar cutar coronavirus kuma yana shafar binciken karatun exorribonuclease, wanda ke ba da matsin lamba don samar da nau'ikan ƙwayoyin cuta masu cutarwa sosai lokacin da aka gabatar da su a cikin sabon baƙo.
Hakanan za a iya samo wasu nau'ikan coronavirus masu cutar ta hanyar sake haɗuwa, wanda zai haifar da siyan sababbin sunadarai ko halaye na sunadarai don daidaitawa ga baƙo.
Saboda haka, ba zato ba tsammani ne cewa mutane uku sun kamu da cutar coronavirus a cikin shekaru ashirin da suka gabata.
Kwayoyin cutar coronavirus ba su da cututtuka ko kuma suna haifar da bayyanar cututtuka a cikin baƙi masu tanadi, kamar su bats da raƙuma.
Suna yin kwayar halitta ba tare da haifar da amsa mai ƙarfi na rigakafi daga baƙo ba.
Wannan shi ne ainihin dalilin da ya sa akwai masu dauke da cutar da ba su da alamun cutar, da kuma abin da ke sa mutane su kamu da cutar.
Abubuwan da ke damun su sun fi yawa ne sakamakon hawan rigakafi da kuma yawan sinadarin cytokines, inda idan ya fi ƙarfin rigakafi, cutar huhu ta fi tsanani.
A maimakon haka, a cikin masu dauke da cutar, an raba amsawar rigakafi da kwayar cutar coronavirus.
Wannan dabarar ta kawar da rigakafin rigakafi na iya samun sakamako mai kyau a maganin SARS-CoV-2.
Maganin interferon yana da ƙarfi sosai a cikin bats.
Saboda haka, gudanar da cutar ta type I, aƙalla a farkon lokacin kamuwa da cutar SARS-CoV-2 a cikin mutane, ya kamata ya kasance mai amfani.
Bugu da ƙari, ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
A cewar wannan tunani, hana NLRP3 mai kumburi tare da MCC950 na iya zama da amfani wajen magance COVID-19.
Fitowar SARS-CoV-2 ta bi layin da ya haifar da fitowar SARS-CoV da MERS-CoV.
Ko da yake an gano betacoronavirus na bats wanda ya raba kashi 95 cikin dari na nucleotide homology tare da SARS-CoV, akwai kuma coronavirus na bats wanda ya raba kashi 96 cikin dari na nucleotide homology tare da SARS-CoV-2.
Ko da yake an gano cewa ciyawa da sauran dabbobi a cikin kasuwanni suna da ƙwayoyin cuta iri ɗaya da SARS-CoV, ba a gano baƙi na SARS-CoV-2 na gaba ba.
An gano betacoronavirus na pangolin da ke da kamanceceniya da SARS-CoV-2, wanda ke nuna cewa pangolin na iya zama ɗaya daga cikin baƙi na tsakiya ko kuma pangolin betacoronavirus na iya ba da ɓangarorin gene ga sigar ƙarshe ta SARS-CoV-2.
Ko da yake akwai tambayoyi, babu wata hujja cewa SARS-CoV-2 mutum ne, ko da gangan ko kuma ta hanyar hatsari.
Coronavirus sun dawo da fifiko saboda sabon barkewar SARS-CoV-2.
Nazarin coronavirus a cikin bats da sauran dabbobi ya canza fahimtarmu game da mahimmancin asalin zoonotic da wuraren adana dabbobi na coronavirus daga mutane a cikin watsawa zuwa mutane.
Akwai hujjoji da yawa da suka nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga bats kuma ana watsa su ga mutane ta hanyar baƙi na tsakiya.
Tun da cutar SARS-CoV ta fito ne daga tuntuɓar mutane da civets a kasuwanni, rufe kasuwanni masu zafi da kashe civets da ke cikinsu na iya zama tasiri wajen dakile cutar SARS.
A cewar wannan dalili, ya kamata a janye pangolin daga kasuwannin ruwa don hana watsa cutar zoonotic, saboda gano wasu zuriyar betacoronavirus na pangolin da ke da alaƙa da SARS-CoV-2.
Koyaya, ko kuma yadda SARS-CoV-2 ke watsawa ga mutane ta hanyar pangolins da sauran dabbobi masu shayarwa ya rage a cikin bincike na gaba.
A gefe guda kuma, cutar ta MERS-CoV ta daɗe tana cikin dromedaries.
Waɗannan raƙuman suna da muhimmanci a cikin sufuri, kuma suna da babban tushen nama, madara, fata da ulu ga mazaunan yankin.
Ana rarraba su a Gabas ta Tsakiya da Afirka.
Saboda haka, ba zai yiwu a kashe dukan raƙuman don sarrafa MERS ba, kamar yadda aka yi a China tare da kasuwannin dabbobin daji don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana sake barkewar cutar MERS, ya kamata a dauki cikakken tsarin samar da ingantattun alluran rigakafin MERS-CoV ga raƙuma, tare da sauran matakan sarrafa kamuwa da cuta.
Tun da ba mu iya kawar da waɗannan ƙwayoyin ba, za a iya samun sababbin nau'ikan kwayoyin halitta da ke haifar da barkewar cutar.
Wani nau'in cutar coronavirus na dabbobi, suna yawo a cikin daji.
Musamman, cututtukan coronavirus na bats tare da yiwuwar zoonotic sun bambanta sosai.
Akwai yiwuwar cewa wadannan cututtukan coronavirus na zoonotic za su samo asali kuma su sake haɗuwa, wanda zai haifar da bayyanar sabbin cututtukan coronavirus waɗanda za su iya zama masu yaduwa ko kuma masu kisa ga mutane a nan gaba.
Ya kamata a daina cin dabbobi a wasu wurare a kasar Sin don rage yawan mutane da dabbobi.
Daga mummunan abubuwan da suka faru da SARS, MERS da COVID-19, ya kamata a yi amfani da shirin shiri da amsa mafi kyau.
A gaskiya, ƙwayoyin cuta da yawa sun wanzu a duniya na dogon lokaci.
Suna zama a wuraren da suke da shi har sai sun sami zarafin yin yaduwarsu.
Ko da yake ƙwari suna da halaye da yawa da ke taimaka wa ƙwayoyin cuta su yada, za a iya rage damar da mutane suke da ita na yin hulɗa da ƙwari da sauran jinsunan daji idan aka yi wa mutane gargaɗi su guje musu.
Ana bukatar ci gaba da lura da dabbobi masu shayarwa don fahimtar yanayin yanayin coronavirus da baƙi na halitta, wanda zai taimaka wajen hana watsa dabba zuwa mutum da barkewar cutar nan gaba.
A ƙarshe, hanya mafi inganci ta hana kamuwa da cutar zoonotic ita ce ta nisantar da mutane daga wuraren da ake ajiye kwayoyin halitta na cutar zoonotic.
Har yanzu akwai wasu abubuwa da suka ɓace a cikin jigon asalin SARS-CoV-2.
Da farko, idan bats suna watsa wani kwayar cutar SARS-CoV-2 ga pangolins, zai zama da ban sha'awa a bincika a wace yanayi bats da pangolins zasu iya raba wuri ɗaya na muhalli.
Na biyu, idan ƙuƙwalwa suna da matsayi na musamman wajen watsawa ga mutane, dole ne a gano yadda mutane ke tuntuɓar ƙuƙwalwa.
Na uku, idan dabba ce ta uku da ke ba da sabis na matsakaici, dole ne a fahimci yadda take hulɗa da jinsuna dabam-dabam, ciki har da mutane, bats, da pangolins.
A ƙarshe, tun da yake dabbobi masu shayarwa da yawa, ciki har da dabbobi na gida, na iya zama masu saurin kamuwa da SARS-CoV-2, dole ne a yi sa ido da kuma kamuwa da cutar gwaji.
Ko dai wani kwari ne, ko wani pangolin ko wani dabba mai shayarwa, ana sa ran SARS-CoV-2 ko kuma kwayoyinsa na asali waɗanda suke kusan iri ɗaya za su iya gano kansu a cikin baƙi na halitta a nan gaba.
Ci gaba da bincike a wannan yanki zai bayyana hanyar juyin halitta na SARS-CoV-2 a cikin dabbobi, tare da mahimman abubuwan da ke tattare da rigakafi da kula da COVID-19 a cikin mutane.
Ana bukatar sabunta ka'idodin ganewar asali na masu cutar COVID-19 da ake zargi da kuma wadanda aka tabbatar da cutar
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagorar shawara mai sauri don ganewa da maganin kamuwa da cutar coronavirus ta 2019 (2019-nCoV), kuma wannan jagorar ya haɗa da kwarewarmu kuma yana da kyakkyawan tushe don yaƙar wannan annoba a duk duniya.
Koyaya, cutar coronavirus 2019 (COVID-19) sabuwar cuta ce, hankalinmu da iliminmu suna ƙaruwa a hankali bisa ga sakamakon binciken da ke gudana da ƙwarewar a cikin aikin asibiti; saboda haka, ana sabunta hanyoyin bincike da magani koyaushe.
A cikin wannan wasikar, mun amsa tsokaci game da jagorarmu kuma mun samar da sabbin ka'idodin ganewar asali na haɗari mai zargi da haɗari da aka tabbatar bisa ga Sabbin Ka'idoji don Gano da Kula da COVID-19 (ƙaddara ta bakwai) da Kwamitin Lafiya na Jamhuriyar Jama'ar Sin ya wallafa.
A watan Disambar 2019, sabon coronavirus 2019 (2019-nCoV) ya haifar da barkewar cutar, wanda yanzu ana kiranta cutar coronavirus 2019 (COVID-19) kuma an kira cutar coronavirus 2 na cutar ta numfashi mai tsanani (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta bayyana COVID-19 a matsayin annoba.
Don yaki da kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta haɓaka jagorar shawara mai sauri wanda aka buga a kan layi a Military Medical Research a ranar 06 ga Fabrairu, 2020.
Ya jawo hankalin mutane tun lokacin da aka wallafa shi.
Duk da haka, dole ne a lura cewa COVID-19 sabon cuta ne, hankalinmu da iliminmu suna ƙaruwa a hankali bisa ga sakamakon binciken da ke gudana da ƙwarewar a cikin aikin asibiti; saboda haka, ana sabunta hanyoyin bincike da magani koyaushe.
Alal misali, Ka'idodin Bincike da Kula da COVID-19 da Kwamitin Lafiya na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/) ya wallafa, tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, sun fito da bugu bakwai kuma wasu mahallin sun canza sosai.
Yanzu, jagorarmu ta karɓi tsokaci daga Zhou et al., sun gabatar da wata shawara mai sauƙi ta rarrabuwa bisa ga kwarewarsu ta asibiti.
Ayyukansa sun kara sabbin hujjoji ga jagorarmu kuma yana da mahimmanci ga wannan annoba a duk duniya.
Muna goyon bayan aikin da suka yi kuma muna godiya.
Duk da haka, aikinsa yana bukatar sabuntawa bisa ga sabuwar Jagorar Gwaji da Magani na COVID-19 (sarrafa ta bakwai) da kuma binciken da aka yi kwanan nan.
A cikin bugu na bakwai (Maris 3, 2020), don tabbatar da wani lamari mai sharri ya zama dole a haɗa kowane ma'anar fasalin tarihin cututtuka tare da maki biyu na bayyanar cututtuka don yin cikakken bincike, ko kuma dole ne a cika maki uku na bayyanar cututtuka idan babu bayyanannen tarihin cututtuka:
Tarihin cututtukan cututtuka: (1) tarihin tafiya ko zama a cikin birnin Wuhan da yankunan da ke kusa da shi, ko wasu al'ummomin da aka ruwaito shari'o'in COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) tarihin tuntuɓar cututtuka masu kamuwa da cutar SARS-CoV-2 (tare da gwajin nucleic acid mai kyau); (3) tarihin tuntuɓar marasa lafiya da zazzabi ko alamun numfashi daga birnin Wuhan da yankunan da ke kusa da shi, ko wasu al'ummomin da aka ruwaito shari'o'in COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) tarihin tuntuɓar rukunin mutane da aka tabbatar da cutar (≥ 2 lokuta da zazzabi ko alamun numfashi da suka faru a cikin makonni 2 a cikin ƙananan yankuna kamar gida, ofishi, aji na numfashi, da sauransu).
Bayanan asibiti: (1) zazzabi ko alamun numfashi; (2) siffofi a cikin hotunan kamuwa da cutar COVID-19; (3) jimlar ƙididdigar ƙwayoyin fari waɗanda ke nuna ƙididdigar ƙwayoyin lymphocyte na al'ada, raguwa ko raguwa a farkon matakin farawa.
Ana buƙatar ganewar asali na wani sanannen labari dangane da wani abu mai mahimmanci tare da wasu halaye na cutar ko gwajin serological kamar haka: (1) gwajin polymerase na ainihin lokacin sakamako mai kyau ga SARS-CoV-2; (2) cikakken ƙwayar cuta ta hanyar tsarawa wanda ke nuna babban homogeneity ga sanannun sababbin coronavirus; (3) sakamako mai kyau ga takamaiman IgM antibody da takamaiman IgG antibody da SARS-CoV-2 a cikin gwajin magani; ko canji na takamaiman IgG antibody da SARS-CoV-2 daga mummunan zuwa tabbatacce, ko haɓaka taken ≥4 sau fiye da a lokacin dawowa fiye da a lokacin gaggawa.
Za mu iya ganin cewa an ƙara gwajin sarkar polymerase na ainihin lokacin don gano nucleic acid a cikin jini ko hanyoyin numfashi zuwa na biyu (18 Janairu 2020) da na uku (22 Janairu 2020).
An kara gano kwayoyin cutar daga samfurin jini zuwa bugu na huɗu (27 ga Janairu, 2020) da na biyar (8 ga Fabrairu, 2020); sannan, an kara gwajin serological zuwa bugu na bakwai.
{NS}
Bugu da ƙari, ana samun ƙarin gwaje-gwaje da ke tuna mana cewa dole ne mu yi hankali da marasa lafiya marasa bayyanar cututtuka da marasa bayyanar cututtuka.
Saboda haka, ya kamata a sabunta tsarin Zhou et al. saboda sun sanya mutumin da ba shi da alamun asibiti a matsayin mai "ƙarancin haɗari".
Dole ne a bincika tsarin ƙimar a wasu nazarin da kuma ayyukan asibiti.
A ƙarshe, muna sa ran ƙarin hujjoji na kai tsaye za su fito kuma muna roƙon masu karatu su aiko mana da ra'ayoyinsu.
Don gano abin da ke damun mutum da kuma abin da ya tabbatar da shi, muna ba da shawarar neman sababbin ka'idoji a ƙasarku kuma ku bi su.
Ƙungiyarmu za ta kuma sabunta jagorarmu a kan lokaci don ba da taimako.
Bangladesh ta ba da rahoton sabbin mutuwar biyar na COVID-19, mafi yawan a rana ɗaya
Bangladesh ta tabbatar da wasu mutane biyar sun mutu a ranar jiya saboda COVID-19.
Wannan shi ne adadin mutuwar da aka yi a rana daya saboda cutar.
Har zuwa jiya, Cibiyar Kula da Cututtuka, Kula da Cututtuka da Bincike (IEDCR) ta Bangladesh ta ba da rahoton cewa adadin wadanda suka kamu da cutar sun hada da mutane 114 da suka kamu da cutar da kuma wadanda suka dawo da cutar 33 da ke cikin gidajensu.
An yi rahoton mutuwar mutane 17.
A wani taron da aka yi a yanar gizo, darektan IEDCR, Dokta Meerjady Sabrina Flora, ta ce wadanda suka mutu maza hudu da mace daya.
A cewar Dr. Meerjady, mutane biyu sun fi shekaru 60, biyu sun kai shekaru 51 zuwa 60 kuma daya ya kai shekaru 41 zuwa 50.
Ya kuma ce biyu daga cikin wadanda suka mutu 'yan garin Dhaka ne.
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba.
Wani jami'in asibitin ya shaidawa kamfanin dillancin labarai na Anadolu cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bangladesh, wanda ake kula da shi a asibitin Kuwait Maitree.
A ranar Asabar, a wani sanarwar da aka yi ta hanyar bidiyo ta yanar gizo, ministan sufuri ta hanyar tituna da gadoji na Bangladesh, Obaidul Quader, ya ce za a dakatar da sufuri na jama'a na tsawon lokaci fiye da yadda aka tsara a farkon, har zuwa wannan Asabar mai zuwa.
Wannan dakatarwar ta hanyar sufuri na jama'a ta fara ne a ranar 26 ga Maris kuma an shirya ta ƙare a ranar Asabar, 4 ga Afrilu.
Har ila yau, ana ba da izinin jigilar kayayyaki masu muhimmanci, kamar su kayayyakin kiwon lafiya, man fetur, da abinci.
Mutane na farko da aka samu sun kamu da cutar COVID-19 a Bangladesh a ranar 8 ga watan Maris, maza biyu ne da suka dawo daga Italiya da matar wani daga cikinsu.
A ranar 19 ga Maris, waɗannan uku sun warke.
Fiye da kamuwa da cutar SARS-CoV-2 miliyan a duniya
A ranar Alhamis, jimlar adadin kamuwa da cutar coronavirus SARS-CoV-2 ta wuce miliyan a duniya, a cewar bayanan Jami'ar Johns Hopkins.
Akalla mutuwar mutane dubu 52 ne da suka shafi COVID-19, cutar da coronavirus ta haifar.
Wannan taron ya faru ne a ranar da Malawi ta tabbatar da kamuwa da cutar coronavirus da kuma Zambia ta fara mutuwa sakamakon cutar.
Koriya ta Arewa ta ce, a ranar Alhamis, tana ɗaya daga cikin ƙasashe kalilan da ba su da kamuwa da cutar coronavirus.
A ranar Talata, Hukumar Lafiya ta Duniya ta ba da rahoton mutum 1,051,635 da aka tabbatar da cutar, ciki har da mutum 79,332 a cikin sa'o'i 24 kafin 10 na safe, na yammacin Turai (UTC-0800), na 4 ga Afrilu.
A Amurka, an yi rikodin fiye da 244,000 na cutar coronavirus, wanda ke da alaƙa da mutuwar akalla 5900.
CBS News ta ruwaito, tana ambaton bayanan Jami'ar Johns Hopkins, cewa a ranar Laraba an sami mutuwar sama da 1000 a Amurka sakamakon kamuwa da cutar coronavirus.
A dukan duniya, ƙasashe sun sanar da tsauraran matakai don hana yaduwar cutar.
A ranar Alhamis, magajin birnin Moscow Sergei Sobyanin ya kara wa birnin rufewa har zuwa 1 ga watan Mayu.
A matakin kasa, Shugaba Vladimir Putin ya bayyana cewa 'yan Rasha za su ci gaba da karbar albashin su ba tare da zuwa aiki ba har zuwa 30 ga Afrilu.
Majalisar dokokin Portugal ta amince da tsawaita dokar ta baci ta kwana 15; an amince da kuri'un 215 a madadin, 10 sun yi tsayayya da kuma daya a kan.
Saudiyya ta mika dokar hana fita a cikin biranen Makka da Madina a duk tsawon yini; a baya, dokar hana fita tana ci gaba ne kawai tsakanin 3:00 na yamma da 6:00 na safe.
Thailand ta shirya aiwatar da dokar hana fita tsakanin 10:00 na yamma da 4:00 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita umurninsa na zama a gida har zuwa 1 ga Mayu.
Kasuwancin sayar da kayayyaki a Ostiraliya sun rage yawan kayayyakin da ake amfani da su a duk lokacin da ake yin kasuwanci
A ranar Lahadi da Asabar da yamma, cibiyoyin kantunan sayar da kayayyaki na Australiya Woolworths da Coles sun rage yawan sayen takardar wanka zuwa biyu da ɗaya a kowace ma'amala a duk manyan kantunan da ke kasar, bi da bi.
A ranar Litinin, ALDI ta kuma yi amfani da iyakar kunshin.
An wallafa waɗannan ƙuntatawa a matsayin saƙonni a cikin akwatunan da kuma shafukan Facebook na cibiyoyin sadarwa.
A cewar rahoton, masu amfani suna samun abinci saboda tsoron COVID-19 idan mutane suka yi zaman kansu.
A ranar Laraba, kamfanin Woolworths ya kuma iyakance sayen takardar bayan gida zuwa kunshin da aka ba da umarni.
An gabatar da waɗannan canje-canjen ne bayan an hana Woolworths da Coles daga fakiti huɗu a kowace ma'amala a ranar 4 da 5 ga Maris, bi da bi.
Coles, a cikin sanarwar ta na 8 ga watan Maris, ya ruwaito cewa, tare da aiwatar da takunkumin fakiti hudu, "manyan manyan kantuna har yanzu suna kashe samfurin a cikin sa'a daya na isarwa", kuma ya ce bukatar "ba ta da precedents", yayin da ALDI, a cikin wani rubutu a Facebook a ranar Talata, ya ce shi ne "mara tsammani".
Tallace-tallace sun tashi da "ƙaruwa mai ƙarfi" a makon da ya gabata, a cewar wani mai magana da yawun Woolworths.
Hakanan babban kanti Costco a Canberra ya iyakance adadin zuwa fakiti biyu a makon da ya gabata.
Don ƙara rage ƙarancin, Coles ya nemi manyan fakiti daga masu samarwa kuma ya ƙara yawan isar da kayayyaki, Woolworths ya ba da umarnin ƙarin kaya, yayin da ALDI ta ba da kayayyaki don tayin musamman na ranar Laraba da aka shirya a gaba.
Russell Zimmerman, babban darektan kungiyar masu sayar da kayayyaki ta Australiya, ya ce 'yan kasuwa suna kokarin kara yawan kayayyakin, amma takunkumin da kotun ke kan lokaci na kawo kaya ta hanyar manyan motoci suna sa hakan ya yi wuya.
Ya yi hasashen cewa farashin samarwa zai ƙaru yayin da masu samar da kayayyaki suke ƙoƙarin biyan bukatar, kuma ba za a samu ƙarin kayayyaki ba.
A ranar Talata, ALDI ta sanar da cewa, bayan an saki kaya a gaba, wasu manyan kantuna ba za su iya yin tayin musamman na ranar Laraba ba.
A wani rahoto a News.com.au, Dakta Gary Mortimer, masanin sayar da kayayyaki a Jami'ar Fasaha ta Queensland, ya ce manyan kantuna suna sayar da kayayyaki a kowace dare.
Ya ce takardar bayan gida abu ne mai yawa, wanda ke haifar da ƙananan adadi na adadi, kuma, lokacin da ya ƙare, ya bar sarari mai yawa a kan ɗakunan ajiya, wanda ke ƙara jin ƙarancin.
Coles da Woolworths sun yi tunanin cewa idan akwai abubuwa da yawa a kan ɗakunan ajiya, idan ana iya sayen kayayyaki kamar takarda da kuma maganin kashe ƙwayoyin cuta, kuma akwai adadi mai yawa, za a rage tsoro, in ji Russell Zimmerman a ABC News.
Kamfanin kera takardar bayan gida mai suna Who Gives to Crap ya ce a ranar Laraba da ta gabata sun yi watsi da kayayyakin.
Kimberly-Clark, wanda ke kera takardar wanka Kleenex, da Solaris Paper, wanda ke kera Sorbent, sun ce suna aiki awanni 24 a rana, kwana 7 a mako, don ci gaba da samarwa, a cewar rahoton da News.com.au.
Domain.com, wani shafin sayar da dukiya, ya ruwaito cewa wasu masu sayar da dukiya suna ba da takardar wanka kyauta ga mai sayarwa na farko a cikin gwanjo a Melbourne, lokacin da aka yi ƙananan gwanjo saboda masu sayen suna da lokacin hutu a ƙarshen mako mai tsawo na ranar Ma'aikata.
Labarin ranar Alhamis na NT News, jaridar da aka buga a Darwin, ya haɗa da wani shafi na takwas da aka tsara don a yanka shi kuma a yi amfani da shi a matsayin takardar wanka.
A farkon, manyan kantuna sun nuna rashin son yin takunkumi, a cewar wani rahoto na ABC Australia na 3 ga Maris, inda suka ce ba su da shirin yin takunkumi a cin kasuwa.
Russell Zimmerman ya ƙara da cewa akwai sauran kayayyaki da ake nema sosai, ciki har da masks, disinfectant, kayayyakin bushe, sabulu mai ruwa da gari.
Hakazalika, a waje da Australia, an lura da ranar Lahadi da yamma cewa kantin sayar da kayayyaki na Ocado na Birtaniya ya iyakance sayen takardar bayan gida ta Andres zuwa fakitin 12 na takarda.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annobar annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana barkewar cutar COVID-19 a matsayin annoba, cutar da coronavirus SARS-CoV-2 ta haifar.
Ko da yake kalmar "zazzabin cuta" tana nufin yadda cutar ke yaduwa, ba yadda ake yin hatsari ba, WHO ta nuna bukatar ƙarfafa gwamnatoci su ɗauki mataki:
Dukkanin kasashe na iya canza yanayin annobar.
Idan kasashen suka gano, suka gwada, suka yi maganin, suka ware, suka gano kuma suka yi wa mazauninsu aiki, in ji Tedros Adhanom Ghebreyesus, babban darektan WHO.
Muna matukar damuwa, duka game da matakan yaduwar da kuma tsanani, da kuma matakan rashin aiki.
A cewar Dr. Tom Frieden, tsohon darektan Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka na Amurka, annobar "ba ta da misali".
A cikin wata sanarwa da CNN ta wallafa a watan Fabrairu ta ce, "ban da mura, ba a gano wani kwayar cutar numfashi ba tun lokacin da ta fara zuwa ci gaba da yaduwar duniya".
Ghebreyesus ya bayyana irin wannan ra'ayi, ya ce "ba mu taba ganin annobar cutar coronavirus ba".
"Kuma ba mu taba ganin annobar da za a iya sarrafawa a lokaci guda ba", in ji shi.
Sabuwar yanayin annobar ta taso ne bayan shawarar WHO a watan Janairu na ayyana barkewar cutar a matsayin gaggawa na lafiyar jama'a na muhimmancin duniya.
Shugaban Cibiyar Kula da Cututtuka da Cututtuka na Ƙasar Amirka, Dokta Anthony Fauci, ya ce game da barkewar cutar, "a ƙarshe, za ta ƙara muni".
Har zuwa ranar Alhamis, Associated Press ta ruwaito cewa akwai akalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, kuma fiye da mutane 4,600 sun mutu.
Cutar coronavirus ta 201920 annobar cutar ce ta cutar coronavirus ta 2019 (COVID-19), wanda cutar coronavirus 2 ta haifar da cutar ta hanyar numfashi mai tsanani (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China, a watan Disambar 2019, an ayyana dokar ta baci ta kiwon lafiya ta duniya a ranar 30 ga Janairu, 2020, kuma an amince da ita a matsayin annoba a ranar 11 ga Maris, 2020.
A ranar 10 ga Afrilu, 2020, an ba da rahoton kimanin mutane miliyan 1.61 da suka kamu da COVID-19 a ƙasashe da yankuna 210 da kusan mutuwar 97,000 a sakamakon haka.
Kimanin mutane 364,000 ne suka warke.
An kiyasta cewa yawan mutuwar mutum ya kai kashi 4 cikin 100 a kasar Sin, yayin da a duniya, ya kasance tsakanin kashi 13.04 cikin 100 a Algeria da kuma 0.08 cikin 100 a New Zealand.
Alamun da ake yawan nunawa sun haɗa da zazzabi, tari da kuma rashin numfashi.
Abubuwan da za su iya jawo wa mutum matsaloli sun haɗa da cutar huhu da kuma rashin numfashi mai tsanani.
Lokaci daga bayyanar cututtuka zuwa bayyanar cututtuka, yawanci yana da kwanaki biyar, amma zai iya bambanta daga kwana biyu zuwa goma sha huɗu.
Babu takamaiman maganin rigakafi ko maganin rigakafi.
Maganin farko shi ne maganin bayyanar cututtuka da kuma tallafi. Abubuwan da aka ba da shawarar na rigakafi sun haɗa da wanke hannu, rufe bakinka yayin tari, nisantar da kai daga wasu mutane da kuma sarrafawa da keɓe kai daga mutanen da suka yi zaton suna da kamuwa da cutar.
Hukumomi a duk faɗin duniya sun amsa ta hanyar aiwatar da ƙuntatawa na tafiya, ƙuntatawa, dokar hana fita, kula da haɗari a wurin aiki da rufe wuraren aiki.
Cutar ta haifar da mummunan canji a fannin tattalin arziki da zamantakewar duniya, jinkirta ko soke abubuwan wasanni, addini, siyasa da al'adu, da kuma rashin wadatar kayayyaki da aka kara da yawa saboda cinikin da ake yi.
Makarantu da jami'o'i sun rufe a kasa ko a gida a kasashe 193, wanda ya shafi kusan kashi 99.4 cikin dari na yawan daliban duniya.
An yada wasu bayanai marasa kyau game da cutar ta yanar gizo, kuma an samu wasu lamuran rashin jin dadin jama'a da nuna bambanci ga Sinawa, wasu daga asalin Asiya ta Gabas da kudu maso gabashin Asiya, da kuma wasu daga yankunan da ke da manyan cututtukan cutar.
Saboda rage yawan tafiye-tafiye da kuma rufe masana'antun masana'antu masu nauyi, an rage gurɓataccen iska da kuma hasken carbon.
A ranar 31 ga watan Disamba na shekarar 2019, hukumomin lafiya a Wuhan, China (babbar birnin lardin Hubei) sun ba da rahoton wasu cututtukan cutar huhu da ba a san dalilinsa ba, kuma a farkon watan Janairun shekarar 2020 aka fara bincike.
Yawancin lokuta sun kasance suna da alaƙa da kasuwar sayar da kifin teku na Huanan, saboda haka an yi tunanin cewa cutar tana da asalin zoonotic.
An gano cewa cutar da ta haifar da barkewar cutar ta zama SARS-CoV-2, sabon kwayar cutar da aka gano da ke da alaƙa da cututtukan kwayar cutar bats, kwayar cutar pangolin, da SARS-CoV. Daga baya, an gano cewa mutumin da aka fara sani da bayyanar cututtuka ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma wannan mutumin ba shi da alaƙa da alamar da aka gani da rukunin kasuwa na ƙarshe.
Daga cikin rukunin farko na shari'o'in da aka ruwaito a watan Disamba na 2019, an gano cewa kashi biyu bisa uku suna da alaƙa da kasuwa.
A ranar 13 ga watan Maris na shekarar 2020, wani rahoton da ba a tabbatar ba na South China Morning Post ya nuna cewa, wani lamari da ya fara ne a ranar 17 ga watan Nuwamba na shekarar 2019, na wani mutum mai shekaru 55 daga lardin Hubei, na iya zama na farko. A ranar 26 ga watan Fabrairun shekarar 2020, WHO ta ruwaito cewa, kamar yadda sabbin shari'o'in da ake bayar da rahoton sun ragu a kasar Sin amma suka karu ba zato ba tsammani a Italiya, Iran da Koriya ta Kudu, adadin sabbin shari'o'in da ke wajen kasar Sin ya zarce, a karon farko, adadin sabbin shari'o'in da ke cikin kasar Sin.
Akwai yiwuwar samun adadin marasa rahoto, musamman a cikin waɗanda ke da alamun rashin lafiya.
A ranar 26 ga Fabrairu, an samu ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙyar ƙyar ƙyar ƙyar ƙyar ƙyar ƙyar ƙyar ƙ
Wannan ya shafi yawan mutanen da suka yi gwajin COVID-19, kuma sun sami tabbataccen sakamako bisa ga tsarin hukuma.
A ranar 23 ga watan Maris, babu wata ƙasa da ta yi gwaji a kan fiye da kashi 3 cikin 100 na yawanta, kuma ƙasashe da yawa sun yi manufofin da ba su yi gwaji a kan mutanen da ke da alamun rashin lafiya ba, kamar Italiya, Netherlands, Spain da Switzerland.
Wani bincike da aka wallafa a ranar 16 ga watan Maris ya bayyana cewa, a kasar Sin, har zuwa 23 ga watan Janairu, an kiyasta kashi 86% na kamuwa da cutar COVID-19 da ba a gano ba, kuma wadannan kamuwa da cutar da ba a rubuta ba su ne tushen kamuwa da cutar na kashi 79% na wadanda aka rubuta.
Wani bincike na kididdiga da aka buga a ranar 30 ga Maris ya nuna cewa adadin kamuwa da cuta a Italiya ya fi yawan wadanda aka ruwaito.
Bayani na farko na yawan haihuwa (R0) don COVID-19 ya kasance daga 1,4 zuwa 2,4.
Wani bincike da cibiyoyin kula da cututtuka da kuma rigakafin cututtuka na Amirka suka wallafa ya nuna cewa zai iya zama 5.7.
Yawancin mutanen da ke fama da COVID-19 suna warkewa.
Ga waɗanda ba su da shi, tsawon lokacin da suka wuce daga bayyanar cututtuka zuwa mutuwa ya kasance daga kwanaki 6 zuwa 41, yawanci kwanaki 14.
A ranar 10 ga Afrilu, 2020, kimanin mutuwar 97,000 an danganta su da COVID-19.
A kasar Sin, a ranar 5 ga watan Fabrairu, kimanin kashi 80 cikin dari na mutuwar sun kasance mutanen da suka wuce shekaru 60, kuma kashi 75 cikin dari suna da cututtukan da suka riga sun kasance, gami da cututtukan zuciya da ciwon sukari.
Ana iya samun adadin mutuwar da ta faru a zahiri saboda COVID-19 ya fi haka, saboda watakila ba a haɗa da mutanen da suka mutu ba tare da an gwada su ba, misali, a gidajensu, gidajen tsofaffi, da sauransu.
Bayanai na Italiya sun bayyana cewa adadin ƙarin mutuwar a lokacin annobar ya wuce rikodin hukuma na mutuwar COVID ta hanyar 4 zuwa 5 sau.
Wani kakakin Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka (CDC) na Amurka ya yarda "Mun san [adadin mutuwar da aka bayyana] ƙima ce", wani da'awar da rahotanni na ƙididdigar ƙididdiga a Amurka suka tabbatar. Wannan ƙimar ta zama ruwan dare a cikin annoba, kamar annobar cutar H1N1 na shekarar 2009.
Mutuwar farko a wajen kasar Sin ta fara a ranar 1 ga watan Fabrairu a Philippines, kuma mutuwar farko a wajen Asiya ta fara a Faransa a ranar 14 ga watan Fabrairu.
A ranar 28 ga watan Fabrairu, a wajen kasar Sin, an samu mutuwar mutane fiye da goma sha biyu a kowace kasa kamar Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga Maris, fiye da ƙasashe da yankuna arba'in sun ba da rahoton mutuwar, a duk nahiyoyi sai Antarctica.
Wadannan lambobi sun bambanta bisa ga yanki da lokaci, kuma ana rinjayar su ta yawan gwaje-gwaje, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokacin da ya wuce tun farkon barkewar cutar da halayen yawan jama'a, kamar shekaru, jinsi da lafiyar gaba ɗaya.
A cewar kididdigar Jami'ar Johns Hopkins, yawan mutuwar duniya a kan shari'o'i ya kai kashi 6.0 cikin dari (97 039/1 617 204) zuwa 10 ga Afrilu, 2020.
Yawan ya bambanta bisa ga yankuna.
A kasar Sin, kimantawar yawan mutuwar a kan kamuwa da cuta ya ragu daga kashi 17.3 cikin dari (a cikin wadanda suka fara bayyanar cututtuka daga 1 zuwa 10 ga Janairu na 2020) zuwa kashi 0.7 cikin dari (a cikin wadanda suka fara bayyanar cututtuka bayan 1 ga Fabrairu na 2020). Sauran alamomi sun haɗa da yawan mutuwar mutum, wanda ke nuna yawan mutanen da aka gano sun mutu saboda cutar, da kuma yawan mutuwar kamuwa da cuta, wanda ke nuna yawan waɗanda suka kamu (masu gano da marasa gano) suka mutu saboda cutar.
Waɗannan kididdigar ba su da wani lokaci kuma suna la'akari da wani mutum na musamman daga kamuwa da cuta har zuwa warwarewar shari'ar.
Wasu masana sun yi ƙoƙarin yin lissafin waɗannan lambobin don ƙayyadaddun ƙwayoyin.
Cibiyar Kula da Magunguna ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar kamuwa da cutar ta cutar ta kasance tsakanin kashi 0.1 zuwa 0.39 cikin dari.
Babban kimantawar wannan zangon ya dace da sakamakon gwajin farko na bazuwar COVID-19 a Jamus, da kuma nazarin kididdiga wanda ya bincika tasirin gwajin a ƙididdigar ƙimar mutuwa ta hanyar shari'a.
Hukumar ta WHO ta ce za a iya sarrafa cutar.
Ƙarshen lokaci da kuma tsawon lokacin da ya faru ba a sani ba kuma zai iya bambanta daga wuri zuwa wuri.
Maciej Boni daga Jami'ar Jihar Pennsylvania ya ce, "Binciken da ake kamuwa da shi idan ba a sarrafa shi ba, yawanci yakan daidaita kuma sai ya fara raguwa idan cutar ta rasa baƙi.
Amma, a yanzu, ba shi yiwuwa a yi hasashen lokacin da hakan zai faru".
Babban mai ba da shawara kan harkokin likitancin gwamnatin kasar Sin, Zhong Nanshan, ya ce "za a iya kammala shi a watan Yuni" idan za a iya motsa dukkan kasashe su bi shawarar WHO game da matakan da za a dauka don dakatar da yaduwar cutar.
A ranar 17 ga watan Maris, Adam Kucharski, na Makarantar Lafiya da Lafiya ta Tropical ta London, ya bayyana cewa SARS-CoV-2 "zai kasance yana yawo, mai yiwuwa na shekara ɗaya ko biyu".
Wani bincike da Neil Ferguson ya gudanar a Imperial College ya nuna cewa ana bukatar a yi nesa da mutane "har sai an samu allurar rigakafi (watannin 18 ko fiye)".
William Schaffner na Jami'ar Vanderbilt ya ce, "Ina ganin ba zai yiwu wannan cutar ta coronavirus ba, tun da yake tana da sauƙin watsawa, ta ɓace gaba ɗaya" kuma "za ta iya zama cuta ta yanayi, ta sake bayyana kowace shekara".
Idan ya sake faruwa, zai dogara ne da yawan mutanen da ke da rigakafi da kuma yadda za a yi yaduwar.
Alamun COVID-19 na iya zama marasa ƙayyadaddun kuma waɗanda suka kamu da cutar na iya zama marasa ƙayyadaddun.
Abubuwan da suka fi kowa a cikin cututtuka biyu sune zazzabi (88%) da kuma tari (68%).
Alamomin da ba su da yawa sun haɗa da gajiya, samar da iska a cikin numfashi (flam), rashin jin ƙanshi, rashin numfashi, ciwon tsoka da haɗin gwiwa, ciwon wuya, ciwon kai, sanyi, zubar da ciki, haemoptisis, diarrhea ko cianosis. WHO ta ce kusan mutum ɗaya cikin shida yana rashin lafiya sosai kuma yana da wahalar numfashi.
A cewar Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka (CDC) na Amurka, alamun gaggawa sun haɗa da wahalar numfashi, matsa lamba ko ciwo mai ci a kirji, rikicewar kwatsam, wahalar farkawa da launin shuɗi a fuska ko lebe; idan bayyanar waɗannan alamun, ana ba da shawarar kula da likita nan da nan.
Wasu daga cikin mutanen da suka kamu da cutar na iya zama marasa alamar cututtuka, ba su da alamun asibiti, ko da yake sakamakon gwajin ya tabbatar da kamuwa da cutar, saboda haka masu bincike sun ba da shawarar lura da kuma bincika waɗanda ke da kusanci da mutanen da suka kamu da cutar don kawar da kamuwa da cutar.
Ƙididdigar kasar Sin game da yawan marasa cututtuka ta kasance daga kashi 44 zuwa kashi 100.
Lokacin da ake yin amfani da shi (lokacin da ke tsakanin kamuwa da cuta da bayyanar cututtuka) ya kai kwanaki 1 zuwa 14; mafi yawan lokuta kwanaki 5. A matsayin misali na rashin tabbas, kimantawar yawan mutanen da ke da COVID-19 da suka rasa ƙanshi a farkon sun kasance 30%, sannan suka ragu zuwa 15%.
Har yanzu ana bincike a kan yadda cutar take yaduwa.
Ana ganin cewa cutar tana yadawa ne a lokacin da aka yi kusa da shi kuma ta hanyar ƙananan saukad da ke faruwa yayin tariwa, taɓo, ko magana; ana ɗaukar kusanci a nesa da mita 1-2 (ƙafa 3 zuwa 6).
A cewar bincike, idan ka yi tari ba tare da ka rufe bakinka ba, za ka iya motsawar ɗigon daga mita 15 zuwa mita 8.2.
Wasu sun bayar da shawarar cewa cutar za ta iya watsawa ta hanyar ƙananan saukad da waɗanda ke kasancewa cikin iska na tsawon lokaci, waɗanda za a iya samarwa yayin magana. Hakanan ana iya haifar da saukad da numfashi yayin numfashi, har ma da magana, kodayake, yawanci, cutar ba ta watsa ta iska.
Sa'ad da aka yi amfani da su a cikin jiki, za su iya shiga cikin bakinsu ko hancin mutane ko kuma su numfasa zuwa huhu.
Wasu hanyoyin likita, kamar su bugun jini da kuma sake farfado da zuciya (CPR), na iya haifar da aerosol na numfashi kuma, saboda haka, yadawa ta iska.
Za a iya yaduwa idan mutum ya taɓa wani gurɓataccen wuri, har da fata, sa'an nan kuma ya taɓa idanunsa da hanci ko bakinsa.
Ko da yake akwai damuwa cewa za a iya watsa ta cikin fitsari, ana ganin wannan haɗarin yana da ƙananan.
Gwamnatin kasar Sin ta musanta yiwuwar watsa SARS-CoV-2 ta hanyar magungunan baka. Kwayar cutar tana da yawa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwar na iya yiwuwa kafin bayyanar cututtuka da kuma a cikin matakan ci gaba na cutar.
Mutane sun sami sakamako mai kyau a gwajin cutar har kwana uku kafin bayyanar bayyanar cututtuka, wanda ke nuna cewa watsawa yana yiwuwa kafin bayyanar cututtuka masu mahimmanci.
Akwai wasu rahotanni na rashin alamun da aka tabbatar da su a cikin dakin gwaje-gwaje, amma, wasu ƙasashe sun gano rashin alamun watsawa a lokacin bincike na tuntuɓar.
Cibiyar Tsare-tsaren Cututtuka ta Turai (ECDC) ta ce, ko da yake ba a san yadda za a iya yada cutar ba, yawanci mutum ɗaya yakan kamu da wasu biyu ko uku.
Musamman, an gano cewa cutar tana iya ganowa har zuwa kwanaki uku a cikin filastik (polypropylene) da karfe 304, kwana ɗaya a cikin kwali da har zuwa awanni huɗu a cikin tagulla.
Wannan, duk da haka, ya bambanta dangane da danshi da zafin jiki. An sami sakamako mai kyau a gwajin COVID-19 da aka yi a kan dabbobi da sauran dabbobi.
Babu tabbacin da ya nuna cewa dabbobi za su iya watsa cutar ga mutane, ko da yake hukumomin Burtaniya sun ba da shawarar wanke hannuwan bayan sun taɓa dabbobi, kamar yadda suka yi bayan sun taɓa wasu wurare da mutane masu kamuwa da cutar suka taɓa.
Cutar coronavirus ta 2 ta cutar ta numfashi mai tsanani (SARS-CoV-2) sabuwar cuta ce, wadda aka fara ware daga mutane uku da ke fama da cutar huhu da ke da alaƙa da cutar numfashi mai tsanani a Wuhan.
Dukkanin halayen sabon kwayar SARS-CoV-2 ana samun su ne a cikin coronavirus da ke da alaƙa da yanayi. A waje da jikin mutum, kwayar cutar tana mutuwa yayin da ta haɗu da sabulu, wanda ke warware murfin kariya. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
An yi imanin cewa yana da asalin dabbobi.
Binciken kwayoyin halitta ya nuna cewa cutar coronavirus tana tattare da kwayoyin halitta tare da nau'in betacoronavirus, subgenus sarbecovirus (lineage B) tare da nau'i biyu na fuka-fuki.
A matakin cikakken kwayoyin halitta, kashi 96 cikin dari ne daidai da sauran samfurori na cutar coronavirus na bats (BatCov RaTG13).
A watan Fabrairun shekarar 2020, masu binciken kasar Sin sun gano cewa akwai bambanci guda daya kawai a amino acid a wasu sassan jerin kwayoyin halitta tsakanin kwayar cutar pangolin da na mutane.
Har zuwa yau, kwatancen cikakken genom ya nuna cewa cutar sankara ta pangolin da SARS-CoV-2 suna da kashi 92 cikin 100 na kwayoyin halitta, wanda bai isa ya nuna cewa pangolin baƙo ne na tsakiya ba.
Ana iya gano kamuwa da cutar ta hanyar cutar a kan bayyanar cututtuka, amma a ƙarshe ana tabbatar da ita ta hanyar yin amfani da jerin abubuwan da aka yi na polymerase tare da maɓallin maɓallin maɓallin maɓallin (rRT-PCR) na ɓarkewar da aka kamu da shi ko ta hanyar hotunan CT.
Wani bincike da aka yi a Wuhan wanda ya kwatanta tsarin polymerase da CT, ya nuna cewa CT ya fi ƙarfin polymerase, ko da yake ba shi da ƙayyadaddun bayanai, kuma yawancin siffofin da ke cikin hotunan sun yi daidai da ayyukan wasu cututtuka da huhu.
Tun daga watan Maris na shekarar 2020, Kwalejin Radiology ta Amirka ta ba da shawarar "kada a yi amfani da CT a matsayin hanyar ganowa ko kuma a matsayin gwajin farko don gano COVID-19".
Hukumar ta WHO ta wallafa wasu hanyoyin gwajin RNA na SARS-CoV-2, na farko daga cikinsu da aka buga a ranar 17 ga Janairu.
Wannan gwajin yana amfani da polymerase tare da real-time reverse transcriptase chain reaction (rRT-PCR).
Ana iya gwada shi a kan jini ko kuma a kan numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin num
A yawancin lokaci, ana samun sakamako a cikin 'yan sa'o'i ko kwanaki.
Yawancin lokaci ana yin wannan gwajin da hanci na hanci, amma ana iya amfani da hanci na hanci. Wasu dakunan gwaje-gwaje da kamfanoni suna haɓaka gwaje-gwaje na serological, wanda ke gano rigakafi.
A ranar 6 ga Afrilu, 2020, babu ɗayan waɗannan da suka tabbatar da cewa sun isa su zama daidai don a amince da su don amfani da su.
A Amurka, an amince da gwajin serological da Cellex ta samar don amfani da gaggawa ta hanyar dakunan gwaje-gwaje masu takardar shaida kawai.
Abubuwan da ke nunawa a cikin hotunan radiographs da CT na mutane masu alamun sun hada da rashin daidaituwa na waje na gilashin gilashin gilashi da kuma ɓarkewar pleural.
Ƙungiyar Radiology ta Italiya tana tattara bayanan bayanai na duniya a kan layi na sakamakon da aka samu a cikin hotunan da aka tabbatar da cutar.
Saboda haɗuwa da wasu cututtuka kamar adenovirus, ganewar asali ta hanyar hotunan da ba a tabbatar da su ba ta hanyar yin layin polymerase yana da iyakanceccen ƙayyadaddun bayani game da gano COVID-19.
Wani bincike mai zurfi da aka yi a kasar Sin ya kwatanta sakamakon CT na ƙirjin da na polymerase chain reaction kuma ya nuna cewa, ko da yake ganewar asali ta hoto ba ta da ƙayyadaddun kamuwa da cuta, amma ta fi sauri da kuma saukin ganewa, wanda ya nuna cewa ana amfani da ita a matsayin kayan aikin ganowa a yankunan da cutar ta shafa.
An ci gaba da cibiyoyin sadarwa na jijiyoyin jiki masu jujjuyawar da ke dogara da ilimin kere-kere don gano halaye na cutar a cikin hotuna, duka tare da radiographs da CT.
Hanyoyi don hana yaduwar cutar sun haɗa da kiyaye tsabtace mutum gaba ɗaya, wanke hannu, guje wa taɓa idanu, hanci ko baki da hannayenku ba tare da wanke su ba, da kuma taƙaitawa ko toshewa a kan tawul ɗin da za a iya zubar da shi kuma jefa tawul ɗin kai tsaye a cikin kwandon shara.
Ana ba da shawarar waɗanda suka riga sun kamu da cutar su saka abin rufe fuska a wurin jama'a.
Ana kuma ba da shawarar yin nesa da mutane don hana yaduwar cutar. Gwamnatoci da yawa sun ƙuntata ko kuma sun hana duk balaguron da ba su da muhimmanci ba zuwa da kuma zuwa ƙasashe da yankunan da cutar ta shafa.
Amma cutar ta kai ga yaduwar al'umma a sassa da yawa na duniya.
Wannan yana nufin cewa cutar tana yaduwa a cikin al'ummomi, kuma wasu 'yan al'umma ba su san inda ko yadda suka kamu ba. Ana ba da shawarar cewa masu ba da kula da lafiya da ke kula da wanda zai iya kamuwa da cutar su ɗauki matakan tsaro na yau da kullun, matakan tuntuɓar da kuma amfani da kariya ta ido.
Amfani da bayanan wuri na wayoyin hannu da gwamnatoci ke yi don wannan dalili ya haifar da damuwa game da sirrin mutum, kuma Amnesty International da fiye da kungiyoyi 100 sun fitar da wata sanarwa don neman iyakance irin wannan sa ido.
An aiwatar ko kuma an gabatar da aikace-aikacen hannu da yawa don amfani da son rai, kuma a ranar 7 ga Afrilu, 2020, fiye da ƙungiyoyin masana goma sha biyu suna aiki akan mafita masu mutunta sirrin mutum, kamar amfani da Bluetooth don yin rikodin kusanci na mai amfani zuwa wasu wayoyin hannu.
Masu amfani za su karɓi saƙo idan sun yi hulɗa da wani da ya yi gwajin COVID-19. Suna yin tunani game da yadda za a hana kamuwa da cutar; misali, wanke hanci da gargar da aka yi da ruwan sha ba su da tasiri.
Babu allurar rigakafin COVID-19, ko da yake kungiyoyi da yawa suna aiki don samar da ita.
Ana bada shawara a wanke hannu don hana yaduwar cutar.
Hukumar kula da lafiyar jiki ta CDC ta ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa a kai a kai na akalla na biyu, musamman bayan sun yi amfani da gidan wanka ko kuma idan hannayensu sun yi datti sosai; kafin su ci abinci da kuma bayan sun yi ihu, su yi tari ko su yi ta hurawa.
Wannan shi ne domin a waje da jikin mutum, kwayar ta mutu ta tuntubi sabulu, wanda ke lalata kumburinta mai kariya.
Cibiyar kula da cututtuka ta CDC ta kuma ba da shawarar yin amfani da maganin hana shan giya na hannu wanda ya ƙunshi aƙalla kashi 60 cikin ɗari na giya a lokacin da babu ruwa da sabulu.
Hukumar ta WHO ta shawarci mutane su guji taɓa idanunsu, hancinsu ko bakinsu da hannayensu ba tare da sun wanke su ba.
Za a iya tsabtace farfajiyar da wasu hanyoyin (a cikin minti daya bayan an yi amfani da maganin kashe cuta a kan farfajiyar bakin karfe), ciki har da ethanol a 6271%, isopropanol a 50100%, sodium hypochlorite a 0,1%, hydrogen peroxide a 0,5%, da kuma iodized povidone a 0,27,5%.
Sauran hanyoyin, kamar benzalkonium chloride da chlorhexidine gluconate, ba su da tasiri sosai.
Hukumar ta CDC ta ba da shawarar cewa, idan ana zargin ko kuma an tabbatar da wani abu na COVID a wani wuri, kamar ofishi ko makarantar yara, a tsabtace duk wuraren kamar ofisoshin, dakunan wanka, wuraren zama na kowa, kayan aikin lantarki da aka raba, kamar kwamfutar hannu, allon taɓawa, maɓallin kewayawa, sarrafawa ta nesa da na'urorin caji na atomatik waɗanda marasa lafiya suka yi amfani da su.
Ƙungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hancinsu da wuyan hannu ko kuma wata takalma da za a iya tuƙa don su yi tari ko kuma su yi ta hurawa, kuma su zubar da takalman nan da nan.
Ana ba da shawarar waɗanda za su iya kamuwa da cutar su yi amfani da abin rufe fuska na tiyata, domin yin amfani da abin rufe fuska zai iya iyakance yawan da kuma nisan da saukowar numfashi ke yi yayin magana, taɓo da kuma tari.
Hukumar ta WHO ta ba da umarni game da lokacin da za a yi amfani da abin rufe fuska da kuma yadda za a yi amfani da shi.
Wani masanin ilimin cututtuka na jami'ar Leeds mai suna Stephen Griffin ya ce: "Samun abin rufe fuska zai iya rage yawan mutane su taɓa fuskarsu, wanda ke da muhimmanci wajen kamuwa da cuta idan ba a tsabtace hannayensu ba".
Hukumar ta WHO ta ba da shawarar yin amfani da abin rufe fuska ga mutanen da ke da lafiya idan suna da haɗari sosai, alal misali, waɗanda ke kula da mutum tare da COVID-19, duk da haka ta kuma yarda cewa yin amfani da abin rufe fuska na iya taimaka wa mutane su guji taɓa fuskarsu.
Kasashe da dama sun fara ƙarfafa jama'a su yi amfani da abin rufe fuska.
A Amurka, CDC ta ba da shawarar yin amfani da masks na likita na likita da aka yi da masana'anta. China ta ba da shawarar musamman don amfani da masks na likita na likita da za a iya amfani da su ta hanyar membobin jama'a masu lafiya, musamman idan suna kusa da (1 mita (3 ƙafa) ko ƙasa da haka) da wasu mutane.
Hong Kong ta ba da shawarar yin amfani da abin rufe fuska na tiyata don hawa hawa ta jama'a ko kasancewa a wurare masu yawan jama'a.
Jami'an kiwon lafiya a Thailand sun ba da shawarar cewa mutane su yi masks na masana'anta a gidajensu kuma su wanke su kullum.
Jamhuriyar Czech da Slovakia sun hana fita a wuraren jama'a ba tare da yin amfani da abin rufe fuska ba ko kuma rufe hanci da bakinsu.
A ranar 16 ga watan Maris, Vietnam ta bukaci kowa ya saka abin rufe fuska a wuraren jama'a domin ya kāre kansa da kuma wasu.
Gwamnatin Austria ta bukaci duk wanda ya shiga wani babban kanti ya saka abin rufe fuska.
Isra'ila ta bukaci duk mazauna su sa abin rufe fuska a fili.
Taiwan, wadda ta yi amfani da masks miliyan goma a kowace rana tun tsakiyar watan Maris, a ranar 1 ga Afrilu ta bukaci fasinjoji su yi amfani da masks a jiragen kasa da bas.
Panama ta sanya wa'adin yin amfani da abin rufe fuska a waje, yayin da ta kuma bada shawarar yin abin rufe fuska da aka yi a gida ga waɗanda ba za su iya saya ba.
An kuma yi amfani da masks a Japan, Koriya ta Kudu, Malaysia da Singapore.
Tsare-tsare na zamantakewa (wanda aka fi sani da nesa na jiki) ya haɗa da matakan sarrafa kamuwa da cuta waɗanda aka tsara don hana yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Hanyoyin sun hada da killacewa, ƙuntatawa kan tafiya da rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo da cibiyoyin kasuwanci.
Mutane za su iya yin amfani da hanyoyin nisantar zamantakewa ta wajen kasancewa a gidajensu, iyakance tafiye-tafiye, guje wa wuraren da mutane suke da yawa, yin amfani da hanyoyin gaisuwa da ba su haɗa da tuntuɓar juna ba, da kuma nisantar da kansu daga wasu mutane.
Yawancin gwamnatoci yanzu suna bukatar ko kuma suna ba da shawarar yin nesa da jama'a a yankunan da cutar ta shafa.
Matsakaicin girman tarurruka da hukumomin gwamnati da kungiyoyin kiwon lafiya na Amurka suka ba da shawarar ya ragu da sauri daga mutane 250 (idan babu sanannen yaduwar COVID-19 a wani yanki) zuwa mutane 50, sannan zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a na mutane sama da biyu. Manya tsofaffi da waɗanda ke da cututtukan da ke ƙarƙashin su kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini, da tsarin rigakafi masu rikitarwa suna da haɗarin kamuwa da cututtuka da rikitarwa masu tsanani, kuma CDC ta ba da shawarar cewa su zauna a gidajen su gwargwadon iko a yankunan al'umma da cutar ta shafa. A ƙarshen Maris 2020, WHO da sauran hukumomin kiwon lafiya sun fara maye gurbin amfani da kalmar "nesa ta zamantakewa" da "nesa ta jiki", don bayyana cewa makasudin shine rage hulɗa ta jiki yayin da ake kiyaye alaƙar zamantakewa, ko dai a zahiri ko kuma nesa.
Amfani da kalmar "tsayawa ta zamantakewa" ya haifar da tunanin cewa mutane suyi amfani da keɓewar zamantakewa gaba ɗaya, maimakon ƙarfafa su su ci gaba da tuntuɓar wasu mutane ta hanyar hanyoyin daban.
Sun haɗa da shawarwari na yin jima'i da mutumin da kake zama da shi kawai, wanda ba shi da cutar ko alamun cutar.
An bada shawarar yin zaman kai a gida ga wadanda aka gano COVID-19 da wadanda suka yi zargin sun kamu da cutar.
Hukumomin lafiya sun wallafa cikakken umarni game da yadda za a yi zaman kai a kai. Gwamnatoci da yawa sun bukaci ko kuma sun ba da shawarar yin zaman kai ga dukan mutanen da ke yankunan da aka shafa.
An ba da umarnin tsauraran umarnin yin keɓe kai ga waɗanda ke cikin rukunin haɗari.
Ana ba da shawarar cewa mutanen da suka yi hulɗa da wani da ke da cutar COVID-19 da suka yi tafiya zuwa wata ƙasa ko yanki da ke da yaduwar yaduwar cutar su yi zaman kansu na kwanaki 14 daga lokacin da suka fara nunawa.
Hanyoyi na sarrafa barkewar cutar su ne hana ko kawar da cutar da kuma rage ta.
Ana yin maganin a farkon fasalin barkewar cutar kuma ana yin hakan ne don ganowa da ware masu kamuwa da cutar, da kuma gabatar da wasu matakan sarrafa kamuwa da cutar da alluran rigakafi don hana cutar yadawa ga sauran jama'a.
Idan ba za a iya sarrafa yaduwar cutar ba, sai a ɗauki mataki na ragewa: ana ɗaukar matakan da za su hana yaduwar cutar da kuma rage tasirin ta a kan tsarin kiwon lafiya da kuma al'umma.
Za a iya ɗaukar haɗuwa da matakan hanawa da kuma ragewa a lokaci guda.
Dakatar da cutar na bukatar karin tsauraran matakai domin a iya juyar da annobar ta hanyar rage yawan adadin haihuwa zuwa kasa da 1. Wani ɓangare na sarrafa barkewar cutar mai kamuwa da cuta ya ƙunshi ƙoƙarin rage ƙaruwar annobar, wanda aka sani da daidaita yanayin annobar.
Wannan yana rage haɗarin rashin lafiyar da ke faruwa kuma yana ba da ƙarin lokaci don ci gaban alluran rigakafi da magani.
Hanyoyin da ba na magani ba da za su iya sarrafa barkewar cutar sun haɗa da matakan kariya na mutum, kamar tsabtace hannu, amfani da masks da keɓe kai; matakan da ke tattare da nisantar jiki, kamar rufe makarantu da soke taron halartar taro; sadaukar da kai na ƙungiyar don ƙarfafa karɓa da shiga cikin irin waɗannan ayyukan; da matakan muhalli da tsabtar wurare. A China, an ɗauki matakan da suka fi ƙarfin gaske don hana barkewar cutar bayan an tabbatar da tsanani, misali, aiwatar da ƙuntatawa a cikin birane duka da kuma sanya takunkumin hana tafiye-tafiye.
Wasu ƙasashe kuma sun ɗauki matakai da dama don rage yaduwar cutar.
Koriya ta Kudu ta aiwatar da kimantawa da kuma sanya rigakafin wuri, kuma ta ba da gargadi game da motsi na mutanen da suka kamu.
Singapore ta ba da tallafi na kudi ga mutanen da suka kamu da cutar da suka yanke shawarar yin rigakafi kuma ta ba da manyan tarar waɗanda ba su yi ba.
Taiwan ta kara samar da masks kuma ta haramta tarin kayayyakin kiwon lafiya. Simulations a Burtaniya da Amurka sun nuna cewa ragewa (wanda ke rage yaduwar annobar amma baya hana ta) da kuma kawar da cutar (wanda ke juyar da ci gaban annobar) suna da manyan kalubale.
Manufofin da suka dace na rage yawan rashin lafiyar da ake bukata za su iya rage yawan bukatar kula da lafiyar da ake bukata da kashi biyu bisa uku da kuma mutuwar da ake samu a cikin rabin, amma har ila yau za su iya jawo mutuwar dubbai da kuma rushewar tsarin kiwon lafiya.
Za a iya yin amfani da maganin kashewa, amma ya kamata a ci gaba da yin amfani da shi a duk lokacin da cutar ta ke yawo a cikin mutane (ko har sai an sami allurar rigakafi, idan hakan ya faru da farko), saboda in ba haka ba, watsawar za ta sake dawowa da sauri lokacin da aka sassauta matakan.
Yin amfani da lokaci mai tsawo don kawar da cutar yana haifar da farashi na zamantakewa da tattalin arziki.
Babu takamaiman magungunan rigakafin cutar da aka amince da su don COVID-19, amma ana yin ƙoƙari don haɓaka su, wanda ya haɗa da gwada magungunan da ke akwai.
Yin amfani da magani don yin sanyi, shan ruwa, da kuma hutawa zai iya taimaka maka ka rage alamun.
Dangane da yadda kake da shi, za ka iya bukatar maganin oxygen, ruwa mai shiga cikin jini, da kuma taimakon numfashi.
Yin amfani da kwayoyin cuta zai iya sa sakamakon ya yi muni.
Ana binciken wasu sinadarai da aka amince da su a baya don maganin wasu cututtukan kwayar cutar don amfani da su wajen magance COVID-19.
WHO ta kuma nuna cewa wasu "magungunan gida da na gargajiya" na iya rage alamun cutar ta SARS-CoV-19.
Hukumar ta WHO ta bayyana karuwa a cikin iyawa da daidaitawar kulawar lafiya ga bukatun marasa lafiya da COVID-19 a matsayin muhimmin mataki na amsawa ga barkewar cutar.
ECDC da Ofishin Yankin Turai na WHO sun tsara jagororin da aka yi wa asibitoci da sabis na kiwon lafiya na farko don sake rarraba albarkatu a matakai daban-daban, wanda ya haɗa da mayar da hankali ga ayyukan dakin gwaje-gwaje kan gwajin COVID-19, soke hanyoyin zaɓin lokacin da zai yiwu, warewa da keɓe marasa lafiya masu COVID-19 da haɓaka ƙarfin kulawa mai tsanani ta hanyar horar da ma'aikata da haɓaka yawan masu numfashi da gado masu samuwa.
Akwai ra'ayoyi da yawa game da inda za a iya samun hali na farko (wanda ake kira marasa lafiya).
An fara samun mutum na farko da aka gano cutar coronavirus a ranar 1 ga watan Disamba na 2019 a Wuhan, Hubei, China.
A cikin wata daya, adadin masu dauke da cutar korona a Hubei ya karu a hankali.
Wadannan sun kasance da alaƙa da kasuwar sayar da kifin teku ta Huanan, wanda kuma ke sayar da dabbobi masu rai, kuma wata ka'ida ita ce cewa kwayar ta fito ne daga ɗayan waɗannan dabbobi; ko, a wasu kalmomin, yana da asalin zoonotic.
A ranar 30 ga watan Disamba, wani rukuni na likitoci a asibitin Wuhan sun gargadi abokan aikin su game da "coronavirus mai kama da SARS".
'Yan sanda sun yi wa likitoci takwas gargadi, ciki har da Li Wenliang, don yada jita-jita, kuma wasu likitoci, Ai Fen, sun yi wa shugabanninsu tsawatawa don yin gargadi.
Bayan haka, a ranar 31 ga watan Disamba, Hukumar Kula da Lafiya ta Wuhan ta ba da sanarwar jama'a kuma ta sanar da WHO.
A farkon watan Janairu, an ba da rahoton isasshen cututtukan huhu na sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen sanannen san
A farkon da tsakiyar watan Janairu na shekarar 2020, cutar ta bazu zuwa wasu lardunan kasar Sin, wanda hakan ya haifar da ƙaurawar sabuwar shekara ta kasar Sin da kuma gaskiyar cewa Wuhan cibiyar sufuri ce da kuma babbar hanyar jirgin kasa.
A ranar 20 ga watan Janairu, kasar Sin ta ba da rahoton sabbin mutane 140 a rana guda, ciki har da mutane biyu a Beijing da kuma daya a Shenzhen.
Bayanai na hukuma na baya sun nuna cewa, a ranar 20 ga Janairu, 2020, mutane 6174 sun riga sun sami alamun cututtuka. A ranar 26 ga Maris, Amurka ta zarce China da Italiya tare da mafi yawan adadin waɗanda aka tabbatar da cutar a duniya. A ranar 9 ga Afrilu, 2020, an ba da rahoton fiye da miliyan 1.61 na cututtuka a duniya; sama da mutane 97,000 sun mutu kuma sama da 364,000 sun warke.
Kasashe da yankuna 200 sun yi akalla shari'ar guda ɗaya.
Saboda annobar a Turai, ƙasashe da yawa a cikin yankin Schengen sun ƙuntata 'yancin tafiya kuma sun kafa ƙuntatawa a kan iyakoki.
Sakamakon haka ya hada da matakan hanawa, kamar yin rigakafi (wanda ake kira umarnin zama a gida, umarnin samun mafaka a wurin ko kuma a tsare) da kuma dokar hana fita. A ranar 2 ga Afrilu, kimanin mutane miliyan 300, ko kusan kashi 90 cikin dari na yawan jama'a, suna bin wani nau'i na tsare a Amurka, fiye da mutane miliyan 50 suna tsare a Philippines, kimanin mutane miliyan 59 suna tsare a Afirka ta Kudu, kuma mutane miliyan 1300 suna tsare a Indiya.
A ranar 26 ga Maris, mutane miliyan 1700 a duniya suna cikin wani irin tsare-tsare, wanda ya karu zuwa mutane biliyan 2.6 bayan kwana biyu, wato kusan kashi ɗaya bisa uku na yawan duniya.
An fara samun mutum na farko da ya kamu da cutar COVID-19 a ranar 1 ga watan Disamba na shekarar 2019 a Wuhan; wani rahoto da ba a tabbatar da shi ba ya nuna cewa mutum na farko ya kamu da cutar a ranar 17 ga watan Nuwamba.
A ranar 26 ga watan Disamba, Dokta Zhang Jixian ta lura da wasu cututtukan cutar huhu da ba a san dalilin da ya sa ba, kuma asibitinta ta sanar da CDC na Jianghan na Wuhan a ranar 27 ga watan Disamba.
Gwajin kwayoyin halitta na farko na samfurin marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna kasancewar coronavirus mai kama da SARS.
A ranar 31 ga watan Disamba, Hukumar Kula da Lafiya ta Wuhan ta fitar da wata sanarwa ta jama'a.
An sanar da Hukumar Lafiya ta Duniya a ranar.
Yayin da ake yin wannan sanarwar, 'yan sanda sun gargadi likitoci a Wuhan saboda " yada jita-jita" game da barkewar cutar.
Hukumar Lafiya ta kasar Sin ta fara da cewa babu "hujja mai kyau" na yaduwar cutar tsakanin mutane.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani babban yunkuri, wanda sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping ya bayyana shi a matsayin "yaƙin jama'a", don dakile yaduwar cutar.
A cikin abin da aka bayyana a matsayin "babban kwanton a tarihin 'yan adam", a ranar 23 ga Janairu an sanar da dokar hana fita da fita daga Wuhan, wannan ya faɗaɗa zuwa birane 15 a Hubei, kuma ya shafi mutane miliyan 57.
An haramta amfani da motocin sirri a cikin birnin.
An soke bikin Sabuwar Shekarar Sin (25 ga Janairu) a wurare da yawa.
Hukumomi sun kuma sanar da gina asibiti na wucin gadi, asibitin Huoshenshan, wanda aka kammala cikin kwanaki 10.
Daga baya, an gina wani asibiti, asibitin Leishenshan, don karɓar ƙarin marasa lafiya.
Baya ga sabbin asibitocin da aka gina, kasar Sin ta kuma mayar da wasu wurare 14 a Wuhan, kamar cibiyoyin taro da filayen wasa, zuwa asibitocin wucin gadi. A ranar 26 ga Janairu, Gwamnati ta aiwatar da ƙarin matakan dakile barkewar COVID-19, wanda ya haɗa da bayar da sanarwar lafiya ga matafiya da kuma tsawaita hutun Bikin bazara.
An kuma rufe jami'o'i da makarantu a fadin kasar.
Yankunan Hong Kong da Macau sun aiwatar da wasu matakai, musamman ma a kan makarantu da jami'o'i.
An kafa matakan aiki na nesa a yankuna da dama na kasar Sin.
An sanya takunkumin tafiye-tafiye a ciki da wajen Hubei.
An sauya zirga-zirgar jama'a kuma an rufe gidajen tarihi na wucin gadi a duk faɗin ƙasar Sin.
An aiwatar da kula da motsi na jama'a a birane da dama, kuma an kiyasta cewa kusan mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wasu nau'ikan ƙuntatawa a waje. Bayan fara fasalin barkewar cutar a duniya a watan Maris, hukumomin China sun ɗauki tsauraran matakai don hana " shigo da " cutar daga wasu ƙasashe.
Alal misali, Beijing ta sanya dokar killace-kwana ta kwanaki 14 ga duk matafiya na duniya da suka shiga birnin. A ranar 23 ga Maris, a cikin babban yankin China, an yi magana ne kawai a matakin ƙasa a cikin kwanaki biyar da suka gabata, a wannan lokacin, ta hanyar matafiyi wanda ya dawo daga Istanbul zuwa Canton.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya ba da rahoton cewa an toshe yaduwar cututtukan da aka watsa a matakin ƙasa kuma an sarrafa barkewar cutar a China.
A ranar 26 ga watan Maris, 2020, Ma'aikatar Harkokin Wajen China ta sanar da cewa za a dakatar da shigar masu ɗaukar biza ko izinin zama daga 28 ga Maris, ba tare da cikakken bayani ba game da lokacin da wannan manufar za ta ƙare.
Waɗanda suke son shiga kasar Sin za su nemi takardar visa a ofisoshin jakadancin kasar Sin ko kuma a ofisoshin jakadancin kasar.
Gwamnatin kasar Sin ta bukaci kamfanoni da masana'antu da su sake budewa a ranar 30 ga watan Maris kuma ta samar da kunshin karfafa tattalin arziki ga kamfanoni.
A ranar 20 ga Janairu, 2020, an tabbatar da cewa COVID-19 ya bazu daga China zuwa Koriya ta Kudu.
A ranar 20 ga watan Fabrairu, hukumar kula da lafiyar kasar ta ruwaito wani karuwar yawan wadanda suka kamu da cutar, wanda aka danganta shi da taron da aka yi a Daegu na wani sabon motsi na addini da ake kira Shincheonji Church of Jesus.
An yi zargin cewa masu bauta wa Shincheonji da suka ziyarci Daegu daga Wuhan ne suka haifar da barkewar cutar.
A ranar 22 ga Fabrairu, daga cikin mabiya 9336 na coci, 1,261 ko kusan kashi 13 cikin ɗari sun ba da rahoton bayyanar cututtuka.
A ranar 28 ga Fabrairu, an samu karin mutane 2000 da aka tabbatar da cutar a Koriya, wanda ya karu zuwa 3150 a ranar 29 ga Fabrairu.
Dukkanin sansanonin sojin Koriya ta Kudu sun kasance cikin killace bayan gwajin ya tabbatar da cewa sojoji uku sun tabbatar da cutar.
An kuma shafi jadawalin kamfanonin jiragen sama, saboda haka an sauya su. Koriya ta Kudu ta gabatar da abin da aka ɗauka shine mafi girma da kuma mafi kyawun shirin da aka tsara a duniya don yin gwajin gano cutar a cikin yawan jama'a da keɓe mutane masu kamuwa da cutar, ban da ganowa da sanya waɗanda suka yi hulɗa da su a cikin killace.
Hanyoyin ganowa sun haɗa da tilasta wa sababbin masu zuwa daga wasu ƙasashe su ba da rahoton kansu game da bayyanar cututtuka ta hanyar aikace-aikacen hannu, cibiyoyin motsa jiki don gudanar da gwajin gano cutar tare da sakamakon da ke samuwa a rana mai zuwa, da kuma ƙara ƙarfin ganewar asali don iya yin gwaji a cikin mutane har zuwa 20,000 kowace rana.
Koriya ta Kudu ta yi nasarar sarrafa cutar duk da cewa ba ta yi amfani da killacewa a dukan birane ba.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman a sallami Moon saboda abin da suka yi la'akari da rashin kula da annobar daga gwamnatin, ko kuma don yabon amsarsa.
A ranar 23 ga watan Maris, an ruwaito cewa Koriya ta Kudu ta samu adadin wadanda suka kamu da cutar a rana daya a kasa da makonni hudu.
A ranar 29 ga watan Maris, an sanar da cewa, daga ranar 1 ga Afrilu, duk sababbin da suka zo daga kasashen waje za su kasance a cikin killace na makonni biyu.
Rahotanni sun ce a ranar 1 ga Afrilu, Koriya ta Kudu ta samu buƙatun taimako don gwajin cutar daga ƙasashe 121 daban-daban.
A ranar 19 ga watan Fabrairu, Iran ta ba da rahoton farkon tabbatar da kamuwa da cutar SARS-CoV-2 a Qom, inda, a cewar Ma'aikatar Lafiya da Ilimin Likita, mutane biyu suka mutu daga baya a wannan rana.
Matakan da gwamnatin ta sanar sun hada da soke bukukuwa da sauran al'adu, wasanni da addu'o'in Juma'a, da rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ba da riyal biliyan biyar don yaki da cutar.
A ranar 26 ga watan Fabrairun 2020, Shugaba Hassan Rouhani ya ce babu wani shiri na sanya wuraren da cutar ta shafa a cikin killace, kuma za a sanya mutane ne kawai a cikin killace.
A watan Maris, an sanar da tsare-tsaren rage tafiye-tafiye tsakanin birane, ko da yake zirga-zirga mai nauyi tsakanin birane sakamakon Sabuwar Shekarar Farisa Nowruz ya ci gaba.
Masallatai na Shi'a a Qom sun kasance a bude ga mahajjata har zuwa 16 ga Maris 2020. A watan Fabrairu, Iran ta zama cibiyar yada cutar bayan China.
A cikin ikirarin rufe girman barkewar cutar a Iran, fiye da kasashe goma sun biye da cututtukan su zuwa Iran a ranar 28 ga Fabrairu, wanda ya nuna cewa girman barkewar cutar na iya zama mafi tsanani fiye da shari'o'in 388 da gwamnatin Iran ta ruwaito a wannan lokacin.
Majalisar dokokin Iran ta rufe, kuma a ranar 3 ga Maris, 23 daga cikin 'yan majalisar 290 sun ba da rahoton cewa sun sami sakamako mai kyau a gwajin cutar.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci hukumomin kurkuku na Iran da su saki 'yan kare hakkin dan Adam da aka tsare da su saboda rashin amincewa da zaman lafiya, ba tare da wata hujja ba, kuma su sake dukan fursunonin da suka cancanta.
Ya nuna cewa akwai hadarin yaduwar cutar a cibiyoyin da aka rufe, kamar cibiyoyin tsare, wadanda kuma ba su da kulawa ta likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana guda, wanda shi ne adadin da aka fi samu a kasar tun lokacin da annobar ta fara.
A ranar 17 ga watan Maris, aƙalla 'yan siyasar Iran 12 ko kuma 'yan siyasa masu aiki sun mutu saboda cutar.
A ranar 23 ga watan Maris, Iran tana fuskantar sabbin mutane 50 a kowace awa da kuma sabon mutuwar kowane minti 10 saboda cutar coronavirus.
Wani jami'in WHO ya ce, akwai yiwuwar a Iran akwai adadin mutane da yawa fiye da sau biyar da ake bayar da rahoto.
An kuma nuna cewa takunkumin da Amurka ta dauka kan Iran na iya shafar karfin kudi na kasar wajen magance cutar.
Babban Kwamishinan Majalisar Dinkin Duniya na 'Yancin Dan Adam ya bukaci a sassauta takunkumin tattalin arziki ga kasashen da cutar ta fi shafa, ciki har da Iran.
A ranar 31 ga watan Janairu, an tabbatar da yaduwar cutar zuwa Italiya, lokacin da masu yawon bude ido biyu na kasar Sin suka tabbatar da gwajin SARS-CoV-2 a Roma.
Mutane sun fara ƙaruwa cikin sauri, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen zuwa da zuwa China kuma ta ayyana dokar ta baci.
Daga bisani, an gano wasu lokuta na COVID-19 da ba su da alaƙa, wanda ya fara da 16 da aka tabbatar a Lombardy a ranar 21 ga Fabrairu.
Firayim Minista, Giuseppe Conte, ya ce, "Ba za a ba da izinin shiga ko fita daga wuraren da cutar ta shafa ba.
An riga an ba da umarnin dakatar da ayyukan aiki da wasanni a waɗannan yankuna". A ranar 4 ga Maris, Gwamnatin Italiya ta ba da umarnin rufe makarantu da jami'o'i a duk faɗin ƙasar yayin da Italiya ta kai mutuwar 100.
Duk manyan abubuwan wasanni, gami da wasannin ƙwallon ƙafa na Serie A, ana buƙatar gudanar da su a rufe har zuwa Afrilu, amma, a ranar 9 ga Maris, an dakatar da duk abubuwan wasanni gaba ɗaya na akalla wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan dukkanin ayyukan kasuwanci sai dai manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Italiyanci ta Anesthesia, Analgesia, Reanimation and Intensive Care (SIAARTI) ta wallafa shawarwarin ɗabi'ar likita game da hanyoyin rarrabuwa da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta zarce kasar Sin a matsayin kasar da ta fi yawan mutuwar da ke tattare da cutar coronavirus a duniya bayan ta ba da rahoton mutuwar 3405 daga annobar.
A ranar 22 ga watan Maris, an bayar da rahoton cewa Rasha ta tura jiragen saman soja tara da kayan aikin likita zuwa Italiya.
A ranar 5 ga Afrilu, an tabbatar da shari'o'i 128,948, mutuwar 15,887 da kuma warkewar 21,815 a Italiya, kuma yawancin waɗannan lokuta sun faru a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa haɗuwa da Italiya da yawan tsofaffi da rashin iyawar yin gwaji ga duk mutanen da suka kamu da cutar har zuwa yau na iya taimakawa wajen yawan mutuwar.
Amsar Burtaniya ga cutar ta fara fitowa a matsayin ɗayan ƙasashe masu rauni mafi sauƙi, kuma har zuwa 18 ga Maris, 2020, Gwamnatin Burtaniya ba ta sanya kowane irin matakan nisantar zamantakewa ko keɓewa mai yawa akan 'yan ƙasa ba.
A sakamakon haka, gwamnati ta sami zargi saboda rashin saurin daurin da ake gani a cikin amsawa ga damuwar da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya yi sanarwar da ya hana tuntuɓar jama'a da duk balaguron da ba su da mahimmanci, kuma ya ba da shawarar cewa mutane suyi aiki daga gidajensu idan ya yiwu kuma su guji wurare kamar sanduna, gidajen abinci da gidajen wasan kwaikwayo.
A ranar 20 ga watan Maris, Gwamnatin ta sanar da rufe dukkan wuraren shakatawa kamar sanduna da wuraren motsa jiki da wuri-wuri, kuma ta yi alkawarin biyan har zuwa kashi 80 cikin dari na albashi na ma'aikata har zuwa iyakar GBP 2500 a kowane wata don hana rashin aikin yi a lokacin rikicin. A ranar 23 ga watan Maris, Firayim Minista ya sanar da tsauraran matakan nesa da zamantakewa, wanda ya hana taron mutane fiye da biyu da kuma hana tafiya da ayyukan waje ga waɗanda aka gani suna da muhimmanci sosai.
Ba kamar matakan da aka ɗauka a baya ba, 'yan sanda za su iya tilasta wa waɗannan ƙuntatawa su cika ta hanyar saka tarar kuɗi da kuma tarwatsa taron.
An ba da umarnin rufe yawancin kamfanoni, sai dai waɗanda aka ɗauka 'mafi mahimmanci,' ciki har da manyan kantuna, kantunan magani, bankuna, masana'antun kayan aiki, masana'antun man fetur da kuma wuraren aiki.
A ranar 20 ga watan Janairu, an tabbatar da sanannen shari'ar COVID-19 a jihar Washington da ke arewa maso yammacin Pacific a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga watan Janairu.
A ranar 29 ga watan Janairu, an kafa kungiyar aiki kan cutar coronavirus a fadar White House.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya ta jama'a, kuma ta sanya takunkumi ga shigowar matafiya daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cututtuka, babbar cibiyar kiwon lafiyar jama'a ta Gwamnatin Amurka, ta sanar da cewa sun haɓaka kayan gwajin kansu.
Duk da haka, Amurka ta yi jinkirin fara gwajin, wanda ya ɓoye ainihin girman barkewar cutar a lokacin.
An yi wa gwajin rauni ne saboda kuskuren gwajin da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewa da gwamnatin tarayya na gwajin gwaji na gwamnati (na makarantun kimiyya, kamfanoni da asibitoci) har zuwa karshen Fabrairu da kuma takunkumin da ke hana mutane cancanta don gwaji har zuwa farkon Maris (bayan haka an buƙaci umarnin likita).
A ranar 27 ga Fabrairu, jaridar Washington Post ta ruwaito cewa an yi gwajin gwaji kasa da 4,000 a Amurka.
A ranar 13 ga Maris, jaridar The Atlantic ta ruwaito cewa an yi gwajin da bai kai 14,000 ba.
A ranar 22 ga Maris, Associated Press ta ruwaito: "Mutane da yawa da ke da alamun cututtuka da kuma umarnin likita sun jira na sa'o'i ko kwanaki don gwaji". Bayan an ruwaito mutuwar farko a Amurka a ranar 29 ga Fabrairu a jihar Washington, Gwamna Jay Inslee ya sanar da dokar ta baci, wani mataki da wasu jihohi suka bi nan da nan.
Makarantun da ke yankin Seattle sun soke darussan a ranar 3 ga Maris, kuma a tsakiyar watan Maris, an rufe makarantun a duk faɗin ƙasar. A ranar 6 ga Maris, 2020, ƙungiyar masana cututtukan cututtuka daga Kwalejin Imperial ta London ta sanar da Amurka game da hasashen tasirin sabon coronavirus a ƙasar.
A wannan rana, Shugaba Trump ya rattaba hannu kan Dokar Ƙarin Bayanai don Shirya da Amsawa ga Coronavirus, wanda ya ba da dala biliyan 8300 a cikin kudaden gaggawa ga hukumomin tarayya don amsa cutar.
Kamfanoni sun sa takunkumin tafiye-tafiye a kan ma'aikata, sun soke taron, kuma sun ƙarfafa ma'aikata su yi aiki daga gida.
A ranar 11 ga Maris, Trump ya sanar da takunkumin tafiye-tafiye zuwa yawancin kasashen Turai, sai dai Burtaniya, na kwanaki 30, daga ranar 13 ga Maris.
A rana ta gaba, ya faɗaɗa takunkumin zuwa Burtaniya da Ireland.
A ranar 13 ga watan Maris, ya bayyana dokar ta baci ta kasa, wanda ya ba da kudade na tarayya don amsa matsalar.
Tun daga ranar 15 ga Maris, kamfanoni da yawa sun rufe ko rage lokutan aiki a duk faɗin Amurka don ƙoƙarin rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da annobar a jihohi 50 da kuma gundumar Columbia. A ranar 23 ga Maris, an ba da rahoton cewa birnin New York yana da ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙarar ƙididdigar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar ƙarar.
A ranar 25 ga watan Maris, gwamnan ya ce, ana ganin an yi amfani da nesa da jama'a, saboda kimar ninka yawan mutane ya tashi daga kwanaki 2 zuwa kwanaki 4.7.
A ranar 28 ga Maris, akwai mutane 32,308 da aka tabbatar da cutar a birnin New York, kuma mutane 672 sun mutu saboda cutar. A ranar 26 ga Maris, an ba da rahoton cewa Amurka tana da ƙarin kamuwa da cutar coronavirus da aka tabbatar fiye da kowace ƙasa a duniya, gami da China da Italiya. A ranar 8 ga Afrilu, an tabbatar da mutane 400,335 a Amurka kuma mutane 12,841 sun mutu.
Rahotanni daga kafofin yada labarai a ranar 30 ga Maris sun nuna cewa Shugaba Trump na Amurka ya yanke shawarar tsawaita ka'idodin nisantar zamantakewa har zuwa 30 ga Afrilu.
A wannan rana, ya sauka a birnin New York a kan jirgin ruwa mai suna USNS Comfort, wato asibiti mai ɗauke da gado dubu.
A ranar 3 ga Afrilu, Amurka ta yi rikodin mutuwar mutane 884 a cikin sa'o'i 24 saboda coronavirus.
A ranar 3 ga Afrilu, a jihar New York, adadin mutane sun wuce 100,000. An soki fadar White House saboda ta raina barazanar da kuma sarrafa saƙonnin ta hanyar ba da umarnin jami'an lafiya da masana kimiyya su daidaita bayanan jama'a da wallafe-wallafen da suka shafi cutar tare da ofishin mataimakin shugaban kasa, Mike Pence.
An yi ta yin watsi da yadda Trump yake magance matsalar a tsakanin 'yan jam'iyyar.
Wasu jami'an Amurka da masu sharhi sun soki dogarowar Amurka kan shigo da kayan aiki masu mahimmanci daga China, gami da kayayyakin kiwon lafiya na musamman.
An yi amfani da nazarin tsarin tafiya don ganowa da hango ko hasashen tsarin yaduwar kuma an buga shi a cikin The Journal of Travel Medicine a tsakiyar Janairu 2020.
Bisa ga bayanan 2018 na Kungiyar Sufurin Jiragen Sama ta Duniya, Bangkok, Hong Kong, Tokyo da Taipei sun sami mafi yawan matafiya daga Wuhan.
Dubai, Sydney da Melbourne sun kuma zama sanannun wuraren da mutane ke tafiya daga Wuhan.
An ruwaito cewa Bali ita ce birni mafi ƙarancin iyawa a cikin shahararrun biranen 20 na duniya daga ra'ayi na shiri, yayin da biranen Ostiraliya suka kasance mafi iyawa.
Ya sanar da cewa har yanzu akwai abubuwa da yawa da za a gano game da COVID-19, kuma cewa Ostiraliya za ta jaddada kula da iyakoki da sadarwa a cikin martani ga annobar.
A ranar 21 ga Maris, an bayyana gaggawa na lafiyar dan Adam a Ostiraliya.
Saboda ingantaccen killacewar jigilar jama'a a Wuhan da Hubei, kasashe da dama sun shirya su kwashe 'yan kasarsu da ma'aikatan diflomasiyya daga yankin, musamman ta hanyar jiragen haya daga ƙasarsu, tare da izinin hukumomin China.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus da Thailand sun kasance daga cikin kasashe na farko da suka shirya fitar da 'yan ƙasarsu.
Pakistan ta ce ba za ta kwashe wani dan kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko danginsu, ban da 'yan Poland hudu, dan kasar Sin da kuma dan kasar Indiya.
'Yan kasar Poland, China da Indiya sun sauka a Poland, inda jirgin Brazil ya tashi kafin ya ci gaba da tafiya zuwa Brazil.
'Yan kasar Brazil da suka tafi Wuhan sun kasance a cikin killace a wani sansanin soja kusa da Brasilia.
A wannan ranar, an kwashe 'yan Kanada 215 (176 daga jirgin sama na farko da 39 daga jirgin sama na biyu da Gwamnatin Amurka ta haya) daga Wuhan zuwa CFB Trenton don kasancewa cikin killacewa na makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama ya sauka a CFB Trenton tare da 'yan Kanada 185 da ke Wuhan.
A ranar 3 da 4 ga watan Fabrairu, hukumomin Ostiraliya sun kwashe 'yan kasar 277 zuwa cibiyar tsare-tsare a tsibirin Kirsimeti, wanda aka sake amfani da shi a matsayin cibiyar killacewa, inda suka zauna har tsawon kwanaki 14.
A ranar 5 ga Fabrairu, jirgin motsa jiki ya isa Auckland daga New Zealand; fasinjojinsa (gami da wasu daga Ostiraliya da Pacific) sun kasance cikin killacewa a wani sansanin ruwa a Whangaparoa, arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa a kan jirgin ruwa mai suna Diamond Princess.
A ranar 21 ga Fabrairu, jirgin sama ya sauka a Trenton, Ontario, yana dauke da fasinjoji 129 da aka kwashe daga Diamond Princess.
A farkon watan Maris, Gwamnatin Indiya ta fara kwashe 'yan kasar daga Iran. A ranar 14 ga Maris, jirgin saman South African Airways da Gwamnatin Afirka ta Kudu ta haya ya koma gida da' yan Afirka ta Kudu 112.
An yi gwajin likita kafin tashi, kuma 'yan Afirka ta Kudu hudu da ke da alamun cutar coronavirus sun zauna don rage haɗarin.
Sai dai 'yan Afirka ta Kudu da suka yi gwajin rashin lafiya ne kawai aka mayar da su.
Sakamakon gwajin ya ba da izinin duk 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal, 'yan sanda da sojoji da suka shiga cikin aikin agaji, waɗanda, a matsayin matakin rigakafi, suka kasance a cikin kallo da keɓewa na kwanaki 14 a The Ranch Resort.
A ranar 20 ga watan Maris, Amurka ta fara janye dakarunta daga Iraki a wani bangare saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen kasar Sin ta ce kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimako ga kasar Sin.
Wasu daliban kasar Sin a jami'o'in Amurka sun hada kai don taimakawa wajen aika taimako zuwa yankunan China da cutar ta shafa, kuma an ruwaito cewa wani rukuni na hadin gwiwa a yankin Chicago ya sami nasarar aikawa da masks N95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don tallafawa kokarin neman allurar rigakafi da magani, da kuma kare "ƙungiyoyin da ke cikin haɗari a Afirka da Kudancin Asiya".
Interaksyon ta ruwaito cewa gwamnatin kasar Sin ta ba da masks 200,000 ga Philippines a ranar 6 ga watan Fabrairu, bayan da Sanata Richard Gordon ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Red Cross ta Singapore ta sanar da cewa za ta tura tallafi na dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da masks miliyan daya ga Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da kayan aikin likita sama da tan 13 zuwa Wuhan, Malaysia ta sanar da bayar da safofin hannu miliyan 18 ga China, Jamus ta aika da kayayyakin kiwon lafiya da dama, ciki har da riguna 10,000 don kayan haɗari, kuma Amurka ta ba da kayayyakin kiwon lafiya tan 17.8 ga China kuma ta yi alkawarin karin dala miliyan 100 a cikin tallafin tattalin arziki ga ƙasashen da cutar ta shafa. Bayan da al'amuran a China suka bayyana sun daidaita, kasar ta kasance tana aika da taimako ga ƙasashe da yawa da cutar ta shafa.
A watan Maris, kasar Sin da Cuba da Rasha sun aika da kayayyakin kiwon lafiya da kuma kwararrun masana don taimakawa Italiya wajen magance barkewar cutar coronavirus.
Jack Ma ya tura kayan gwaji miliyan 1.1 da masks miliyan 6 da kuma riguna 60,000 zuwa Addis Ababa, Habasha, domin kungiyar tarayyar Afirka ta rarraba su.
Daga nan sai ya aika da kayan gwaji 5,000, da masks 100,000 da kuma na'urori masu numfashi 5 zuwa Panama.
Ma kuma ta ba da kayayyakin kiwon lafiya ga Kanada. Netherlands, Spain, Turkiyya, Georgia da Jamhuriyar Czech sun nuna damuwa game da masks da kuma kayan gwajin da aka yi a kasar Sin.
Misali, Spain ta cire kayan gwajin coronavirus 58,000 da aka yi a kasar Sin tare da daidaito na kashi 30 cikin dari, yayin da Netherlands ta cire kayan shafa na kasar Sin 600,000 da suka lalace.
Belgium ta cire masks 100,000 da ba za a iya amfani da su ba, wanda aka yi zaton sun fito ne daga kasar Sin, amma a gaskiya sun fito ne daga Kolombiya.
A ranar 2 ga Afrilu, Bankin Duniya ya fara ayyukan gaggawa na tallafawa kasashe masu tasowa.
Hukumar ta WHO ta yaba wa kokarin da gwamnatin kasar Sin ke yi wajen hana cutar da kuma hana ta yaduwa.
Hukumar ta WHO ta nuna bambanci tsakanin barkewar cutar SARS ta 2002 zuwa 2004, lokacin da aka zargi hukumomin kasar Sin da yin shiru wanda ya hana kokarin hanawa da kuma hanawa, da kuma rikicin da ke faruwa a yanzu, inda gwamnatin tsakiya "ta samar da sabuntawa na yau da kullum don kauce wa firgita a ranar hutun Sabuwar Shekara ta Lunar".
A ranar 23 ga Janairu, a cikin martani ga shawarar da hukumomin tsakiya suka yanke na aiwatar da haramcin sufuri a Wuhan, wakilin WHO Gauden Galea ya lura cewa, yayin da "ba shakka ba shawarar da WHO ta yi ba", ya kasance "babban alamar sadaukarwa don dakile cutar a inda ta fi yawaita" kuma ya ce "babu wani abin da ya faru a tarihin lafiyar jama'a". A ranar 30 ga Janairu, bayan an tabbatar da watsa tsakanin mutane a waje da China da karuwar adadin shari'o'i a wasu ƙasashe, WHO ta ayyana barkewar cutar a matsayin gaggawa ta lafiyar jama'a na duniya (ESPII), ESPII na shida tun lokacin da aka fara kiran matakin a lokacin annobar cutar mura ta 2009.
Babban darektan WHO, Tedros Adhanom, ya ce ESPII na da "hadarin yaduwar duniya, musamman ga ƙasashen da ke da ƙananan da matsakaitan kuɗi ba tare da tsarin kiwon lafiya mai ƙarfi ba".
A mayar da martani ga aiwatar da takunkumin tafiye-tafiye, Tedros ya bayyana cewa "babu wani dalili na daukar matakan da ba dole ba da ke tsoma baki a cikin kasuwanci da tafiye-tafiye na duniya" kuma cewa "WHO ba ta ba da shawarar iyakance kasuwanci ko motsi ba".
A ranar 5 ga watan Fabrairu, WHO ta nemi taimakon da ya kai dala miliyan 675 daga al'ummar duniya don tallafawa shirye-shiryen da ake yi a ƙasashen da ke da ƙananan kuɗin shiga, kuma ta ambata gaggawa na tallafa wa ƙasashen da "ba su da tsarin gano mutanen da suka kamu da cutar, idan akwai su".
Tedros ya kuma yi bayani cewa "mu ne kawai masu karfi kamar yadda mu ne mafi rauni" kuma ya bukaci al'ummar duniya su "yi zuba jari a yau ko kuma su biya karin a nan gaba".
A wannan ranar, Tedros ya bayyana cewa babban sakataren Majalisar Dinkin Duniya, António Guterres, ya amince ya ba da "ikon dukan tsarin Majalisar Dinkin Duniya a cikin amsa".
A sakamakon haka, an kunna ƙungiyar kula da rikicin Majalisar Dinkin Duniya, wanda ya ba da damar daidaita ayyukan duk Majalisar Dinkin Duniya, wanda, a cewar WHO, zai ba su damar "daidaita kansu kan amsawar lafiya yayin da sauran hukumomi za su iya ba da ƙwarewar su don magance tasirin zamantakewa, tattalin arziki da ci gaban ci gaban barkewar cutar".
A ranar 14 ga Fabrairu, an kunna ƙungiyar aikin hadin gwiwa da WHO ta jagoranci tare da China don samar da masana na duniya da na WHO a kan filin a China don taimakawa wajen gudanar da ƙasa da kimanta "zafin hali da watsawar cutar" ta hanyar shirya bitar bita da tarurruka tare da manyan cibiyoyin a matakin ƙasa da kuma yin ziyara a wurin don kimanta " tasirin ayyukan amsawa a lardin da gundumar, gami da yanayin birane da na karkara". A ranar 25 ga Fabrairu, WHO ta bayyana cewa "duniya dole ne ta yi ƙari don shirya don yiwuwar annobar coronavirus", kuma ta lura cewa, kodayake har yanzu yana da wuri don cutar, ƙasashe dole ne su kasance "a cikin matakin shiri".
A martani ga barkewar cutar a Iran, WHO ta aika da ƙungiyar aiki tare don tantance halin da ake ciki. A ranar 28 ga Fabrairu, jami'an WHO sun ce kimantawar barazanar coronavirus a duniya za ta tashi daga "babba" zuwa "mai girma", matakin da ya fi girma na faɗakarwa da kimanta haɗari.
Mike Ryan, darektan gudanarwa na shirin gaggawa na kiwon lafiya na WHO, ya yi gargadin a wata sanarwa cewa "Wannan tabbaci ne na gaskiya ga dukan gwamnatocin duniya: ku farka.
Wannan kwayar cutar na iya kasancewa a kan hanya kuma dole ne mu kasance a shirye", yana mai da hankali cewa matakan da suka dace na iya taimaka wa duniya ta guje wa "mafi muni".
Ryan ya kuma ce bayanan da ake samu a yanzu ba su tabbatar da cewa jami'an kiwon lafiya na duniya za su bayyana cutar ta duniya ba, kuma ya ce wannan sanarwa zai nuna cewa "ainihin muna amincewa da cewa dukkan mutane a duniya za su kasance a cikin wannan cutar".
A ranar 11 ga watan Maris, WHO ta ayyana barkewar cutar coronavirus a matsayin annoba.
Babban daraktan ya ce WHO tana "da matukar damuwa, duka game da matakan yaduwar da kuma tsanani, da kuma matakan rashin aiki". WHO ta sami manyan zargi saboda abin da ake la'akari da rashin dacewar gudanar da cutar, gami da sanarwar gaggawa game da gaggawa na lafiyar jama'a da kuma rarraba cutar a matsayin cutar.
A cikin wannan mummunan martani, an haɗa da takardar murabus na Babban Daraktan WHO, Tedros Adhanom, wanda mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu.
A ranar 26 ga watan Maris na shekarar 2020, masana kan hakkin dan adam da dama na Majalisar Dinkin Duniya sun jaddada cewa ana girmama hakkokin kowa a lokacin annobar COVID-19.
Kungiyar ta ce kowa yana da hakkin yin ayyukan da za su ceci rayuka kuma gwamnati ce ke da wannan alhakin.
Ƙungiyar ta nuna cewa ba a taɓa yin amfani da rashin albarkatu ko inshorar lafiya a matsayin hujja ga nuna bambanci ga wani rukuni na musamman ba.
Masana sun nuna cewa kowa yana da hakkin samun lafiya, ciki har da nakasassu, da waɗanda ke cikin ƙananan kungiyoyi, tsofaffi, da waɗanda aka yi gudun hijira a cikin gida, da marasa gida, da waɗanda ke rayuwa a cikin matsanancin talauci, da waɗanda aka tsare, da kuma 'yan gudun hijira da sauran kungiyoyin da ba a ƙayyade ba da ke bukatar tallafin gwamnati.
Kungiyoyin gwamnati na duniya suna magance tasirin zamantakewa da tattalin arziki na rikicin COVID-19.
Hukumar hadin kan tattalin arziki da ci gaban tattalin arziki ta kaddamar da dandamali don samar da cikakken bayani game da amsoshin siyasa a kasashe a duniya, da ra'ayoyi da shawarwari.
Daga manufofi don karfafa tsarin kiwon lafiya da tattalin arzikin duniya zuwa magance tasirin confinement da takunkumin tafiya, cibiyar dijital ta haɗa da mai bin diddigin manufofi ta kowace ƙasa, kuma tana da manufar taimaka wa ƙasashe su koya daga juna da kuma samar da daidaitaccen amsa duniya ga ƙalubalen coronavirus.
Gwamnatin kasar Sin ta fuskanci sukar Amurka, Ministan ofishin ofishin gwamnatin Burtaniya, Michael Gove, da dan shugaban Brazil Jair Bolsonaro, Eduardo Bolsonaro, kan yadda suka gudanar da annobar, wadda ta fara a lardin Hubei na kasar Sin.
An sallami wasu gwamnoni a lardin jam'iyyar kwaminisancin kasar Sin (CPC) saboda gudanar da kokarin da suka shafi killacewa a tsakiyar kasar Sin, a wata sanarwa ta rashin jin dadin yadda tsarin siyasa ya amsa barkewar cutar a wadannan yankuna.
Wasu masu sharhi sun yi imanin cewa an dauki wannan matakin ne domin kare babban sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping, daga fushin jama'a game da barkewar cutar coronavirus.
Wasu jami'an kasar Sin, kamar Zhao Lijian, sun yi watsi da wani sanarwa na farko game da fara barkewar cutar coronavirus a Wuhan, a madadin ka'idojin shiririri game da asalin COVID-19 a Amurka ko Italiya.
Gwamnatin Donald Trump ta Amurka ta yi magana game da coronavirus a matsayin "taurin cutar Sin" ko "taurin Wuhan", kuma ta ce "tsabtace-tsabtace na China ya ciyar da wani kwayar cutar da ta zama annobar duniya", wanda wasu masu sukar suka nuna a matsayin wariyar launin fata da "rashin hankali" game da gazawar gwamnatinsu na dakile cutar.
Jaridar Daily Beast ta samu sakon daga gwamnatin Amurka wanda ya bayyana dabarun sadarwa da ake ganin ya fito ne daga Majalisar Tsaro ta Kasa, kuma an ambaci dabarar a matsayin "Dukkanin China".
An gaya mana mu yi kokarin isar da wannan sakon ta kowace hanya da za mu iya, ciki har da taron manema labarai da kuma fitowar talabijin. "Kafofin watsa labarai kamar Politico, Foreign Policy da Bloomberg sun ce kokarin da China ke yi na aikawa da taimako ga kasashen da cutar ta shafa wani ɓangare ne na propaganda don samun tasiri a duniya.
Wakilin siyasar waje na Tarayyar Turai, Josep Borrell, ya yi gargadin cewa "akwai wani bangare na siyasa wanda ya hada da gwagwarmayar tasiri ta hanyar yada labaran da kuma siyasa ta karimci".
Borrell ya kuma ce "Sin tana tura sakon da karfi cewa, ba kamar Amurka ba, ita ce abokiyar da za a iya dogara da ita".
Kasar Sin ta kuma bukaci Amurka ta dage takunkumin da ta dauka kan Syria da Venezuela da Iran, yayin da ta bayar da rahoton cewa ta tura taimakon ga kasashen biyu.
A ranar 3 ga watan Afrilu, Amurka ta hana Jack Ma ba da masks 100,000 ga Cuba.
An kuma zargi hukumomin Amurka da karkatar da taimakon da aka ba wa wasu ƙasashe zuwa ƙasarsu.
An kuma samu rahotanni game da rikice-rikice game da abin rufe fuska tsakanin wasu ƙasashe, kamar Jamus, Austria da Switzerland; da kuma tsakanin Jamhuriyar Czech da Italiya.
Bugu da ƙari, Turkiyya ta kama ɗaruruwan na'urorin numfashi da aka tura zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin kai na Tarayyar Turai da Italiya, wanda cutar ta shafa.
Jakadan Italiya a Tarayyar Turai, Maurizio Massari, ya ce: "China ce kawai ta amsa a bangare biyu.
Wannan ba alama ce mai kyau na haɗin kai na Turai ba".
A ranar 22 ga watan Maris, bayan da ya yi wa Firayim Ministan Italiya Giuseppe Conte kira ta waya, shugaban Rasha Vladimir Putin ya ba da umarnin cewa sojojin Rasha su tura likitocin soja, motocin kashe cututtuka na musamman da sauran kayan aikin likita zuwa Italiya.
Jaridar Italiya La Stampa ta yi ƙaulin wani "tushen siyasa mai girma" da ba a san shi ba wanda ya ce kashi 80 cikin 100 na taimakon da Rasha ke bayarwa "ba su da amfani ko kuma ba su da amfani ga Italiya".
Majiyar ta zargi Rasha da yin harin yaudarar "jiho-da-ra'ayi da diplomasiyya".
Shugaban Lombardy, Attilio Fontana, da ministan harkokin wajen Italiya, Luigi Di Maio, sun yi watsi da rahoton da aka bayar a jaridu kuma sun nuna godiya.
Rasha ta kuma tura wani jirgin sama mai dauke da kayan aiki zuwa Amurka.
Kakakin gwamnatin Kremlin Dmitry Peskov ya ce, "ta wajen ba da taimako ga abokan aikinsa na Amirka, [Putin] ya ɗauka cewa, sa'ad da masana'antun Amurka na kayan aikin likita da na'urori suka samu ci gaba, za su iya ba da taimako idan ya cancanta".
Aikin soja na NATO da aka shirya "Defender 2020" a Jamus, Poland da Baltic Countries, shine mafi girman aikin soja na NATO tun bayan ƙarshen Cold War, za a gudanar a ƙarancin sikelin.
Babban sakataren Kamfen don Rashin Makamai na Nukiliya, Kate Hudson, ta soki aikin Defender 2020: "A cikin rikicin lafiyar jama'a na yanzu, yana barazana ga rayukan ba kawai sojojin Amurka da ƙasashen Turai daban-daban da ke shiga ba, har ma da na mazaunan ƙasashen da suke aiki a ciki". Gwamnatin Iran ta sami mummunan tasiri daga cutar, tare da kusan 'yan majalisa biyu da suka kamu, ban da wasu mutane goma sha biyar na yanzu da na baya.
A ranar 14 ga watan Maris na shekarar 2020, shugaban kasar Iran, Hassan Rouhani, ya rubuta wasikar jama'a ga shugabannin duniya domin neman taimako, ya ce kasarsa na fuskantar matsaloli wajen yaki da annobar saboda rashin samun damar zuwa kasuwannin duniya sakamakon takunkumin Amurka kan Iran.
Masu nazarin siyasa sun yi hasashen cewa zai iya shafar yiwuwar sake zaben Donald Trump a zaben shugaban kasa na 2020. Dangantakar diflomasiyya tsakanin Japan da Koriya ta Kudu ta tabarbare saboda annobar.
Koriya ta Kudu ta soki "ƙoƙarin killacewar da ba a fahimta ba da kuma yin aiki da shi" na Japan, bayan da Japan ta sanar da cewa duk wani mutumin da ya fito daga Koriya ta Kudu zai kasance a cikin killacewa na makonni biyu a wuraren da gwamnati ta tsara.
A farkon, al'ummar Koriya ta Kudu sun kasance masu rarrabewa game da yadda Moon Jae-in ya amsa rikicin.
Yawancin 'yan Koriya sun sanya hannu kan buƙatun neman tsige Moon saboda abin da suka yi la'akari da rashin kula da annobar ta gwamnati, ko kuma, don yabon amsarsa.
Wasu masu sharhi sun nuna damuwa cewa zai iya ba gwamnatoci damar karfafa ikon su.
A Hungary, majalisar ta amince da izinin firaministan kasar Viktor Orbán ya yi mulki ta hanyar doka har abada, ya dakatar da majalisar da kuma zaben, kuma ya hukunta wadanda ake ganin sun yada bayanan karya game da cutar da kuma yadda gwamnatin ke kula da rikicin.
An zargi barkewar cutar coronavirus da karancin kayayyaki, sakamakon amfani da kayan aiki a duniya don yaki da barkewar cutar, sayayya da tsoro da katsewa na ayyukan logistics da masana'antu.
Hukumar Kula da Abinci da Magunguna ta Amirka ta ba da gargadi game da rashin magani da kuma kayan aikin likita saboda yawan bukatar masu amfani da kuma katsewar masu samar da kayayyaki.
Wasu yankuna ma sun ga sayayya da ake yi a cikin firgici da ke barin ɗakunan kayan abinci marasa amfani, kamar abinci, takarda da ruwa mai kwalba, wanda ya haifar da karancin kayayyaki.
A fannin fasaha, musamman, an yi gargadin jinkirin aikawa da kayayyakin lantarki.
A cewar babban darektan WHO, Tedros Adhanom, bukatar kayan kare kanka ta karu sau 100.
Wannan bukatar ta haifar da karuwar farashin har zuwa sau ashirin na farashin al'ada kuma ta haifar da jinkiri na watanni hudu zuwa shida a cikin samar da kayayyakin kiwon lafiya.
Hakan ya kuma jawo karancin kayan kare kai a duniya, kuma WHO ta yi gargadin cewa hakan zai sa ma'aikatan kiwon lafiya cikin hatsari.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu sayen daigou su sayar da kayayyakin Ostiraliya zuwa China.
Aikin ya haifar da karancin abinci ga jarirai a wasu manyan kantuna kuma daga baya Gwamnatin Ostiraliya ta hana shi. Duk da yawan cututtukan COVID-19 a arewacin Italiya da yankin Wuhan, da kuma buƙatar abinci, babu ɗayan waɗannan yankunan da aka shafa da karancin abinci.
Matakan da kasar Sin da Italiya suka dauka kan tarawa da kuma cinikin kayayyakin da ba a yarda da su ba sun yi nasara, kuma sun hana samun karancin abinci da aka yi tsammani a Turai da Arewacin Amirka.
Arewacin Italiya, da yawan aikin gona, ba ta da raguwa mai yawa, amma farashin zai iya tashi, a cewar wakilan masana'antar.
Abincin abinci a kan gado ya kasance a banza na ɗan lokaci, har ma a birnin Wuhan, yayin da jami'an gwamnatin kasar Sin suka saki naman alade don tabbatar da isasshen abinci ga jama'a.
A Italiya, akwai irin wannan dokar da ta bukaci masu samar da abinci su ajiye kayayyaki don irin wannan gaggawa.
An ji lalacewar tattalin arzikin duniya a China: a cewar wani rahoto na jarida na 16 ga Maris, tattalin arzikin China ya sha wahala sosai a farkon watanni biyu na 2020 saboda matakan da gwamnati ta ɗauka don dakatar da yaduwar cutar, kuma tallace-tallace na kiri sun ragu da 20,5%.
Tun da babban yankin kasar Sin babban cibiyar tattalin arziki da masana'antu ne, an dauki kamuwa da cutar ta zama barazanar kawo rashin kwanciyar hankali ga tattalin arzikin duniya.
Agathe Demarais daga sashen bincike na The Economist ta yi hasashen cewa kasuwanni za su ci gaba da yin tashin hankali har sai an bayyana cikakken sakamakon.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa sakamakon tattalin arzikin annobar a kan ci gaban duniya zai iya wuce na barkewar cutar SARS na 2002 zuwa 2004.
Wani masanin jami'ar Washington a St. Louis ya ce hakan zai iya jawo asarar fiye da dala biliyan 300 a sarkar samar da kayayyaki a duniya har tsawon shekaru biyu.
An ruwaito cewa kungiyar kasashen da ke fitar da man fetur (OPEC) ta "rubuce" bayan da farashin man fetur ya fadi sosai saboda karancin bukatar kasar Sin.
A ranar 24 ga Fabrairu, kasuwannin jari na duniya sun fadi saboda ƙaruwar yawan shari'o'in COVID-19 a wajen babban yankin China.
A ranar 27 ga Fabrairu, saboda damuwa game da barkewar cutar coronavirus, wasu alamun jari na Amurka, gami da NASDAQ-100, S&P 500 da Dow Jones Industrial Average sun fitar da mafi ƙarancin faɗuwa tun daga 2008, Dow ya faɗi maki 1191, mafi girma a cikin rana ɗaya tun lokacin rikicin kuɗi na 200708.
Dukkanin alamun sun ƙare makon da suka yi kasa da kashi 10.
A ranar 28 ga Fabrairu, kamfanin Scope Ratings GmbH ya tabbatar da matsayin mallakar kasar Sin, amma ya ci gaba da yin la'akari da hakan.
Aikin ya sake faɗuwa bisa tsoron coronavirus, mafi girma ya faru a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai yi sanyi.
Masanin tattalin arziki Mohamed El-Erian ya yaba da matakan gaggawa da jihohi da kuma manyan bankuna suka dauka.
Babban bankin ya yi sauri fiye da yadda ya yi a lokacin da aka yi ta rushewar kudi a 2008.
Yawon shakatawa na daga cikin bangarorin da aka fi shafa saboda haramtawar tafiya, rufe wuraren jama'a da suka hada da wuraren jan hankali na tafiya da kuma shawarar gwamnatoci kada su yi tafiya a ko'ina cikin duniya.
A sakamakon haka, kamfanonin jiragen sama da yawa sun soke jiragen saboda karancin bukatar, ciki har da British Airways, China Eastern Airlines da Qantas, yayin da kamfanin jirgin saman yankin na Burtaniya Flybe ya rushe.
Tasirin da ke tattare da kamfanonin jirgin ruwa ya kai matakin da ba a taɓa gani ba.
An rufe tashoshin jirgin kasa da tashoshin jiragen ruwa da yawa.
Cutar ta yi daidai da Chunyun, wani muhimmin lokacin tafiya da ya shafi hutun Sabuwar Shekarar Sin.
Gwamnatocin ƙasa da na yanki sun soke wasu taron da ke tattare da taro masu yawa, gami da bukukuwan Sabuwar Shekara, yayin da kamfanoni masu zaman kansu suka rufe shagunan su da wuraren yawon buɗe ido, kamar Hong Kong Disneyland da Shanghai Disneyland.
An rufe abubuwan da ake yi da kuma wuraren yawon bude ido da yawa don kada a yi taro, ciki har da birnin Beijing da kuma bikin haikalin gargajiya.
A larduna 24 daga cikin 31 da ke kasar Sin, hukumomi sun tsawaita hutun Sabuwar Shekara har zuwa 10 ga Fabrairu, kuma sun umarci yawancin wuraren aiki da kada su sake budewa har zuwa wannan ranar.
Waɗannan yankuna sun kai kashi 80 cikin 100 na GDP da kuma kashi 90 cikin 100 na fitarwa na ƙasar.
Hong Kong ta ɗaga matakin amsawa ga cutar mai kamuwa da cuta zuwa mafi girma kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa Maris kuma ta soke bikin Sabuwar Shekara.
Ziyarar masu sayar da kayayyaki a Turai da Latin Amirka ta ragu da kashi 40%.
Masu sayar da kayayyaki a Arewacin Amirka da Gabas ta Tsakiya sun ragu da kashi 50 zuwa 60 cikin ɗari.
Wannan kuma ya haifar da raguwar 33 zuwa 43 cikin dari a cikin zirga-zirgar ƙafa zuwa wuraren kasuwanci a watan Maris idan aka kwatanta da Fabrairu.
Masu gudanar da cibiyoyin kasuwanci a duk faɗin duniya sun sanya ƙarin matakan, kamar tsaftacewa, shigar da na'urorin bincike na zafi don sarrafa zafin jiki na masu siye da soke taron.A cewar kimantawar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, koma bayan tattalin arziki da cutar ta haifar na iya barin mutane miliyan 14 zuwa 22 a cikin matsanancin talauci a Latin Amurka fiye da waɗanda suka kasance a cikin wannan yanayin ba tare da cutar ba.
A watan Janairu da Fabrairu na shekarar 2020, a lokacin da annobar ta kai sama a birnin Wuhan, mutane kimanin miliyan 5 a kasar Sin sun rasa ayyukansu.
Yawancin ma'aikatan karkara da ke gudun hijira a kasar Sin kusan miliyan 300 sun makale a gidajensu a lardunan cikin gida ko kuma a cikin lardin Hubei. A watan Maris na 2020, fiye da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Rikicin korona na iya kashe ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi na iya kaiwa kashi 32 cikin dari, a cewar kimantawar bankin tsaron tarayya na St. Louis. Rikice-rikicen Indiya ya bar dubban miliyoyin ma'aikatan Indiya masu ƙaura (waɗanda ke karɓar albashi na yau da kullun) marasa aiki. A cewar binciken da Cibiyar Angus Reid ta gudanar, kashi 44 cikin dari na gidajen Kanada sun sami wasu nau'ikan rashin aikin yi. Kimanin ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da aka fara rigakafin a tsakiyar watan Maris na 2020.
A cikin rabin watan Maris, ma'aikata miliyan 4 a Faransa sun nemi albashi na rashin aikin yi na wucin gadi, kuma ma'aikata miliyan 1 a Burtaniya sun nemi tsarin bashi na duniya. Kusan kamfanoni miliyan biyar a Jamus sun aiwatar da tsarin aiki na gajeren lokaci da gwamnati ke tallafawa, wanda ake kira Kurzarbeit, ga ma'aikatansu.
Faransa da Birtaniya sun amince da tsarin biyan kuɗin gajeren lokaci na Jamus.
An yi wa fannonin fasaha da al'adun gargajiya mummunan tasiri ta hanyar annobar, wanda ya shafi ayyukan kungiyoyi da kuma mutane, duka masu aiki da masu zaman kansu, a duk duniya.
Ƙungiyoyin al'adu da fasaha sun yi ƙoƙari su cika aikinsu (wanda yawanci ana tallafawa ta kudade na gwamnati) don samar wa al'umma damar samun dukiyar al'adu, kiyaye lafiyar ma'aikatan su da kuma jama'a, da kuma tallafa wa masu fasaha a duk lokacin da zai yiwu.
A watan Maris na shekarar 2020, a duk faɗin duniya da kuma a matakai daban-daban, gidajen tarihi, dakunan karatu, wuraren wasan kwaikwayo da sauran cibiyoyin al'adu sun rufe har abada, kuma an soke ko kuma an jinkirta baje kolin su, abubuwan da suka faru da kuma abubuwan da suka nuna.
A sakamakon haka, an yi ƙoƙari sosai don samar da ayyuka na madadin ta hanyar dandamali na dijital. Wani sakamako na kwanan nan da ke ƙaruwa a cikin saurin cutar shine soke ayyukan addini. manyan abubuwan wasanni da sauran abubuwan zamantakewa, kamar bukukuwa na kiɗa da kide kide, tarurruka na fasaha da nunin kaya.
A lokacin da ake yin bikin, an yi watsi da bikin mako mai tsarki a Roma, wanda ake yi a makon ƙarshe na lokacin tuba na Kirista na Azumi.
Yawancin majami'u sun ba da shawarar cewa tsofaffin Kiristoci su zauna a gidajen su maimakon yin taro a ranar Lahadi. Wasu majami'u sun ba da sabis na addini ta rediyo, watsa shirye-shirye ta Intanet ko talabijin, yayin da wasu suka ba da wuraren yin addu'a daga mota.
Bayan da Roman Catholic Diocese of Rome ta yanke shawarar rufe majami'u da majami'u da kuma Plaza de San Pedro da ke cike da masu bautar Kirista, wasu kungiyoyin addini sun soke ayyukan su kuma sun iyakance taron jama'a a majami'u, masallatai, majami'u, haikalin da gurdwaras.
Ma'aikatar Lafiya ta Iran ta sanar da soke ayyukan sallar Juma'a a yankunan da cutar ta shafa sannan kuma ta rufe wuraren ibada, yayin da Saudiyya ta haramta shigar da baƙi da mazaunanta zuwa wuraren ibada a Makka da Madina.
Cutar ta haifar da canji mafi girma a cikin kalandar wasanni na duniya tun lokacin yakin duniya na biyu.
Yawancin manyan abubuwan wasanni an soke ko jinkirta, ciki har da UEFA Champions League 201920, Premier League 2019-20, UEFA Euro 2020, NBA 201920 kakar wasa da kuma NHL 201920 kakar wasa.
Fashewar ta katse shirye-shiryen Wasannin Olympics na 2020, wanda aka tsara a baya don farawa a ƙarshen Yuli; Kwamitin Olympic na Duniya ya sanar a ranar 24 ga Maris cewa za a " sake tsara taron don kwanan wata bayan 2020 amma ba bayan lokacin bazara na 2021 ba".
Wannan ya sa masu caca da yawa suka koma Intanet, shafukan caca da yawa na kan layi sun ba da rahoton ƙaruwar ƙimar sabon rajista. Masana'antar nishaɗi ma an shafa, ƙungiyoyin kiɗa da yawa sun dakatar ko soke yawon shakatawa.
Yawancin manyan gidajen wasan kwaikwayo, kamar na Broadway, sun dakatar da duk wasan kwaikwayon.
Wasu masu fasaha sun gano hanyoyin da za su ci gaba da samarwa da raba ayyukansu ta hanyar Intanet a matsayin madadin wasan kwaikwayon raye na gargajiya, kamar watsa shirye-shiryen raye-raye na wasan kwaikwayo ko ƙirƙirar "ƙungiyoyi" a kan Intanet don masu fasaha suyi aiki, rarraba ko buga aikin su.
A yanar gizo, an yada wasu shafukan intanet game da cutar coronavirus, saboda mutane da yawa suna amfani da haushi da kuma jan hankali a cikin rashin tabbas.
Tun bayan barkewar cutar COVID-19, an lura da karuwar nuna bambanci, ƙiyayya da wariyar launin fata ga mutanen da ke fitowa daga kasar Sin da Asiya ta Gabas, da kuma mutanen da ke yankunan Turai, Amurka da sauran ƙasashe inda halin da ake ciki yake da mahimmanci.
An lura da abubuwan tsoro, shakku da kuma zalunci a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amirka da kuma yankin Asiya da Pacific.
Rahotanni na watan Fabrairu (lokacin da yawancin shari'o'in har yanzu ke iyakance ga China) sun rubuta ra'ayoyin wariyar launin fata a cikin kungiyoyi da yawa a duniya waɗanda suka bayyana cewa Sinawa sun cancanci cutar ko kuma suna karɓar abin da suka ɗauka mai adalci ne.
Wasu ƙasashen Afirka sun kuma ga ƙaruwar motsin rai game da ƙasar Sin.
Mutane da yawa da ke birnin Wuhan da kuma Hubei sun ce an nuna musu wariya saboda asalin yankin da suke ciki.
Sinawa da kuma wadanda ke yankunan da cutar ta shafa sun samu tallafi, a kan intanet da wajen intanet.
Bayan barkewar cutar ta koma sabbin kasashe inda halin da ake ciki yake da matukar damuwa, mutanen Italiya, kasar Turai ta farko da ta fara fuskantar mummunan barkewar COVID-19, na iya zama sanadiyyar shakku da kuma rashin jin daɗin jama'a.
A Japan, hashtag #ChineseDontComeToJapan ya zama sananne a shafin Twitter.
Kasashen Sin da kuma wasu 'yan Asiya a Birtaniya da Amurka sun ruwaito cewa an samu karin cin zarafin wariyar launin fata da kuma zalunci.
An soki shugaban Amurka, Donald Trump, saboda ya kira coronavirus "kwararriyar cuta ta kasar Sin", kalma da masu sukar da yawa suka dauka ta nuna wariyar launin fata da kuma tsayayya da kasar Sin.
Masu zanga-zangar a Ukraine sun kai hari kan motocin bas da ke dauke da 'yan Ukraine da kuma 'yan kasashen waje da suka bar birnin Wuhan zuwa birnin Novi Sanzhary.
Rahotanni sun ce daliban da ke arewa maso gabashin Indiya, wanda ke da iyaka da China, da ke karatu a manyan biranen Indiya, sun sha wahala daga cutar coronavirus.
Shugaban jam'iyyar Bharatiya Janata ta jihar Bengal ta yamma, Dilip Ghosh, ya bayyana cewa, Sin ta lalata yanayi kuma "saboda haka Allah ya yi musu rashi".
A kasar Sin, rashin jin dadin jama'a da wariyar launin fata ga mazauna kasashen waje sun karu sakamakon annobar, kuma an bayyana 'yan kasashen waje a matsayin "ƙazamar kasashen waje" da kuma "ƙazanta".
Yawancin jaridu da ke da bangon biyan kuɗi sun cire su don wasu sassan ko duk labaran da suka yi game da cutar coronavirus.
Yawancin wallafe-wallafen kimiyya sun buga labarai na kimiyya game da barkewar cutar a buɗe.
Wasu masana kimiyya sun zaɓi su raba sakamakon da sauri a kan sabobin da aka buga kamar bioRxiv.
Cutar da ke tasowa: Cutar da ke tasowa da ke tasowa, sau da yawa sabon a cikin yaduwar yaduwar ko hanyar watsawa
Duniya da cututtuka: Bayani na gaba na duniya da kuma yaduwar cutar
Jerin annoba da annoba: Jerin yawan mutuwar da ake yi saboda cututtukan da ke kamuwa da cuta
Cinikin daji da kuma zoonosis: haɗarin kiwon lafiya da ke tattare da cinikin daji
Gwaje-gwajen dakin gwaje-gwaje na cutar ta numfashi ta coronavirus 2019 (COVID-19) da kuma cutar SARS-CoV-2 da ke hade da ita sun haɗa da hanyoyin gano kasancewar cutar da waɗanda ke gano rigakafin da aka samar don amsa cutar.
Ana tabbatar da kasancewar kwayar cutar a cikin samfuran ta hanyar gwajin sarkar polymerase tare da maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano RNA na SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da cututtuka na kwanan nan ko na yanzu.
Ana iya amfani da maganin rigakafi (serology) don ganewar asali da kuma lura da yawan jama'a.
Gwajin rigakafi ya nuna yawan mutanen da suka kamu da cutar, har da waɗanda suka nuna alamun da ba su da tsanani sosai ko kuma waɗanda ba su da alamun cutar.
Daga sakamakon wannan gwajin, za a iya sanin ainihin yawan mutuwar da ake yi a cutar da kuma matakin rigakafin da ake yi a cikin jama'a.
Saboda karancin gwaje-gwaje, har zuwa watan Maris na shekarar 2020, babu wata ƙasa da ke da tabbacin gaskiyar cutar a cikin al'ummarta.
A ranar 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin 100 na yawanta, kuma akwai bambancin gaske a yawan gwaje-gwajen da aka yi a ƙasashe daban-daban.
Wannan bambancin yana iya shafar yawan cututtukan da aka yi wa rahoto, wanda wataƙila an yi yawa a wasu ƙasashe.
Ta hanyar yin amfani da polymerase tare da real-time reverse transcriptase (rRT-PCR) ta hanyar yin gwaji, ana iya yin gwajin a cikin samfurori na numfashi da aka samu ta hanyar hanyoyi daban-daban, ciki har da nasopharyngeal hisopads ko samfurori na sputum.
A yawancin lokaci, ana samun sakamako a cikin 'yan sa'o'i ko kwanaki biyu.
Gwajin gwagwarmayar polymerase tare da reverse transcriptase da aka yi da faringeous hypopads yana da tabbaci ne kawai a makon farko na cutar.
Daga baya, cutar za ta iya ɓacewa a cikin garkuwar, amma za ta ci gaba da ƙaruwa a cikin huhu.
A cikin mutanen da ke da cutar da ake gwada su a mako na biyu, za a iya samun samfurin daga cikin rami na numfashi ta hanyar tsotsa catheter, ko kuma za a iya amfani da kayan da aka fitar a cikin coughing (sputum).
An gudanar da gwajin farko na polymerase a Charité, Berlin, a watan Janairun 2020, ta amfani da polymerase tare da madaidaicin lokaci na ainihin lokaci (rRT-PCR), kuma ya zama tushen kayan aikin 250 000 da Hukumar Lafiya ta Duniya (WHO) ta rarraba.
A ranar 23 ga Janairu, 2020, Burtaniya ta kuma ci gaba da gwaji. A ranar 28 ga Janairu, 2020, kamfanin Kogenebiotech na Koriya ta Kudu ya haɓaka kayan aikin gano SARS-CoV-2 dangane da tasirin sarkar polymerase mai digiri na asibiti (PowerChek Coronavirus).
Yana neman gene "E" wanda duk betacoronavirus ke rabawa da SARS-CoV-2 takamaiman gene RdRp. A China, BGI Group na ɗaya daga cikin kamfanoni na farko da suka sami amincewar gaggawa ta Amincewa da Hukumar Kula da Kayan Aikin Likita ta China na SARS-CoV-2 kit ɗin ganowa dangane da tasirin sarkar polymerase. A Amurka, Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka (CDC) suna rarraba kwamitin bincikensu na rikitarwa na sarkar polymerase tare da ainihin lokacin rikitarwa na coronavirus 2019 (2019-nCoV) ga dakunan gwaje-gwaje na jama'a ta hanyar International Reagent Resource.
Daya daga cikin gwaje-gwaje uku na kwayoyin halitta a cikin sigar gwajin gwajin da suka gabata sun haifar da sakamakon da bai dace ba saboda ƙwayoyin cuta, da kuma cunkoso a gudanar da gwaje-gwaje a CDC a Atlanta; a sakamakon haka, an aiwatar da samfurori ƙasa da 100 a kowace rana a kan matsakaici a duk Fabrairu 2020.
Ba a tabbatar da amincin gwaje-gwajen da ke amfani da sassan biyu ba har zuwa 28 ga Fabrairu, 2020, kuma daga nan ne aka ba da izinin ci gaba da gwajin gwaje-gwaje ga dakunan gwaje-gwaje na jihar da na gida.
Hukumar Abinci da Magunguna ta amince da gwajin a ƙarƙashin izinin amfani da gaggawa. Labs na kasuwanci na Amurka sun fara yin gwaji a farkon Maris 2020.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da samun gwajin COVID-19 a cikin ƙasa dangane da sarkar polymerase tare da maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin.
Hakazalika, a ranar 9 ga Maris, 2020, Quest Diagnostics ta ba da gwajin COVID-19 a matakin ƙasa.
Babu iyakancewar adadi da aka sanar; ana bukatar a tattara samfurori da kuma sarrafa su bisa ga bukatun CDC.
A Rasha, Cibiyar Nazarin Kwayar cutar da Fasaha ta VECTOR ce ta samar da gwajin COVID-19.
A ranar 11 ga Fabrairu, 2020, Hukumar Kula da Kula da Lafiya ta Tarayya ta yi rajistar gwajin. A ranar 12 ga Maris, 2020, an ruwaito cewa Mayo Clinic ta haɓaka gwajin don gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don gwajin da za a iya yi a cikin awanni 3.5 a cikin babban girma, wanda ya ba da damar inji ɗaya ya yi kimanin gwaje-gwaje 4128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa ga Abbott Laboratories don gwaji a cikin tsarin m2000 na Abbott; FDA ta ba da izini iri ɗaya ga Hologic, LabCorp, da Thermo Fisher Scientific a baya.
A ranar 21 ga Maris, 2020, Cepheid ta samu izinin amfani da gaggawa daga FDA don gwajin da ke ɗaukar kimanin minti 45.
Hukumar ta amince da gwajin da ke amfani da fasahar isothermal amplification na nucleic acid maimakon polymerase chain reaction.
Tun da ba a buƙatar jerin sake zagayowar zafin jiki na maye, wannan hanyar na iya samar da sakamako mai kyau a cikin minti biyar kawai da sakamako mara kyau a cikin minti 13.
A halin yanzu, akwai kimanin 18,000 na waɗannan injunan a Amurka kuma Abbott na shirin ƙara samarwa don yin gwaje-gwaje 50,000 a kowace rana. A Taiwan, ana haɓaka gwajin da ke amfani da antibody na monoclonal wanda ke haɗuwa musamman da furotin nucleocapside (protein N) na sabon coronavirus, da fatan zai iya samar da sakamako a cikin minti 15 zuwa 20 kamar yadda gwajin sauri don mura.
A watan Maris na shekarar 2020, binciken da aka yi ya nuna cewa "rawanin X-ray na ƙirjin ba su da ƙimar ganewar asali a farkon matakan, yayin da za a iya samun sakamakon CT [tomography] tun kafin bayyanar cututtuka".
Abubuwan da ke cikin TC sun haɗa da tsinkayen gilashin gilashi mai launin fata da yawa tare da rarraba gefe, asymmetric, da baya.
Yayin da cutar ta ci gaba, ana samun tsarin subpleural, tsarin matattarar da kuma ƙarfafawa.
A cewar wani bincike da aka gudanar a Wuhan, a wurin da cutar ta barke a yanzu, inda aka kwatanta aikin sarkar polymerase da na CT, aikin sarkar na CT ya fi na polymerase da yawa, ko da yake ba shi da takamaiman bayani, kuma yawancin siffofin da ke cikin hotunan sun yi daidai da ayyukan wasu cututtuka da huhu.
Tun daga Maris 2020, Kwalejin Radiology ta Amurka ta ba da shawarar "kada a yi amfani da CT a matsayin hanyar ganowa ko a matsayin gwajin farko don gano COVID-19". Tun daga Maris 2020, CDC ta ba da shawarar polymerase chain reaction a matsayin gwajin farko.
Wani ɓangare na tsarin garkuwar jiki na yin maganin cutar shi ne samar da rigakafi, ciki har da IgM da IgG.
Ana iya amfani da su don gano kamuwa da cuta a cikin mutane a cikin kwanaki 7 bayan bayyanar cututtuka, don tantance rigakafi da kuma lura da yawan jama'a. Ana iya yin gwaje-gwaje a cikin manyan dakunan gwaje-gwaje ko ta hanyar gwaji a wurin kulawa.
A cikin manyan dakunan gwaje-gwaje masu aiki na atomatik, a cikin dakunan gwaje-gwaje masu yawa, za a iya yin waɗannan gwaje-gwajen, amma kasancewa a wurin zai dogara da yawan yawan aikin da ake yi a kowace hanya.
Don bincike a cikin manyan dakunan gwaje-gwaje, ana amfani da samfurin jini guda ɗaya na jini, ko da yake ana iya amfani da samfurin jini don bin diddigin amsawar rigakafi.
Don gwajin a wurin da ake saka ido, yawanci ana samun jini guda ɗaya ta hanyar saƙa a cikin fata.
Ba kamar hanyoyin yin layin polymerase ba, ba a buƙatar mataki na cirewa kafin bincike. A ranar 26 ga Maris, 2020, FDA ta nada hukumomi 29 waɗanda suka ba da sanarwar ga hukumar kamar yadda ya dace kuma saboda haka yanzu suna iya rarraba gwajin rigakafin su.
A ranar 7 ga Afrilu, 2020, FDA ta amince da gwaji guda ɗaya kawai a ƙarƙashin izinin amfani da gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan gwajin su, waɗanda zasu iya gano IgG da IgA antibodies da cutar a cikin samfurin jini.
Ƙarfin gwajin yana da yawa daga cikin daruruwan samfurori a cikin sa'o'i kuma saboda haka yana da sauri fiye da gwajin gwajin RNA mai linzami na yau da kullum.
Ana iya gano rigakafin kwanaki 14 bayan kamuwa da cutar. A farkon watan Afrilu, Burtaniya ta gano cewa babu wani daga cikin kayan gwajin rigakafin da ta saya da ya isa ta yi amfani da su.
Hong Kong ta kirkiro shirin da marasa lafiya masu zargin za su iya zama a gidajensu, "sashen gaggawa ya ba da asibiti bututun samfurin", mai haƙuri ya yi fesawa a cikin bututun, ya aika da shi kuma ya sami sakamako a cikin ɗan lokaci. NHS ta Burtaniya ta sanar da cewa tana aiwatar da shirin gwaji don nazarin shari'o'in da ake zargi a gidajensu, wanda ke kawar da haɗarin cewa mai haƙuri zai kamu da wasu idan ya je asibiti ko buƙatar lalata motar asibiti idan aka yi amfani da ɗaya. A cikin gwajin a cibiyoyin tuki-ta hanyar COVID-19 na shari'o'in da ake zargi, ƙwararren likita na kiwon lafiya yana ɗaukar samfurori da matakan da suka dace.
Cibiyoyin motsa jiki sun taimaka wa Koriya ta Kudu ta yi wasu gwaje-gwaje mafi sauri da kuma mafi girma a kowace ƙasa. A Jamus, Ƙungiyar Likitoci na Ƙasar ta Sanarwar Kiwon Lafiya ta Sanarwar ta ce a ranar 2 ga Maris cewa tana da damar yin gwajin kusan 12,000 a rana a cikin yanayin waje kuma an gwada mutane 10,700 a makon da ya gabata.
Asusun inshorar lafiya yana biyan kuɗin idan likita ya umurce ku ku yi gwajin.
Shugaban Cibiyar Robert Koch ya ce Jamus tana da iyawar yin gwaje-gwaje 160,000 a mako.
A ranar 19 ga Maris, an yi gwaji ta hanyar tsarin motsawa a manyan birane da yawa.
A ranar 26 ga Maris, 2020, ba a san yawan gwajin da aka yi a Jamus ba, saboda sakamakon da aka bayar ne kawai.
Binciken farko na dakunan gwaje-gwaje ya bayyana cewa, a cikin mako na 12/2020, an bincika samfurori akalla 483 295 a cikin duka, har zuwa da ciki har da mako na 12/2020, kuma samfurori 33 491 (6,9%) sun ba da sakamako mai kyau ga SARS-CoV-2. A Isra'ila, masu bincike daga Cibiyar Technion da Asibitin Rambam sun haɓaka kuma sun gwada hanyar nazarin samfurori daga marasa lafiya 64 a lokaci guda, wanda ya ƙunshi tattara samfurori da yin ƙarin bincike idan samfurin haɗin ya kasance mai kyau. A ranar 5 ga Fabrairu, 2020, a Wuhan, BGI ya buɗe dakin gwaje-gwaje na gaggawa na mita 2000 mai faɗi da ake kira "Huo-Yan" (Sin: 火眼, ko "Fire Eye" a Turanci), wanda zai iya sarrafa samfurori sama da 10,000 a kowace rana.
A lokacin da aka yi aikin, wanda wanda wanda ya kafa BGI, Wang Jian ya duba, kuma ya ɗauki kwanaki 5, samfurin ya nuna cewa a Hubei, an samu kashi 47 cikin ɗari na yawan mutane da suka kamu da cutar kuma an ninka farashin yin rigakafi ba tare da wannan damar yin gwaji ba.
Bayan dakin gwaje-gwaje na Wuhan, nan take aka gina dakin gwaje-gwaje na Huo-Yan a Shenzhen, Tianjin, Beijing da Shanghai, a jimlar birane 12 na kasar Sin.
A ranar 4 ga Maris, 2020, yawan samar da kwayoyi na yau da kullun ya kai 50,000 a kowace rana. An aiwatar da zane-zane masu yawa na budewa waɗanda aka samar ta hanyar nazarin origami wanda ke ba da damar tantance samfurori 1122 na marasa lafiya don COVID19 ta amfani da bincike 93 kawai. Wadannan ƙirar daidaitawa za a iya amfani da su a ƙananan dakunan gwaje-gwaje ba tare da buƙatar amfani da robots na sarrafa ruwa ba.
A watan Maris, ƙarancin da kuma rashin yawan sinadarai sun shafi gwaji mai yawa a cikin Tarayyar Turai da Amurka.
Wannan ya sa wasu marubuta su binciki tsarin shirya samfurori wanda ke nufin dumama samfurori zuwa 98 °C (208 °F) na minti 5 don sakin kwayoyin RNA don yin ƙarin gwaje-gwaje. A ranar 31 ga Maris, an sanar da cewa Hadaddiyar Daular Larabawa yanzu tana yin ƙarin gwajin gano coronavirus a cikin yawanta fiye da kowace ƙasa, kuma an ƙaddamar da shi don ƙara matakin gwaji don ɗaukar yawancin yawan jama'a.
Wannan an cimma shi ta hanyar haɗuwa da damar motsawa da sayen dakin gwaje-gwaje na samar da taro a matakin yawan jama'a na Group 42 da BGI (wanda ya dogara da dakin gwaje-gwajen gaggawa na 'Huo-Yan' a China).
An gina shi a cikin kwanaki 14, kuma dakin gwaje-gwaje na iya yin gwaje-gwaje na dubban dubban polymerase da ke yin jerin gwano a kowace rana tare da juyin juya hali na transcriptase kuma shi ne na farko a duniya a irin wannan girman da ke aiki a wajen kasar Sin.
An samar da wasu hanyoyin gwaji da ke magance sassa daban-daban na tsarin kwayoyin cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar lafiya ta duniya ta dauki tsarin Jamus na kera kayan aiki wanda ta tura wa kasashen da ba su da wadata wajen samar da kayan aikin kansu.
An buga tsarin Jamus a ranar 17 ga Janairu, 2020; yarjejeniyar da Cibiyoyin Kula da Cututtuka da Tsare-tsare na Amurka suka haɓaka ba ta kasance ba har zuwa 28 ga Janairu, wanda ya jinkirta gwajin da ke cikin Amurka. China da Amurka sun sami matsala game da amincin kayan gwajin a farkon barkewar cutar, kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da isasshen kayan aiki don biyan buƙatu da shawarwarin masana kiwon lafiya game da gwaji ba.
Akasin haka, masana sun ce wadatar gwajin da Koriya ta Kudu ta bayar ta taimaka wajen rage yaduwar sabon coronavirus.
Gwamnatin Koriya ta Kudu ta samu damar gudanar da gwaje-gwaje, musamman a cikin dakunan gwaje-gwaje na kamfanoni masu zaman kansu, a cikin shekaru da yawa.
A ranar 16 ga watan Maris, Hukumar Lafiya ta Duniya ta nemi a kara yawan shirye-shiryen gudanar da gwaje-gwaje a matsayin hanya mafi kyau don rage ci gaban annobar COVID-19. Babban buƙatar gwaje-gwaje saboda yaduwar cutar ta haifar da jinkirin gwajin ɗaruruwan dubbai a cikin dakunan gwaje-gwaje masu zaman kansu na Amurka, kuma wadatar hisopates da magungunan sinadarai sun ƙarewa.
A watan Maris na shekarar 2020, kasar Sin ta ba da rahoton matsaloli game da daidaito na kayan gwajin ta.
A Amurka, kayan gwajin da CDC ta haɓaka suna da "laifuka"; Gwamnati ta kawar da shinge na hukuma wanda ya hana gudanar da gwaje-gwaje masu zaman kansu.
Kamfanin ya bayyana cewa sakamakon da bai dace ba zai iya kasancewa saboda ba daidai ba ne a tattara samfurori ko kuma ba daidai ba ne a yi amfani da kayan aikin.
Ma'aikatar Spain ta ce za ta cire kayan aikin da suka fitar da sakamakon da bai dace ba kuma ta maye gurbin su da wani kayan aikin gwaji daban-daban wanda Shenzhen Bioeasy ta bayar. 80% na kayan aikin gwajin da Jamhuriyar Czech ta saya daga China sun ba da sakamakon da bai dace ba.
Firayim Minista Matovič ya ba da shawarar a jefa su cikin Danube. Ateş Kara, na Ma'aikatar Lafiya ta Turkiyya, ya ce kayan gwajin da Turkiyya ta saya daga China suna da "ƙimar kuskure" kuma ba su "sa su cikin amfani ba".
Yin gwaje-gwaje, tare da yin rigakafin waɗanda suka sami sakamako mai kyau da kuma gano mutanen da suka sadu da waɗanda suka sami sakamako mai kyau na SARS-CoV-2, sun haifar da sakamako mai gamsarwa.
Masu bincike da ke aiki a birnin Vò na Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje guda biyu a cikin mazaunan kusan 3400, tare da bambanci na kwanaki goma.
Kimanin rabin mutanen da suka samu sakamako mai kyau ba su da wata alama, kuma an sanya duk waɗanda aka gano a cikin killace.
Ta hanyar hana tafiye-tafiye a cikin gari, wannan ya kawar da sababbin cututtuka gaba ɗaya.
Tare da bin diddigin lamba, takunkumin tafiye-tafiye daga ƙasashen waje, gudanar da gwaje-gwaje da killacewa, annobar cutar coronavirus 2020 a Singapore ta ci gaba da jinkiri fiye da sauran ƙasashe masu tasowa, amma ba su aiwatar da ƙuntatawa masu tsanani ba, kamar tilasta rufe gidajen abinci da wuraren sayar da kayayyaki.
An soke taron da yawa, kuma a ranar 28 ga Maris Singapore ta fara ba da shawarar mazauna su zauna a gidajensu, amma makarantu sun sake buɗewa a kan lokaci bayan hutun 23 ga Maris.
Sauran ƙasashe ma sun sarrafa annobar ta hanyar bin diddigin lamba, ƙuntatawa kan tafiya daga ƙasashen waje, gudanar da gwaje-gwaje da ƙuntatawa, amma tare da ƙuntatawa mai ƙarancin ƙarfi, kamar Iceland da Koriya ta Kudu.
Wani bincike ya nuna cewa kasashen da suka yi gwaji sosai, dangane da yawan mutuwar, suna da ƙananan yawan mutuwar, wataƙila saboda waɗannan ƙasashen suna da damar gano mutanen da ke da alamun bayyanar cututtuka ko kuma ba su da alamun bayyanar cututtuka.
WHO ta ba da shawarar cewa kasashen da ba su da damar yin gwaji kuma suna da dakunan gwaje-gwaje na ƙasa da ƙarancin gogewa a kan COVID-19 su aika da samfuransu biyar na farko masu kyau da kuma samfuransu goma na farko marasa kyau don COVID-19 zuwa ɗayan dakunan gwaje-gwaje na WHO 16 don yin gwajin tabbatarwa.
Daga cikin dakunan gwaje-gwaje guda 16, bakwai suna Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amirka, ɗaya kuma a Ostiraliya.
A cikin teburin da ke gaba, an nuna shafi Positive as % of tests wanda ya shafi manufofin da ake bi don gudanar da gwaje-gwaje a kasar.
Kasar da ke gwada mutane ne kawai da ke shiga asibiti za ta samu kashi daya da suka fi na mutane masu cutar, kamar yadda kashi daya na mutane ke gani, fiye da kasar da ke gwada dukkan 'yan kasar, ko suna da alamun cutar ko a'a, sauran batutuwan daidai suke.
Yin wanka da hannu, ko kuma tsabtace hannu, aikin wanke hannu ne don kawar da datti, kitse, ƙwayoyin cuta ko wasu abubuwa marasa kyau.
Yin wanka da sabulu a kai a kai a wasu "lokaci masu muhimmanci" a rana yana hana yaduwar cututtuka da yawa, kamar su fitsari da kuma zazzabi, da ake yadawa ta hanyar magunguna.
Mutane kuma za su iya kamuwa da cututtukan numfashi, kamar mura ko sanyi na yau da kullum, misali, idan ba su wanke hannu kafin su taɓa idanunsu, hanci ko bakinsu (watau mucous membranes).
Abubuwa biyar masu muhimmanci a rana da ya kamata a yi wanka da sabulu a hannu sun haɗa da: kafin da bayan bayan bayan bayan wanka, bayan wanke wutsiya ko canja gashin ciki, kafin a ciyar da yaro, kafin a ci abinci da kuma kafin da bayan shirya abinci ko sarrafa naman alade, kifi ko naman tsuntsu.
Idan ba a yi amfani da sabulu ko ruwa ba, za a iya wanke hannuwanka da toka.
Kafin, a lokacin da kuma bayan shirya abinci.
Kafin ka kula da wani mai ciwo da kuma bayan ka kula da shi.
Bayan ka canja sutura ko kuma ka wanke wani yaro da ya yi amfani da gidan wanka.
Bayan ka yi ihu, ka yi tari ko ka yi ta hurawa.
Bayan ka taɓa dabbobi, abinci ga dabbobi ko kuma sharar dabbobi.
Hanyar tsabtace hannu na likita tana nufin ayyukan tsabtace jiki da suka shafi hanyoyin likita.
Yin wanka kafin ka ba da magani ko kuma ka kula da lafiyarka zai iya hana ko rage yaduwar cututtuka.
Babban manufar wanke hannu a likitanci shi ne kawar da kwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta ko wasu ƙwayoyin cuta da za su iya haifar da cuta) da kuma sunadarai da za su iya haifar da cutar ko cutar.
Wannan yana da muhimmanci musamman ga mutanen da ke sarrafa abinci ko kuma waɗanda ke aiki a fannin likita, amma kuma yana da muhimmanci ga jama'a.
Yin wanka hannu yana da fa'idodi masu yawa ga lafiyar jiki, ciki har da rage yaduwar mura, coronavirus da sauran cututtukan cuta; hana cututtukan cuta na fitsari; rage kamuwa da cututtukan numfashi;
kuma rage yawan mutuwar yara a cikin haihuwar gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa inganta ayyukan wanke hannu zai iya haifar da ƙananan ci gaba a girma a cikin yara a ƙarƙashin shekara biyar.
A ƙasashe masu tasowa, ana iya rage yawan yaran da ke mutuwa daga cututtukan numfashi da kuma fitsari ta wajen yin canje-canje a halayyarsu, kamar wanke hannu da sabulu.
Wannan aikin zai iya rage yawan mutuwar da ake yi a irin waɗannan cututtuka da kusan kashi 50.
Hanyar da ke ƙarfafa wanke hannu na iya rage yawan cututtukan ciki da kashi ɗaya bisa uku, kuma wannan yana kama da samar da ruwa mai kyau a yankunan da ba su da isasshen kuɗi.
Kashi 48 cikin 100 na rage yawan cututtukan da ke faruwa a cikin ciki na iya kasancewa da nasaba da wanke hannu da sabulu. Wanke hannu da sabulu shine hanya mafi inganci da tanadi don hana diarrhea da cututtukan numfashi masu tsanani, kamar yadda ya zama dabi'ar atomatik a gidaje, makarantu da al'ummomi a duk faɗin duniya.
Cutar huhu, wata cuta mai tsanani ta numfashi, ita ce babbar sanadin mutuwar yara 'yan ƙasa da shekara biyar, kuma ana kashe yara miliyan 1.8 a kowace shekara.
A kowace shekara, kusan yara miliyan 3.5 ne suke mutuwa sakamakon ciwon ciki da ciwon huhu.
UNICEF ta ce yin amfani da sabulu a wanke hannu kafin cin abinci da kuma bayan yin amfani da gidan wanka zai iya ceton rayuka fiye da allurar rigakafi ko kuma magani, kuma hakan zai rage mutuwar da ke faruwa a lokacin da ake shan diarrhea da kuma mutuwa daga kamuwa da cututtukan numfashi da ke faruwa a cikin jiki da kashi ɗaya bisa huɗu.
A yawancin lokaci, ana haɗa wanke hannu da wasu ayyukan tsabtace jiki a matsayin ɓangare na shirye-shiryen ruwa, tsabtace jiki da tsabtace jiki (WASH).
Yin wanka da hannu yana kāre ka daga cutar da ake samu ta hanyar yin jima'i da kai tsaye.
Wani sakamako mai tsanani na wanke hannu shi ne, yin wanke hannu a kai a kai zai iya jawo lalacewar fata saboda fari ya bushe.
Wani bincike a ƙasar Denmark da aka yi a shekara ta 2012 ya nuna cewa yin wanka sosai a hannu zai iya haifar da cututtukan fata da ke sa a yi ta jin ƙai kuma a sa a yi fata da aka sani da eczema na hannu ko kuma dermatitis na hannu, wanda ya fi faruwa a ma'aikatan lafiya.
Yin wanka hannu sau da yawa yana nuna cewa mutum yana da matsalar rashin tausayi.
Akwai lokatai biyar masu muhimmanci a rana da wanke hannu da sabulu yake da muhimmanci wajen rage yaduwar cututtuka ta bakin-fagal: bayan yin amfani da gidan wanka (sanya, zubar da ciki), bayan wanke wutsiya na yaro (canja sutura), kafin ciyar da yaro, kafin cin abinci da kuma kafin/bayan shirya abinci ko kuma sarrafa naman alade, kifi ko naman tsuntsu.
Sauran lokatai da za a yi amfani da wanke hannu don hana kamuwa da cututtuka sun haɗa da kafin da bayan da aka yi wa wani ciwo ko rauni, bayan da aka yi wa mutum bugun jini, tari ko kuma ya yi hanci, bayan da ya taɓa takardar dabbobi ko kuma ya yi amfani da dabbobi, da kuma bayan ya taɓa shara.
A ƙasashe da yawa, yawan wanke hannu da sabulu ba shi da yawa.
Wani bincike kan wanke hannu a kasashe 54 da aka gudanar a shekarar 2015 ya kammala cewa, a matsakaita, kashi 38.7 cikin dari na iyalai suna wanke hannu da sabulu. Wani binciken da aka gudanar a shekarar 2014 ya nuna cewa Saudiyya ce ta fi yawan wanke hannu da kashi 97 cikin dari; Amurka kusan rabin da kashi 77 cikin dari; kuma China ce ta fi yawan wanke hannu da kashi 23 cikin dari. A halin yanzu, akwai hanyoyin da za a canza halayyar, don kara karɓar halayyar wanke hannu da sabulu a lokutan da suka dace.
"Shirye-shiryen kula da lafiya mai mahimmanci" da Ma'aikatar Ilimi ta Philippines ta aiwatar misali ne na wani mataki na musamman don inganta lafiyar yara da ilimi.
Yin wanke-wanke sau biyu a shekara, ban da wanke hannu da sabulu a kullum, da kuma wanke hakora a kullum da fluoride, su ne tushen wannan shirin na kasa.
An yi amfani da shi sosai a Indonesia.
Ana samun sakamako mai kyau wajen kawar da ƙwayoyin cuta daga fata ta wajen ƙara sabulu ko kuma wanke-wanke a cikin ruwa.
Babban aikin sabulu da kuma tsabtace ruwa shine rage shinge ga bayani da kuma kara solubility.
Ruwa shi kaɗai ba ya tsabtace fata domin kitse da furotin da ke cikin abubuwa masu rai ba sa narkewa cikin ruwa.
Amma, ruwa mai kyau yana taimaka wa mutum ya tsabtace shi.
Sabulu mai ƙarfi, saboda yanayin sake amfani da shi, na iya ƙunsar ƙwayoyin cuta da aka samu a baya.
Wasu bincike da suka yi game da yadda kwayoyin cuta suke canja wurin sabulu mai ƙarfi da aka gurɓata sun ce ba zai yiwu ba domin baƙar ƙwayoyin cuta suna yin wanka da kumfa.
Amma, CDC ta ce "abin da ya fi dacewa shi ne sabulu mai ruwa da ke da matakai na sarrafawa da ba a yi amfani da hannayensu ba".
An yi amfani da sabulu na rigakafi sosai don yaɗa ga jama'a masu kula da lafiya.
A halin yanzu, babu wata hujja da ta nuna cewa yin amfani da maganin kashe cuta ko maganin hana cutar da aka ba da shawarar zai iya kiyaye kwayoyin da ke da tsayayya da maganin rigakafi ta halitta.
Duk da haka, sabulu na antibacterial suna dauke da wasu kwayoyin antibacterial, kamar triclosan, wanda ke da jerin sunayen kwayoyin da ke da ƙarfi.
Saboda haka, ko da sabulu na kashe kwayoyin ba su da ƙwayar da za ta iya hana maganin rigakafi, ba za su yi tasiri sosai ba kamar yadda ake tallatawa.
Baya ga wakili mai tsabta da kuma kare fata, kayan da aka gyara na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) da kuma mai daidaita pH, benzoic acid tare da aikin antimicrobial da ƙarin kayan shafawa don fata (aloe vera, bitamin, mentol, kayan lambu). Wani cikakken bincike daga Makarantar Kiwon Lafiya ta Jami'ar Oregon ya nuna cewa sabulu na yau da kullum suna da tasiri kamar sabulu na antibacterial ga mabukaci wanda ya ƙunshi triclosan don hana cututtuka da kawar da ƙwayoyin cuta daga hannayen.
Ruwan da ke da kyau don wanke hannuwanmu ba zai isa ya kawar da ƙwayoyin cuta ba.
Kwayoyin ƙwayoyin cuta suna girma da sauri a zafin jiki (37 °C).
Amma, ruwan sabulu mai dumi ya fi ruwan sabulu mai sanyi kyau wajen kawar da man fetur na ƙasa da kuma ƙwayoyin cuta.
Amma, a akasin abin da mutane suke tunani, binciken kimiyya ya nuna cewa yin amfani da ruwa mai dumi ba ya rage yawan kwayoyin a hannayenmu.
Maganin hana shan kwayar hannu ko maganin hana shan kwayar hannu wani abu ne mai tsabtace hannu wanda ba shi da ruwa.
A ƙarshen 1990s da farkon karni na 21, wakilai don tsabtace hannu ba tare da ruwa ba da kuma giya don shafawa (wanda aka fi sani da maganin shan giya don shafawa, maganin hana hana hana hannu don shafawa ko maganin hana kamuwa da cuta don hannu) sun fara samun farin jini.
Mafi yawansu suna dogara ne akan isopropyl alcohol ko ethanol da aka yi da wani abu mai kauri kamar carbomer (acrylic acid polymer) a cikin gel, ko mai danshi kamar glycerin a cikin ruwa, ko kumfa don sauƙin amfani da kuma rage tasirin bushewar giya.
Ƙara hydrogen peroxide mai narkewa yana ƙara ƙaruwa ga aikin antimicrobial. Maganin hana hannu mai ƙunshe da barasa aƙalla kashi 60 zuwa 95 cikin ɗari yana kawar da ƙwayoyin cuta yadda ya kamata.
Magungunan kashe kwayoyin cuta da ke da ƙwayoyin cuta da ke da ƙwayoyin cuta da ke hana shan magani (SARM da ERV), da kuma cutar tarin fuka da wasu ƙwayoyin cuta (ciki har da HIV, herpes, VSR, rhinovirus, allurar rigakafi, mura da cutar hanta) da kuma naman kaza.
Disinfectants na giya don shafawa da ke dauke da kashi 70 cikin dari na barasa suna kawar da kashi 99.97 cikin dari (ƙanƙan logarithms 3.5 kamar rage na decibels 35) na ƙwayoyin cuta a hannayen mutum na dakika 30 bayan amfani da su, da kuma kashi 99.99 cikin dari zuwa kashi 99.999 cikin dari (ƙanƙanƙan logarithms 4 zuwa 5) na ƙwayoyin cuta a hannayen mutum na minti 1 bayan amfani da su.
Magungunan kashe shan giya don hannayen hannu kusan ba su da tasiri a kan ƙwayoyin cuta irin su norovirus (ko Norwalk), wanda shine mafi yawan sanadin cututtukan gastroenteritis. Ya kamata a yi amfani da isasshen maganin hana maganin hana kumburi ko maganin shan giya don shafawa, kamar yadda za a yi zafi ko rufe hannuwan biyu gaba ɗaya.
Ka shafa hannayen hannu da bayan hannuwanka, tsakanin yatsunsu da kuma ƙarshen yatsunsu na tsawon dakika 30 har sai ruwa, kumfa ko gel sun bushe.
Ƙungiyoyin Kula da Cututtuka da Cututtuka na Amirka sun ba da shawarar yin wanka kafin a yi amfani da maganin hana shan ƙwayoyin cuta don shafa hannu, musamman ma idan hannuwan suna da tsabta sosai.
Ƙara amfani da waɗannan magungunan ya dogara ne da sauƙin amfani da kuma saurin kawar da ƙwayoyin cuta; duk da haka, ba za a yi amfani da su a matsayin maye gurbin wanke hannu ba sai dai idan babu ruwa ko sabulu.
Yin amfani da maganin hana shan giya a hannu sau da yawa zai iya bushe fata, sai dai idan an ƙara emollients ko moisturizers ga fata ga kayan aiki.
Za a iya rage ko kawar da tasirin shan giya ta wajen ƙara glycerin ko wasu emollients zuwa ga formula.
A cikin gwaji na asibiti, maganin hana shan giya na hannu da ke dauke da maganin shafawa ya haifar da ƙarancin haushi da bushewar fata fiye da sabulu ko kuma wankewar ƙwayoyin cuta.
Cututtuka masu saurin haɗuwa da fata, cututtukan ƙwayoyin cuta na haɗuwa da juna, ko kuma rashin jin daɗin barasa ko kuma abubuwan da ke cikin maganin shafawa na hannayen hannu da aka yi amfani da giya ba su da yawa.
Ƙananan yanayin da zai iya haifar da cututtukan fata na tuntuɓar mutum ya zama mai kyau idan aka kwatanta da wanke hannu da ruwa da sabulu.
Duk da yadda suke da tasiri, kayan da ba su da ruwa ba ba suna cire abubuwa na zahiri daga hannayensu, amma suna tsabtace su.
Saboda haka, maganin hana kamuwa da cuta na hannu ba shi da tasiri kamar ruwa da sabulu wajen hana kamuwa da cutar da yawa, domin har yanzu ana shanta a hannun mutane.
Aikin tsabtace hannu mai tsabta ya dogara da kayan da aka yi amfani da shi, kuma a tarihi, ya fi na giya da kuma maganin shafawa da giya.
A kwanan nan, an tabbatar da cewa magungunan da ke amfani da benzalkonium chloride suna da ci gaba da aiki mai ƙyama na antimicrobial bayan amfani, ba kamar barasa ba, wanda tasirinsa ya ragu bayan amfani da shi sau da yawa, mai yiwuwa saboda ci gaba da mummunan sakamako na fata.
Mutane da yawa a cikin al'ummomin da ba su da kuɗi sosai ba za su iya sayen sabulu ba kuma za su yi amfani da toka ko ƙasa.
Ash ko ƙasa za su iya yin aiki fiye da ruwa, amma ba su da kyau fiye da sabulu.
Wani abin da ya damu shi ne, idan ƙasa ko toka sun gurɓata da ƙwayoyin cuta, hakan zai iya ƙara yaduwar cututtuka maimakon rage su.
Kamar sabulu, toka ma mai tsabtace jiki ne, domin idan ya zo ruwa, yana samar da maganin alkaline.
Hukumar ta duniya ta ba da shawarar yin amfani da toka ko yashi a matsayin madadin sabulu idan babu sabulu.
Daidaicin aikin wanke hannu da Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka na Amirka suka ba da shawarar don hana yaduwar cututtuka ya haɗa da waɗannan matakai:
Ka wanke hannunka da ruwa mai sanyi ko dumi.
Ana ba da shawarar ruwan da ke gudana a yanzu domin ana iya gurɓata kwantena da ruwa a ciki, amma yanayin zafin ruwan ba ya kawo bambanci.
Ka shafa hannunka don ka yi kumfa da yawan sabulu, ciki har da bayan hannunka, tsakanin yatsanka da kuma ƙarƙashin kusoshi.
Sabulu yana cire ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane sukan wanke hannu sosai sa'ad da suke amfani da sabulu fiye da idan suke amfani da ruwa kaɗai.
Ka yi taƙama na akalla sakan 20.
Ƙuntataccen jiki yana haifar da taɓawa, wanda ke taimakawa wajen kawar da ƙwayoyin cuta daga fata, kuma yin taƙaice na tsawon lokaci yana kawar da ƙwayoyin cuta da yawa.
Ka wanke shi da ruwa mai gudana.
Ruwa a cikin kwantena zai iya sake gurɓata hannayenka.
Ka bushe shi da tawul mai tsabta ko ka bar shi ya bushe a cikin iska.
Hannun da suka yi ruwa da kuma rigarsu suna da saukin sake gurɓatawa. Abubuwan da aka fi manta da su su ne yatsan ƙafar, ƙafar hannu, yankunan da ke tsakanin yatsunsu da kuma ƙarƙashin kusoshi.
Kayan ƙusa da kuma ƙusa mai ƙusa da aka cire za su iya zama gurɓataccen ƙwayoyin cuta.
Ana yawan amfani da maganin shafawa don hana hannayenka su bushe. Gashin da ya bushe zai iya haifar da lalacewar fata wanda zai iya ƙara haɗarin kamuwa da cuta.
Za a iya amfani da zaɓuɓɓukan tattalin arziki da yawa don sauƙaƙe wanke hannu lokacin da babu ruwan sabulu ko sabulu na yau da kullun, misali, zubar da ruwa daga tukunyar da aka rataye ko kuma kwandon ruwa tare da ramuka masu dacewa ko amfani da toka idan ya cancanta a ƙasashen da ke tasowa. A cikin yanayi inda akwai iyakantaccen samar da ruwa (kamar makarantu ko yankunan karkara a ƙasashen da ke tasowa), akwai hanyoyin adana ruwa, kamar "faif ɗin gida" da sauran zaɓuɓɓukan tattalin arziki.
Fayafai na gida fasaha ce mai sauƙi wanda ta ƙunshi amfani da kwanon rufi da aka rataye da igiya da kuma ƙafa don zuba ruwa kaɗan a hannayenku da sabulu a cikin sandar.
Yin bushewa mai kyau na hannu wani muhimmin ɓangare ne na tsarin tsabtace hannu, amma akwai wasu muhawara game da yadda za a bushe da kyau a cikin wanka na jama'a.
Ƙari ga haka, bincike ya nuna cewa tawul ɗin takarda sun fi na'urar busar hannu da ake amfani da ita a wanka.
A shekara ta 2008, Jami'ar Westminster, London, ta gudanar da wani bincike, wanda ƙungiyar masana'antar tawul ɗin takarda ta Turai Tissue Symposium ta tallafawa, don kwatanta matakan tsabta da takarda ta takarda, masu bushewa na hannu mai iska mai zafi da kuma masu bushewa na iska mai iska na zamani ke bayarwa.
Bayan an wanke hannayensu kuma an bushe su da na'urar bushewa da iska mai zafi, an lura cewa adadin ƙwayoyin cuta ya ƙaru da kashi 194 cikin ɗari a yatsunsu da kuma kashi 254 cikin ɗari a hannuwansu.
Yin busassun iska da iska ya sa adadin kwayoyin ya ƙaru da kashi 42 cikin 100 a yatsunsu da kuma kashi 15 cikin 100 a hannayensu.
Bayan an wanke hannuwansu kuma an bushe su da tawul ɗin takarda, adadin kwayoyin ya ragu da kashi 76 cikin 100 a yatsunsu da kuma kashi 77 cikin 100 a hannayensu. Masana kimiyya sun kuma gudanar da gwaje-gwaje don sanin ko akwai yiwuwar gurɓataccen gurɓataccen ruwa daga wasu masu amfani da gidan wanka da kuma yanayin wanka sakamakon kowane irin hanyar bushewa.
Mai bushewa ta iska, wanda ke busa iska daga na'urar a saurin, kamar yadda aka ce, na 180 m/s (650 km/h; 400 mph), ya sami damar busa ƙwayoyin cuta daga hannayensu da na'urar kuma, mai yiwuwa, gurɓata sauran masu amfani da gidan wanka da kuma yanayin gidan wanka a nesa har zuwa mita 2.
Yin amfani da na'urar busar hannu mai iska mai zafi ya sa ƙwayoyin cuta suka yadu zuwa mita 0.25 daga wurin busar.
A shekara ta 2005, wani bincike da kamfanin TÜV Produkt und Umwelt ya yi, ya gwada hanyoyin bushewa na hannu daban-daban.
An lura da canje-canje a cikin ƙididdigar ƙwayoyin cuta bayan an bushe hannu:
Akwai masana'antun bushewa da yawa, kuma an kwatanta bushewa da takarda.
Yin wanka da wanke hannu da wanke-wanke na hannu na iya zama zaɓi na biyu a lokacin tafiya, lokacin da babu ruwa ko sabulu.
Dole ne a yi amfani da maganin hana shan giya don hana shan shan shan magani a hannu aƙalla kashi 60 cikin ɗari na giya.
Da daɗewa bayan Ignaz Semmelweis, likitan Hungary, ya gano cewa yana da amfani wajen hana cututtuka a asibiti a shekara ta 1846, likitoci sun bukaci a yi musu wanka a hannu.
Akwai na'urorin lantarki da ke ba da bayani don tunatar da ma'aikatan asibiti su wanke hannu idan sun manta.
Wani bincike ya nuna cewa yawan kamuwa da cuta ya ragu da amfani da shi.
Likitoci suna wanke hannuwansu na akalla dakika 15, suna amfani da ruwa da sabulu ko gel da yawa don su zama kumfa kuma su daidaita hannuwansu.
Ka haɗa hannayenka da yatsunsu.
Idan akwai wasu ragowar ƙusa a ƙarƙashin ƙusa, za a iya cire su ta amfani da goga.
Tun da yake ƙwayoyin cuta suna iya kasancewa a cikin ruwa a hannayenmu, yana da muhimmanci mu wanke su sosai kuma mu bushe su da tawul mai tsabta.
Bayan an bushe, ya kamata a yi amfani da tawul ɗin takarda don rufe ruwa (kuma a buɗe kofa ta fita idan ya cancanta).
Wannan zai hana hannuwanmu su sake gurɓata kansu daga waɗannan farfajiyar.
Manufar wanke hannu a cikin yanayin kula da lafiya ita ce kawar da kwayoyin cuta ("kwayoyi") da kuma hana su yadawa.
A cewar jaridar New England Journal of Medicine, rashin wanke hannu yana ci gaba da kasancewa a wurare da yawa da ba za a iya yarda da su ba, inda likitoci da ma'aikatan jinya da yawa sukan manta su wanke hannu kafin su taɓa marasa lafiya kuma hakan yana sa su kamu da ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kuma wasu ayyuka masu sauƙi za su iya rage yawan cututtukan jini da ke tattare da cututtukan jini da kashi 66 cikin ɗari.
Za a iya samun sigar farko ta jagorar tsabtace hannu ta ƙungiyar a shafin yanar gizon su don masu sauraro su yi sharhi.
Whitby da wasu sun yi bincike mai muhimmanci.
Kayan aiki na kasuwanci na iya auna da kuma duba tsabtace hannu, idan ana buƙatar tabbatar da bin doka.
Hukumar Lafiya ta Duniya ta ba da "Lokaci Biyar" don wanke hannu:
bayan an yi masa jinin jini ko na jiki
kafin aikin aseptic da
Bayan ka yi wa marasa lafiya hidima, an ƙara sinadarai masu hana shan magani a cikin sabulu (abin da ake kira " magani " ko " maganin kwayoyin cuta ") don a iya kawar da kayan wanke hannu.
Don wanke hannu kafin a yi tiyata, kana bukatar ka yi amfani da famfo da za ka iya buɗewa da rufewa ba tare da taɓa hannu ba, da kuma wasu kayan wanke-wanke na chlorhexidin ko iodine, da kuma wasu tawul da za a yi amfani da su don bushe hannuwanka bayan an wanke su, da kuma wani kayan wanke-wanke da za a yi amfani da shi don wanke-wanke da kuma wani kayan aiki da za a yi amfani da shi don tsaftace-tsaftace a ƙarƙashin kusoshi.
Dole ne a cire dukan kayan ado.
Wannan aikin yana bukatar wanke hannuwanka da hannuwanka har zuwa gwiwoyinka, a kullum na tsawon minti 2 zuwa 6.
Ba a bukatar yin wanka na dogon lokaci (minti 10) ba.
Idan aka wanke shi, ya kamata a hana ruwa daga gaban hannu ya koma hannayensu.
Bayan an wanke hannuwan, sai a bushe su da wani tufafi da aka yi wa rigar da aka yi wa rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, ya fi kyau a wanke hannu kafin kuma bayan ka kula da marasa lafiya.
Don hana kamuwa da cuta daga shan taba a asibitoci, an gano cewa mafi yawan amfanin wanke hannu yana cikin kashi 20 cikin 100 na wanke hannu kuma babu ƙarin amfanin da ake samu idan yawan wanke hannu ya ƙaru fiye da kashi 35 cikin 100.
Yin wanka da sabulu na yau da kullum ya haifar da fiye da sau uku na yawan kamuwa da cututtukan kwayar cuta da aka watsa zuwa abinci idan aka kwatanta da wankewa da sabulu na antibacterial. Idan aka kwatanta wanke hannu tare da maganin shan giya da wanke hannu tare da sabulu na antibacterial na tsawon lokaci na kimanin dakika 30 a kowane hali, an lura cewa rubbing da barasa ya rage gurɓataccen kwayar cuta da kashi 26 cikin dari fiye da sabulu na antibacterial.
Duk da haka, ruwa da sabulu sun fi tasiri wajen rage cutar mura ta A H1N1 da kuma ɓarnar Clostridium difficile a hannayen mutum fiye da maganin hana shan giya. Hanyoyin da za a inganta tsabtace hannu a cibiyoyin kiwon lafiya na iya haɗa da horar da ma'aikatan game da wanke hannu, ƙara samun maganin hana shan giya da kuma tunatarwa ta rubutu da ta baki ga ma'aikatan.
Akwai bukatar ƙarin bincike game da irin waɗannan hanyoyin da suka fi tasiri a fannoni daban-daban na kiwon lafiya.
A ƙasashe masu tasowa, ana ganin wanke hannu da sabulu a matsayin kayan aiki mai tsada da kuma muhimmanci don samun lafiya da kuma abinci mai kyau.
Amma rashin wadatar ruwa mai kyau, sabulu ko kuma wuraren wanke hannu a gidaje, makarantu da wuraren aiki, yana sa ya zama ƙalubale a samu halaye na wanke hannu a duniya.
Alal misali, a yawancin yankunan karkara na Afirka, akwai ƙananan famfo don wanke hannu kusa da wuraren wanka na jama'a ko na masu zaman kansu, ko da yake akwai zaɓuɓɓukan da za su iya biyan kuɗi don gina wuraren wanke hannu.
Amma, rashin yawan wanke hannu zai iya faruwa ne domin mun san cewa muna da halaye masu kyau, ba don babu sabulu ko ruwa ba.
Ƙarfafa wanke hannu da sabulu na iya rinjayar yanke shawara na siyasa, ƙara wayar da kan jama'a game da amfanin wanke hannu, da kuma kawo canji a cikin halayyar mutane a cikin dogon lokaci.
Don yin wannan aiki yadda ya kamata, dole ne a bi da shi kuma a yi nazari.
A cikin nazarin nazarin bincike na 70, an lura cewa hanyoyin da jama'a ke bi don ƙara wanke hannu a cikin PRBMs sun yi tasiri, yayin da kamfen ɗin tallan zamantakewar jama'a ba su da tasiri. Misali na inganta wanke hannu a makarantu shine tsarin "Taurari Uku" na UNICEF, wanda ke ƙarfafa makarantu su ɗauki matakan sauƙi da araha don tabbatar da cewa ɗalibai suna wanke hannu da sabulu, tsakanin sauran bukatun tsabta.
Idan aka kai ga mafi ƙarancin ka'idoji, makarantu za su iya tashi daga taurari ɗaya zuwa uku.
Gina wuraren wanke hannu na iya kasancewa wani ɓangare na kamfen na inganta wanke hannu da ake gudanarwa don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya misali ne na wani yunkuri na wayar da kan jama'a wanda ke neman sauya halaye.
Kadan ne suka yi la'akari da yadda ake amfani da wanke hannu a ƙasashe masu tasowa a matsayin riba ga AVAD da aka guje wa.
Amma, wani bincike ya nuna cewa ƙarfafa wanke hannu da sabulu ya fi sauran hanyoyin ruwa da kuma tsabtace jiki tasiri sosai.
A tsakiyar ƙarni na 20, likitan Hungary Ignaz Semmelweis, wanda ya yi aiki a birnin Vienna, Austria, da kuma Florence Nightingale, wata 'yar Ingila, wadda ta kafa aikin jinya na zamani, sun fahimci muhimmancin wanke hannu ga lafiyar mutane, musamman ga waɗanda suke cikin yanayi mai wuya, kamar yadda mata da suka haifi yara ko kuma sojoji a asibitoci suka yi.
A lokacin, yawancin mutane suna ganin cewa miyagun ƙwayoyi ne suke jawo kamuwa da cuta.
A shekarun 1980, barkewar cututtukan abinci da cututtukan da ke tattare da kiwon lafiya sun sa Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka su ƙara inganta tsabtace hannu a matsayin babbar hanyar hana yaduwar cututtuka.
Cutar mura ta alade a shekarar 2009 da annobar COVID-19 a shekarar 2020 sun sa a kasashen da dama a kara wayar da kan mutane kan muhimmancin wanke hannu da sabulu don kare kansu daga cututtukan da ke kamuwa da cuta.
Alal misali, a Jamus, an saka alamun da ke ɗauke da "hanyar wanke hannu" a kusa da wankan gidajen wanka na jama'a da kuma na ofisoshin da ke filin jirgin sama.
Maganar nan "ka wanke hannuwanka" furci ne na rashin son ka mallaki wani abu ko kuma ka ba da hannu a wani abu.
An samo asali ne daga nassin Matta a cikin Littafi Mai Tsarki inda Pontius Bilatus ya wanke hannayensa a gaban shawarar da aka yanke na gicciye Yesu Kristi, amma ya zama magana da aka fi amfani da ita a wasu al'ummomin Turanci.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta a cikin ƙoƙari don tsabtace tabo na tunanin, wanda ya nuna ta da laifi game da laifukan da ta aikata kuma ta sa mijinta ya aikata.
An kuma lura cewa bayan sun tuna ko kuma sun yi bimbini a kan ayyukan da ba su da kyau, mutane suna yawan wanke hannuwansu fiye da wasu kuma suna daraja abubuwa da suke wanke hannu.
Bugu da ƙari, waɗanda suka yi amfani da wannan hanyar don yin wanka a hannuwansu ba su da wataƙila za su yi wasu ayyuka na "tsabtace" kamar su aikin agaji.
Addinai suna ba da shawarar wanke hannu don dalilai na tsabta da alama. Wanke hannu na alama, tare da ruwa, amma ba tare da sabulu ba, wani ɓangare ne na wanke hannu na al'ada a cikin addinai da yawa, kamar Baha'i, Hindu, Tevila da Netilat yadayim a Yahudanci, wankewa a cikin Kiristanci da wudu a Islama. Addinai kuma suna ba da shawarar wanke hannu na tsabta, musamman bayan wasu ayyuka.
Addinin Hindu, Yahudanci da Musulunci sun tilasta wanke hannuwanka bayan ka je gidan wanka.
Addinin Hindu, Buddha, Shi'a, Yahudawa da Musulunci sun bukaci mutum ya wanke hannu kafin ya ci abinci da kuma bayan ya ci abinci.
Kula da haɗari a wurin aiki a gaban COVID-19
Kula da haɗari a wurin aiki a gaban COVID-19 ya shafi amfani da hanyoyin tsabtace jiki da aminci a cikin kula da haɗari don rigakafin cutar coronavirus 2019 (COVID-19).
Kula da haɗari mai kyau a wurin aiki ya dogara da wurin aiki da aikin aiki kuma ya dogara da kimanta haɗari daga tushen fallasa, tsanani na cutar a cikin al'umma, da kuma abubuwan haɗari na ma'aikata waɗanda zasu iya kamuwa da COVID-19.
Hukumar Kula da Lafiya da Lafiya a Aikin Amurka (OSHA) ta ce, a wuraren da ake samun haɗarin rashin aiki, mutane da abokan aiki ba sa yin aiki sosai. Ana ba su shawara su guji kamuwa da cututtuka na yau da kullum, kamar su wanke hannu, ba da shawara ga ma'aikata su zauna a gida idan suna ciwo, da kuma kiyaye tsabtace jiki da kuma tsabtace wuraren aiki.
Ayyukan da ke da haɗarin haɗarin haɗari na matsakaici sun haɗa da waɗanda ake buƙatar haɗuwa da yawa ko kusa da mutanen da ba a san su ba ko kuma suna zargin suna da COVID-19, amma waɗanda za su iya kamuwa da cutar ta hanyar watsawar al'umma ko ta hanyar tafiya ta duniya.
Wannan ya haɗa da ma'aikata da ke hulɗa da jama'a a fili, kamar a makarantu, wuraren aiki da ke da yawan mutane da kuma wasu manyan wuraren sayar da kayayyaki.
Ana gudanar da ayyukan kula da haɗari ga wannan rukunin, ban da matakan hana kamuwa da cuta na asali, sun haɗa da iska mai tsabta da ke da ingantattun matattarar iska, rufin kariya da kuma kayan kariya na mutum wanda ke samuwa idan akwai mutum da COVID-19.
OSHA ta ce ma'aikatan kiwon lafiya da ayyukan jana'izar da aka fallasa ga mutanen da aka sani ko ake zargin suna da COVID-19, suna da haɗarin haɗari mai yawa, wanda ya ƙaru sosai idan sun gudanar da hanyoyin da za su iya samar da aerosols a cikin mutanen da aka sani ko ake zargin suna da COVID-19 ko kuma sun ɗauki ko sarrafa samfurori daga waɗannan mutanen.
Ƙarin haɗarin da ya dace da waɗannan ma'aikata ya haɗa da sarrafa injiniya, kamar dakunan iska masu ƙarancin matsa lamba, da kuma kayan kariya na mutum da suka dace da aikin aiki.
Cutar COVID-19 na iya haifar da sakamako daban-daban a wurin aiki.
Ma'aikata suna iya yin rashin aiki don rashin lafiya, kula da wasu, ko kuma tsoron haɗari.
Abubuwan da ake sayarwa a cikin kasuwanci na iya canzawa, duka game da abin da ake buƙata da kuma hanyoyin da za a saya waɗannan kaya (kamar sayen a lokacin da ba a lokacin da ake yin amfani da shi ba, ta hanyar sabis na jigilar kaya zuwa gida ko ta taga daga mota).
A ƙarshe, ana iya dakatar da aikawa da kayayyaki daga yankunan da COVID-19 ya shafa sosai. Ana iya amfani da shirin shiri da amsawa ga cututtukan kamuwa da cuta don jagorantar matakan rigakafi.
Shirye-shiryen suna magance matakan haɗari da suka shafi wuraren aiki da ayyukan aiki daban-daban, gami da tushen haɗari, abubuwan haɗari da ke fitowa daga gida da kuma al'ummomin gida, da abubuwan haɗari ga ma'aikata, kamar tsufa ko cututtukan likita na kullum.
Sun kuma bayyana abubuwan da ake bukata don magance waɗannan haɗarin da kuma shirye-shiryen gaggawa don yanayin da zai iya tasowa daga barkewar cutar.
Shirye-shiryen shiri da kuma amsawa ga cututtukan cututtuka na iya zama batun shawarwari na kasa ko na yanki.
Abubuwan da ake so su magance cutar sun hada da rage watsawa tsakanin ma'aikatan, kare mutanen da ke da haɗarin kamuwa da cututtukan kiwon lafiya masu cutarwa, kula da ayyukan kasuwanci da rage tasirin illa ga sauran hukumomin a cikin sarkar samar da su.
Matsayin da cutar take shafar al'ummar da kamfanin yake ciki yana shafar matakan da ake ɗauka.
Tsarin kula da haɗari na haɗari shi ne tsarin da aka yi amfani da shi sosai a fannin tsabtace jiki da lafiya a aiki don rarraba matakan haɗari bisa ga ingancin su.
Idan ba za a iya kawar da haɗarin COVID-19 ba, ingantattun sarrafawa sune sarrafawa na injiniya, sannan na gudanarwa kuma, ƙarshe, kayan aikin kariya na mutum.
Gudanar da aikin injiniya yana nufin ware ma'aikata daga haɗarin aiki ba tare da yin amfani da halayyar ma'aikata ba kuma yana iya zama mafi kyawun mafita don aiwatar da shi.
Gudanar da ayyukan gudanarwa canje-canje ne a cikin manufofin aiki ko hanyoyin aiki da ke buƙatar aiki daga ma'aikaci ko mai aiki.
Ana ganin cewa kayan kariya na mutum ba su da tasiri fiye da na aikin injiniya da na gwamnati, amma suna iya taimakawa wajen hana wasu bayyanar.
Duk nau'ikan kayan kariya na mutum dole ne a zaba su bisa ga haɗarin da ke tattare da ma'aikaci, a sanya su yadda ya kamata (misali masu numfashi), a yi amfani da su yadda ya kamata kuma a yi amfani da su, a duba su akai-akai, a yi musu kulawa, a maye gurbin su idan ya cancanta kuma a cire su, a tsabtace su kuma a adana su ko a zubar da su yadda ya kamata don kada su gurbata.
Hukumar Kula da Lafiya da Tsaro a Aikin Amurka (OSHA) ta ce, a wuraren da ake samun haɗarin rashin aiki, mutane da abokan aiki ba sa yawan aiki.
Abubuwan da ake bukata don hana kamuwa da cuta a wuraren aiki sun haɗa da yin wanka sosai da kuma sau da yawa, ba da shawarar ma'aikata su zauna a gida idan suna rashin lafiya, ka'idodin tsabtace numfashi wanda ya haɗa da rufe kansu yayin coughing da sneezing, samar da tawul na takarda da kwantena don shara, shirya don aiki ta waya ko kuma sauyawa idan ya cancanta, hana ma'aikata amfani da kayan aiki da kayan aiki na waje, da kuma kula da tsabtace da kuma tsabtace yanayin aiki.
Ganowa da keɓe mutanen da za su iya kamuwa da cutar nan take muhimmiyar mataki ne don kare ma'aikata, abokan ciniki, baƙi da kuma wasu a wurin aiki.
Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka (CDC) sun ba da shawarar cewa ma'aikata da ke da alamun cututtukan numfashi na gaggawa su zauna a gidajensu har sai sun daina samun zazzabi, alamun zazzabi, da kowane irin bayyanar cututtuka na akalla awanni 24 ba tare da shan magunguna don rage alamun ko rage zazzabi ba; cewa manufofin izinin rashin lafiya su kasance masu sassauƙa kuma su ba ma'aikata izinin zama a gida don kula da dangin da ke ciwo, kuma ma'aikata sun san waɗannan manufofin.
A cewar OSHA, ayyukan da ke da haɗarin haɗarin haɗari na matsakaici sun haɗa da waɗanda ke buƙatar haɗuwa da yawa ko kusa da ƙasa da ƙafa shida (1.8 m) tare da mutanen da ba a san su ba ko kuma ake zargin suna da COVID-19, amma waɗanda zasu iya kamuwa da SARS-CoV-2 saboda watsawar al'umma a lokacin a kusa da wurin da kamfanin yake, ko kuma saboda mutumin ya yi tafiya ta duniya kwanan nan zuwa wurin da ke da yaduwar COVID-19.
Waɗannan sun haɗa da ma'aikata waɗanda ke hulɗa da jama'a gaba ɗaya, kamar a makarantu, wuraren aiki da ke da yawan jama'a da yawa da kuma wasu manyan wuraren sayar da kayayyaki.Suna gudanar da ayyukan injiniya ga wannan rukunin da kuma rukunin masu haɗarin haɗari sun haɗa da shigar da matatun iska mai inganci, haɓaka ƙimar iska, shigar da shinge na zahiri kamar su murfin filastik mai tsabta da sanya taga don sabis na kulawa don abokin ciniki ya iya neman daga mota.Suna gudanar da ayyukan gudanarwa ga wannan rukunin da manyan rukunin haɗari sun haɗa da ba da shawarar ma'aikatan marasa lafiya su zauna a gida, maye gurbin tarurruka ta hanyar sadarwar kai tsaye, kafa wuraren shakatawa, dakatar da hannuwan da ba su da damar yin amfani da kayan aiki na musamman don kare lafiyar COVID-19, haɗarin haɗari da ke tattare da ayyukanmu, haɗarin haɗari da kayan aiki da kuma hanyoyin da za su iya amfani da su, haɗarin aiki da kuma kula da yanayin aiki, haɗarin aiki da kuma kula da yanayin aiki, haɗarin aiki da kuma kula da yanayin aiki, haɗarin aiki da kuma kula da yanayin aiki, haɗarin aiki da yanayin aiki, da kuma yadda ake amfani da kayan aiki don kula da yanayin aiki, da yanayin aiki da yanayin aiki da yanayin aiki, da kuma hanyoyin da ake amfani da su don kare lafiyar jiki da aiki, da hanyoyin da hanyoyin da ke tattare da yanayin aiki, da kuma kula da yanayin aiki, da yanayin aiki da yanayin aiki, da kuma hanyoyin da ke tattare da yanayin aiki, da kuma hanyoyin da ke tattare da yanayin aiki, da ke tattare da yanayin aiki da yanayin aiki, da ke tattare da yanayin aiki da yanayin aiki da yanayin aiki, da yanayin aiki da yanayin aiki da yanayin aiki, da yanayin aiki, da yanayin aiki, da yanayin aiki, da yanayin aiki, da yanayin aiki, da yanayin aiki, da yanayin aiki, da yanayin aiki, da yanayin aiki, da yanayin aiki.
Ma'aikata da ke cikin wannan rukunin haɗari ba sa bukatar yin amfani da na'urar numfashi.
Idan mutum ya yi rashin lafiya a jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da ware mai rashin lafiya daga wasu a nesa da ƙafa 6, sanya wani ɗan jirgin don kula da mai rashin lafiya kuma ya ba da abin rufe fuska ga mai rashin lafiya ko kuma ya nemi ya rufe bakinsa da hancinsa da takarda na takarda lokacin da yake taɓo ko ya yi taho.
Ma'aikatan jirgin suna bukatar su yi amfani da safofin hannu na tiyata don kula da wani mai haƙuri ko kuma su taɓa ruwan jiki ko farfajiyar da za ta iya zama mai ƙazanta, kuma, watakila, kayan kariya na mutum idan mai haƙuri yana da zazzabi, tari mai ci ko wahalar numfashi.
Dole ne a zubar da safar hannu da sauran kayan da za a iya zubar da su a cikin jakar mai haɗari don ɓarnatar da kwayoyin halitta, kuma dole ne a tsabtace da kuma tsabtace wurare masu gurɓataccen wuri daga baya. A cikin yanayin jirgin ruwa na kasuwanci, kamar jiragen ruwa da sauran jiragen ruwa masu jigilar fasinjoji, abubuwan da ke cikin haɗari sun haɗa da jinkirta tafiya saboda rashin lafiya, keɓe kai tsaye, da sanar da cibiyar likita a jirgin nan da nan idan wani ya sami zazzabi ko wasu alamomi yayin da yake cikin jirgin.
A mafi kyau, ana duba lafiyar a cikin ɗakin da ke keɓewa. A cikin yanayin makarantu da cibiyoyin kula da yara, CDC ta ba da shawarar rufewa na ɗan gajeren lokaci don tsaftacewa ko kawar da cutar idan wani mai kamuwa da cutar ya kasance a cikin ginin makarantar, ba tare da la'akari da watsawar al'umma ba.
Lokacin da watsawar al'umma ta kasance ƙasa ko matsakaici, ana iya aiwatar da dabarun nisantar zamantakewa, kamar soke tafiye-tafiye, taro da sauran taro, kamar darussan ilimin jiki ko waƙar waƙa ko cin abinci a ɗakin cin abinci, ƙara sarari tsakanin tebur, daidaita lokutan shiga da fita, iyakance ziyarar da ba ta da mahimmanci, da amfani da wuri na musamman don dakin kiwon lafiya don yara da ke da alamun mura.
Idan akwai watsawa mai yawa a cikin al'ummar gida, ban da dabarun nisantar zamantakewa, ana iya la'akari da fadada sokewar ajiya. Ga ma'aikatan 'yan sanda da ke gudanar da ayyukan yau da kullun, CDC suna ganin haɗarin lafiyar kai tsaye yana da ƙasa.
Ana ba da shawarar jami'an rundunar 'yan sanda su tuntubi mutanen da ke da tabbacin kamuwa da cutar ko kuma waɗanda ake zargin suna da cutar COVID-19 su bi ka'idodin da masu aikin likita na gaggawa ke bi, gami da amfani da kayan kare kansu.
Idan akwai kusanci a lokacin da aka tsare, ma'aikata za su tsabtace da kuma tsabtace belinsu na aiki da kayan aiki tare da spray ko tawul na tsabtace gida kafin su sake amfani da su kuma su bi tsarin aiki na yau da kullum don riƙewa da zubar da kayan aikin kare kai da kuma riƙewa da wanke tufafi.
OSHA ta ce wasu ma'aikatan kiwon lafiya da kuma gawaji suna cikin manyan ko kuma manyan haɗarin haɗari.
Daga cikin ayyukan da ke da haɗarin haɗari, akwai na ma'aikatan bayarwa, tallafi, dakin gwaje-gwaje da sufuri na likita waɗanda ke fuskantar marasa lafiya da aka tabbatar da ganewar asali ko kuma suna da shakku na COVID-19.
Wadannan suna zama ayyukan haɗarin haɗari sosai idan ma'aikata suka yi hanyoyin samar da aerosols a cikin marasa lafiya tare da tabbatar da ganewar asali ko zargin COVID-19 ko kuma idan sun ɗauki ko sarrafa samfuran waɗannan marasa lafiya.
Wasu hanyoyin samar da aerosols sune intubation, hanyoyin shigar da tari, bronchoscopy, wasu hanyoyin hakora da jarrabawa ko kuma daukar samfurori.
Ayyukan gidan gawa masu haɗarin haɗari sun haɗa da waɗanda ma'aikata ke da hannu wajen shirya gawawwakin mutanen da ke da COVID-19 ko waɗanda aka yi zaton za su iya samun sa a lokacin mutuwa; waɗannan suna da haɗarin haɗari sosai idan sun yi autopsies. Ƙarin binciken injiniya don waɗannan rukunin haɗari sun haɗa da ɗakunan keɓewa don marasa lafiya da aka tabbatar da ganewa ko waɗanda ake zargi da COVID-19, koda lokacin da aka yi musu hanyoyin samar da aerosols.
Ƙarfin iska mai ƙarancin ƙarfi zai iya zama da kyau a wasu wuraren kula da lafiya da kuma gawawwakin gawawwakin.
Dole ne a yi amfani da samfurori ta hanyar yin amfani da matakan tsaro na 3.
Hukumar Lafiya ta Duniya (WHO) ta bada shawarar cewa marasa lafiya da ke shiga su ware kansu a dakunan jiran su dangane da ko ana zargin su da COVID-19. Baya ga wasu nau'ikan kayan kare kai, OSHA ta bada shawarar yin amfani da masks ga mutanen da ke aiki a nesa da ƙafa 6 daga marasa lafiya da suka kamu da cutar ko kuma waɗanda ake zargin sun kamu da cutar SARS-CoV-2 da waɗanda ke yin hanyoyin samar da aerosols.
A Amurka, N95 masu numfashi tare da masks na tacewa da NIOSH ta amince da su ko mafi girma ya kamata a yi amfani da su a cikin tsarin shirin numfashi na rubuce-rubuce wanda ya haɗa da gwajin daidaitawa, horo, da kuma gwajin likita.
Ƙari ga haka, WHO ba ta ba da shawarar yin amfani da takalma masu kariya ba, domin COVID-19 cuta ce ta numfashi, ba ta jiki ba.
Hukumar ta WHO ta ba da shawarar yin amfani da abin rufe fuska na tiyata ne kawai ga ma'aikatan rarraba marasa lafiya da ke shiga.
Ga wadanda ke daukar samfurori na numfashi na marasa lafiya da ke fama da COVID-19, suna ba su kulawa ko kuma suna jigilar su ba tare da yin hanyoyin samar da aerosols ba, WHO ta ba da shawarar yin amfani da maskara na tiyata, tabarau ko kariya ta fuska, rigar da safofin hannu.
Idan an yi aikin samar da aerosols, dole ne a maye gurbin masks na tiyata da N95 ko FFP2 respirator.
Saboda samar da kayan kare kai ba ya isa, WHO ta ba da shawarar rage bukatar amfani da su, ta maye gurbin su da telemedicine, shinge na zahiri kamar windows masu haske, iyakance izinin shiga ɗakin wani mai haƙuri da COVID-19 ga waɗanda ke cikin kulawa ta kai tsaye, amfani da abin rufe fuska ɗaya ba tare da cire shi ba yayin da ake ba da kulawa ga marasa lafiya da yawa tare da ganewar asali ɗaya, saka idanu da daidaita sarkar samar da kayan kare kai da hana amfani da abin rufe fuska ta hanyar marasa lafiya marasa alama.
ED: Katherine Maher, Shugaba na Gidauniyar Wikimedia
Ga: Dukan ma'aikatan Wikimedia Foundation
[Covid-19] Saukaka Nauyinmu da Kuma Shirya Mu don Nan Gaba
RANAR SATA: 14 ga Maris, 2020, 00:24 h, lokaci na duniya
IYAR HALIN: CC0: Babu haƙƙoƙin da aka tanada
A wannan watan, mun fuskanci yanayi na musamman.
Cutar COVID-19 ta nuna yadda mutane suke hulɗa a duniya da kuma yadda muke da alhakin juna.
Kalubalen da yake fuskanta ba su da misaltuwa, amma mun san cewa amsarmu mafi kyau ta dangana ne a kan jin kai, hadin kai da kuma gina al'umma ta duniya da ke cikin ainihin wannan ƙungiyar.
Abokantaka da kuma damuwar da muka gani tsakanin dukkan abokan aikinmu a cikin imel, kira da tattaunawa babban tabbaci ne na yadda mutane masu ban mamaki muke sa'a mu yi aiki tare.
Ba zan iya jin daɗin yin godiya da kuma alfahari da ku duka don ku zama abokan aikina ba.
A makon da ya gabata, wani ya gaya mini yadda yake daraja aikinmu.
Sun tunatar da ni yadda yake da muhimmanci a duniya ta samu damar shiga Wikipedia a wannan lokacin da kuma alamar da ke da iko da ke nuna cewa wannan muhimmin kayan aiki yana kasancewa a kan layi kuma yana samuwa ga kowa.
Aikin su na sa hakan ya yiwu, ko ta wajen kiyaye wuraren aiki, ko kuma ta wajen taimaka wa abokan aikinmu su samu albashin su ko kuma ta wajen kiyaye al'ummominmu.
Duniya tana bukatar bayanan da Wikipedia ke bayarwa, yanzu fiye da kowane lokaci.
Wannan lokaci ne da ba kawai abin da muke yi ba, amma kuma yadda muke yi zai yi tasiri sosai a duniya.
Saboda muhimmancin wannan manufa da kuma rawar da suke takawa a cikinta, daga wannan makon mai zuwa, za mu yi wasu muhimman canje-canje ga yadda muke aiki tare.
Gyara ayyukanmu da jadawalinmu
Kamar yadda Robyn ta ambata a baya, tawagar C ta taru a daren jiya don tattauna yadda muke aiki da kuma jadawalinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun tattauna abin da muka yi imanin zai zama amsar da ta dace ga abin da muke fuskanta da kuma yadda za mu ci gaba da kasancewa da dorewar ƙungiyar a wannan lokacin.
A mafi girma, muna so mu kawar da damuwa kuma mu tallafa wa aikinmu na dogon lokaci.
Idan kana bukatar ka rage gudu, to, kana da kyau.
Ga dukan ma'aikata, masu kwangila da ma'aikata masu kwangila:
Za mu yi aiki na sa'o'i 4 a rana ko 20 a mako har sai mun sanar da kai.
Ba mu da hutu; idan za ka iya yin aiki a wani lokaci na yau da kullum, wannan zai taimaka wa aikin.
Amma, duniya wuri ne da ba za a iya tsammani ba a yau, kuma ko muna kula da ƙaunatattunmu, ko muna yin sayayya, ko kuma muna zuwa wurin likita, muna saka lafiyarsu kan gaba.
Ba mu da lissafin sa'o'in da suke yi.
Idan yana rashin lafiya, kada ku yi aiki.
Ko da yake bai kamata mu faɗi hakan ba, muna faɗi hakan.
Ba lallai ne ku nemi izinin rashin lafiya ko lokacin hutu da aka biya ku ba; ku gaya wa manajan ku kawai kuma ku taimaka wa ƙungiyar ku duba jadawalin aiki da jadawalin aiki don tabbatar da cewa an rufe mahimman wuraren aikin.
(Idan ka samu kamuwa da cutar COVID-19, ka sanar da Bryan, na T&C Operations, don T&C ta taimaka da tallafi kuma ta tabbata cewa manajan sun san halin da kake ciki).
Mutane da suke aiki a kowace awa za su sami cikakken albashin.
Kamar yadda muka faɗa, muna sabunta alkawarinmu ga 'yan kwangila da abokan aikinmu da suke aiki a kowane lokaci.
Za a biya kowa bisa ga yawan sa'o'insa da aka yi aiki a yanayi na yau da kullum.
Wannan ya shafi yanayin rashin lafiya kuma ba zai iya aiki ba.
Idan kana son ka yi aiki, muna goyon bayan ka.
Mutane da yawa suna amfani da aikin su wajen daidaita damuwarsu da duniyar da ke kewaye da su.
Abin da muke yi yana iya zama da ban sha'awa, musamman a waɗannan lokutan.
Wannan kuma batun kula da kai ne.
Abin da muke roƙonku shi ne ku tuntuɓi manajanku don mu san abin da za mu jira kuma mu daidaita yadda ya kamata.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da za mu ci gaba da yi.
Ƙungiyoyin Injiniya na Amincewa da Yanki, Ayyukan Ayyukan Mutum, Amincewa da Tsaro da Tattalin Arziki, da sauransu, suna yin aiki mai mahimmanci wanda zai iya buƙatar ƙarin tallafi.
Za mu fara aiki tare da dukkan sassan don tantance manufofinmu na yanzu da kuma gyara tsarinmu don tallafawa abin da ke da muhimmanci ga aikinmu.
Akwai ayyuka da yawa da za mu yi a nan gaba, amma mun fi mayar da hankali ga ayyukan da suka fi muhimmanci.
Saurin gudu a yau ba zai cutar da mu ba gobe.
Ba mu da shirin "bi sau biyu na sa'o'i don sabuntawa" lokacin da annobar ta ƙare.
Ba za a sa ran yin karin sa'o'i ba don cika takaddun da ba su da kyau.
Mun amince cewa yanayi ya canja kuma za mu yi aiki don kafa sababbin manufofi da kuma lokacin da ya dace.
Mene ne ke faruwa da APP, ko kuma Shirin Shekara?
Don daidaitawa da sabon gaskiyarmu da tsammanin lokutan aiki na yau da kullun, muna shirin daidaita jadawalin don isar da Shirin Shekararmu na 2020-2021.
Muna da niyyar gabatar da wani tsawo na shirinmu na 2019-2020 wanda zai ba da karin lokaci ga kasafin kuɗi don haka ma'aikata za su iya fifita aiki mai mahimmanci, kula da kansu da kula da ƙaunatattun su yayin da muke daidaitawa da bukatun waɗanda suke buƙatar ko so su yi aiki tare da ragewa a cikin makonni masu zuwa.
Wannan tsawaita tsarinmu ya rage nauyin tsarawa da kuma matsa lamba a dukan ƙungiyar.
Za mu gabatar da shawararmu ga Majalisar a mako mai zuwa kuma za mu sanar da 'yan majalisa da kuma kungiyoyin matakan da za su biyo baya da zarar mun samu tabbaci.
Na gode wa tawagar APP don jagorancin da suka yi a wannan yanayin.
Yanayin ofishin, bayyanarsa da tsabtace shi
A makon da ya gabata ne muka samu labari cewa wani abokin aikinmu a ofishinmu na San Francisco na iya kamuwa da cutar COVID-19.
Amma, a matsayin abin da ya kamata mu yi, mun ɗauki wani jami'in tsabtace da ke hana cutar a cikin ofishinmu a birnin San Francisco.
Sun yi amfani da maganin rigakafi na asibiti don tsabtace dukan wurare, ban da ɗakin karɓa da kuma ɗagawa da ke zuwa bene.
Ginin ya yi amfani da tsarin kulawar kansa, yana amfani da kayayyakin da ke tallafawa lafiyar mazauninsa.
Muna da tabbaci cewa ofishin zai kasance a shirye sosai don lokacin da muka yanke shawarar komawa.
Ofishinmu a DC yana cikin wani WeWork, wanda ya raba yarjejeniyar COVID-19 tare da mu da duk ma'aikatan ofisoshin DC.
Tun makon da ya gabata, ofishinmu na DC ya koma wani wuri mai nisa bisa ga ka'idojin da aka ba San Francisco.
Kamar yadda wasu abokan aikinmu a birnin New York suka sani, mun tattauna batun haya a Brooklyn.
Waɗannan tattaunawar suna ci gaba amma suna iya ɗaukar lokaci.
Wasu abokan aikinmu suna aiki a nesa a karon farko.
Abokan aikinmu da suka yi aiki a nesa sun san cewa wannan yanayin yana bukatar daidaitawa, don haka suna ba da shawarwari masu zuwa:
Ka rage tsawon taron zuwa sa'a ɗaya ko biyu a lokaci.
Idan ana bukatar ƙarin zaman, ka yi la'akari da yadda za ka yi zaman a cikin kwanaki da yawa.
Ka sa taron ya kasance da kyau kuma ka rubuta jerin batutuwa da za ka karanta a gaba.
Yana amfani da bidiyo ta hanyar tsoho, ta amfani da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin kai da haɗin kai.
Ka naɗa shugaban da zai daidaita kowane taro, wanda zai bincika tambayoyin da ke cikin hira da jerin masu magana, da kuma wanda zai taimaka wajen yin rubutu (ko yin rubutu a cikin haɗin kai).
Ka aika wa masu goyon bayan sana'a imel idan kana bukatar na'urorin kunne masu kyau.
Ka yi amfani da kuɗin jin daɗin abinci don abincin dare.
Ka shiga tashar #remoties a Slack don ka yi magana da abokanka game da aikin da aka rarraba
RR.H. ta ƙungiyar Ayyuka suna nazarin jagororin ergonomics dangane da taron karawa juna sani na yanar gizo don tallafawa karuwar aikin da aka rarraba a duk faɗin Gidauniyar.
A makon da ya gabata mun nemi duk masu karbar tallafin al'umma su soke taron jama'a da Wikimedia ke tallafawa, kamar editatons, har sai WHO ta bayyana ƙarshen annobar.
Mun sanar da ku cewa mun fahimci cewa buƙatarmu na sokewa da sauran ƙuntatawa na iya hana ku cika wani ɓangare na ayyukan da aka amince da su don tallafi kuma babu wani hukunci don jinkirta ko canza waɗannan manufofin.
A mako mai zuwa za mu bi ta da ƙarin jagororin a Wikimania da kuma sauran taron yanki da na al'umma.
Abin da jama'a ke ji a duniya a yau shi ne, a wani ɓangare, baƙin ciki saboda katsewa, kuma a wani ɓangare, sauƙi saboda bayyanar da kuma ikon mayar da hankali ga al'ummomin su, duka Wikimedia da sauransu.
Daga nan gaba, CRT za ta yi aiki don kafa shafi a Meta-Wiki don samar da sarari ga al'umma don saka idanu kan tasiri da kuma bin hanyoyin sadarwa da su.
Ci gaba da tuntuɓarmu game da al'amuran COVID-19
Za mu aika muku da gayyata ta kalandarku na ranar Alhamis mai zuwa, 14:00 UTC, 07:00 UTC, don taron ma'aikata na musamman.
Za mu yi amfani da wannan zarafin don mu raba ƙarin labarai, mu amsa tambayoyinku kuma mu ciyar da lokaci muna haɗa kanmu da juna.
Muna aiki tare a wannan kuma muna shirye mu taimaka a duk hanyar da za mu iya.
A halin yanzu, za ka iya ci gaba da samun bayanan wannan imel ɗin da kuma duk wasu muhimman bayanai game da COVID-19 a kan Office Wiki.
CRT za ta ci gaba da sabunta waɗannan shafuka da kuma dukan bayanan a wuri guda.
Muna kuma aiki don mu ci gaba da sadarwa da ma'aikatan da ke zama a ƙasashen da ake fama da irin wannan mummunan yanayi a yanzu.
Idan kana da tambayoyi game da tafiye-tafiye, abubuwan da suka faru, babban aiki, wasu matsalolin ɗaukar hoto ko wani abu da za ka iya buƙatar taimako da shi, kada ka yi shakka ka sanar da CRT kuma ka yi aiki tare da su.
Muna nan don taimaka mana mu tallafawa da kuma kasancewa a matsayin hanyar sadarwa idan ya cancanta.
Idan kuna da batutuwa masu mahimmanci ko masu mahimmanci, aika imel zuwa Bryan Judan, Daraktan Ayyukan Duniya na RR HH.
Babu wani canji da ya kamata a ɗauka a matsayin watsi da aikinmu da kuma ayyukanmu.
Maimakon haka, sun nuna cewa a yanzu, aikinmu da kuma ayyukanmu suna iya daidaitawa a hanyar da ba a taɓa yi ba.
Waɗannan su ne matakan da muke ganin ya kamata mu ɗauka don tallafa wa juna don mu ci gaba da aiki, mu ba da motsinmu goyon baya da kuma ba wa duniya sabis ɗin da ta amince da shi.
Aikinmu da aka tsara zai kasance a wurin a lokacin da ya dace.
A yanzu, lokaci ya yi da za mu goyi bayan juna kuma mu sa wuri don muhimmin aikin da zai faru a cikin makonni masu zuwa, kuma wataƙila a cikin watanni masu zuwa.
Muna bukatar ku duka don wannan ya yiwu, kuma saboda haka muna bukatar ku kula da ku da kuma kula da iyalanku domin ku kasance cikin mafi kyawun yanayi a lokacin da bukata ta taso.
Yanzu, don Allah ka wanke hannunka kuma kada ka taɓa fuskarka!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M da Tony S) da sauran ƙungiyar jagoranci (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M da Toby N).
Angiotensin 2 (ECA2) mai canza enzyme enzyme ne wanda ke manne wa farfajiya ta waje (ƙwayoyin halitta) na ƙwayoyin huhu, jijiyoyi, zuciya, koda, da hanji.
ECA2 yana magance aikin enzymes masu canza angiotensin (ECA) ta hanyar rage adadin angiotensin II da haɓaka angiotensin (1-7), yana mai da shi manufa mai magani don maganin cututtukan zuciya. ECA2 kuma yana aiki a matsayin hanyar shiga sel don wasu coronavirus.
Ana kiran sigar mutum ta wannan enzyme hECA2.
Angiotensin 2 mai canza enzyme shine ƙarfe mai ƙunsar zinc kuma yana samuwa a saman ƙwayoyin endothelial da sauran nau'ikan.
Protein ECA2 yana dauke da wani yanki na N-terminal na peptidase M2 da kuma wani yanki na C-terminal na renal mai ɗaukar amino acid na colectrin.
ECA2 wani furotin ne mai laushi guda ɗaya na nau'i na I, tare da yankin enzymatically mai aiki a farfajiya a kan ƙwayoyin huhu da sauran kayan.
Ƙarfin ECA2 na waje na ƙwayoyin halitta yana rabu da ƙwayoyin halitta na transmembrane ta wani enzyme da ake kira shedase kuma a sakamakon haka, an saki furotin mai narkewa a cikin jini kuma a ƙarshe an fitar da shi ta cikin fitsari.
ECA2 yana cikin yawancin gabobin: ECA2 yana da alaƙa da ƙwayoyin halitta na ƙwayoyin ƙwayoyin cuta na huhu na nau'i na II, ƙwayoyin ƙwayoyin cuta na hanji, ƙwayoyin jini da ƙwayoyin endothelial na jini, da ƙwayoyin jijiyoyin jini na ƙwayoyin tsoka a yawancin gabobin.
Ana kuma samun maganganun ECA2 na mRNA a cikin ƙwaƙwalwar kwakwalwa, a cikin jiki, a cikin hypothalamus, da kuma a cikin ƙashin ƙwaƙwalwar ƙwaƙwalwa.
Babban aikin ECA2 shi ne ya magance ECA.
ECA ta cire hormone daga angiotensin I kuma ta samar da angiotensin II, wanda shi ne mai hana jini.
ECA2 kuma ya raba amino acid carboxyl-terminal phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma ya hydrolyz shi don samar da angiotensin vasodilator (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ECA2 kuma yana iya raba wasu sauran peptides, ciki har da [des-Arg9]-bradiquinine, apoline, neurotensin, dinorphine A, da ghrelin.
ECA2 kuma yana daidaita zirga-zirgar membrane na SLC6A19 wanda ke dauke da amino acid mai tsaka tsaki kuma an danganta shi da cutar Hartnup.
A matsayin furotin na transmembrane, ECA2 yana aiki a matsayin babban wurin shiga ga wasu coronavirus, gami da HCoV-NL63; SARS-CoV (virus da ke haifar da SARS); da SARS-CoV-2 (virus da ke haifar da COVID-19).
Musamman, haɗuwa da furotin S1 na SARS-CoV da SARS-CoV2 tare da ikon enzymatic na ECA2 a saman sel yana haifar da endocytosis da kuma canja wurin cutar tare da enzyme zuwa endosomes da ke cikin sel.
Wannan tsarin shigarwa kuma yana buƙatar shirya furotin S ta hanyar TMPRSS2 protease serine na mai masaukin, wanda a halin yanzu ana binciken hana shi a matsayin yiwuwar magani. Wannan ya haifar da wasu zato cewa rage matakan ECA2 a cikin kwayoyin zai iya taimakawa wajen yaki da kamuwa da cuta.
Duk da haka, kungiyoyi da kuma hukumomi da dama sun ba da shawarar ci gaba da maganin hana ECA da BRA.
Wani bita da aka yi da kuma nazarin da aka yi a kan tsarin da aka buga a ranar 11 ga Yuli, 2012 ya nuna cewa "ana amfani da maganin hana ECA don rage yawan cutar huhu da kashi 34 cikin dari idan aka kwatanta da shari'ar da aka yi da su".
Bugu da ƙari, "hadarin kamuwa da cutar huhu ya ragu a cikin marasa lafiya da aka yi musu magani da masu hana ECA kuma suna da haɗarin kamuwa da cutar huhu, musamman waɗanda ke fama da bugun jini da rashin zuciya.
Amfani da ECA inhibitors kuma ya shafi rage yawan mutuwa da ke tattare da cutar huhu, ko da yake sakamakon bai kasance mai ƙarfi ba ga haɗarin cutar huhu gaba ɗaya".
ECA2 na mutum (rhECA2) ya zama sabon magani don cutar huhu mai tsanani kuma ya inganta haemodynamics na huhu da kuma satar oxygen a cikin aladu da ke da cututtukan numfashi mai tsanani da lipopolysaccharides ke haifar.
Rayuwar rhECA2 a cikin mutane kusan awa 10 ne, kuma farkon aikinsa minti 30 ne, ban da tsawon sa'o'i 24.
Wasu binciken sun nuna cewa rhECA2 na iya zama magani mai ban sha'awa ga waɗanda ke fama da rashin haƙuri ga masu hana tsarin renin-angiotensin (sRA inhibitors) ko kuma a cikin cututtuka da ke da hawan jini na jini na II. An kimanta infusion na rhECA2 a cikin gwaji na asibiti don magance cutar ta fama da numfashi.
Aikace-aikacen COVID-19 aikace-aikacen software ne na na'urorin hannu waɗanda aka tsara don taimakawa tare da bin diddigin lambobin sadarwa don amsa cutar coronavirus ta 2019-2020, wato, tsarin gano mutanen ("lambobi") waɗanda zasu iya kasancewa cikin hulɗa da mutumin da aka kamu da cutar.
An ci gaba ko kuma an gabatar da aikace-aikace daban-daban tare da goyon bayan gwamnati a wasu yankuna da hukumomi.
An samar da tsarin da yawa don ƙirƙirar aikace-aikacen bin diddigin lamba.
Akwai damuwa game da sirrin sirri, musamman game da tsarin da ke dogara da bin diddigin yanayin masu amfani da aikace-aikacen.
Akwai wasu zaɓuɓɓuka masu sauƙi, kamar yin amfani da siginar Bluetooth don yin rikodin kusanci na mai amfani da wasu wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Apple da Google sun sanar a hade cewa za su haɗa aikin don tallafawa waɗannan aikace-aikacen da ke kan Bluetooth kai tsaye a cikin tsarin aiki na iOS da Android.
A kasar Sin, gwamnatin kasar Sin, tare da Alipay, ta tura wani aikace-aikacen da ke ba 'yan kasar damar duba ko sun yi hulɗa da mutanen da ke da COVID-19.
Yanzu haka ana amfani da shi a birane 200 a kasar Sin. A Singapore ana amfani da wani app da ake kira TraceTogether.
An kirkiro aikace-aikacen ne ta hanyar ƙungiyar IT ta gida, an ƙaddamar da shi azaman aikace-aikacen buɗe tushen kuma za a ba da shi ga gwamnati. A Arewacin Macedonia an ƙaddamar da "StopKorona!", aikace-aikacen da ke dogara da Bluetooth don bin diddigin haɗarin waɗanda ke iya kamuwa da cutar da kuma ba da amsa mai sauri ga hukumomin lafiya.
Ma'aikatar Sadarwa da Fasaha da kuma Ma'aikatar Lafiya ne suka kirkiro wannan aikace-aikacen.
A ranar 14 ga Afrilu, 2020, aikace-aikacen yana jiran amincewa daga Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnatin ta ba da rahoton cewa aikace-aikacen bin diddigin lamba yana cikin ci gaba da ci gaba kuma zai kasance a shirye don aiwatarwa a cikin makonni masu zuwa.
Kasashen Ostiraliya da New Zealand suna la'akari da aikace-aikacen da ke dogara da aikace-aikacen TraceTogether da kuma yarjejeniyar BlueTrace ta Singapore. Rasha na shirin gabatar da aikace-aikacen geoperimetry ga marasa lafiya da ke zaune a Moscow kuma sun sami binciken COVID-19, wanda aka tsara don tabbatar da cewa ba sa barin gidajensu.
Ross Anderson, farfesa a Jami'ar Cambridge na Kimiyyar Tsaro, ya fallasa matsaloli masu yawa na aiki tare da tsarin da ke dogara da aikace-aikace, gami da ƙididdigar ƙarya da yiwuwar rashin inganci idan karɓar aikace-aikacen ya iyakance ga ƙaramin ɓangare na yawan jama'a.
Dangane da damuwar game da yaduwar aikace-aikacen "coronavirus" masu yaudara ko cutarwa, Apple ya iyakance nau'ikan ƙungiyoyi waɗanda zasu iya ƙara aikace-aikacen da suka shafi coronavirus a cikin App Store zuwa ƙungiyoyin "masu hukuma" ko masu amincewa kawai.
Google da Amazon sun yi irin wannan takunkumin.
Masu kare sirrin sun nuna damuwarsu game da sakamakon saka idanu ta hanyar aikace-aikacen coronavirus kuma, musamman, game da ko za a rushe kayan aikin da aka kirkira don magance cutar coronavirus da zarar barazanar ta wuce.
Amnesty International da wasu kungiyoyi sama da 100 sun gabatar da wata sanarwa domin neman a takaita irin wannan sa ido.
Ƙungiyoyi sun kafa sharuɗɗa takwas don ayyukan gwamnati:
Wannan ya kamata ya kasance 'doka, dole kuma ya dace da shi.'
Ana bukatar a yi amfani da sassan kashewa don faɗaɗa sa ido da kuma saka idanu.
amfani da bayanan zai zama iyakance ga manufofin da suka shafi COVID-19;
Ana bukatar a kare tsaro da kuma rashin sani kuma ya kamata a samu hujjoji na wannan kariya.
Ana buƙatar yin amfani da bayanan sirri don tabbatar da cewa an sami damar yin amfani da bayanan sirri.
Duk wani musayar bayanai tare da wasu ya kamata a bayyana a cikin doka;
ya kamata a kafa kariya daga zalunci da kuma kafa hakkin 'yan kasa don amsa wannan zalunci;
An kuma ba da jerin abubuwan da za a yi amfani da su don yin bincike a kan matsalar da ke tattare da lafiyar jama'a da kuma wasu kungiyoyin da ba su da alaka da aikin.
Shirin da Google/Apple ya gabatar yana nufin magance matsalar saka idanu ta dindindin ta hanyar cire tsarin bin diddigin tsarin aiki na su lokacin da ba a buƙatar shi ba.
A wasu ƙasashe, an yi amfani da bin diddigin wuri bisa hanyar sadarwa, maimakon aikace-aikace, wanda ya kawar da buƙatar sauke aikace-aikace da kuma ikon guje wa bin diddigin.
A Isra'ila, an amince da bin diddigin da ke bisa hanyar sadarwa.
Yanayin da ke tattare da cibiyoyin sadarwa da ke samun damar samun bayanai na wurare masu yawa suna da manyan matsalolin sirri.
Duk da haka, ba dole ba ne duk tsarin da ke da sabobin tsakiya su sami damar samun bayanan wurin mutum; an kirkiro tsarin kare sirrin sirri da yawa waɗanda ke amfani da sabobin tsakiya kawai don sadarwa (duba sashe na gaba).
A Koriya ta Kudu, an yi amfani da tsarin da ba a dogara da aikace-aikace ba don bin diddigin lambobin sadarwa.
Maimakon amfani da takamaiman aikace-aikace, tsarin ya tattara bayanan bin sawu daga tushe daban-daban, gami da bayanan bin sawu na na wayoyin hannu da bayanan ma'amaloli na katin kuɗi, kuma ya haɗu da su don samar da sanarwa ta hanyar saƙonnin rubutu ga mutanen da ke da yuwuwar kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da yiwuwar tuntuɓar, gwamnati ta kuma sanya bayanin wurin a bayyane ga jama'a, wani abu da aka ba da izini saboda canje-canje masu yawa ga dokokin tsare sirrin bayanai bayan barkewar cutar MERS a ƙasar.
Wasu ƙasashe, ciki har da Jamus, sun yi la'akari da amfani da tsarin tsare sirri da ke da tsakiya.
A ranar 6 ga Afrilu, 2020, har yanzu ba a bayyana cikakken bayani ba.
Kula da lambobin sadarwa tare da kariya ta sirri ra'ayi ne mai kyau, tare da bincike mai yawa da aka buga wanda ya fara aƙalla 2013. A ranar 7 ga Afrilu, 2020, fiye da ƙungiyoyin masana goma sha biyu suna aiki a kan hanyoyin da ke da mutunci, kamar amfani da Bluetooth mai ƙarancin kuzari (BLE) don yin rikodin kusanci ga mai amfani da wasu wayoyin salula.
Duk da haka, PEPP-PT wani aiki ne mai daidaitawa wanda ya ƙunshi duka hanyoyin da aka tsara da kuma hanyoyin da aka tsara kuma ba yarjejeniya guda ɗaya ba. Yarjejeniyar da aka tsara ta haɗa da bin diddigin kusanci don kiyaye sirri (DP-PPT/DP-3T), lambobin tuntuɓar lokaci (TCN, da aka sani da lambobin taron tuntuɓar, CEN) da kuma yarjejeniyoyi da hanyoyin don bin diddigin wayar hannu don kare sirrin sirri (PACT), da sauransu.
A cikin waɗannan yarjejeniyoyi, bayanan sirri ba su taɓa fita daga na'urar ba kuma duk abin da aka haɗa yana faruwa a cikin na'urar.
Kungiyar Tsare Sirri ta MIT Media Lab ta kasance tana haɓaka SafePaths, dandamali don amfani da fasahohin kare sirrin yayin tattarawa da amfani da bayanan wuri ko hanyar haɗuwa don bin diddigin yaduwar COVID-19.
Ya dogara ne akan binciken rahoton fasaha "Aikace-aikace a waje da iko: Yadda ake kiyaye sirrin mutum yayin annobar", wanda aka buga a watan Maris na 2020. Wani irin wannan ƙoƙari shine dandamali na SafeTrace na Enigma MPC, kamfani wanda ke haɓaka fasahar sirrin da aka kafa a asalin MIT Media Lab.
SafeTrace yana amfani da fasahar tsaro ta kayan aiki da ke ba masu amfani damar raba bayanai masu mahimmanci game da wuri da lafiya tare da sauran masu amfani da jami'ai, ba tare da yin amfani da sirrin bayanan ba.
A ranar 5 ga Afrilu, 2020, ƙungiyoyi da yawa da suka haɗu a kusa da abin da ke da mahimmanci iri ɗaya kuma tare da yarjejeniyoyi masu yawa sun kafa TCN Coalition na Duniya tare da manufar rage rarrabuwa da ba da damar haɗin kai na duniya na aikace-aikacen bin sawu da faɗakarwa, wani muhimmin abu don cimma karbuwa mai yawa.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta bude lambar yarjejeniyar BlueTrace da aka yi amfani da ita ta hanyar aikace-aikacen gwamnati na hukuma.
A ranar 10 ga Afrilu, 2020, Apple da Google, kamfanonin da ke kula da dandamali na iOS da Android, sun sanar da wani shiri don bin diddigin lambobin sadarwa wanda, kamar yadda suka tabbatar, zai kare sirrin mutum, wanda ya dogara da haɗakar da fasahar Bluetooth mai ƙarancin kuzari da kuma ɓoye sirrin sirrin sirrin sirri.
Sun kuma wallafa takaddun fasahar da ake amfani da ita a cikin tsarin.
A cewar Apple da Google, ana shirin aiwatar da tsarin a matakai uku:
aiwatar da kayan aiki don gwamnatoci su kirkiro aikace-aikacen bin diddigin coronavirus na hukuma waɗanda ke kare sirrin mutum
Google da Apple suna shirin magance matsalolin tallafi da kuma saka idanu na dindindin ta hanyar rarraba tsarin ta hanyar sabunta tsarin aiki sannan kuma cire su ta hanyar da ta dace da barazanar ta wuce.
b'Abin da ake kira sake yin magani (wanda ake kira sake yin magani ko kuma canja wurin magani) shi ne sake yin amfani da magani da aka amince da shi don magance wata cuta wadda ba wadda aka fara yi mata ba.
Wannan ya yi daidai da binciken kimiyya da ake yi a yanzu don samar da hanyoyin lafiya da inganci don COVID-19.
Sauran layin bincike sun haɗa da haɓaka allurar rigakafin COVID-19 da kuma karɓar plasma na convalescent. SARS-CoV-2 yana da ƙwayoyin sunadarai guda 66 masu ƙira, kowannensu yana da wuraren haɗin gwiwa da yawa tare da ligand.
Binciken wadannan wuraren da ake hadawa da su ya ba da kyakkyawan tushe ga aikin samar da magani mai cutar kan kwayoyin cutar COVID-19.
Daga cikin manyan furotin masu niyya na SARS-CoV-2 akwai protease mai kama da papain, RNA polymerase mai jagorantar RNA, helicase, protein S, da ribophosphatease ADP.
Hussein A. A. et al. sun yi nazarin wasu kwayoyin da ke da sha'awa na likita wanda suka inganta kuma suka bincika don gano kamanceceniya tsakanin babban sarkar su da ƙarin magungunan da aka amince da su don hanzarta haɓaka magungunan mai ƙarfi na SARS-CoV-2 a cikin binciken su na farko kuma su ba da shawarar shi don ƙirar binciken asibiti.
Chloroquine magani ne na yaki da zazzabin cizon sauro da ake amfani da shi wajen magance wasu cututtukan da ke hana kamuwa da cutar.
A ranar 18 ga Maris, WHO ta sanar da cewa chlorine da hydroxychloroquine da ke da alaƙa za su kasance cikin magunguna huɗu da za a yi nazari a cikin gwajin asibiti na Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin jihar New York akan chlorine da hydroxychloroquine zai fara a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da sulfate na hydroxychloroquine da phosphate na chlorine ta hanyar izinin amfani da gaggawa (USA).
Ba a amince da maganin ba ta hanyar gwajin gwaji na FDA kuma an ba shi izini a Amurka a matsayin gwaji na gaggawa don amfani a cikin marasa lafiya da ke asibiti amma ba za su iya samun magani a gwajin gwaji ba.
Hukumar ta CDC ta ce "amfani, sashi ko tsawon lokacin hydroxychloroquine don rigakafi ko maganin kamuwa da cutar SARS-CoV-2" har yanzu ba a kafa ba.
Likitoci sun ce suna amfani da miyagun ƙwayoyi a lokacin da "babu wani zaɓi".
Wani rukunin bincike na Turkiyya a birnin Istanbul na gudanar da wani karamin bincike game da amfani da chlorine a hade da zinc, bitamin A, bitamin C da bitamin D.
A Jami'ar Duke da Jami'ar Oxford, akwai manyan bincike a kan wannan batu.
Kwalejin likitancin NYU ta Langone tana gudanar da gwaji game da amincin da kuma ingancin amfani da hydroxychloroquine a hanyar rigakafi.
Gwaje-gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun tabbatar da cewa favipiravir "a bayyane yake yana da tasiri".
Mutane 35 a birnin Shenzhen sun yi gwajin da ba su da lafiya a matsakaita kwanaki 4, yayin da marasa lafiya 45 da ba su samu ba suka yi kwanaki 11 da rashin lafiya.
A wani bincike da aka yi a Wuhan a kan marasa lafiya 240 da ke fama da cutar huhu, rabin sun karɓi favipiravir, yayin da aka ba rabin su umifenovir.
Hukumar Magunguna ta Italiya ta tunatar da jama'a cewa akwai karancin shaida da ke goyon bayan maganin.
A ranar 2 ga watan Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don tanadin ta kuma za ta nemi sojoji don isar da maganin ga asibitocin jami'a, inda za a yi amfani da shi wajen kula da marasa lafiya da COVID-19.
A cewar jaridar South China Morning Post, Shinzo Abe ya gabatar da shawarwari ga gwamnatin Trump game da sayan maganin. Maganin na iya zama da kasa tasiri a cikin mummunan yanayin cutar idan cutar ta riga ta ninka.
Yana iya zama da haɗari ga mata masu ciki ko waɗanda suke ƙoƙarin yin ciki.
Wani bincike na lopinavir/ ritonavir (Kaletra), wani nau'i na maganin lopinavir da ritonavir, ya kammala cewa "ba a samu sakamako mai kyau ba".
An tsara magungunan don hana kwayar cutar ta HIV ta hanyar haɗa shi da protease.
Wani rukuni na masu bincike a Jami'ar Colorado na kokarin gyara magunguna don gano wani fili wanda zai haɗu da protease na SARS-CoV-2. A cikin al'ummar kimiyya, an yi ta sukar sanya albarkatu don sake amfani da magunguna da aka haɓaka musamman don HIV / AIDS.
Hukumar lafiya ta duniya ta hada da lopinavir/ritonavir a cikin gwajin Solidarity na duniya.
Gilead Sciences ta kirkiro kuma ta haɓaka remdesivir a matsayin magani don cutar Ebola da cututtukan cutar Marburg. Gilead Sciences daga baya ta gano cewa remdesivir yana da aikin antiviral in vitro akan filovirus da yawa, pneumovirus, paramixovirus da coronavirus.
Wata matsala da ake fuskanta a maganin rigakafi ita ce ci gaban juriya ta hanyar maye gurbin da zai iya haifar da ciwo mai tsanani da kuma watsawa.
Wasu nazarin farko kafin gwaji sun nuna cewa remdesivir na iya samun babban shinge na kwayoyin halitta akan juriya. Gwaje-gwaje na asibiti da yawa suna gudana, ciki har da biyu da asibitocin Jami'ar Cleveland ke gudanarwa; ɗaya ga mutanen da ke da rashin lafiya mai matsakaici da kuma wani ga waɗanda ke da cutar mafi tsanani.
Ana gudanar da gwaje-gwaje uku na maganin shan magani na bitamin C ga mutanen da ke asibiti da kuma waɗanda COVID-19 ya shafa sosai; biyu suna sarrafa su da placebo (China, Kanada) da kuma ɗaya ba tare da kulawa ba (Italiya).
Jihar New York ta fara gwaji da maganin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya da Magunguna ta Japan (NCGM) tana shirin yin gwaji tare da Alvesco (ciclesonide) na Teijin, wani corticosteroid mai numfashi don asma, a matsayin magani ga marasa lafiya marasa alamar cutar coronavirus.
Wani nau'i na angiotensin 2 mai canza enzyme, wani gwaji na II yana gudana kuma za a shiga cikin marasa lafiya masu tsanani 200 da ke asibiti a Denmark, Jamus da Austria don a ga yadda magani yake da tasiri.
Masu bincike a Cibiyar Zuciya ta Montreal a Kanada a halin yanzu suna nazarin rawar da colchicine ke takawa wajen rage kumburi da rikitarwa na huhu a cikin marasa lafiya da ke da alamun COVID-19.
Wannan binciken, wanda ake kira COLCORONA, yana shiga cikin manya 6000 masu shekaru 40 da haihuwa tare da ganewar asali na COVID-19 da alamun bayyanar cututtuka waɗanda ba sa buƙatar asibiti.
Mata masu ciki, masu shayarwa ko kuma waɗanda ba su da maganin hana haihuwa na iya cancanta.
Ana gwada wasu magungunan hana jini a Italiya.
Ana amfani da ƙananan nauyin kwayoyin halitta na heparin a yawancin mutane don magance marasa lafiya, kuma haka Hukumar Magunguna ta Italiya ta wallafa jagororin amfani da shi.
A ranar 14 ga Afrilu, an sanar da wani bincike mai yawa a Italiya da ya shafi marasa lafiya 300 da ke bincika amfani da sodium enoxaparin a allurai masu hanawa da kuma magani.
Tun da SARS-CoV-2 kwayar cuta ce, masana kimiyya suna mai da hankali sosai ga sake amfani da magungunan rigakafin cutar da aka haɓaka don barkewar cutar SROM, SRAG da West Nile.
Ribavirin: An bada shawarar ribavirin don maganin COVID-19 bisa ga fitowar 7 na jagororin kasar Sin
Umifenovir: an bada shawarar umifenovir don maganin COVID-19 bisa ga tsarin ƙa'idodin kasar Sin na 7.
Ga wasu magunguna da aka gano don yiwuwar sake daidaitawa don maganin COVID-19:
Tocilizumab (yana toshe IL-6) mai karɓa: an amince da shi a kasar Sin.
{NS}
b'Alurar rigakafin COVID-19 allurar rigakafin cutar coronavirus 2019 (COVID-19) ce.
Ko da yake babu wani magani da ya kammala gwajin asibiti, ana ƙoƙari sosai a ci gaba da yin maganin.
A karshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin za a samu allurar rigakafin cutar SARS-CoV-2, cutar da ke haddasa cutar, a cikin watanni 18 ba.
A watan Afrilu, ana gudanar da bincike na farko na rigakafin guda biyar.
An gano COVID-19 a watan Disambar 2019.
Wani babban yaduwar cutar ya bazu a duniya a shekarar 2020, wanda ya haifar da saka hannun jari mai yawa da kuma ayyukan bincike don haɓaka allurar rigakafi.
Yawancin kungiyoyi suna amfani da bayanan da aka buga don samar da alluran rigakafin SARS-CoV-2.
An kafa shi a watan Afrilu, bukatun shirin CEPI na samar da allurar rigakafi sune saurin gudu, iya samarwa, aiwatarwa a sikelin, da samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun ruwaito cewa ana bincike da bunkasa dandamali daban-daban 10 a farkon shekarar 2020 don samar da allurar rigakafin COVID-19.
Daga cikin manyan dandamali da suka koma ga binciken tsaro na mataki na 1 akwai:
nucleic acid (DNA da RNA) (mai haɓaka mataki na I da yiwuwar allurar rigakafi: Moderna, mRNA-1273)
mai ɗaukar hoto (mai haɓaka mataki na I da yiwuwar allurar: CanSino Biologics, mai ɗaukar hoto na adenovirus nau'i 5)
Kamar yadda masana kimiyya na CEPI suka ruwaito a watan Afrilu, a total, allurai 115 na yiwuwar allurai suna cikin matakai na farko na ci gaba, 78 daga cikinsu an tabbatar da su a cikin ayyukan aiki (79, a cewar Cibiyar Milken) da sauran 37 an sanar da su, amma tare da ƙarancin bayanai da ake samu (ana tsammanin ana shirin ko ci gaba).
A Phase I ko Phase II gwajin yana gudanar da gwaji na farko na aminci da rigakafi, yawanci bazuwar ne, ana sarrafa shi ta hanyar placebo kuma ana gudanar da shi a wurare dabam dabam, yayin da yake ƙayyade ƙarin madaidaicin da kuma tasiri.
A cikin gwaji na mataki na uku, yawanci ana samun ƙarin masu halarta, ciki har da ƙungiyar kulawa, kuma ana tantance tasirin allurar rigakafin cutar, yayin da ake sarrafa tasirin da ke faruwa a lokacin da aka ba da mafi kyawun sashi.
Daga cikin alluran rigakafi 79 da ke ci gaba da aiki (wanda aka tabbatar a farkon Afrilu 2020), 74 har yanzu ba su cikin kimantawa a cikin mutane ba (suna ci gaba da bincike na 'kwararrun').
A ranar 24 ga Janairu, 2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana bincike kan yiwuwar allurar rigakafin da ke da ƙwayoyin cuta wanda zai iya canza kwayoyin cutar ta hanyar kwayoyin halitta don haɓaka rigakafin rigakafi.
A ranar 24 ga Janairu, 2020 a Kanada, Cibiyar Vaccine ta Duniya (VIDO-InterVac) ta Jami'ar Saskatchewan ta sanar da fara aikin allurar rigakafi kuma tana sa ran gwajin a cikin mutane zai fara a 2021.
An sanar da ayyukan ci gaban alluran rigakafi a Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta China a ranar 26 ga Janairu, 2020 da Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanonin Magunguna na Janssen, karkashin Hanneke Schuitemaker, sun sanar da cewa sun fara samar da allurar rigakafi.
Janssen yana aiki tare da abokin aikinsa na fasaha, Vaxart, wajen samar da allurar baki.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwa tare da Vaxart don haɓaka allurar.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya wallafa takarda da ke dauke da zane don allurar rigakafi da ke da fasaha irin ta da ake amfani da ita wajen maganin allurar cutar kansa.
A ranar 25 ga watan Maris, shugaban cibiyar bincike ya sanar da cewa sun kammala hada-hadar allurar kuma suna fara gwaji.
A ranar 27 ga Fabrairu, 2020, wani reshen Generex, NuGenerex Immuno-Oncology, ya sanar da cewa yana fara aikin ƙirƙirar allurar peptides li-key na COVID-19.
Sun so su samar da wata allurar rigakafi da za a iya gwadawa a kan mutane "a cikin kwanaki 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da ayyukanta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Rundunar Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta shiga Novavax Inc.
a wajen samar da rigakafi.
Abokan hulɗa sun kuma sanar da shirye-shirye don gwajin asibiti da gwajin asibiti na lokaci na farko a watan Yuli na 2020.
A ranar 12 ga watan Maris na shekarar 2020, ma'aikatar lafiya ta Indiya ta sanar da cewa tana aiki da masu zaman kansu 11 kuma ko da yake tana ci gaba da sauri, zai dauki aƙalla shekara ɗaya da rabi zuwa shekaru biyu don samar da allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin kere kere a birnin Quebec, Quebec, ya ba da rahoton ci gaban wani abu mai kama da coronavirus tare da wani ɓangare na kudaden shiga daga Cibiyoyin Nazarin Lafiya na Kanada.
Ana sa ran gwajin a jikin mutum zai fara a watan Yuli ko Agusta na shekarar 2020.
A baya a wannan makon, jaridar The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba CureVac "'babban kudade domin samun damar yin amfani da allurar rigakafin COVID-19", wanda gwamnatin Jamus ta koka a kai.
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin da ke dogara da mRNA.
A halin yanzu ana gudanar da gwaje-gwajen farko na yiwuwar allurar ta hanyar RNAm BNT162, kuma ana sa ran gwajin gwaji zai fara a watan Afrilu na 2020.
A Italiya, a ranar 17 ga Maris, 2020, Takis Biotech, wani kamfanin kimiyyar halittu na Italiya, ya sanar da cewa zai sami sakamakon gwajin farko a watan Afrilu na 2020 kuma gwajin mutum na yiwuwar allurar ƙarshe na iya farawa a kaka.
A Faransa, a ranar 19 ga Maris, 2020, Coalition for Innovations in Epidemic Preparation (CEPI) ta sanar da saka hannun jari na dala miliyan 4.9 a cikin haɗin gwiwar bincike na allurar rigakafin COVID-19 wanda ya haɗa da Institut Pasteur, Themis Bioscience (Vienna, Austria) da Jami'ar Pittsburgh, wanda ya kawo jimlar saka hannun jari na CEPI don haɓaka allurar rigakafin COVID-19 zuwa dala miliyan 29.
Sauran abokan haɗin gwiwar CEPI don haɓaka allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi na alluran rigakafi shida.
Masu binciken Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris, 2020 cewa suna haɓaka allurar RNA tare da karɓar kansa akan COVID-19.
An samu yiwuwar yin allurar riga-kafi a cikin kwanaki 14 bayan an samu jerin daga kasar Sin.
A ƙarshen Maris, Gwamnatin Kanada ta ba da sanarwar samun kuɗi na CAD miliyan 275 don ayyukan bincike 96 kan matakan likita don magance COVID-19, wanda ya haɗa da tarin alluran rigakafi a kamfanoni da jami'o'in Kanada, kamar ayyukan Medicago da Jami'ar Saskatchewan.
A daidai wannan lokaci, Gwamnatin Kanada ta sanar da amfani da CAD miliyan 192 musamman don haɓaka allurar rigakafin COVID-19, tare da shirye-shiryen ƙirƙirar "bank na allurar rigakafi" tare da sabbin alluran rigakafi da yawa waɗanda za a iya amfani da su idan wani barkewar cutar coronavirus ta faru.
A ranar 2 ga Afrilu, 2020, masu binciken Kwalejin Likitancin Jami'ar Pittsburgh sun sanar da gwajin PittCoVacc, yiwuwar allurar rigakafin COVID-19, a cikin beraye kuma sun ce " alluran SARS-CoV-2 na S1 da MNA ta gudanar sun sami amsa mai ƙarfi daga takamaiman antibodies na antigens (a cikin beraye) waɗanda suka bayyana makonni biyu bayan allurar".
A Kanada, a ranar 16 ga Afrilu, 2020, Kwalejin Magunguna ta Jami'ar Waterloo ta sanar da ƙirar yiwuwar allurar rigakafin DNA a matsayin mai yiwuwa sprayer na hanci.
Ta amfani da kwayoyin cuta, za a sanya DNA don yin kwafi a cikin kwayar mutum kuma ya samar da ƙwayoyin da ba su da lahani kamar cutar, wanda zai iya motsa tsarin garkuwar jiki don samar da rigakafi ga cutar SARS-CoV-2.
A watan Maris na 2020, Gwamnati, masana'antu da jami'o'i uku na Amurka sun haɗu da albarkatu don samun damar manyan kwamfutocin IBM, tare da albarkatun kwamfuta na girgije na Hewlett Packard Enterprise, Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da sakamako marar kyau.
Hakan yana nufin cewa za su iya amfana fiye da cututtukan da suke hanawa.
Wani gwaji a Ostiraliya ya yi da'awar cewa za a yi wa ma'aikatan kiwon lafiya 4,170 rajista.
Alurar riga kafi da ake ci gaba da samarwa ba za su iya zama lafiya ko tasiri ba.
Binciken farko don kimanta ingancin alluran rigakafi tare da takamaiman samfurin dabba na COVID-19, kamar linzamin kwamfuta mai canzawa wanda ke bayyana ECA2, sauran dabbobi na dakin gwaje-gwaje da primates waɗanda ba mutane ba, ya nuna buƙatar samun matakan hana lafiyar jiki na matakin 3 don sarrafa ƙwayoyin cuta masu rai da kuma daidaitawar ƙasa da ƙasa don tabbatar da hanyoyin aminci na daidaitawa.
An gwada alluran rigakafin SRAG da SROM a kan samfurin dabba ba na mutum ba.
A shekarar 2020, babu magani ko allurar rigakafi da ke kare mutane daga SRAG da ta tabbatar da cewa tana da lafiya da tasiri a cikin mutane.
Bisa ga wallafe-wallafen bincike na 2005 zuwa 2006, ganowa da kuma samar da sababbin alluran rigakafi da magunguna don magance SRAG ya kasance fifiko ga gwamnatoci da hukumomin kiwon lafiya na jama'a a duniya.
Lokacin da SROM ya zama gama gari, an yi imanin cewa binciken da ake yi game da SRAG zai iya zama samfurin da zai taimaka wajen haɓaka alluran rigakafi da magani na kamuwa da cutar MERS-CoV.
A watan Maris na shekarar 2020, an kammala gwajin gwaji na farko na SARS (wanda ya danganci DNA) a cikin mutane, kuma an ci gaba da yin gwaji na uku, dukansu alluran rigakafin masu cutar ne, biyu na adenoviral (ChAdOx1-MERS, BVRS-GamVac) da kuma na MVA (MVA-MERS-S).
Shafukan sada zumunta sun gabatar da ka'idar ta'addanci cewa an san cutar COVID-19 kuma an riga an sami allurar rigakafi.
Patents da wasu kafofin watsa labarun suka ambata sun shafi patents na asali da kuma alluran rigakafi don wasu nau'ikan coronavirus, kamar SRAG coronavirus.
b'Cutar coronavirus ta 2019 (COVID-19) cuta ce mai kamuwa da cuta ta coronavirus na cutar ta numfashi mai tsanani 2 (SARS-CoV-2).
Alamomin da aka fi sani sun haɗa da zazzabi, tari da kuma wahalar numfashi.
Sauran alamun sun haɗa da gajiya, ciwon tsoka, fitsari, ciwon wuya, rashin wari, da ciwon ciki.
Lokaci tsakanin bayyanar cututtuka da bayyanar cututtuka yana da kwanaki biyar, amma zai iya bambanta daga kwana biyu zuwa goma sha huɗu.
Ko da yake yawancin cututtuka suna da sauƙi, wasu suna ci gaba da kamuwa da cutar huhu da kuma rashin aiki da yawa.
A ranar 17 ga Afrilu, 2020, an ba da rahoton fiye da miliyan 2.24 na kamuwa da cutar a ƙasashe da yankuna 210 tare da mutuwar sama da 153,000.
Fiye da mutane 568,000 ne suka warke, kuma cutar tana yaduwa tsakanin mutane a lokacin da suka yi kusa da juna, yawanci ta hanyar saukad da jini da suke faruwa sa'ad da suke tari ko suna taho ko kuma suna magana.
Ko da yake waɗannan saukad da suna faruwa ne a lokacin numfashi, yawanci suna fāɗa a ƙasa ko a saman ƙasa, maimakon su zama masu yaduwa a nesa mai nisa.
Mutane za su iya kamuwa da cutar ta hanyar taɓa wani gurɓataccen wuri kuma su taɓa idanunsu, hanci ko bakinsu.
Kwayar cutar za ta iya tsira a saman ƙasa har tsawon sa'o'i 72.
Yana da matukar damuwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, ko da yake yaduwar yana yiwuwa kafin bayyanar cututtuka da kuma a cikin matakan da suka gabata na cutar.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda suka yi zaton suna da cutar da kuma masu kula da su.
Wasu hukumomi sun ba da shawarar kada a yi amfani da su, wasu sun ba da shawarar yin amfani da su, wasu kuma sun bukaci yin amfani da su.
A halin yanzu babu allurar rigakafi ko maganin rigakafin cutar COVID-19.
An samu karuwar cutar a gida a mafi yawan ƙasashe a cikin yankuna shida na WHO.
Waɗanda suka kamu da cutar za su iya zama marasa bayyanar cututtuka ko kuma su nuna alamun da suka yi kama da na mura, kamar zazzabi, tari, gajiya da kuma wahalar numfashi.
Alamun gaggawa sun haɗa da wahalar numfashi, ciwo ko ciwon kirji na yau da kullun, rikicewa, wahalar tafiya da fuska ko lebe masu launin shuɗi. Idan waɗannan alamun sun bayyana, ana ba da shawarar neman likita nan da nan.
Ba a yawan ganin alamun a cikin hanyoyin numfashi na sama ba, kamar su taurin kai, numfashi da ciwon wuya.
An gano alamun gastrointestinal, kamar nausy, vomiting, da kuma diarrhea, a cikin yawan adadin.
Wasu mutane a kasar Sin sun fara samun ciwon kirji da kuma bugun jini.
A wasu, cutar ta ci gaba zuwa ciwon huhu, rashin aiki da yawa, da kuma mutuwa.
Wannan shi ne lokacin yin amfani da shi.
Lokacin yin amfani da COVID-19 yawanci kwanaki biyar zuwa shida ne, amma zai iya bambanta daga kwana biyu zuwa goma sha huɗu.
Kashi 97.5 cikin 100 na mutanen da suke da alamun cutar sun yi hakan a cikin kwanaki 11.5 bayan kamuwa da cutar.
Ba a san cikakken matsayin waɗannan masu ɗaukar alamun ba tukuna; duk da haka, shaidar farko ta nuna cewa suna iya taimakawa wajen yada cutar.
A halin yanzu ba a san adadin mutanen da suka kamu da cutar ba kuma ana nazarin su. Cibiyoyin Kula da Cututtuka da Rigakafin Cutar Koriya (KCDC) sun ruwaito cewa kashi 20 cikin dari na wadanda aka tabbatar da cutar sun kasance marasa alamun cutar yayin da suke asibiti.
Hukumar Lafiya ta kasar Sin ta fara hada marasa alamar cututtuka a cikin cututtuka na yau da kullum a ranar 1 ga Afrilu. Daga cikin cututtuka 166 da aka samu a wannan rana, 130 (78%) sun kasance marasa alamar cututtuka a lokacin da aka yi gwajin.
Ƙarƙashin ƙanƙara da saliva suna iya samun manyan ƙwayoyin cuta.
Yin magana da babbar murya yana fitar da ƙarin digo fiye da yadda ake yin magana da sautin sauti.
Wani bincike a Singapore ya gano cewa idan ba a rufe bakinka ba sa'ad da kake tari, za ka iya yin tafiya da ƙafa 15 zuwa ƙafa 15.
Ko da yake cutar ba ta yaduwa ta iska ba ce, amma Kungiyar Kimiyya ta Kasa ta ce za a iya yaduwa ta hanyar amfani da kwayoyin halitta kuma ta bayyana cewa masu karɓar iska a cikin kwandon da ke wajen dakunan kwana sun nuna cutar ta RNA.
Wasu hanyoyin likita kamar su intubation da kuma karyar zuciya da huhu (CPR) na iya haifar da aerosol na numfashi da kuma, sakamakon haka, watsawa ta iska.
Ko da yake akwai damuwa game da yiwuwar yaduwar ta cikin fitsari, ana ganin cewa haɗarin yana da ƙasa. Kwayar cutar tana da haɗari sosai lokacin da mutane ke da alamun; ko da yake yaduwar tana yiwuwa kafin bayyanar cututtuka, haɗarin yana da ƙasa.
Cibiyar Tsare-tsare ta Turai don Hana Cututtuka da Kuma Kula da Su (ECDC) ta bayyana cewa ko da yake ba a san yadda za a iya samunsa ba, mutum ɗaya yakan kamu da mutum biyu ko uku.
Musamman, an gano cutar a cikin kwana ɗaya a cikin kwali, har zuwa kwana uku a cikin filastik (polypropylene) da bakin karfe (AISI 304), har zuwa sa'o'i huɗu a cikin kayayyakin da ke da kashi 99 cikin dari na jan ƙarfe.
Amma, wannan ya bambanta bisa ga yanayin zafi da kuma yanayin zafi.
Sabulu da kuma wankewa suna da tasiri idan aka yi amfani da su yadda ya kamata. Samfurori na sabulu suna lalata ƙwayar ƙwayar ƙwayar ƙwayar cuta kuma suna kashe shi, ban da cire shi daga fata da sauran farfajiya.
Wasu hanyoyin da ba su da tasiri sosai kamar su benzalkonium chloride da chlorhexidine glucanate (abin da ke hana cutar a tiyata). A wani bincike a Hong Kong, an yi amfani da saliva a matsakaici kwanaki biyu bayan da aka soma asibiti.
A cikin mutum biyar daga cikin mutum shida, samfurin farko ya fi yawan ƙwayar cuta. A cikin mutum na shida, an lura da mafi yawan ƙwayar cuta a rana ta biyu ta gwaji.
Cutar coronavirus ta cutar ta numfashi mai tsanani 2 (SARS-CoV-2) sabon coronavirus ne na cutar numfashi mai tsanani, wanda aka fara ware shi daga mutane uku da ke fama da cutar huhu da ke hade da wata ƙungiya ta cututtukan numfashi a Wuhan.
Dukkanin siffofin sabon kwayar SARS-CoV-2 ana samun su ne a cikin coronavirus na irin wannan yanayi.
A waje da jikin mutum, sabulu na gida yana kashe kwayar cutar, saboda yana lalata kumburinta mai kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
Fushi ne gabobin da COVID-19 ya fi shafa, saboda cutar ta shiga cikin ƙwayoyin mai masaukin baki ta hanyar enzyme mai canzawa na angiotensin I nau'in 2 (ECA2), wanda ya fi yawa a cikin ƙwayoyin alveolar nau'in II na huhu.
Kwayar cutar tana amfani da wani glycoprotein na musamman da ake kira "specilla" (peplomer) don haɗawa da ECA2 kuma ya shiga cikin tantanin halitta.
Kashi 12 cikin 100 na mutanen da suka kamu da cutar da aka kwantar a birnin Wuhan na kasar Sin sun sami rauni mai tsanani na zuciya, wanda ya fi yawa a cikin cututtuka masu tsanani.
Yawan cututtukan zuciya suna da yawa saboda amsawar kumburi da kuma rashin lafiyar tsarin garkuwar jiki a yayin da cutar ke ci gaba, amma rauni na zuciya na iya kasancewa yana da alaƙa da ECA2 masu karɓa a zuciya.
ECA2 masu karɓa suna da babban magana a zuciya kuma suna da hannu wajen aiki.
An gano yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttuk
Ko da yake SARS-COV-2 yana da tropism ta ƙwayoyin epithelial da ke bayyana ECA2 na hanyoyin numfashi, marasa lafiya da ke fama da COVID-19 suna da alamun ciwon hanta.
Musamman, an lura cewa kwayoyin cutar GM-CSF masu ɓoye T suna da alaƙa da karɓar kwayoyin IL-6 masu ɓoye guda ɗaya da kuma mummunan cututtukan huhu a cikin marasa lafiya da COVID-19.
A lokacin da aka yi autopsies, an kuma samu rahoton wasu 'yan'uwa da suka yi amfani da kwayoyin halitta.
Hukumar ta WHO ta wallafa wasu hanyoyin gwaji don gano cutar.
Hanyar gwaji ta yau da kullum ita ce polymerase chain reaction tare da ainihin lokacin reverse transcription (rRT-PCR).
Ana yin gwajin ne a kan samfurori na numfashi da aka samu ta hanyar nasopharyngeal hypophad; duk da haka, ana iya amfani da samfurori na nasal hypophad ko sputum.
A yawancin lokaci, ana samun sakamako a cikin sa'o'i ko kwanaki biyu.
Ana iya yin gwajin jini, amma sai a ɗauki jini biyu da suka yi mako biyu a tsakanin juna kuma sakamakon ba shi da muhimmanci sosai.
Masana kimiyya na kasar Sin sun samu nasarar ware kwayar cutar coronavirus kuma sun wallafa tsarin kwayoyin halitta don dakunan gwaje-gwaje na duniya su iya ci gaba da gwajin polymerase chain reaction (PCR) da kansu don gano kamuwa da cutar.
A ranar 4 ga Afrilu, 2020, ana ci gaba da gwajin rigakafi (wanda zai iya gano kamuwa da cuta mai aiki da kuma idan mutum ya kamu da cutar a baya) amma ba a amfani da su sosai.
Gwajin da aka yi a kasar Sin ya nuna cewa daidaito ya kai kashi 60 zuwa 70 cikin 100.
Hukumar kula da lafiya ta Amurka ta amince da gwajin bincike na farko a ranar 21 ga Maris, 2020 don amfani da shi a ƙarshen wannan watan. Jagororin bincike da asibitin Zhongnan na Jami'ar Wuhan ya wallafa sun ba da shawarar hanyoyin gano kamuwa da cuta bisa ga halaye na asibiti da haɗarin annoba.
Abubuwan da ke cikin gilashin da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da aka yi da a da a da aka yi da a da aka yi da aka yi da a da aka yi da da aka yi da aka yi da da da aka yi da aka yi da da aka yi da da da aka yi da da da aka yi da da da aka yi da da aka yi da da da aka yi da aka yi da da da da aka yi da da da da da aka yi da da da da da da aka yi da aka yi da da da da aka yi da da da aka yi da da da da da da da aka yi da da da da da da da aka yi da da da da da da da da da da da da aka yi da da da da da da da da da da da da da da da aka yi da da da da da da da da da da da aka yi da da da da da da aka yi da da da da da da da da da da da da da da aka yi da da da da da aka yi da da da da da
Yayin da cutar ta ci gaba, za a iya samun tsarin subpleural, tsarin da ba a daidaita ba (sashin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta tare da cika alveolar mai canji) da kuma ƙarfafawa.
Akwai bayanai kadan game da cutar ta cutar COVID-19 da kuma cututtukan jiki.
Babban sakamakon cututtuka na autopsies sune:
Macroscopy: pleuritis, pericarditis, ƙwayar huhu da kuma kumburi na huhu
Ana iya lura da nau'i hudu na cutar huhu:
ƙananan huhu: kumburi na huhu, ƙwayar huhu mai yawa, ƙananan ƙwayar huhu, kumburi mai yawa, kumburi na tsakanin da ke shiga cikin lymphocytes da kuma samar da ƙwayoyin cuta masu yawa
mummunan cutar huhu: lalacewar alveolar da ta bazu (DAD) tare da ɓarkewar alveolar da ta bazu.
DAD yana haifar da ciwon hankula na numfashi (SDRA) da kuma rashin ƙarfi mai tsanani.
cututtukan huhu masu warkarwa: shirya exudate a cikin rami na alveolar da kuma pulmonary interstitial fibrosis
Jini: Ƙarƙashin jini mai yaduwa (CID); ƙwayar cutar leukerotrophic
Abubuwan da za a iya yi don rage yiwuwar kamuwa da cuta sun haɗa da kasancewa a gida, guje wa wuraren da mutane da yawa suke, wanke hannuwanka da ruwa da sabulu sau da yawa na akalla sakan 20, kiyaye tsabtace numfashi da kuma guje wa taɓa idanu, hanci ko baki ba tare da wanke hannu ba.
Hukumar kula da lafiyar jiki ta ce a rufe bakinka da hancinka da tawul sa'ad da kake tari ko kuma kana tafin jiki, kuma idan ba ka da tawul, ka yi amfani da ciki na kugu.
Ana bada shawara a tsabtace hannayenka sosai bayan ka yi tari ko ka yi ta hurawa.
Hukumar ta CDC ta ba da shawarar yin amfani da murfin masana'anta a wuraren jama'a, daya daga cikin dalilan shi ne rage watsawa daga mutanen da ba su da alamun cutar. Dabarun nisantar zamantakewa suna neman rage hulɗa da mutanen da suka kamu da cutar da manyan kungiyoyi ta hanyar rufe makarantu da wuraren aiki, taƙaita tafiye-tafiye da soke taron jama'a da yawa.
Dokokin nesa kuma sun ce mutane su kasance a nesa da ƙafa 6 (1.8 m).
Babu wani magani mai tasiri don hana COVID-19. Kamar yadda ba a tsammanin akwai allurar rigakafi har zuwa 2021, a cikin gaggawa, wani muhimmin ɓangare na sarrafa COVID-19 shine ƙoƙarin hana ƙaruwar annobar, wanda ake kira "shirya layin".
Cibiyar kula da cututtuka ta CDC ta kuma ba da shawarar yin wanka a kai a kai da ruwa da sabulu na akalla na tsawon dakika 20, musamman bayan ka je gidan wanka ko kuma idan hannunka suna da tsabta a bayyane, kafin ka ci abinci da kuma bayan ka yi ta hanci, ka yi tari ko ka yi ta hurawa.
Suna kuma ba da shawarar yin amfani da maganin hana shan maganin hana shan maganin hana shan magani da aka yi amfani da shi wanda ya ƙunshi aƙalla kashi 60 cikin ɗari na giya, amma kawai idan babu ruwa da sabulu a lokacin.
A cikin waɗannan maganganun, maganin antimicrobial yana samuwa ne daga ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don kawar da ƙwayoyin cuta a cikin giya; "ba abu ne mai aiki ba don maganin maganin hannayen hannu".
Ana ƙara glycerol a matsayin mai ƙonawa.
Ana kula da marasa lafiya da taimako, wanda zai iya haɗa da sake samun ruwa, maganin oxygen, da kuma kula da sauran gabobin da suka shafi rayuwa.
Hukumar kula da cututtuka ta Amurka ta ba da shawarar cewa duk wanda ya yi zaton yana da cutar ya yi amfani da abin rufe fuska mai sauƙi.
An yi amfani da Oxygenation by Extracorporeal Membrane (OMEC) wajen magance matsalar rashin numfashi, amma ana nazarin amfanin.
Don a taimaka wa mutum ya kasance da 'yancin yin rigakafi, an ba da shawarar yin tsabta da kuma yin rayuwa mai kyau da kuma cin abinci mai kyau.
Maganin tallafi na iya zama da amfani ga waɗanda ke da alamun bayyanar cututtuka a farkon matakin kamuwa da cutar. WHO da Hukumar Lafiya ta Kasa ta China sun fitar da shawarwari don kula da mutanen da ke asibiti da COVID-19.
Masu aikin gaggawa da masu ilimin huhu a Amirka sun tattara shawarwarin da hukumomi da yawa suka bayar a cikin wani kayan aiki kyauta, wato, IBCC.
A watan Afrilu na shekarar 2020, babu takamaiman magani ga COVID-19.
Don maganin farko na bayyanar cututtuka, wasu likitoci suna ba da shawarar parecetamol (acetaminophen), maimakon ibuprofen.
Ya kamata a yi la'akari da yadda za a rage haɗarin watsa kwayar cutar, musamman a wuraren kula da lafiya lokacin da ake gudanar da hanyoyin da za su iya haifar da aerosols, kamar su intubation ko iska ta hannu.
CDC ta ba da shawarar cewa masu kula da kiwon lafiya da ke kula da mutanen da ke da COVID-19 su sanya mai haƙuri a cikin yankin keɓewar kamuwa da cutar ta iska (AIIR), ban da amfani da daidaitattun matakan tsaro, matakan tuntuɓar da kuma matakan kiyayewa don kauce wa watsawa ta iska.
Kayan da aka ba da shawarar su ne rigar EPP, mask, tabarau masu kariya da safofin hannu na likita.
An amince da N95 masks don yanayin masana'antu, amma FDA ta ba da izinin amfani da su ta hanyar izinin gaggawa (USA).
An tsara su don kare su daga ƙwayoyin da ke cikin iska, kamar foda, amma ba a ba da tabbacin ingancin su ga wani takamaiman wakili na halitta wanda ba a bayyana a cikin bayanin samfurin ba.
Idan babu masks, CDC ta ba da shawarar yin amfani da masks masu kariya ko, a matsayin mafita, masks na gida.
Yawancin shari'o'in COVID-19 ba su da tsanani sosai don buƙatar iska ta inji ko madadin, amma kashi ɗaya cikin ɗari na shari'o'in suna da tsanani.
Ana nazarin irin wannan taimakon numfashi ga mutanen da ke asibiti da rashin numfashi da ke da alaƙa da COVIDA-19 kuma an riga an sami wasu shaidu cewa ana iya kauce wa intubation tare da babban canon hanci ko kuma bugun jini mai kyau a cikin hanyoyin numfashi.
Har yanzu ba a san ko kowanne daga cikin waɗannan biyu yana ba da amfanin iri ɗaya ga mutanen da ke cikin mawuyacin hali ba.
Wasu likitoci sun fi son yin amfani da iska mai iska mai iska lokacin da yake samuwa saboda wannan fasaha ta iyakance yaduwar ƙwayoyin aerosol idan aka kwatanta da ƙwayoyin hanci masu tsayi.
Kasashe da yawa da suka ci gaba ba su da isasshen gadaje a asibitoci, wanda ke iyakance ikon tsarin kiwon lafiya don sarrafa ƙaruwar gaggawa na manyan shari'o'in COVID-19 da ke buƙatar asibiti.
Wani bincike a ƙasar Sin ya gano cewa kashi 5 cikin 100 sun shiga cibiyar kula da marasa lafiya, kashi 2.3 cikin 100 sun bukaci taimakon iska, kuma kashi 1.4 cikin 100 sun mutu.
A kasar Sin, kimanin kashi 30 cikin dari na mutanen da aka kwantar da su asibiti da cutar COVID-19 a ƙarshe an tura su zuwa ICU.
Fitar da iska ta inji tana da rikitarwa idan mai cutar COVID-19 ya sami ciwon hankulan numfashi mai tsanani (SDRA) kuma oxygenation yana da wuya.
Ana bukatar masu numfashi da ke da hanyoyi daban-daban na kula da matsa lamba da PPTE don ƙara yawan iskar oxygen, yayin rage haɗarin cutar huhu da ke tattare da numfashi da huhu.
Tsoffin masu numfashi ba su da PPTE mai girma.
Bincike game da yiwuwar maganin ya fara ne a watan Janairun 2020 kuma ana gudanar da gwaji na asibiti kan magungunan rigakafin cutar da dama.
Remsivir ya zama mafi al'ajabi.
Ko da yake ci gaban sababbin magunguna na iya ɗaukar lokaci har zuwa 2021, wasu magunguna da ake gwadawa sun riga an amince da su don wasu amfani ko kuma suna cikin gwaji na ci gaba.
Ana iya gwada magungunan rigakafi a kan waɗanda suke da ciwon da ya fi tsanani.
Hukumar ta ba da izini na wucin gadi ga plasma na convalescents a matsayin magani na gwaji a lokuta inda rayuwar mutum ke cikin haɗari mai tsanani da nan take.
Ba a yi gwajin asibiti ba don tabbatar da cewa yana da lafiya da tasiri ga wani cuta.
A watan Fabrairun shekarar 2020, kasar Sin ta kaddamar da wani aikace-aikacen wayar hannu don magance barkewar cutar.
Dole ne masu amfani su shigar da sunayensu da lambar ID.
Aikace-aikacen zai iya gano 'tausayi mai kusanci' kuma, saboda haka, yiwuwar kamuwa da cuta ta hanyar bayanan sa ido.
Kowane mai amfani zai iya lura da yanayin wasu masu amfani uku.
Idan aka gano wani hadari, ba wai kawai aikace-aikacen yana ba da shawarar yin iyaka ba, amma kuma yana faɗakar da jami'an lafiya na gida. Ana amfani da nazarin bayanai na wayar hannu, fasahar gano fuska, bin diddigin wayoyin hannu, da kuma ilimin kere-kere don bin diddigin mutanen da suka kamu da cutar da waɗanda suka yi hulɗa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba hukumomin tsaro damar bin diddigin wayar salula na mutanen da ake zargi da cutar coronavirus.
An dauki wannan matakin ne don karfafa killacewa da kare wadanda zasu iya tuntuɓar 'yan ƙasa da suka kamu.
A watan Maris na shekarar 2020, kamfanin Deutsche Telekom ya raba bayanan da aka taƙaita game da inda wayoyin ke da alaka da hukumar gwamnatin tarayya ta Jamus, Cibiyar Robert Koch, don bincike da hana yaduwar cutar.
Rasha ta tura fasahar gano fuska don gano rashin bin dokar killacewa.
Kwamishinan kiwon lafiya na yankin Giulio Gallera ya ce masu amfani da wayar hannu sun sanar da shi cewa "a kowane hali, kashi 40 cikin dari na mutane suna ci gaba da yin tafiya".
Gwamnatin Jamus ta gudanar da wani hackathon na tsawon sa'o'i 48 a karshen mako tare da fiye da mutane 42,000.
Bugu da kari, shugaban Estonia, Kersti Kaljulaid, ya yi bukatar neman hanyoyin samar da hanyoyin magance yaduwar cutar coronavirus a duniya.
Mutane za su iya jin tsoro game da zaman kansu a cikin gida, ƙuntatawa a kan tafiya, da kuma sakamakon maganin, ko kuma su ji tsoron kamuwa da cutar.
BBC ta yi ƙaulin Rory O'Connor: "Ƙara yawan warewar jama'a, kaɗaici, damuwa game da lafiya, damuwa da kuma matsalolin tattalin arziki babban hadari ne ga lafiyar mutum da kuma lafiyar jikinsa".
Cutar za ta iya ci gaba da sauƙi, ba tare da bayyanar cututtuka ba, don haka za ta zama kamar sauran cututtukan iska na sama, kamar sanyi.
A cikin mako biyu, ana samun sauƙi a cikin marasa lafiya masu tsanani, yayin da a cikin mako uku zuwa shida, ana iya samun sauƙi a cikin marasa lafiya masu tsanani.
Mata masu juna biyu na iya fuskantar haɗarin kamuwa da cutar COVID-19 mai tsanani, bisa ga bayanan wasu irin ƙwayoyin cuta, kamar SRAG da SROM, amma bayanan COVID-19 bai isa ba. A wasu mutane, COVID-19 na iya shafar huhu kuma ya haifar da huhu.
A cikin mafi tsanani, COVID-19 na iya ci gaba da sauri zuwa ciwon rashin numfashi na ruwa (SDRA) wanda ke haifar da rashin numfashi, bugun jini da rashin ƙarfi.
Abubuwan da ke tattare da COVID-19 sun haɗa da sepsis, lalata hawan jini da kuma cutar zuciya, koda da hanta.
An lura da matsalar hawan jini, musamman karuwar lokacin protombine, a kashi 6 cikin 100 na marasa lafiya da ke asibiti da COVID-19; yayin da aka lura da matsalar koda a kashi 4 cikin 100 na wannan rukunin.
Kimanin kashi 20 zuwa 30 cikin 100 na mutanen da ke da cutar COVID-19 suna da ƙwayoyin cuta na hanta (aminotransferases).
Rahoton ya nuna cewa matsakaicin lokacin da aka fara bayyanar cututtuka da mutuwa ya kai kwanaki goma, kuma kwana biyar aka yi a asibiti.
Amma, ga marasa lafiya da aka tura zuwa ICU, an yi matsakaicin kwanaki bakwai tsakanin saka su asibiti da mutuwa.
A cikin wani binciken da aka yi a cikin yara, matsakaicin lokaci daga bayyanar cututtuka na farko zuwa mutuwa ya kai kwanaki 14, tare da cikakken lokaci daga kwanaki 6 zuwa 41.
A wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin ta yi, an samu mace-mace da kashi 2.8 cikin dari a tsakanin maza da kuma 1.7 cikin dari a tsakanin mata.
Binciken da aka yi wa samfurori na huhu bayan mutuwa ya nuna lalacewar alveolar da ta taso a cikin huhu biyu.
An lura da canje-canje na cututtukan huhu na cutar.
Halin da aka yi a huhu ya yi kama da na rashin numfashi mai tsanani (SDRA).
A cikin kashi 11.8 cikin dari na mutuwar da Hukumar Lafiya ta kasar Sin ta bayar, cutar zuciya ta kasance sakamakon yawan yawan troponin ko kuma asarar zuciya.
A cewar bayanan watan Maris na Amirka, kashi 89 cikin 100 na mutanen da aka kwantar da su a asibiti suna da wani yanayin da suka riga sun kamu da shi.
Ƙididdigar mutuwar da ake samu daga cutar ta bambanta saboda bambancin yankuna, amma kuma saboda wahalar da ake samu ta hanyar yin aiki.
Ƙananan ƙididdigar ƙananan cututtuka na iya sa yawan mutuwa ya yi yawa.
Amma, gaskiyar cewa mutuwar ta zo ne daga wasu cututtuka na dā na iya nuna cewa adadin mutuwar da ake yi a yanzu ba shi da kyau.
Masu shan sigari sun fi samun alamun COVID-19 sau 1.4 da kuma kusan sau 2.4 da suka fi bukatar kulawa mai tsanani ko mutuwa fiye da wadanda ba sa shan sigari.
Hukumar asibitocin Hong Kong ta gano raguwar kashi 20 zuwa 30 cikin 100 na ƙarfin huhu a wasu mutanen da suka warke daga cutar, kuma hotunan huhu sun nuna cewa gabobin sun lalace.
Wannan kuma zai iya haifar da ciwon ciwon hankula bayan dawowa.
A watan Maris na shekarar 2020, ba a san ko cututtukan da suka gabata sun haifar da rigakafin dogon lokaci a cikin mutanen da suka warke daga cutar ba.
Da alama ana iya samun rigakafi, bisa ga halayyar wasu coronavirus, amma an bayar da rahoton samun nasarar COVID-19 wanda daga baya ya haifar da cutar coronavirus.
Ana ganin cewa waɗannan cututtukan sun fi muni daga kamuwa da cuta na kullum ba reinfection ba.
Ana ganin cewa wannan kwayar halitta ce kuma ta zo daga dabba, ta hanyar kamuwa da cutar interspecific.
Ba a san ainihin asalinsa ba, amma, a watan Disamba na 2019, yaduwar kamuwa da cuta kusan gaba ɗaya saboda watsa tsakanin mutane.
Wani binciken da aka yi na farkon mutane 41 da aka tabbatar da cutar COVID-19, wanda aka buga a watan Janairun 2020 a The Lancet, ya nuna cewa ranar farko da alamun cutar suka fara ne a ranar 1 ga Disamba, 2019.
Ofishin WHO ya bayyana cewa bayyanar cututtuka ta farko ta kasance a ranar 8 ga Disamba, 2019.
A yawancin lokaci, ana yin wasu matakai don a ƙayyade yawan mutuwa.
Wadannan adadi sun bambanta a yankuna da kuma tsawon lokaci, kuma suna shafar yawan gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokaci tun farkon barkewar cutar, da kuma halaye na yawan jama'a, kamar shekaru, jima'i da kuma lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambobin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan
Bisa ga kididdigar Jami'ar Johns Hopkins, yawan mutuwar duniya ya kai kashi 6.9 cikin dari (153 822/2 240 191) zuwa 17 ga Afrilu, 2020.
Sauran matakan sun haɗa da yawan mutuwar marasa lafiya da aka gano (CFR), wanda ke nuna yawan mutanen da aka gano da suka mutu daga cutar, da kuma yawan mutuwar mutane da suka kamu da cutar, wanda ke nuna yawan mutanen da suka kamu da cutar (tare da ko ba tare da ganewar asali ba) da suka mutu daga cutar.
Waɗannan kididdigar ba su dogara da lokaci ba kuma suna bin wani yanki na mutane daga kamuwa da cuta zuwa warwarewar shari'o'i.
Ko da yake ba dukan mutanen da suka kamu da cutar suke samar da rigakafi ba, kasancewa da su zai iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A tsakiyar annobar a Italiya, Castiglione d'Adda, wani ƙaramin gari mai yawan mazauna 4,600, 80 (1.7%) sun riga sun mutu.
A Gangelt, cutar ta yadu a lokacin bukukuwan carnival kuma ta shafi matasa, saboda haka akwai ƙananan mutuwar, kuma ba duk mutuwar COVID-19 ba ne aka sanya su a matsayin haka.
Bugu da ƙari, tsarin kiwon lafiya na Jamus bai yi nasara ba.
A ƙasar Netherlands, kusan kashi 3 cikin 100 na mutanen da ke da rigakafi sun samu daga masu ba da jini.
An tabbatar da cewa 69 (0,004%) na yawan jama'a sun mutu daga COVID-19.
Sakamakon annobar da kuma mutuwar mata sun bambanta ga maza da mata.
A cikin binciken da aka yi a kasar Sin da Italiya, mace-mace sun fi maza yawan mutuwa.
A cikin maza, haɗarin ya fi girma ga waɗanda suka kai shekara 50, kuma bambanci tsakanin maza da mata yana ƙaruwa ne kawai a cikin shekaru 90.
A kasar Sin, yawan mutuwar maza ya kai 2.8 a cikin maza, mata kuma ya kai 1.7 a cikin mata.
Ba a san ainihin dalilin da ya sa wannan bambancin ya faru ba, amma zai iya kasancewa saboda abubuwan da suka shafi al'ada da kuma hali.
Bambancin rigakafi bisa jinsi, ƙarancin yawan mata da suke shan sigari da kuma gaskiyar cewa maza suna da cututtukan da ke tattare da cutar, kamar hawan jini, a cikin yara na iya taimakawa wajen samun mafi yawan mutuwar maza.
A Turai, kashi 57 cikin 100 na mutanen da suka kamu da cutar maza ne kuma kashi 72 cikin 100 na waɗanda suka mutu daga COVID-19 maza ne.
A watan Afrilu na shekarar 2020, Gwamnatin Amurka ba ta gano wani abu game da jima'i a cikin kamuwa da cutar COVID-19 ba.
Bincike ya nuna cewa cututtuka na cuta kamar Ebola, HIV, mura da kuma SRAG suna shafan maza da mata a hanyoyi dabam dabam.
Yawancin ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne, kuma suna da mafi yawan haɗarin kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan hukuma na cutar zai zama "COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO na nufin corona, VI zuwa virus, D zuwa cuta da 19 zuwa ranar da aka gano barkewar cutar: 31 ga Disamba na 2019.
An zabi sunan don kauce wa ambaton wani wuri na musamman (misali, China), nau'in dabba ko rukuni na mutane, daidai da shawarwarin duniya a sama don hana lalata.
WHO ta yi amfani da "virus na COVID-19" da kuma "virus da ke da alhakin COVID-19" a cikin sadarwa ta jama'a.
Ana amfani da kalmar "coronavirus" don nufin cutar da kuma kwayar cutar.
A lokacin barkewar cutar a Wuhan, China, an saba yin magana game da cutar da cutar a matsayin "coronavirus" da "coronavirus na Wuhan".
A watan Janairun 2020, WHO ta ba da shawarar 2019-nCov da Ruwa na numfashi na ruwa don 2019-nCoV a matsayin sunaye na wucin gadi don kwayar cutar da cutar, daidai da alamar 2015 don kada a yi amfani da wurare a cikin sunan ƙwayoyin cuta da cututtuka.
An fitar da sunayen hukuma na COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda ƙuntatawa a cikin hanyoyin samar da kayayyaki, wasu masana'antun dijital suna buga kayan kiwon lafiya, kamar hanci da sassan numfashi.
Alal misali, sa'ad da asibiti a Italiya ya bukaci fanfunan numfashi da gaggawa kuma mai ba da kayayyaki bai iya ba da shi a lokacin da ya dace ba, wani kamfani a wurin ya yi aikin injiniya kuma ya buga fanfunan da ake bukata 100 a daren.
Bayan barkewar cutar COVID-19, ka'idodin makirci, bayanan karya da rashin fahimta game da asalin cutar, girmanta, rigakafi, magani da sauran fannoni sun bazu cikin sauri ta hanyar Intanet.
Da alama mutane na iya watsa kwayar cutar ga wasu dabbobi.
Binciken bai gano wata hujja ta kwayar cutar a cikin alade, ducks ko kaji ba.
Babu magani ko allurar rigakafi da aka amince da su don magance cutar.
Kungiyoyin gwamnati, kungiyoyin ilimi da masu bincike a bangaren suna gudanar da bincike na kasa da kasa kan alluran rigakafi da magunguna don COVID-19.
A watan Maris, Hukumar Lafiya ta Duniya ta fara "Tunanin Solidarity" don tantance tasirin maganin maganin rigakafin cutar guda huɗu da ke nan da suka fi yin alkawari a fannin inganci.
Babu allurar rigakafi, amma hukumomi da dama suna aiki sosai wajen samar da alluran rigakafi.
Ana amfani da aikin da aka yi a baya kan SARS-CoV saboda SARS-CoV da SARS-CoV-2 suna amfani da mai karɓar ECA2 don shiga cikin ƙwayoyin mutum.
Ana bincike kan dabarun rigakafi guda uku.
Da farko, masu bincike suna neman su samar da cikakken allurar rigakafin cutar.
Amfani da wannan kwayar cutar, ko ita ce mara aiki ko ta mutu, yana nufin samar da amsawar rigakafin jikin mutum cikin sauri ga sabon kamuwa da cutar COVID-19.
Hanyar biyu, wato allurar rigakafi, tana nufin samar da allurar rigakafi da za ta sa tsarin garkuwar mutum ya san wasu alluran cutar.
A cikin SARS-CoV-2, wannan binciken ya mai da hankali ne akan furotin S wanda ke taimakawa kwayar cutar ta shiga cikin mai karɓar ECA2.
Hanyar uku ita ce allurar rigakafin nucleic acid ( allurar rigakafin DNA ko RNA, sabuwar fasaha don ƙirƙirar allurar rigakafi).
Ya kamata a yi nazarin alluran gwaji na kowane ɗayan waɗannan dabarun don tantance amincin su da ingancinsu. A ranar 16 ga Maris, 2020, an fara gwajin asibiti na farko na allurar tare da masu sa kai huɗu a Seattle.
Alurar rigakafi tana dauke da kwafin kwayoyin halitta na kwayar cutar da ke haifar da cutar. An nuna cewa ingantawar antibody yana da ƙalubale ga ci gaban alluran rigakafin SARS-COV-2, amma wannan abu ne mai ban mamaki.
A watan Afrilu na shekarar 2020, akwai gwajin asibiti sama da 300.
Gwaje-gwaje bakwai sun yi la'akari da hanyoyin da aka riga aka amince da su don cutar zazzabi, ciki har da gwaje-gwaje hudu game da hydroxychloroquine ko chloroquine.
Ana yin bincike a kan magungunan rigakafin rigakafi da aka sake amfani da su a kasar Sin, wanda ya ƙunshi gwaji tara na mataki na III a kan remdesivir a ƙasashe da yawa, wanda ya kamata a ba da rahoto a ƙarshen Afrilu.
A watan Afrilu na shekarar 2020, ana gudanar da bincike mai zurfi kan ci gaban asibiti game da allurar rigakafi da kuma yiwuwar magungunan COVID-19. Ana tantance magungunan rigakafin cutar don magance COVID-19, gami da: remdesivir, chlorine da hydroxychloroquine, lopinavir/ritonavir da lopinavir/ritonavir a hade da interferon-beta.
A watan Maris na shekarar 2020, akwai hujjoji na gwaji game da ingancin remdesivir.
An samu ci gaba a asibiti a cikin marasa lafiya da aka yi amfani da remdesivir tare da tausayi.
Ana gudanar da gwaje-gwaje na III a Amurka, China da Italiya. An yi nazarin chloroquine, wanda a baya aka yi amfani da shi don magance malaria a China a watan Fabrairun 2020.
Duk da haka, ana neman a yi nazari da kai a kan bincike.
Hukumomin kiwon lafiya na Koriya da na kasar Sin sun bada shawarar yin amfani da chloroquine.
Duk da haka, ko da yake Cibiyar Kwayar cutar Wuhan ta ba da shawarar kashi ɗaya na gram a kowace rana, ta ce sau biyu na wannan kashi yana da haɗari sosai kuma yana iya zama mai kisa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin gaggawa don amfani da hydroxychloroquine da chlorochine a kan ikon likitocin da ke kula da marasa lafiya da COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar babban ribavirin don hana SARS-CoV-2 a cikin vitro.
An ba da shawarar yin ƙarin nazarin in vivo na nitazoxanide, bayan an gano cewa ƙananan taro suna hana SARS-CoV-2. Nazarin ya nuna cewa asalin asalin furotin S wanda ke aiwatar da serine-protease transmembrane type 2 (TMPRSS2) yana da mahimmanci don shigar SARS-CoV-2 ta hanyar hulɗa da mai karɓar ECA2.
Nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba suna da manyan iyakoki waɗanda ke hana ƙungiyar likitanci ɗaukar waɗannan hanyoyin magani ba tare da ƙarin bincike ba. Oseltamivir ba ya hana SARS-CoV-2 in vitro kuma ba shi da aikin da aka sani a cikin maganin COVID-19.
Fitar da cytokines na iya zama rikitarwa a cikin matakai na ƙarshe na COVID-19 mai tsanani.
Akwai hujja cewa hydroxychloroquine na iya samun kaddarorin da ke hana sakin cytokines. Hukumar Lafiya ta kasar Sin ta hada da tocilizumab a cikin jagororin magani bayan kammala karamin bincike.
Yana cikin wani gwaji na kasa na lokaci na biyu a Italiya bayan ya nuna sakamako mai kyau a cikin mutanen da ke da mummunan cutar.
Ana sa ran cewa idan aka yi amfani da gwajin jini na ferritin serum don gano fitowar cytokine, za a iya magance waɗannan sakamakon, wanda ake ganin ya sa wasu mutane da suka kamu da cutar suka mutu.
Hukumar ta amince da antagonist na interleukin-6 mai karɓar karɓa bisa ga lokuta na baya don maganin cututtukan cytokine na fitowar steroid mai karɓa wanda ya haifar da wani dalili, maganin T-CAR T lymphocytes, a cikin 2017.
Har zuwa yau, babu wata hujja da aka yi a kan cutar da ba ta dace ba da ke nuna cewa tocilizumab yana da tasiri wajen magance CRS.
Ana binciken canja wurin antibodies masu tsaftacewa da kuma concentrates da tsarin rigakafin ke samarwa daga waɗanda suka dawo daga COVID-19 zuwa ga mutanen da ke buƙatar su a matsayin hanyar rigakafin hanawa ba tare da allurar rigakafi ba.
An gwada wannan dabarar tare da SRAG tare da sakamakon da ba shi da kyau.
Kwayar cutar ta hana aiki ita ce hanyar da ake tsammani ta hanyar da maganin rigakafi na iya kare kansa daga SARS-CoV-2.
Amma akwai wasu hanyoyin da za su iya faruwa, kamar su ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Ana ci gaba da yin amfani da wasu hanyoyin da za a iya amfani da su wajen magance cutar ta hanyar amfani da maganin rigakafi, misali, ta yin amfani da maganin rigakafi na monoclonal.
Ana iya ƙara samar da maganin convalescent, wanda ya ƙunshi ruwa daga jinin marasa lafiya da aka dawo da su kuma yana dauke da takamaiman rigakafi ga wannan kwayar cutar, don samun saurin rarraba.
Cutar coronavirus, wata ƙungiya ta cututtuka masu alaƙa
Li Wenliang, likita a asibitin Wuhan na tsakiya, wanda daga baya ya mutu daga COVID-19 bayan ya sami wayewar kai game da yaduwar cutar.
